data_2dnh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dnh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.833 0.349 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 mt -130.84 153.63 48.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -116.0 108.92 16.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.916 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.6 t -99.85 145.02 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.107 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -137.69 -170.44 11.88 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.4 mmt 52.39 53.01 13.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.1 mt -117.39 156.14 28.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -94.12 175.49 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.0 pttm -92.61 17.02 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -108.06 -13.69 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.491 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 20.4 mt-30 -90.09 152.11 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 95.9 p -131.96 166.23 22.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -45.77 -47.12 15.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -54.83 -53.76 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -43.03 -64.82 0.56 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 154' ' ' PHE . 77.7 t -53.67 -63.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.458 ' CD2' HD12 ' A' ' 160' ' ' ILE . 31.4 mt -42.82 -36.98 1.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.28 -40.83 77.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -84.57 -8.6 58.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.575 ' CE1' ' CD1' ' A' ' 194' ' ' LEU . 3.1 m-85 -99.89 -37.19 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 10.2 tm0? -47.31 -46.87 57.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.722 . . . . 0.0 110.902 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.89 -17.18 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.731 2.287 . . . . 0.0 112.363 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 75.2 m-85 -101.95 -35.07 9.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.84 161.31 30.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.512 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 80.9 t -75.03 97.98 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.458 HD12 ' CD2' ' A' ' 151' ' ' LEU . 36.5 mt -66.66 137.25 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.167 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -81.86 -61.43 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -139.54 143.57 37.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . 0.427 ' CB ' HD23 ' A' ' 151' ' ' LEU . 10.6 t -134.02 135.78 43.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.83 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.0 m -139.09 157.74 45.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.97 130.82 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 60.3 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.0 mttm . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.802 0.334 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 71.44 21.76 78.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.52 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 3.2 m -136.55 159.78 40.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -158.1 161.67 37.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -112.23 121.73 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.15 122.94 70.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -111.68 131.27 55.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 187' ' ' ALA . 41.2 m-85 -101.7 166.68 10.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.3 t -66.81 -35.53 80.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.8 p -133.79 166.65 22.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -66.94 -55.25 15.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.4 m -43.73 -53.7 5.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -49.12 -48.1 44.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.453 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . . . -59.81 -52.2 66.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.094 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.42 -42.66 15.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.19 -63.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.73 -37.17 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 195' ' ' HIS . 54.1 mt -63.9 -72.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.106 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -57.48 -13.78 4.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.16 -40.24 15.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.575 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 18.1 mt -119.16 22.66 11.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.4 t60 -82.91 124.82 30.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.56 32.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.502 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 195' ' ' HIS . 54.4 p -100.19 -35.26 9.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.338 . . . . 0.0 110.849 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -100.27 161.1 13.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 12.9 m -134.6 77.14 1.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.163 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.491 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 14.0 mmt -39.43 138.45 0.94 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.597 0.713 . . . . 0.0 110.868 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.39 146.73 9.78 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.12 -34.16 3.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.27 134.0 35.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.312 . . . . 0.0 111.133 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 80.4 p -90.25 -8.72 50.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.838 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 37.0 m -99.98 160.72 14.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.3 m -84.34 158.81 21.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 196' ' ' GLY . 13.4 tp -57.57 141.68 47.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.73 104.37 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 12.4 t -115.65 120.67 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.097 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -158.16 150.13 21.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.843 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.4 tttt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.838 0.351 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.562 HD13 ' CE1' ' A' ' 181' ' ' PHE . 44.3 mt -135.85 148.16 48.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -118.35 110.72 17.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.66 138.91 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.118 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -136.36 178.37 18.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.0 mmt 62.46 45.04 6.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 mt -102.73 153.81 19.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 28.2 t30 -108.2 169.58 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -78.45 45.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -132.11 -34.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.513 ' NE2' ' CE ' ' A' ' 200' ' ' MET . 6.7 mt-30 -86.75 146.97 26.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.7 p -126.34 -177.56 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -58.73 -46.33 87.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.848 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -56.72 -53.19 60.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -42.53 -66.67 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.547 HG11 ' CE1' ' A' ' 154' ' ' PHE . 86.5 t -48.08 -63.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.46 ' HA ' ' CD1' ' A' ' 160' ' ' ILE . 33.4 mt -44.24 -40.77 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -69.01 -40.36 78.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.2 tp -84.21 -9.98 58.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.547 ' CE1' HG11 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.55 -35.6 9.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.36 -46.87 58.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 0.0 110.925 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.1 Cg_exo -47.95 -17.49 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.356 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 74.5 m-85 -100.58 -46.29 5.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -161.2 160.92 32.58 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.474 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.6 t -76.16 95.69 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 151' ' ' LEU . 28.4 mt -63.85 142.92 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.099 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.68 -55.99 3.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -144.92 140.37 28.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 40.6 t -132.48 142.78 49.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.2 m -151.01 143.07 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 86.1 t -112.58 134.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttm . . . . . 0 C--O 1.23 0.031 0 CA-C-O 120.859 0.362 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 61.36 33.28 84.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.529 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 7.8 p -148.42 154.15 39.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -159.02 176.67 12.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -129.74 141.12 50.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.06 128.82 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -111.9 134.17 53.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.562 ' CE1' HD13 ' A' ' 136' ' ' LEU . 36.8 m-85 -108.96 164.86 12.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.4 t -69.31 -27.08 65.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.3 t -144.03 159.33 42.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.846 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -60.22 -57.49 12.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 99.9 m -38.82 -59.39 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -40.83 -52.75 2.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -57.97 -57.16 14.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -37.91 -45.91 0.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 191' ' ' ILE . . . -66.16 -66.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -38.65 -27.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 195' ' ' HIS . 59.2 mt -74.3 -71.07 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -59.88 -12.27 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -89.84 -31.3 17.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.9 mt -125.91 21.63 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.3 t60 -83.72 124.55 30.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.62 31.92 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.463 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 195' ' ' HIS . 79.3 p -100.25 -36.09 9.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.894 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -100.32 150.35 22.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 51.0 m -122.76 80.16 1.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.154 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.513 ' CE ' ' NE2' ' A' ' 145' ' ' GLN . 15.3 mmt -40.34 140.61 0.94 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.532 0.682 . . . . 0.0 110.899 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.471 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 74.5 Cg_exo -48.07 147.69 7.7 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.711 2.274 . . . . 0.0 112.306 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.09 -45.69 3.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.457 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -77.28 138.59 39.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.754 0.311 . . . . 0.0 111.085 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.5 t -91.62 -11.39 37.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.2 t -99.97 173.08 6.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.419 ' HB3' ' C ' ' A' ' 196' ' ' GLY . 59.0 m -99.67 150.87 21.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 14.1 tp -47.49 147.97 1.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.457 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 58.8 t -117.22 104.05 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.132 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 8.7 t -111.72 122.48 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.457 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 14.9 ptpt -161.43 150.25 15.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.542 ' HE2' ' CD1' ' A' ' 178' ' ' PHE . 71.3 tttt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.776 0.322 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.406 HD11 ' CE1' ' A' ' 181' ' ' PHE . 18.2 mt -124.25 156.3 37.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -126.68 112.95 16.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 30.4 t -97.14 148.23 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -142.31 -172.12 13.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.479 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.2 mmt 54.49 38.76 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.3 mt -95.22 160.93 14.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -100.91 -175.62 2.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -100.3 34.75 2.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -129.14 -30.98 2.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -77.79 145.77 36.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 55.1 p -119.79 -175.84 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.53 -31.78 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -64.87 -48.39 74.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -48.39 -68.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.828 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.569 HG13 ' CD1' ' A' ' 154' ' ' PHE . 99.0 t -48.46 -53.95 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.463 ' CD2' HG22 ' A' ' 160' ' ' ILE . 38.9 mt -51.46 -40.68 59.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -69.27 -39.41 78.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.8 tp -84.31 -11.12 56.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.569 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -98.44 -36.21 10.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.57 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.06 -47.02 55.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.592 0.71 . . . . 0.0 110.921 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.5 Cg_exo -47.92 -16.77 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.355 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 72.3 m-85 -99.75 -35.28 9.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.38 164.38 37.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.86 91.23 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 111.136 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.463 HG22 ' CD2' ' A' ' 151' ' ' LEU . 68.6 mt -59.54 132.81 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -84.94 -55.06 4.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.1 143.07 28.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 151' ' ' LEU . 9.8 t -134.04 129.84 36.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.6 m -139.26 144.68 38.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.418 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 73.6 t -109.97 151.93 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.1 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.987 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.2 mttp . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.794 0.331 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.27 23.91 70.25 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.442 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 2.6 p -144.79 158.63 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.816 0.341 . . . . 0.0 110.925 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.47 175.1 11.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.128 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.542 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 81.8 m-85 -124.98 137.84 54.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.457 HG11 ' CE1' ' A' ' 181' ' ' PHE . 98.3 t -127.76 127.5 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -111.72 133.61 53.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.457 ' CE1' HG11 ' A' ' 179' ' ' VAL . 44.3 m-85 -110.0 156.83 19.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.1 t -56.9 -28.87 62.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.845 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 t -140.9 177.35 8.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -76.64 -59.01 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.5 m -39.37 -54.39 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -44.78 -49.91 10.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.61 -57.11 14.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.09 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -38.65 -45.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.5 -62.17 1.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.07 -27.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 195' ' ' HIS . 74.1 mt -76.77 -64.8 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -64.64 -7.9 12.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -99.26 -24.74 14.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.103 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 23.1 mt -132.36 27.12 4.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.2 t60 -93.04 122.43 35.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 36.39 31.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.461 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -99.23 -36.98 9.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.358 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.474 ' OE1' ' CE ' ' A' ' 200' ' ' MET . 16.2 pt20 -100.35 165.06 11.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 18.4 m -134.96 85.82 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.474 ' CE ' ' OE1' ' A' ' 198' ' ' GLN . 14.2 mmt -44.95 139.78 3.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.706 . . . . 0.0 110.901 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -48.15 137.45 23.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.692 2.261 . . . . 0.0 112.326 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 91.21 -48.12 2.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.481 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -76.51 131.63 39.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.079 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.7 p -86.4 -7.39 58.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.7 t -99.71 171.45 7.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.4 m -100.08 143.19 30.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.459 HD23 ' NE2' ' A' ' 198' ' ' GLN . 14.8 tp -40.04 151.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.53 103.93 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.23 121.06 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -156.92 152.42 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.529 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 7.7 ttmt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.815 0.34 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.55 HD13 ' CE1' ' A' ' 181' ' ' PHE . 55.5 mt -112.32 139.34 47.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -109.23 116.01 31.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.13 146.36 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -140.13 179.86 18.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 mmt 57.3 48.23 15.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 110.879 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 48.9 mt -108.27 162.7 13.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -103.77 172.17 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -88.64 16.05 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -106.92 -18.21 13.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.976 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -87.77 147.92 24.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.951 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.3 p -124.77 -179.19 4.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -63.21 -32.57 74.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -66.43 -48.02 71.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -50.92 -49.53 59.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.545 HG13 ' CD1' ' A' ' 154' ' ' PHE . 83.6 t -68.33 -50.35 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.436 ' CD2' HG21 ' A' ' 160' ' ' ILE . 52.0 mt -56.59 -32.24 65.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.421 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 11.7 mmm180 -81.24 -36.12 30.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.901 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.7 tp -85.01 -14.04 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.545 ' CD1' HG13 ' A' ' 150' ' ' VAL . 4.1 m-85 -100.05 -37.25 9.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 3.7 mt-30 -47.19 -48.91 54.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.635 0.731 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.8 Cg_exo -47.97 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.513 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.6 m-85 -100.43 -30.28 11.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 173.86 158.69 18.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.512 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.52 135.74 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 111.156 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.436 HG21 ' CD2' ' A' ' 151' ' ' LEU . 55.2 mt -111.75 125.22 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -69.89 -65.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -143.31 141.03 30.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 44.1 t -132.22 108.43 9.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.8 m -109.66 128.13 55.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.154 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.453 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 73.4 t -91.91 135.91 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.165 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.0 mttm . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 58.38 24.17 55.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 17.9 m -147.77 165.08 31.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.842 0.353 . . . . 0.0 110.902 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.62 -179.06 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.529 ' CD1' ' HD3' ' A' ' 135' ' ' LYS . 57.7 m-85 -131.31 124.91 31.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.7 t -119.96 123.32 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -108.32 119.24 38.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 136' ' ' LEU . 30.5 m-85 -92.98 164.98 13.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.1 m -72.43 -32.37 66.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 t -133.37 160.28 37.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.827 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -64.72 -59.82 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 186' ' ' GLU . 53.0 m -38.68 -64.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.8 OUTLIER -36.6 -53.0 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 188' ' ' GLN . . . -57.22 -59.8 4.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.101 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 187' ' ' ALA . 1.5 mm-40 -37.3 -47.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 190' ' ' ALA . . . -62.47 -67.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -35.56 -38.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.051 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.74 -73.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -55.33 -14.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.513 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.69 -41.08 14.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.43 30.54 7.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -99.51 122.98 43.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 45.75 20.16 0.39 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.46 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 60.7 p -100.04 -35.71 9.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -100.1 154.82 18.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 49.3 m -134.78 86.33 2.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 12.4 mmt -47.11 138.31 7.75 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.582 0.706 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -48.62 153.03 3.7 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.734 2.29 . . . . 0.0 112.331 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.55 -35.67 2.45 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.537 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.93 136.09 34.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.077 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 84.0 p -85.69 -13.93 46.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.7 m -100.0 157.72 16.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 6.1 p -79.81 -178.75 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.31 149.22 35.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.46 ' CG1' ' HE2' ' A' ' 210' ' ' LYS . 73.8 t -118.0 103.93 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.9 t -113.48 123.15 68.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.46 ' HE2' ' CG1' ' A' ' 208' ' ' VAL . 0.9 OUTLIER -159.96 148.48 17.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.4 tptt . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.568 HD11 ' CE1' ' A' ' 181' ' ' PHE . 38.4 mt -121.46 157.8 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.928 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -125.7 119.28 27.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 29.5 t -101.46 148.12 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -141.58 -179.65 18.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.9 mmt 57.95 39.88 26.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 67.3 mt -97.04 158.24 15.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 21.2 t-20 -113.16 170.99 7.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -79.49 44.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -133.01 -40.75 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.448 ' CD ' ' SD ' ' A' ' 200' ' ' MET . 31.2 mt-30 -81.89 121.84 26.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.1 p -106.02 173.79 6.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -47.78 -46.51 30.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -53.84 -51.79 62.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -47.75 -68.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.575 HG13 ' CD1' ' A' ' 154' ' ' PHE . 96.8 t -47.16 -54.99 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.454 ' CD2' HD13 ' A' ' 160' ' ' ILE . 32.1 mt -52.18 -39.77 60.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -70.2 -38.68 75.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.08 -9.09 58.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.575 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -100.04 -38.94 8.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.1 tm0? -46.99 -47.01 54.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.627 0.727 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.5 Cg_exo -47.94 -20.34 2.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.263 . . . . 0.0 112.304 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -100.04 -43.35 6.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.65 156.37 27.53 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.8 t -74.75 96.9 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 111.129 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.454 HD13 ' CD2' ' A' ' 151' ' ' LEU . 41.9 mt -66.3 141.52 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.451 ' N ' HG22 ' A' ' 160' ' ' ILE . 74.6 m-20 -94.42 -54.39 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -141.52 141.76 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 43.2 t -133.97 143.61 48.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.8 m -148.96 154.08 38.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.169 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.435 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 58.0 t -124.9 142.94 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.121 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.0 mttm . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.815 0.341 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 61.56 24.52 64.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.442 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 4.9 p -139.65 138.43 36.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 0.0 110.906 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -150.57 168.04 25.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -121.45 144.86 48.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.02 132.37 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -112.36 128.25 56.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.568 ' CE1' HD11 ' A' ' 136' ' ' LEU . 37.7 m-85 -100.27 162.51 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.0 p -67.09 -23.14 65.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.8 t -151.71 150.98 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.873 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.411 ' CG ' ' H ' ' A' ' 185' ' ' THR . 9.7 p80 -51.26 -57.45 8.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.411 ' H ' ' CG ' ' A' ' 184' ' ' HIS . 63.6 m -38.19 -66.6 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.08 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.3 OUTLIER -37.97 -51.09 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -57.29 -57.27 13.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.079 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -40.44 -43.41 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 191' ' ' ILE . . . -65.77 -68.48 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.082 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -35.57 -33.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 195' ' ' HIS . 83.3 mt -66.62 -70.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -62.04 -15.62 45.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.859 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -90.44 -22.7 21.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.077 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.463 HD21 ' NE2' ' A' ' 198' ' ' GLN . 75.7 mt -132.51 23.38 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.8 t60 -89.04 124.59 34.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.425 ' C ' ' HB3' ' A' ' 206' ' ' SER . . . 36.18 29.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.543 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 195' ' ' HIS . 76.4 p -100.14 -35.27 9.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.328 . . . . 0.0 110.846 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.463 ' NE2' HD21 ' A' ' 194' ' ' LEU . 22.4 mt-30 -100.28 155.05 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 25.7 m -129.18 81.51 2.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.448 ' SD ' ' CD ' ' A' ' 145' ' ' GLN . 14.9 mmt -45.67 141.03 4.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.547 0.689 . . . . 0.0 110.93 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.415 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 74.5 Cg_exo -47.97 153.05 2.83 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.708 2.272 . . . . 0.0 112.312 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 79.24 -41.79 2.29 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.446 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.15 140.06 31.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 111.064 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 25.2 t -94.8 -8.82 36.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.8 t -100.06 172.48 7.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.425 ' HB3' ' C ' ' A' ' 196' ' ' GLY . 19.4 m -97.96 145.93 25.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 8.6 tp -42.31 154.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 73.3 t -125.66 104.08 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.4 t -111.72 122.25 65.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -151.31 146.94 26.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.8 mt -137.69 145.82 43.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -109.15 110.77 22.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.4 t -97.68 147.57 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -144.14 -175.81 17.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.519 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.2 mmt 56.45 48.24 17.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.5 mt -109.06 165.1 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -106.75 174.03 6.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -87.71 16.3 5.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -105.99 -22.92 12.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.475 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 16.3 mt-30 -82.25 149.67 27.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.8 p -130.94 172.69 11.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -50.54 -51.03 51.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -52.16 -52.79 49.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -42.53 -67.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.567 HG13 ' CD1' ' A' ' 154' ' ' PHE . 35.9 t -52.87 -51.28 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.136 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.1 mt -54.04 -32.17 53.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -79.61 -37.04 37.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.7 tp -84.35 -14.17 50.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.567 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.4 m-85 -100.22 -35.97 9.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.534 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 3.7 mt-30 -47.18 -49.0 53.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.549 0.69 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.5 Cg_exo -47.98 -17.13 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 72.2 m-85 -100.03 -34.14 10.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.9 169.59 42.55 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.481 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.38 107.75 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 111.126 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.7 mt -79.15 126.27 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -86.47 -65.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -114.65 126.02 54.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 16.7 t -133.15 127.11 33.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.3 m -146.38 149.66 34.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.403 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 77.7 t -114.53 137.89 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 27.2 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 179.926 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.8 mttt . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.803 0.335 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.1 24.69 76.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.51 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.78 154.78 41.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 110.866 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.403 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -156.45 176.07 13.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.02 124.14 34.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.83 134.72 60.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -114.99 144.28 43.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -118.9 161.13 20.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 17.3 t -59.16 -34.25 71.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.5 t -142.42 171.79 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.416 ' CG ' ' N ' ' A' ' 185' ' ' THR . 44.5 p-80 -64.76 -54.95 23.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.416 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 48.7 m -36.84 -63.92 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 185' ' ' THR . 23.8 mm-40 -37.8 -53.39 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -55.9 -59.13 5.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -40.26 -41.51 1.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -71.4 -63.73 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.68 -34.02 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.112 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 195' ' ' HIS . 72.5 mt -65.89 -71.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -59.15 -13.73 8.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -88.98 -32.05 17.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 32.5 mt -125.78 24.98 6.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.9 t60 -86.68 123.04 31.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 207' ' ' LEU . . . 34.56 32.94 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.455 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 195' ' ' HIS . 82.6 p -100.13 -35.14 9.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 110.874 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.21 155.8 17.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 90.2 m -132.61 77.51 1.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.475 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 11.5 mmt -39.92 139.13 1.0 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.601 0.715 . . . . 0.0 110.845 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.21 150.49 5.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.732 2.288 . . . . 0.0 112.358 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.48 -36.22 2.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -89.58 136.92 32.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.322 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 15.7 t -90.77 -10.87 41.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.847 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.9 t -99.51 172.08 7.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.4 m -99.82 154.79 18.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 196' ' ' GLY . 13.5 tp -54.36 138.16 40.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.454 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 54.1 t -108.09 117.09 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.1 t -123.23 124.8 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.454 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 14.6 ptpt -160.8 144.67 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.5 tptt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.786 0.327 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 181' ' ' PHE . 65.8 mt -119.11 152.21 36.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -119.78 121.02 38.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.23 144.05 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.118 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -138.08 -172.41 12.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.5 mmt 54.05 51.48 14.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.333 . . . . 0.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.2 mt -111.06 155.42 22.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.459 ' ND2' ' HD2' ' A' ' 201' ' ' PRO . 3.2 p30 -91.58 159.49 15.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -81.95 42.67 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.412 ' HG2' ' CG ' ' A' ' 142' ' ' ASN . 6.2 pt20 -133.22 -35.02 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.413 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 34.0 mt-30 -71.12 150.27 45.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.0 p -119.59 -177.85 3.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -63.03 -46.88 85.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -54.71 -50.82 67.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -42.72 -47.68 5.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.57 HG13 ' CD1' ' A' ' 154' ' ' PHE . 95.8 t -70.31 -45.78 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.177 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.445 ' CD2' HD12 ' A' ' 160' ' ' ILE . 86.0 mt -57.57 -32.44 67.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.403 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 16.1 mmt180 -81.35 -35.39 30.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.2 tp -84.32 -16.09 44.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.57 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -100.18 -35.3 9.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.532 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 6.1 mt-30 -47.2 -49.04 53.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.6 0.714 . . . . 0.0 110.865 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.7 Cg_exo -47.96 -17.02 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.707 2.272 . . . . 0.0 112.303 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.475 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 71.3 m-85 -99.9 -36.53 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.62 163.38 35.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.528 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.62 104.84 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.445 HD12 ' CD2' ' A' ' 151' ' ' LEU . 62.2 mt -76.04 128.12 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -76.48 -54.33 6.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -147.07 145.3 29.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 43.1 t -133.74 148.0 51.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.94 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.0 m -151.49 151.5 31.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.161 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.42 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 68.4 t -122.63 146.98 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.809 0.338 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 49.55 30.57 13.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.48 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 7.1 p -149.79 149.47 30.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -160.03 161.18 33.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -113.71 133.26 55.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 70.4 t -122.81 126.09 73.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -108.63 123.18 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.421 ' CE1' HD13 ' A' ' 136' ' ' LEU . 34.6 m-85 -97.52 168.34 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 84.2 p -68.92 -36.72 78.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.8 m -135.25 171.79 13.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.409 ' CD2' ' H ' ' A' ' 184' ' ' HIS . 7.8 p80 -72.17 -44.71 62.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.4 m -52.24 -59.46 4.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -41.54 -49.68 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -58.05 -59.17 5.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -38.87 -47.37 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.42 -63.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.37 -39.37 1.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 195' ' ' HIS . 73.8 mt -60.99 -72.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -57.34 -12.95 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -87.5 -37.74 16.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.086 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 18.5 mt -120.22 23.53 10.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.0 t60 -83.36 123.03 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.7 33.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.9 p -100.31 -36.51 9.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.798 0.332 . . . . 0.0 110.859 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -100.4 160.66 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 37.9 m -134.16 81.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.413 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 15.9 mmt -41.38 137.47 1.68 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.56 0.695 . . . . 0.0 110.884 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.459 ' HD2' ' ND2' ' A' ' 142' ' ' ASN . 75.5 Cg_exo -48.74 147.06 10.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 0.0 112.317 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.65 -34.44 3.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.482 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.33 141.4 28.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.069 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 57.7 m -93.52 -12.81 28.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 66.7 m -99.53 157.17 16.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.9 m -78.36 172.13 14.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 196' ' ' GLY . 13.7 tp -71.97 140.15 48.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.2 t -106.24 106.72 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.7 t -117.99 120.3 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -159.54 156.29 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.926 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 tptt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.808 0.337 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 mt -117.26 157.6 25.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -125.25 122.11 36.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.9 140.88 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -136.23 -176.98 14.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.466 ' HE2' ' CB ' ' A' ' 205' ' ' SER . 11.5 mmt 60.17 38.26 20.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.2 mt -99.02 154.61 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 144' ' ' GLN . 23.1 p30 -98.11 170.29 9.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -80.57 -0.18 36.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.409 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 57.0 mt-30 -102.05 32.68 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -134.99 154.18 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.4 p -132.25 167.0 20.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -54.41 -44.83 72.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -53.74 -45.9 70.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -50.3 -55.2 16.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.576 HG12 ' CD1' ' A' ' 154' ' ' PHE . 71.8 t -60.87 -46.3 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.469 HD23 ' CB ' ' A' ' 163' ' ' CYS . 35.1 mt -57.97 -39.09 77.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -70.08 -38.87 75.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.9 tp -84.05 -10.32 57.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.576 ' CD1' HG12 ' A' ' 150' ' ' VAL . 3.2 m-85 -100.17 -36.4 9.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.557 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -46.92 -47.03 53.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.638 0.732 . . . . 0.0 110.938 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.0 Cg_exo -47.99 -18.85 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.695 2.263 . . . . 0.0 112.314 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 75.8 m-85 -100.32 -38.07 8.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -172.49 162.7 34.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.8 t -76.41 103.4 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 111.102 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.463 HD13 ' CD2' ' A' ' 151' ' ' LEU . 20.7 mt -73.4 142.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.083 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -103.13 -61.62 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -114.18 119.31 36.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . 0.469 ' CB ' HD23 ' A' ' 151' ' ' LEU . 25.5 t -134.14 121.0 20.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -141.37 151.67 43.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.451 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 95.0 t -116.16 139.93 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 60.0 mt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 mttm . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.872 0.368 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.78 76.01 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -139.37 153.79 47.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.862 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -161.94 157.46 23.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -109.2 144.65 37.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.461 HG11 ' CE1' ' A' ' 181' ' ' PHE . 59.0 t -134.86 126.62 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.13 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -113.8 123.94 51.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.461 ' CE1' HG11 ' A' ' 179' ' ' VAL . 49.2 m-85 -99.79 162.95 12.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.8 t -66.28 -37.34 85.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 t -132.83 158.09 43.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.87 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.5 ' CG ' ' N ' ' A' ' 185' ' ' THR . 26.2 p-80 -59.24 -53.61 56.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.5 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 26.3 m -45.59 -52.73 10.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -47.27 -45.25 23.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.37 -59.27 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -40.19 -38.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -69.53 -63.84 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.071 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.32 -31.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 195' ' ' HIS . 74.7 mt -69.44 -71.51 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -56.73 -15.78 5.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.816 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -87.91 -34.93 17.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.503 HD11 ' CE1' ' A' ' 154' ' ' PHE . 26.0 mt -122.39 25.55 8.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.917 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.9 t60 -89.04 122.18 32.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.862 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.49 32.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 195' ' ' HIS . 60.3 p -100.14 -37.08 9.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.844 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.466 ' NE2' HD21 ' A' ' 207' ' ' LEU . 10.4 pt20 -100.37 161.77 13.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 27.0 m -131.19 84.59 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 16.9 mmt -39.19 139.2 0.81 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.555 0.693 . . . . 0.0 110.856 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.27 137.94 23.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.251 . . . . 0.0 112.331 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.0 3.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.43 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -69.93 139.36 52.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.1 m -92.82 -8.63 42.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.466 ' CB ' ' HE2' ' A' ' 140' ' ' MET . 4.6 t -99.94 170.89 8.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 25.0 m -100.14 145.05 28.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.466 HD21 ' NE2' ' A' ' 198' ' ' GLN . 10.9 tp -44.86 143.72 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.5 t -115.67 108.57 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.77 121.61 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.185 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -157.27 148.35 21.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 136' ' ' LEU . 13.3 tppt? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.867 0.365 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.515 HD12 ' CE1' ' A' ' 181' ' ' PHE . 63.6 mt -139.2 135.57 34.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -102.45 117.13 34.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.9 t -106.53 145.43 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -140.03 -164.18 9.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.507 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.9 mmt 48.8 49.77 18.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.4 mt -110.31 153.31 25.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.597 HD22 ' N ' ' A' ' 201' ' ' PRO . 0.4 OUTLIER -95.12 173.96 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -90.38 42.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -134.4 -35.34 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.448 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 26.7 mt-30 -70.88 145.8 50.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.9 p -121.51 -178.53 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -64.69 -35.07 79.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -64.2 -35.67 81.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.56 -65.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.899 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 154' ' ' PHE . 92.8 t -53.72 -53.02 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.415 HD21 ' CB ' ' A' ' 163' ' ' CYS . 70.3 mt -52.46 -39.36 61.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -69.62 -39.5 77.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.5 tp -84.7 -9.28 58.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.571 ' CD1' HG12 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.98 -37.27 9.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.2 tm0? -47.29 -46.76 57.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.597 0.713 . . . . 0.0 110.934 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.3 Cg_exo -47.99 -17.18 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.307 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -100.27 -32.2 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.95 171.71 43.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.8 t -80.79 105.27 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.869 0.366 . . . . 0.0 111.072 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.441 HD11 ' CB ' ' A' ' 154' ' ' PHE . 47.5 mt -75.35 130.06 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.34 -61.31 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.838 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -146.37 145.25 30.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . 0.415 ' CB ' HD21 ' A' ' 151' ' ' LEU . 16.2 t -133.81 118.36 17.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.9 m -124.48 140.1 53.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.154 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.458 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 97.6 t -108.15 138.09 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.1 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.4 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.789 0.328 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 54.69 30.87 52.65 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.472 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.7 p -144.27 160.57 40.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 110.847 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -166.76 171.09 11.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -124.53 130.33 52.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.24 131.24 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -114.38 122.62 47.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.515 ' CE1' HD12 ' A' ' 136' ' ' LEU . 37.5 m-85 -94.95 163.96 13.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.8 p -70.46 -26.42 63.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.0 t -143.25 151.48 40.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.544 ' CG ' ' N ' ' A' ' 185' ' ' THR . 17.2 p80 -55.81 -51.62 66.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.544 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 66.4 m -43.03 -66.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.155 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.3 OUTLIER -37.2 -52.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -55.68 -59.26 5.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -38.7 -48.17 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.2 -63.28 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -40.09 -30.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.072 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 195' ' ' HIS . 72.5 mt -69.51 -71.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -64.63 -9.28 18.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -90.29 -25.59 20.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 24.6 mt -133.29 16.11 4.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 191' ' ' ILE . 2.0 t60 -87.89 126.45 35.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.854 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 45.66 20.15 0.37 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.526 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 60.4 p -100.38 -37.35 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.469 ' HG3' ' N ' ' A' ' 199' ' ' THR . 1.5 tt0 -100.44 156.26 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' THR . . . . . 0.469 ' N ' ' HG3' ' A' ' 198' ' ' GLN . 85.9 m -127.61 80.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.461 ' HE1' ' NE2' ' A' ' 198' ' ' GLN . 20.1 mmt -37.03 137.85 0.56 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.573 0.701 . . . . 0.0 110.859 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.597 ' N ' HD22 ' A' ' 142' ' ' ASN . 72.8 Cg_exo -47.21 154.29 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.7 2.267 . . . . 0.0 112.343 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.7 -45.92 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.498 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -79.14 136.08 37.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.086 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.4 t -87.48 -11.57 48.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 71.0 m -99.41 163.66 12.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.817 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 58.8 p -80.91 174.52 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.61 155.38 37.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.468 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 49.2 t -122.62 104.35 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 12.0 t -118.58 121.53 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.148 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.468 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 12.7 ptpt -159.15 146.5 17.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.4 tttp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.813 0.34 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.462 HD23 ' CD1' ' A' ' 191' ' ' ILE . 78.6 mt -106.97 154.67 20.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -121.59 115.26 22.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.36 149.3 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -142.73 -176.59 16.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.5 mmt 59.28 38.68 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.828 0.347 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 36.1 mt -98.98 153.65 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -105.27 164.88 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -77.61 47.6 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -133.77 -34.1 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.496 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 6.3 mt-30 -82.31 140.04 33.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.6 p -119.22 171.56 8.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -47.94 -51.92 21.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -54.93 26.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -43.14 -65.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.567 HG12 ' CE1' ' A' ' 154' ' ' PHE . 71.0 t -49.05 -62.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.466 ' CD2' HD12 ' A' ' 160' ' ' ILE . 29.4 mt -46.85 -37.3 8.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -69.9 -39.78 76.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.8 tp -83.83 -9.83 58.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 150' ' ' VAL . 3.2 m-85 -100.26 -36.19 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -46.99 -47.07 54.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.558 0.694 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.1 Cg_exo -47.94 -18.38 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.706 2.271 . . . . 0.0 112.329 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.44 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 76.4 m-85 -101.4 -45.33 5.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.05 156.72 27.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 83.1 t -74.86 95.34 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 111.12 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.466 HD12 ' CD2' ' A' ' 151' ' ' LEU . 40.3 mt -65.98 143.74 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.443 ' N ' HG21 ' A' ' 160' ' ' ILE . 0.9 OUTLIER -91.48 -59.7 2.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -138.69 137.15 36.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . 0.462 ' HB2' ' CD2' ' A' ' 151' ' ' LEU . 42.7 t -134.06 143.3 47.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 99.4 m -151.76 140.34 20.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.47 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 79.0 t -105.31 141.35 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 42.1 mttm . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.799 0.333 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 75.37 30.2 58.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.492 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.18 151.37 30.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -152.91 178.14 9.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -128.87 125.78 38.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.74 123.42 70.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.179 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.38 122.26 45.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.46 164.8 12.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.856 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.6 t -66.31 -35.76 81.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.1 t -137.65 168.12 20.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -66.15 -60.06 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.7 m -39.67 -52.74 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -47.3 -49.96 22.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -61.22 -55.97 25.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -39.97 -42.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -68.45 -64.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.52 -35.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.462 ' CD1' HD23 ' A' ' 136' ' ' LEU . 61.8 mt -67.15 -70.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -56.21 -13.59 2.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.44 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -89.62 -39.72 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.497 HD11 ' CE1' ' A' ' 154' ' ' PHE . 23.1 mt -118.23 29.19 7.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.3 t60 -96.32 122.54 39.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 42.36 24.15 0.2 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.531 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 195' ' ' HIS . 51.3 p -100.26 -37.44 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 0.0 110.877 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.472 ' NE2' ' HB3' ' A' ' 194' ' ' LEU . 1.9 pt20 -100.54 151.18 21.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 59.9 m -123.97 86.08 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.496 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 16.9 mmt -43.7 139.66 2.71 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.539 0.685 . . . . 0.0 110.895 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.67 151.14 5.38 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 82.31 -47.97 3.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.459 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -77.24 148.53 35.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.09 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 45.1 t -94.86 -17.76 21.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.2 m -100.07 164.71 11.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.921 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.0 p -79.13 -174.91 4.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.875 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.41 152.29 25.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -118.15 107.75 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.5 t -116.47 121.24 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.139 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -157.85 149.43 21.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.495 ' HE2' ' CD1' ' A' ' 178' ' ' PHE . 48.2 tttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.8 mt -121.31 152.5 38.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -117.72 114.95 24.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.55 146.77 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -145.33 -178.99 21.31 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.4 mmt 55.59 48.23 19.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.47 ' CD2' HD12 ' A' ' 207' ' ' LEU . 42.4 mt -106.37 165.23 11.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -105.41 165.04 11.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.73 41.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -128.75 -35.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.35 152.97 36.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.7 p -129.23 178.9 6.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.411 ' HG3' ' CG2' ' A' ' 165' ' ' VAL . 5.2 mt-10 -57.02 -41.44 78.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.59 -55.03 38.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -43.2 -64.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.569 HG11 ' CE1' ' A' ' 154' ' ' PHE . 66.4 t -49.96 -60.76 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.461 ' CD2' HD11 ' A' ' 160' ' ' ILE . 35.8 mt -47.37 -37.61 11.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -69.48 -40.17 77.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.6 tp -83.81 -10.27 58.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.569 ' CE1' HG11 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.64 -35.54 9.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.0 tt0 -47.04 -46.96 55.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.601 0.715 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.2 Cg_exo -48.02 -17.13 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.621 2.214 . . . . 0.0 112.349 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.567 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 73.8 m-85 -100.63 -37.06 8.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.12 165.2 38.53 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.8 t -80.79 93.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.785 0.326 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.461 HD11 ' CD2' ' A' ' 151' ' ' LEU . 51.5 mt -65.37 129.31 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -77.77 -64.64 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -132.35 137.78 47.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . 0.439 ' CB ' HD23 ' A' ' 151' ' ' LEU . 42.8 t -134.07 139.21 45.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.1 m -144.44 153.88 42.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.153 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.411 ' CG2' ' HG3' ' A' ' 147' ' ' GLU . 81.6 t -113.41 147.69 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.163 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.0 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.3 mttm . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.833 0.349 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 67.68 25.69 73.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.65 153.36 41.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 110.868 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -156.34 159.21 38.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.495 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 49.1 m-85 -108.98 141.12 41.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.76 125.4 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.65 125.63 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -99.71 162.47 12.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.3 t -63.53 -30.7 71.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.0 m -141.39 168.95 18.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -68.23 -52.45 33.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 99.3 m -44.85 -61.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -40.04 -45.76 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.0 -54.44 34.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -43.36 -36.18 1.81 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.54 -59.72 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -45.61 -30.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.481 ' O ' ' N ' ' A' ' 195' ' ' HIS . 67.9 mt -68.43 -72.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -59.53 -17.3 31.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.567 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -80.51 -36.38 33.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.505 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 14.9 mt -123.28 23.05 9.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.2 t60 -87.24 124.34 33.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.87 30.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.525 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.08 -36.6 9.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.809 0.338 . . . . 0.0 110.872 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.37 159.55 15.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 30.0 m -134.47 81.04 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.175 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.6 mmt -41.55 140.28 1.35 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.584 0.707 . . . . 0.0 110.865 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.08 139.51 20.62 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.737 2.291 . . . . 0.0 112.328 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 90.47 -47.91 3.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.508 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -78.98 126.84 31.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.761 0.315 . . . . 0.0 111.147 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.8 t -83.26 -7.39 59.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.826 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.8 p -100.11 157.7 16.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -87.13 144.64 26.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.47 HD12 ' CD2' ' A' ' 141' ' ' LEU . 14.3 tp -44.57 144.63 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.943 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 63.6 t -112.74 114.61 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.5 t -125.5 119.59 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.128 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -158.43 150.6 21.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.989 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 136' ' ' LEU . 2.9 tppp? . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.807 0.337 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.51 HD12 ' CE1' ' A' ' 181' ' ' PHE . 96.6 mt -136.32 144.94 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -112.92 122.48 47.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 t -113.05 144.45 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.21 -169.01 11.45 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.8 mmt 52.34 39.37 27.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.402 HD21 ' CD ' ' A' ' 145' ' ' GLN . 26.8 mt -100.26 145.51 28.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -89.64 -177.76 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.17 -7.24 59.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -99.99 29.4 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.936 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.418 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 59.8 mt-30 -127.04 105.56 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.946 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.1 p -103.08 166.32 10.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -43.8 -41.85 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -59.55 -48.11 82.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -50.52 -54.43 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.568 HG12 ' CD1' ' A' ' 154' ' ' PHE . 73.6 t -66.62 -55.93 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.441 ' CD2' HD11 ' A' ' 160' ' ' ILE . 73.6 mt -50.9 -33.61 24.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.422 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 15.2 mmm180 -77.65 -37.51 49.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.2 tp -84.31 -12.84 53.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.568 ' CD1' HG12 ' A' ' 150' ' ' VAL . 3.6 m-85 -100.46 -37.21 8.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.52 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 4.6 mt-30 -47.07 -49.31 51.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.541 0.686 . . . . 0.0 110.929 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.94 -17.19 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.717 2.278 . . . . 0.0 112.339 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 193' ' ' ALA . 73.3 m-85 -100.87 -39.98 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.77 155.67 27.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 69.6 t -71.43 93.9 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.441 HD11 ' CD2' ' A' ' 151' ' ' LEU . 75.1 mt -61.82 143.44 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -92.44 -59.53 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -140.5 144.44 36.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 3.7 t -134.02 133.14 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.7 m -137.2 125.75 23.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.464 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 58.8 t -96.95 151.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.4 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.4 mttp . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.832 0.349 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.84 24.86 70.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.32 160.07 42.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 110.898 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.45 158.39 20.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.426 ' HB3' ' NZ ' ' A' ' 135' ' ' LYS . 76.8 m-85 -112.27 132.98 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.407 HG11 ' N ' ' A' ' 180' ' ' LYS . 48.8 t -124.22 137.96 55.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.407 ' N ' HG11 ' A' ' 179' ' ' VAL . 23.9 ttmt -119.13 135.88 54.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.51 ' CE1' HD12 ' A' ' 136' ' ' LEU . 43.2 m-85 -107.94 167.93 9.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.5 t -71.44 -23.89 61.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.5 m -143.84 176.23 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.837 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -80.33 -42.23 23.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.812 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.4 m -53.56 -58.0 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -42.92 -47.3 5.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -59.65 -60.31 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.118 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -39.71 -41.67 1.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.39 -63.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.16 -32.69 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.127 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 195' ' ' HIS . 40.5 mt -66.34 -71.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.138 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -59.25 -10.98 3.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 157' ' ' PHE . . . -96.2 -24.44 16.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.424 HD21 ' NE2' ' A' ' 198' ' ' GLN . 30.2 mt -131.42 24.42 4.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 191' ' ' ILE . 2.4 t60 -90.6 119.8 31.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.69 33.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 195' ' ' HIS . 38.3 p -100.27 -38.07 8.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.826 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.424 ' NE2' HD21 ' A' ' 194' ' ' LEU . 18.3 mt-30 -100.53 163.2 12.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 26.3 m -129.93 84.58 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.418 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 21.4 mmt -40.52 137.9 1.29 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.612 0.72 . . . . 0.0 110.866 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.49 143.89 14.86 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.303 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 82.28 -40.15 2.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.507 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.66 138.85 35.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 90.9 p -92.42 -9.48 41.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.4 m -99.03 167.19 10.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.4 m -92.48 154.1 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 196' ' ' GLY . 11.6 tp -51.55 141.28 16.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.6 t -112.1 111.66 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.3 133.3 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -165.7 144.12 6.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.936 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.872 0.368 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.522 HD13 ' CE1' ' A' ' 181' ' ' PHE . 44.7 mt -120.09 153.78 35.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -120.44 120.13 35.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.69 147.62 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -141.04 -170.54 12.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.6 mmt 54.91 34.11 21.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.427 ' CD2' HD13 ' A' ' 207' ' ' LEU . 47.0 mt -93.31 153.52 18.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -106.95 165.58 11.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -77.32 46.9 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -133.81 -34.55 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -81.23 145.48 30.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 77.1 p -125.6 169.86 12.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -49.57 -46.84 49.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -54.61 -53.28 56.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -45.56 -65.69 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.568 HG13 ' CE1' ' A' ' 154' ' ' PHE . 95.2 t -48.9 -60.29 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.09 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.462 ' CD2' HD11 ' A' ' 160' ' ' ILE . 35.2 mt -47.53 -40.09 17.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -69.69 -39.42 76.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.1 tp -84.8 -9.1 58.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.573 ' CE1' ' CD1' ' A' ' 194' ' ' LEU . 3.2 m-85 -100.34 -37.32 8.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -47.29 -46.87 57.65 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 0.0 110.877 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.9 Cg_exo -48.0 -18.46 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.654 2.236 . . . . 0.0 112.366 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.565 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 75.5 m-85 -100.38 -47.32 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.57 164.77 33.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.51 104.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.462 HD11 ' CD2' ' A' ' 151' ' ' LEU . 45.1 mt -76.91 131.47 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.43 -64.38 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -122.37 132.21 54.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . 0.462 ' CB ' HD21 ' A' ' 151' ' ' LEU . 34.9 t -132.73 136.79 46.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.4 m -153.7 152.81 31.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.466 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 65.6 t -117.12 148.24 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.2 mttm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.828 0.347 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 51.86 29.4 26.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 17.0 p -144.28 151.48 39.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -160.18 166.12 30.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -117.72 144.94 44.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 26.6 t -137.51 121.54 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -103.89 129.86 51.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.522 ' CE1' HD13 ' A' ' 136' ' ' LEU . 36.4 m-85 -103.66 164.73 11.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 88.2 p -63.49 -33.12 74.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.6 m -141.49 179.05 7.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -75.44 -51.85 12.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 31.0 m -48.83 -53.32 19.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.101 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -47.04 -47.98 22.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.419 ' HB3' ' CD1' ' A' ' 136' ' ' LEU . . . -62.37 -57.57 10.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.132 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -40.71 -40.67 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -67.36 -61.1 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.61 -31.67 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.095 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 195' ' ' HIS . 74.6 mt -67.5 -71.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.175 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -57.17 -13.64 3.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.565 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.72 -41.15 14.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.573 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 33.2 mt -113.51 16.26 18.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -83.03 126.21 32.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 37.94 28.43 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.541 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 195' ' ' HIS . 77.2 p -100.4 -39.61 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.351 . . . . 0.0 110.843 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.468 ' NE2' ' CE ' ' A' ' 200' ' ' MET . 6.6 pt20 -100.66 160.83 14.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 200' ' ' MET . 96.3 m -135.0 81.14 1.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.468 ' CE ' ' NE2' ' A' ' 198' ' ' GLN . 26.5 mmt -37.72 137.84 0.67 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.582 0.706 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.77 153.66 3.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 2.286 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 78.33 -42.88 2.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.509 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.62 138.23 35.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.9 t -87.22 -13.41 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 6.0 t -100.08 169.61 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 24.6 p -87.86 -174.81 4.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 141' ' ' LEU . 11.7 tp -86.86 122.67 31.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.53 109.48 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.101 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 36.4 t -118.22 124.81 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.083 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -164.33 150.6 10.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.6 tttt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.749 0.309 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 181' ' ' PHE . 37.3 mt -96.41 150.52 20.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -116.13 113.27 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.86 143.71 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -140.02 -171.56 12.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.491 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.4 mmt 51.6 42.4 29.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 49.6 mt -102.19 157.33 16.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -99.17 168.12 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -84.14 37.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -127.62 -44.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -62.9 146.79 52.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 53.5 p -122.81 178.31 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.3 -48.19 81.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.876 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -54.18 -50.23 67.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -44.98 -68.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.572 HG11 ' CD1' ' A' ' 154' ' ' PHE . 46.9 t -49.04 -60.31 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.465 ' CD2' HG22 ' A' ' 160' ' ' ILE . 35.4 mt -46.48 -38.06 8.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -69.21 -40.4 78.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.93 -10.55 57.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.572 ' CD1' HG11 ' A' ' 150' ' ' VAL . 3.1 m-85 -98.83 -35.75 10.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.3 OUTLIER -47.18 -46.94 56.58 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.551 0.691 . . . . 0.0 110.908 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.6 Cg_exo -48.0 -16.95 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.639 2.226 . . . . 0.0 112.359 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 72.7 m-85 -99.85 -46.83 5.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.1 174.49 36.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.5 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.4 t -87.6 102.32 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.465 HG22 ' CD2' ' A' ' 151' ' ' LEU . 23.7 mt -74.07 134.37 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.46 -60.36 2.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -139.9 142.26 36.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . 0.42 ' CB ' HD22 ' A' ' 151' ' ' LEU . 9.8 t -134.01 144.78 48.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.6 m -153.81 144.08 22.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.23 139.52 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 67.4 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.1 mttt . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.843 0.354 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 59.46 28.95 65.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 6.2 p -145.93 156.43 43.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -160.47 172.1 17.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -126.61 124.01 38.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 85.7 t -115.9 130.58 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.408 ' O ' ' CG2' ' A' ' 160' ' ' ILE . 20.7 ttmt -111.9 131.22 55.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.454 ' CE1' HD11 ' A' ' 136' ' ' LEU . 40.9 m-85 -105.77 166.8 10.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.7 t -81.53 -3.14 52.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.0 m -162.96 149.76 12.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.858 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -59.84 -46.04 90.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.7 m -48.71 -61.14 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.108 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 181' ' ' PHE . 0.5 OUTLIER -42.33 -51.24 4.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -57.75 -56.84 16.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -38.62 -51.51 1.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.955 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.39 -61.21 2.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -40.99 -35.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 195' ' ' HIS . 63.4 mt -65.69 -69.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -62.25 -14.56 39.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.91 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -90.84 -25.03 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.497 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 76.9 mt -130.06 23.03 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -85.95 123.66 31.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 207' ' ' LEU . . . 34.15 39.46 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.478 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 22.6 p -100.09 -37.73 8.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -100.57 164.82 11.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 200' ' ' MET . 28.6 m -135.01 79.7 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.155 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 199' ' ' THR . 15.0 mmt -38.36 138.42 0.73 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.606 0.717 . . . . 0.0 110.853 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.27 145.18 11.74 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.42 -39.19 2.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.532 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -83.83 129.03 34.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.3 m -84.98 -7.51 59.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.8 t -99.3 170.4 8.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.1 m -99.94 151.97 20.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 196' ' ' GLY . 16.4 tp -53.19 137.82 33.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.62 119.34 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.01 117.52 49.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.073 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -158.05 153.01 25.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.1 tptm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.803 0.335 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.8 mt -126.75 156.79 40.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -125.77 115.96 20.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.5 t -100.8 153.93 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.126 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -144.42 -172.88 15.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.0 mmt 51.11 50.14 19.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.418 ' HB2' ' C ' ' A' ' 175' ' ' GLY . 34.1 mt -107.71 154.97 20.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -99.43 171.06 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -86.26 28.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.89 -31.44 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.439 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 6.6 mt-30 -79.62 147.02 32.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.2 p -124.62 -176.61 3.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -62.69 -44.29 96.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -57.03 -45.16 83.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -52.33 -58.94 5.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.576 HG13 ' CD1' ' A' ' 154' ' ' PHE . 83.6 t -57.4 -50.49 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.464 ' CD2' HD13 ' A' ' 160' ' ' ILE . 33.9 mt -55.54 -39.49 70.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -70.05 -38.68 75.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.8 tp -84.22 -10.47 57.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.576 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.2 m-85 -100.15 -35.93 9.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.562 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.01 -46.92 54.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.601 0.715 . . . . 0.0 110.936 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.97 -17.13 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 193' ' ' ALA . 74.8 m-85 -101.66 -44.59 5.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.36 164.72 35.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.18 103.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.352 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.464 HD13 ' CD2' ' A' ' 151' ' ' LEU . 44.0 mt -75.25 137.79 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.97 -61.89 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.78 134.9 47.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . 0.447 ' CB ' HD21 ' A' ' 151' ' ' LEU . 36.7 t -134.08 135.12 43.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 80.4 m -147.76 145.3 28.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.109 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 77.3 t -112.56 148.02 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.912 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.5 mttm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.833 0.349 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.418 ' C ' ' HB2' ' A' ' 141' ' ' LEU . . . 82.83 -3.33 83.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.472 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.3 169.0 16.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.835 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -164.67 173.59 11.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -123.94 132.39 53.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 64.1 t -125.61 131.58 71.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -117.45 113.11 21.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -86.26 166.35 15.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 95.6 p -68.47 -35.17 77.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -134.51 164.92 26.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -65.92 -50.97 62.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.91 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.4 m -48.96 -62.39 1.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.179 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -44.38 -42.05 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -59.39 -60.56 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -45.76 -50.28 14.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -50.28 -55.57 14.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.1 -35.68 59.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 58.3 mt -64.87 -68.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -57.88 -12.39 3.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 157' ' ' PHE . . . -91.08 -39.02 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.568 HD11 ' CE1' ' A' ' 154' ' ' PHE . 28.6 mt -115.2 25.68 10.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.8 t60 -88.72 122.62 32.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.61 33.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 195' ' ' HIS . 23.5 p -100.22 -38.33 8.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 110.866 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -100.52 162.47 12.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 47.5 m -132.75 84.1 2.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.439 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 14.6 mmt -39.93 137.92 1.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.568 0.699 . . . . 0.0 110.881 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.83 144.46 15.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.659 2.24 . . . . 0.0 112.332 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.34 -40.93 3.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.515 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -83.36 142.42 31.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 111.108 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 73.9 p -94.2 -12.65 27.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.7 m -98.94 157.94 15.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.7 m -78.27 174.94 10.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 196' ' ' GLY . 9.9 tp -73.97 145.6 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.926 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 57.3 t -113.46 111.51 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.6 t -122.27 123.6 69.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.093 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -161.81 149.56 14.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.94 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.846 0.355 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.46 HD22 ' CD1' ' A' ' 191' ' ' ILE . 18.9 mt -121.7 153.86 37.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -116.0 109.99 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.54 139.29 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -133.83 -173.05 13.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.452 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.468 ' HE3' ' CB ' ' A' ' 205' ' ' SER . 11.9 mmt 57.36 43.32 23.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 43.6 mt -102.23 156.89 17.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -96.23 161.32 14.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -81.98 43.12 0.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -134.38 -37.84 0.85 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.492 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 5.9 mt-30 -67.87 151.36 47.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.0 p -129.6 164.27 24.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -44.33 -48.52 9.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.24 -54.42 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -42.55 -67.79 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 154' ' ' PHE . 99.7 t -49.63 -61.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.439 ' CD2' HD13 ' A' ' 160' ' ' ILE . 34.2 mt -44.83 -38.25 4.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -69.45 -40.52 77.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.93 -9.38 58.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.53 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.2 m-85 -100.26 -35.81 9.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.564 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.13 -46.97 56.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.92 -16.67 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.325 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.568 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.4 m-85 -99.69 -41.95 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.22 168.02 37.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.62 134.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.153 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.439 HD13 ' CD2' ' A' ' 151' ' ' LEU . 75.4 mt -109.04 109.08 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.143 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' LYS . 18.5 m-20 -45.3 -61.28 1.73 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.875 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -157.88 148.43 20.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 20.6 t -133.74 135.61 44.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.8 m -139.44 141.9 37.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.69 135.06 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.5 mttm . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.833 0.349 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 50.48 33.65 25.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 29.7 m -150.03 169.05 22.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 110.856 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -165.69 179.24 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -133.98 118.7 18.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.452 HG12 ' CE1' ' A' ' 181' ' ' PHE . 97.9 t -110.85 118.91 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 161' ' ' ASP . 13.4 ttmm -105.02 117.91 35.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.944 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.452 ' CE1' HG12 ' A' ' 179' ' ' VAL . 35.9 m-85 -93.29 154.14 18.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 m -57.4 -41.04 79.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -134.38 136.01 43.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.425 ' CD2' ' H ' ' A' ' 185' ' ' THR . 7.6 p-80 -38.57 -56.32 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.425 ' H ' ' CD2' ' A' ' 184' ' ' HIS . 94.3 m -37.53 -67.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -41.03 -43.62 2.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.0 -53.95 48.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -45.21 -46.93 12.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -60.94 -65.74 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.4 -38.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 195' ' ' HIS . 62.3 mt -61.63 -71.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.146 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -57.09 -13.14 2.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.568 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -90.94 -32.33 16.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.125 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.508 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 40.8 mt -122.43 20.64 10.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -86.53 123.96 32.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 41.52 28.36 0.36 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 82.9 p -100.53 -38.67 8.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.862 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.536 ' NE2' ' CD2' ' A' ' 207' ' ' LEU . 9.7 pt20 -100.58 146.0 27.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 200' ' ' MET . 86.9 m -123.91 80.25 1.79 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.147 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.492 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 14.1 mmt -34.58 138.1 0.34 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.558 0.694 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.63 151.58 7.43 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.733 2.289 . . . . 0.0 112.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.69 -43.9 2.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -78.84 136.33 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 111.097 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 70.1 m -86.49 -13.0 47.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.468 ' CB ' ' HE3' ' A' ' 140' ' ' MET . 23.1 m -100.08 161.24 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.3 p -85.27 -178.41 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.536 ' CD2' ' NE2' ' A' ' 198' ' ' GLN . 11.9 tp -82.71 123.49 29.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.4 t -92.24 106.04 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 14.6 t -113.27 117.43 55.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.16 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -157.46 150.6 23.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.1 tttt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.827 0.346 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 181' ' ' PHE . 58.1 mt -115.92 153.3 31.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -123.36 114.04 19.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.2 t -101.18 143.75 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.77 -173.85 13.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.6 mmt 57.8 37.46 27.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.446 ' CD2' ' OE1' ' A' ' 145' ' ' GLN . 24.3 mt -95.37 155.1 16.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -108.84 173.99 6.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.66 12.51 2.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -99.96 -22.61 15.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.451 ' CD ' ' SD ' ' A' ' 200' ' ' MET . 34.4 mt-30 -97.57 149.36 22.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 p -130.77 178.16 6.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -56.94 -49.24 76.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -52.23 -59.47 4.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -39.65 -67.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 154' ' ' PHE . 84.1 t -45.16 -60.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.466 ' CD2' HD12 ' A' ' 160' ' ' ILE . 33.9 mt -47.98 -40.31 22.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -69.57 -39.53 77.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -84.19 -10.04 58.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.571 ' CD1' HG12 ' A' ' 150' ' ' VAL . 3.2 m-85 -99.94 -36.2 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -47.11 -47.01 55.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.592 0.71 . . . . 0.0 110.919 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.2 Cg_exo -48.01 -17.13 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.695 2.263 . . . . 0.0 112.332 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 193' ' ' ALA . 74.2 m-85 -101.32 -48.15 4.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -156.3 160.43 30.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.88 93.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.117 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.466 HD12 ' CD2' ' A' ' 151' ' ' LEU . 63.5 mt -62.87 138.6 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -95.13 -62.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.28 132.92 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . 0.456 ' HB2' ' CD2' ' A' ' 151' ' ' LEU . 42.7 t -134.02 136.17 43.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 50.7 m -152.69 139.52 18.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.445 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 53.5 t -104.06 144.84 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 53.1 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.921 179.957 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.74 10.79 86.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.35 148.13 50.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.835 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -153.37 166.15 33.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -120.83 136.06 55.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.928 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 81.2 t -130.51 124.31 56.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -107.9 129.65 55.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.559 ' CE1' HD13 ' A' ' 136' ' ' LEU . 28.4 m-85 -103.59 167.71 9.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.3 t -64.97 -32.31 73.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.3 t -143.19 175.94 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.569 ' CG ' ' N ' ' A' ' 185' ' ' THR . 4.4 p-80 -72.13 -49.63 34.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.569 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 89.4 m -43.79 -61.54 1.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -40.94 -51.31 3.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.466 ' CB ' HD22 ' A' ' 136' ' ' LEU . . . -56.6 -57.63 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.065 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -39.65 -47.24 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 190' ' ' ALA . . . -61.95 -67.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -36.53 -42.93 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 195' ' ' HIS . 77.7 mt -57.36 -74.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -57.05 -13.3 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.86 -35.79 18.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 21.5 mt -126.51 26.41 6.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.8 t60 -86.41 121.41 28.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 207' ' ' LEU . . . 33.86 32.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.51 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.38 -38.77 8.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.343 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -100.62 160.1 14.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 19.3 m -130.83 87.59 2.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.451 ' SD ' ' CD ' ' A' ' 145' ' ' GLN . 16.8 mmt -39.62 154.86 0.17 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.87 122.73 9.65 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 2.273 . . . . 0.0 112.305 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 111.97 -43.91 1.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -82.94 153.05 25.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 84.5 p -98.63 -12.8 20.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 64.8 m -100.14 164.96 11.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.852 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 67.5 m -87.49 161.28 17.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 196' ' ' GLY . 14.9 tp -57.09 141.65 45.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.447 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 55.8 t -110.28 107.12 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.1 t -118.24 114.52 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.447 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 17.6 ptpt -148.3 155.4 41.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.765 0.317 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.401 HD13 ' CD1' ' A' ' 181' ' ' PHE . 21.0 mt -125.06 144.93 50.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -112.64 114.76 27.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -103.85 146.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.133 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -142.34 -173.53 14.32 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.417 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.3 mmt 55.81 42.35 29.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.4 mt -103.35 154.87 18.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -98.12 165.82 11.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -82.48 39.93 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -128.53 -38.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -69.49 151.29 46.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.1 p -128.55 176.67 7.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -55.41 -44.62 76.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.861 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.83 -49.18 74.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.12 -69.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.574 HG12 ' CD1' ' A' ' 154' ' ' PHE . 74.6 t -49.96 -59.75 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.448 ' CD2' HD11 ' A' ' 160' ' ' ILE . 25.4 mt -47.34 -38.34 12.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -69.62 -40.13 76.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.1 tp -84.49 -8.96 58.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.574 ' CD1' HG12 ' A' ' 150' ' ' VAL . 3.1 m-85 -100.18 -37.24 9.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.2 tm0? -47.2 -46.89 56.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.645 0.736 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.97 -17.28 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.242 . . . . 0.0 112.361 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 193' ' ' ALA . 73.3 m-85 -99.88 -33.4 10.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.97 164.02 33.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.441 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 94.5 t -76.47 103.41 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.448 HD11 ' CD2' ' A' ' 151' ' ' LEU . 85.6 mt -72.37 133.99 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.428 ' N ' HG21 ' A' ' 160' ' ' ILE . 36.3 m-20 -81.51 -62.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -141.89 139.79 32.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . 0.442 ' CB ' HD21 ' A' ' 151' ' ' LEU . 45.0 t -134.04 141.11 47.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.6 m -146.7 139.44 25.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.458 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 87.3 t -105.6 136.63 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 49.9 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.953 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.0 mttt . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.794 0.33 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 55.94 38.94 77.01 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.482 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 22.7 p -156.17 149.76 24.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.805 0.336 . . . . 0.0 110.916 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -159.47 166.77 30.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.5 136.05 54.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.5 t -127.18 125.25 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -105.72 130.72 53.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 136' ' ' LEU . 22.8 m-85 -106.29 158.83 16.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.7 t -53.21 -43.6 67.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.6 m -128.26 173.53 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.403 ' CD2' ' H ' ' A' ' 184' ' ' HIS . 7.7 p80 -71.8 -49.97 33.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.5 m -47.67 -63.62 1.01 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -40.25 -39.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.22 -65.76 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.105 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.424 ' C ' ' CD ' ' A' ' 188' ' ' GLN . 0.0 OUTLIER -43.39 -36.82 2.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.95 -61.87 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.44 -34.68 4.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 195' ' ' HIS . 45.1 mt -60.04 -71.83 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -55.59 -18.73 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 157' ' ' PHE . . . -79.05 -37.4 39.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.46 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 12.2 mt -126.51 28.26 5.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.5 t60 -84.81 120.98 27.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.04 34.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.452 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.3 -38.84 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.844 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -100.6 152.23 20.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 200' ' ' MET . 15.7 m -122.31 86.28 2.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 199' ' ' THR . 13.2 mmt -37.11 155.25 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 110.855 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.41 128.11 15.87 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.695 2.263 . . . . 0.0 112.372 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 103.51 -39.46 2.79 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.96 154.71 21.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.067 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.7 t -99.98 -14.96 18.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.1 m -100.12 161.54 13.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 66.9 m -88.64 158.27 18.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 14.3 tp -52.45 141.75 19.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 52.4 t -110.08 108.64 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.15 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 4.7 t -118.6 124.45 73.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -158.85 148.59 19.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 136' ' ' LEU . 12.4 tppt? . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.763 0.316 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.449 HD13 ' CE1' ' A' ' 181' ' ' PHE . 88.7 mt -140.1 150.66 44.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -117.2 117.61 30.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.11 147.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.41 -170.5 11.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.52 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.4 mmt 51.68 51.19 17.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.778 0.323 . . . . 0.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 207' ' ' LEU . 43.5 mt -111.13 155.75 22.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -97.61 165.07 12.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -82.37 40.69 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -129.16 -40.05 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -69.43 144.65 53.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.3 p -122.91 171.27 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -48.43 -48.71 37.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.92 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.45 ' OE1' ' C ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -51.74 -51.41 56.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -46.6 -67.35 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.577 HG12 ' CD1' ' A' ' 154' ' ' PHE . 31.7 t -49.27 -62.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.469 ' CD2' HD12 ' A' ' 160' ' ' ILE . 25.0 mt -46.49 -38.35 9.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -69.51 -40.1 77.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.76 -10.2 58.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.577 ' CD1' HG12 ' A' ' 150' ' ' VAL . 3.2 m-85 -99.84 -35.73 9.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -47.1 -47.07 55.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.59 0.71 . . . . 0.0 110.897 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.99 -17.27 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.666 2.244 . . . . 0.0 112.365 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.563 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 74.1 m-85 -101.26 -47.16 4.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.97 166.14 34.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.503 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.5 t -80.6 101.8 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 0.0 111.14 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.469 HD12 ' CD2' ' A' ' 151' ' ' LEU . 38.5 mt -73.07 131.37 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.69 -64.17 1.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -130.77 140.98 50.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . 0.443 ' CB ' HD23 ' A' ' 151' ' ' LEU . 12.3 t -134.13 131.61 38.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.4 m -136.43 138.19 41.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.471 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 92.3 t -108.45 135.36 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.999 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.802 0.334 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 67.68 20.61 72.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.3 m -143.49 164.43 30.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.792 0.33 . . . . 0.0 110.883 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -164.02 170.92 15.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.05 121.9 36.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 94.3 t -114.22 131.51 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -110.71 129.57 55.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.891 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.449 ' CE1' HD13 ' A' ' 136' ' ' LEU . 32.6 m-85 -102.47 165.23 11.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.7 p -67.32 -39.14 85.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.0 p -132.52 146.09 51.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.42 ' CG ' ' N ' ' A' ' 185' ' ' THR . 6.8 p80 -50.44 -50.41 52.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.42 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 85.9 m -48.66 -53.34 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -45.75 -50.42 13.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -59.89 -48.51 81.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.126 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.71 -43.41 17.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.41 -59.2 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.106 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.01 -36.81 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 195' ' ' HIS . 63.3 mt -61.37 -73.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.1 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -57.41 -12.05 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.563 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -85.09 -40.09 17.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.92 19.41 11.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.4 t60 -80.08 124.97 29.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.21 32.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.495 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 195' ' ' HIS . 58.8 p -100.38 -39.31 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.83 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -100.53 160.47 14.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 200' ' ' MET . 19.6 m -135.02 86.62 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 199' ' ' THR . 13.8 mmt -36.1 154.56 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.706 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.45 129.32 17.71 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.64 2.227 . . . . 0.0 112.359 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 101.66 -38.62 3.08 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.482 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.48 146.91 26.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.31 . . . . 0.0 111.081 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.8 t -93.39 -12.38 30.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 69.3 m -100.16 158.77 15.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.828 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 70.1 m -85.3 169.32 13.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.826 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.467 ' CD1' HD22 ' A' ' 141' ' ' LEU . 19.5 tp -65.87 128.12 34.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.1 113.86 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.9 t -123.19 124.08 69.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -162.3 148.61 13.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.98 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.6 tttp . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.796 0.331 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.509 HD12 ' CE1' ' A' ' 181' ' ' PHE . 36.0 mt -121.81 155.0 36.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 176' ' ' CYS . 44.7 t80 -124.42 112.79 17.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.52 152.66 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -146.16 174.93 25.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.4 mmt 57.48 46.01 18.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.336 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.473 ' CD2' ' OE1' ' A' ' 145' ' ' GLN . 60.2 mt -100.07 147.32 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 36.4 t30 -90.12 164.82 14.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -66.98 -3.66 7.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.416 HE21 ' ND2' ' A' ' 142' ' ' ASN . 6.2 pt20 -109.31 43.71 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.496 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 74.1 mt-30 -135.21 109.24 8.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 p -104.08 170.74 7.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -52.86 -41.93 64.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.5 -47.32 86.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -48.03 -63.99 0.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.839 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 154' ' ' PHE . 94.9 t -58.49 -60.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.439 ' HA ' ' CD1' ' A' ' 160' ' ' ILE . 29.6 mt -44.4 -38.68 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -68.82 -41.11 79.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -84.0 -9.78 58.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.564 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.14 -35.88 9.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.56 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.0 OUTLIER -47.18 -46.91 56.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 0.0 110.914 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -48.03 -16.75 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.652 2.235 . . . . 0.0 112.315 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 193' ' ' ALA . 72.4 m-85 -99.87 -42.1 6.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.73 171.16 42.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -80.48 102.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 151' ' ' LEU . 38.3 mt -72.13 151.34 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -103.13 -57.15 2.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.462 ' CG ' ' HB3' ' A' ' 180' ' ' LYS . 9.7 pt-20 -138.69 137.89 37.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.7 t -133.72 102.14 5.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.3 m -107.51 119.64 39.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.163 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.461 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 50.3 t -99.91 131.87 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.131 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.9 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.997 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.1 mttt . . . . . 0 CA--C 1.525 0.015 0 CA-C-O 120.812 0.339 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.45 -16.3 44.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.448 ' HB3' ' CE1' ' A' ' 137' ' ' PHE . 1.7 m -125.99 160.14 30.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 110.87 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.461 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -158.73 175.98 12.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -136.04 126.27 26.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.18 130.0 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.462 ' HB3' ' CG ' ' A' ' 162' ' ' GLU . 27.0 tttt -106.25 130.35 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.509 ' CE1' HD12 ' A' ' 136' ' ' LEU . 33.6 m-85 -104.0 160.63 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.4 t -72.43 -19.85 61.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.863 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -142.15 164.94 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.451 ' CG ' ' N ' ' A' ' 185' ' ' THR . 4.4 p-80 -75.39 -41.75 55.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.806 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.451 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 44.7 m -54.64 -59.76 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -41.12 -47.73 3.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 188' ' ' GLN . . . -60.79 -62.05 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.093 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 187' ' ' ALA . 1.8 mm-40 -35.44 -44.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.85 -63.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.054 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.36 -28.86 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.074 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.481 ' O ' ' N ' ' A' ' 195' ' ' HIS . 36.2 mt -70.71 -72.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.143 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -59.85 -17.14 34.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 157' ' ' PHE . . . -84.74 -25.8 28.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.129 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.5 mt -132.59 24.95 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.3 t60 -89.69 121.45 31.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.1 30.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 195' ' ' HIS . 60.6 p -100.25 -39.48 8.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.83 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.43 ' OE1' ' CD2' ' A' ' 207' ' ' LEU . 4.9 pt20 -100.66 163.98 12.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 200' ' ' MET . 29.3 m -134.82 81.3 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.496 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 13.9 mmt -37.03 156.01 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.698 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.473 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 54.1 Cg_endo -68.0 136.48 38.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.395 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.12 -35.95 4.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -89.36 150.85 22.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.5 t -100.08 -12.48 19.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.867 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.1 t -100.08 170.07 8.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -94.27 148.94 21.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.808 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.43 ' CD2' ' OE1' ' A' ' 198' ' ' GLN . 10.7 tp -45.68 151.4 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.97 104.29 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 6.6 t -115.94 116.41 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -155.35 148.36 24.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.1 m -39.71 107.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -74.32 139.59 44.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 67.08 179.36 11.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 92.6 p -167.45 176.4 6.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.6 m -151.57 143.82 24.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -172.6 -174.49 39.9 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.493 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 57.9 m -57.45 149.81 20.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.0 110.855 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -139.63 109.26 6.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.3 p -66.44 166.91 11.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -80.19 130.04 34.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.806 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.58 -39.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.84 169.96 29.9 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.468 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -115.5 117.87 31.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.767 0.318 . . . . 0.0 110.912 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -89.85 104.23 16.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -88.86 30.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -112.41 157.21 21.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 mt -130.84 153.63 48.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -116.0 108.92 16.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.916 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.6 t -99.85 145.02 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.107 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -137.69 -170.44 11.88 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.4 mmt 52.39 53.01 13.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.1 mt -117.39 156.14 28.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -94.12 175.49 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.0 pttm -92.61 17.02 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -108.06 -13.69 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.491 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 20.4 mt-30 -90.09 152.11 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 95.9 p -131.96 166.23 22.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -45.77 -47.12 15.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -54.83 -53.76 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -43.03 -64.82 0.56 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 154' ' ' PHE . 77.7 t -53.67 -63.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.458 ' CD2' HD12 ' A' ' 160' ' ' ILE . 31.4 mt -42.82 -36.98 1.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.28 -40.83 77.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -84.57 -8.6 58.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.575 ' CE1' ' CD1' ' A' ' 194' ' ' LEU . 3.1 m-85 -99.89 -37.19 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 10.2 tm0? -47.31 -46.87 57.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.722 . . . . 0.0 110.902 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.89 -17.18 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.731 2.287 . . . . 0.0 112.363 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 75.2 m-85 -101.95 -35.07 9.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.84 161.31 30.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.512 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 80.9 t -75.03 97.98 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.458 HD12 ' CD2' ' A' ' 151' ' ' LEU . 36.5 mt -66.66 137.25 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.167 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -81.86 -61.43 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -139.54 143.57 37.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . 0.427 ' CB ' HD23 ' A' ' 151' ' ' LEU . 10.6 t -134.02 135.78 43.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.83 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.0 m -139.09 157.74 45.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.97 130.82 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 60.3 mt -72.84 147.97 44.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -148.23 165.58 30.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -100.12 -161.83 28.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.487 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.07 -50.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.664 2.243 . . . . 0.0 112.299 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.64 -39.56 88.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 121.28 39.83 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.521 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 70.2 m -121.99 118.12 28.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 110.863 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.0 t -50.01 136.57 18.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -84.5 11.24 9.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 71.44 21.76 78.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.52 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 3.2 m -136.55 159.78 40.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -158.1 161.67 37.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -112.23 121.73 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.15 122.94 70.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -111.68 131.27 55.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 187' ' ' ALA . 41.2 m-85 -101.7 166.68 10.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.3 t -66.81 -35.53 80.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.8 p -133.79 166.65 22.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -66.94 -55.25 15.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.4 m -43.73 -53.7 5.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -49.12 -48.1 44.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.453 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . . . -59.81 -52.2 66.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.094 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -46.42 -42.66 15.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.19 -63.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.73 -37.17 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 195' ' ' HIS . 54.1 mt -63.9 -72.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.106 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -57.48 -13.78 4.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.54 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.16 -40.24 15.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.575 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 18.1 mt -119.16 22.66 11.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.4 t60 -82.91 124.82 30.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.56 32.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.502 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 195' ' ' HIS . 54.4 p -100.19 -35.26 9.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.338 . . . . 0.0 110.849 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -100.27 161.1 13.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 12.9 m -134.6 77.14 1.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.163 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.491 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 14.0 mmt -39.43 138.45 0.94 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.597 0.713 . . . . 0.0 110.868 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.39 146.73 9.78 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.12 -34.16 3.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.27 134.0 35.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.312 . . . . 0.0 111.133 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 80.4 p -90.25 -8.72 50.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.838 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 37.0 m -99.98 160.72 14.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.3 m -84.34 158.81 21.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 196' ' ' GLY . 13.4 tp -57.57 141.68 47.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.73 104.37 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 12.4 t -115.65 120.67 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.097 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -158.16 150.13 21.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.843 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -47.99 147.35 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.11 -36.56 77.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.108 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.56 78.51 1.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 39.1 p -59.04 -73.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -118.59 46.76 1.76 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.88 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -118.15 87.07 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -112.72 110.15 20.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.2 t -78.72 96.48 5.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.82 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 172.55 147.27 5.73 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.1 133.2 13.33 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.664 2.243 . . . . 0.0 112.372 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.0 t -77.05 -46.22 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 m -96.9 -59.94 1.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.494 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 53.7 m 61.17 41.77 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.863 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 79.4 p -73.44 120.77 19.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.808 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 154.55 126.12 1.03 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.507 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.5 m -161.3 152.38 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.362 . . . . 0.0 110.892 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -121.68 140.13 52.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -129.2 -179.3 15.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.546 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 t -87.12 88.1 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 110.907 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -111.44 86.87 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t -60.06 123.26 16.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.82 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -57.91 117.87 4.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.45 51.78 0.38 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 117.7 123.3 3.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.538 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.459 ' N ' ' HD3' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -113.49 70.09 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.926 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 132' ' ' ARG . 13.7 m-20 -34.49 -44.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 134' ' ' ARG . 20.2 mtm105 59.23 29.64 19.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -114.66 154.08 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.562 HD13 ' CE1' ' A' ' 181' ' ' PHE . 44.3 mt -135.85 148.16 48.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -118.35 110.72 17.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.66 138.91 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.118 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -136.36 178.37 18.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.0 mmt 62.46 45.04 6.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 mt -102.73 153.81 19.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 28.2 t30 -108.2 169.58 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -78.45 45.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -132.11 -34.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.513 ' NE2' ' CE ' ' A' ' 200' ' ' MET . 6.7 mt-30 -86.75 146.97 26.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.7 p -126.34 -177.56 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -58.73 -46.33 87.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.848 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -56.72 -53.19 60.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -42.53 -66.67 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.547 HG11 ' CE1' ' A' ' 154' ' ' PHE . 86.5 t -48.08 -63.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.46 ' HA ' ' CD1' ' A' ' 160' ' ' ILE . 33.4 mt -44.24 -40.77 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -69.01 -40.36 78.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.2 tp -84.21 -9.98 58.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.547 ' CE1' HG11 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.55 -35.6 9.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.36 -46.87 58.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 0.0 110.925 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.1 Cg_exo -47.95 -17.49 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.356 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 74.5 m-85 -100.58 -46.29 5.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -161.2 160.92 32.58 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.474 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.6 t -76.16 95.69 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 151' ' ' LEU . 28.4 mt -63.85 142.92 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.099 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.68 -55.99 3.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -144.92 140.37 28.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 40.6 t -132.48 142.78 49.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.2 m -151.01 143.07 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 86.1 t -112.58 134.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.62 144.04 39.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -132.32 174.59 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -101.25 -158.98 27.17 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.35 -18.48 13.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.678 2.252 . . . . 0.0 112.355 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -125.56 32.82 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 172' ' ' SER . . . 81.88 -38.92 2.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 171' ' ' GLY . 16.9 t -35.66 102.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.869 0.366 . . . . 0.0 110.822 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.3 t -55.36 139.59 42.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -83.32 13.94 3.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 61.36 33.28 84.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.529 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 7.8 p -148.42 154.15 39.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -159.02 176.67 12.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -129.74 141.12 50.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.06 128.82 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -111.9 134.17 53.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.562 ' CE1' HD13 ' A' ' 136' ' ' LEU . 36.8 m-85 -108.96 164.86 12.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.4 t -69.31 -27.08 65.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.3 t -144.03 159.33 42.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.846 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -60.22 -57.49 12.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 99.9 m -38.82 -59.39 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -40.83 -52.75 2.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -57.97 -57.16 14.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -37.91 -45.91 0.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 191' ' ' ILE . . . -66.16 -66.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -38.65 -27.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 195' ' ' HIS . 59.2 mt -74.3 -71.07 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -59.88 -12.27 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -89.84 -31.3 17.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.9 mt -125.91 21.63 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.3 t60 -83.72 124.55 30.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.62 31.92 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.463 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 195' ' ' HIS . 79.3 p -100.25 -36.09 9.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.894 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -100.32 150.35 22.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 51.0 m -122.76 80.16 1.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.154 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.513 ' CE ' ' NE2' ' A' ' 145' ' ' GLN . 15.3 mmt -40.34 140.61 0.94 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.532 0.682 . . . . 0.0 110.899 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.471 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 74.5 Cg_exo -48.07 147.69 7.7 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.711 2.274 . . . . 0.0 112.306 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.09 -45.69 3.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.457 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -77.28 138.59 39.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.754 0.311 . . . . 0.0 111.085 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.5 t -91.62 -11.39 37.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.2 t -99.97 173.08 6.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.419 ' HB3' ' C ' ' A' ' 196' ' ' GLY . 59.0 m -99.67 150.87 21.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 14.1 tp -47.49 147.97 1.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.457 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 58.8 t -117.22 104.05 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.132 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 8.7 t -111.72 122.48 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.457 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 14.9 ptpt -161.43 150.25 15.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -50.2 136.95 18.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -57.31 152.08 14.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.111 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -39.28 141.48 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 12.7 t -161.8 135.12 6.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -168.39 119.72 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -75.58 135.41 40.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.923 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -114.11 -52.42 2.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.5 t -41.48 158.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -172.4 -166.63 31.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.521 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.04 -43.21 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.705 2.27 . . . . 0.0 112.294 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 46.0 m -115.61 121.64 43.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 70.6 m -62.54 115.51 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.504 179.987 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.9 p 42.92 42.54 3.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.833 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.2 t -48.8 -47.86 41.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.92 136.69 2.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.44 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.3 m -145.19 115.57 7.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.823 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.3 m -93.38 -49.92 5.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.99 61.79 6.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.483 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 94.4 p -127.5 95.18 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 110.866 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -58.2 127.53 32.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 87.3 p -168.36 143.47 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -99.81 -44.09 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.29 -149.77 49.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.489 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.05 171.55 55.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 184' ' ' HIS . 13.5 mmt180 -102.91 113.93 27.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.866 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.68 121.58 6.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 10.2 mtm-85 -97.09 26.54 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.542 ' HE2' ' CD1' ' A' ' 178' ' ' PHE . 71.3 tttt -112.28 137.97 49.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.406 HD11 ' CE1' ' A' ' 181' ' ' PHE . 18.2 mt -124.25 156.3 37.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -126.68 112.95 16.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 30.4 t -97.14 148.23 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -142.31 -172.12 13.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.479 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.2 mmt 54.49 38.76 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.3 mt -95.22 160.93 14.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -100.91 -175.62 2.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -100.3 34.75 2.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -129.14 -30.98 2.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -77.79 145.77 36.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 55.1 p -119.79 -175.84 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.53 -31.78 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -64.87 -48.39 74.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -48.39 -68.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.828 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.569 HG13 ' CD1' ' A' ' 154' ' ' PHE . 99.0 t -48.46 -53.95 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.463 ' CD2' HG22 ' A' ' 160' ' ' ILE . 38.9 mt -51.46 -40.68 59.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -69.27 -39.41 78.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.8 tp -84.31 -11.12 56.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.569 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -98.44 -36.21 10.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.57 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.06 -47.02 55.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.592 0.71 . . . . 0.0 110.921 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.5 Cg_exo -47.92 -16.77 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.355 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 72.3 m-85 -99.75 -35.28 9.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.38 164.38 37.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.86 91.23 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 111.136 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.463 HG22 ' CD2' ' A' ' 151' ' ' LEU . 68.6 mt -59.54 132.81 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -84.94 -55.06 4.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.1 143.07 28.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 151' ' ' LEU . 9.8 t -134.04 129.84 36.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.6 m -139.26 144.68 38.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.418 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 73.6 t -109.97 151.93 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.1 mt -88.2 142.16 27.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.403 ' C ' ' NZ ' ' A' ' 174' ' ' LYS . 53.0 mtt180 -153.77 155.06 35.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.52 -162.72 31.92 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.516 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.89 -45.89 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.72 2.28 . . . . 0.0 112.383 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.13 -42.85 99.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 125.51 41.73 0.34 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.535 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.8 p -110.78 146.65 36.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 110.892 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.1 t -79.97 124.5 28.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.403 ' NZ ' ' C ' ' A' ' 167' ' ' ARG . 38.2 mttp -78.24 8.05 5.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.27 23.91 70.25 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.442 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 2.6 p -144.79 158.63 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.816 0.341 . . . . 0.0 110.925 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.47 175.1 11.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.128 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.542 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 81.8 m-85 -124.98 137.84 54.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.457 HG11 ' CE1' ' A' ' 181' ' ' PHE . 98.3 t -127.76 127.5 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -111.72 133.61 53.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.457 ' CE1' HG11 ' A' ' 179' ' ' VAL . 44.3 m-85 -110.0 156.83 19.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.1 t -56.9 -28.87 62.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.845 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 t -140.9 177.35 8.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.408 ' HB3' ' NH1' ' A' ' 132' ' ' ARG . 12.5 t60 -76.64 -59.01 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.5 m -39.37 -54.39 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -44.78 -49.91 10.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.61 -57.11 14.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.09 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -38.65 -45.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.5 -62.17 1.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.07 -27.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 195' ' ' HIS . 74.1 mt -76.77 -64.8 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -64.64 -7.9 12.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -99.26 -24.74 14.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.103 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 23.1 mt -132.36 27.12 4.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.2 t60 -93.04 122.43 35.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 36.39 31.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.461 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -99.23 -36.98 9.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.358 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.474 ' OE1' ' CE ' ' A' ' 200' ' ' MET . 16.2 pt20 -100.35 165.06 11.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 18.4 m -134.96 85.82 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.474 ' CE ' ' OE1' ' A' ' 198' ' ' GLN . 14.2 mmt -44.95 139.78 3.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.706 . . . . 0.0 110.901 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -48.15 137.45 23.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.692 2.261 . . . . 0.0 112.326 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 91.21 -48.12 2.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.481 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -76.51 131.63 39.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.079 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.7 p -86.4 -7.39 58.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.7 t -99.71 171.45 7.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.4 m -100.08 143.19 30.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.459 HD23 ' NE2' ' A' ' 198' ' ' GLN . 14.8 tp -40.04 151.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.53 103.93 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.23 121.06 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -156.92 152.42 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -51.5 139.22 20.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.05 -42.66 80.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.11 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -156.83 163.63 38.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.3 t -162.9 169.85 19.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.153 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -123.57 79.7 1.72 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -56.92 127.74 33.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -109.54 113.97 27.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.6 t -121.43 155.29 35.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 165.86 74.59 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.57 -45.92 15.45 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.711 2.274 . . . . 0.0 112.337 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.5 m -138.67 160.47 39.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 17.6 t -139.35 117.89 12.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.478 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 96.5 p -78.82 140.03 38.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.869 0.366 . . . . 0.0 110.843 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.8 p -64.89 114.57 4.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.824 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.91 -145.92 8.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.436 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 t -82.56 136.42 34.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 110.856 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.7 p -103.21 -53.37 2.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 170.03 144.52 4.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 m -49.11 -57.42 6.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.866 0.365 . . . . 0.0 110.826 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -148.31 152.3 36.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.4 m -120.82 45.4 2.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.883 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -110.04 115.42 29.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 163.32 -84.84 0.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.43 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -140.72 93.34 0.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -46.12 130.91 10.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.28 118.58 22.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.903 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 181' ' ' PHE . 21.9 ttm105 -124.69 42.5 3.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.529 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 7.7 ttmt -117.75 139.5 50.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.55 HD13 ' CE1' ' A' ' 181' ' ' PHE . 55.5 mt -112.32 139.34 47.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -109.23 116.01 31.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.13 146.36 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -140.13 179.86 18.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 mmt 57.3 48.23 15.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 110.879 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 48.9 mt -108.27 162.7 13.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -103.77 172.17 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -88.64 16.05 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -106.92 -18.21 13.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.976 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -87.77 147.92 24.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.951 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.3 p -124.77 -179.19 4.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -63.21 -32.57 74.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -66.43 -48.02 71.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -50.92 -49.53 59.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.545 HG13 ' CD1' ' A' ' 154' ' ' PHE . 83.6 t -68.33 -50.35 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.436 ' CD2' HG21 ' A' ' 160' ' ' ILE . 52.0 mt -56.59 -32.24 65.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.421 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 11.7 mmm180 -81.24 -36.12 30.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.901 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.7 tp -85.01 -14.04 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.545 ' CD1' HG13 ' A' ' 150' ' ' VAL . 4.1 m-85 -100.05 -37.25 9.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 3.7 mt-30 -47.19 -48.91 54.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.635 0.731 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.8 Cg_exo -47.97 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.513 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.6 m-85 -100.43 -30.28 11.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 173.86 158.69 18.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.512 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.52 135.74 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 111.156 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.436 HG21 ' CD2' ' A' ' 151' ' ' LEU . 55.2 mt -111.75 125.22 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -69.89 -65.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -143.31 141.03 30.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 44.1 t -132.22 108.43 9.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.8 m -109.66 128.13 55.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.154 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.453 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 73.4 t -91.91 135.91 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.165 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 47.1 mt -76.16 142.95 41.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -154.04 171.67 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -104.12 -171.97 25.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.0 -9.28 17.98 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.673 2.249 . . . . 0.0 112.341 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -90.92 -37.29 13.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 132.06 -19.19 4.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.459 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 12.8 t -67.9 170.66 7.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.3 t -106.53 144.38 33.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -83.97 20.34 1.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 58.38 24.17 55.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 17.9 m -147.77 165.08 31.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.842 0.353 . . . . 0.0 110.902 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.62 -179.06 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.529 ' CD1' ' HD3' ' A' ' 135' ' ' LYS . 57.7 m-85 -131.31 124.91 31.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.7 t -119.96 123.32 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -108.32 119.24 38.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.55 ' CE1' HD13 ' A' ' 136' ' ' LEU . 30.5 m-85 -92.98 164.98 13.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.1 m -72.43 -32.37 66.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 t -133.37 160.28 37.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.827 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -64.72 -59.82 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 186' ' ' GLU . 53.0 m -38.68 -64.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.8 OUTLIER -36.6 -53.0 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 188' ' ' GLN . . . -57.22 -59.8 4.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.101 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 187' ' ' ALA . 1.5 mm-40 -37.3 -47.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 190' ' ' ALA . . . -62.47 -67.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -35.56 -38.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.051 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.74 -73.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -55.33 -14.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.513 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.69 -41.08 14.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.43 30.54 7.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -99.51 122.98 43.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 45.75 20.16 0.39 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.46 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 60.7 p -100.04 -35.71 9.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -100.1 154.82 18.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 49.3 m -134.78 86.33 2.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 12.4 mmt -47.11 138.31 7.75 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.582 0.706 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -48.62 153.03 3.7 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.734 2.29 . . . . 0.0 112.331 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.55 -35.67 2.45 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.537 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.93 136.09 34.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.077 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 84.0 p -85.69 -13.93 46.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.7 m -100.0 157.72 16.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 6.1 p -79.81 -178.75 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 15.7 tp -77.31 149.22 35.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.46 ' CG1' ' HE2' ' A' ' 210' ' ' LYS . 73.8 t -118.0 103.93 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.9 t -113.48 123.15 68.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.46 ' HE2' ' CG1' ' A' ' 208' ' ' VAL . 0.9 OUTLIER -159.96 148.48 17.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -47.68 157.36 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 213' ' ' ASP . . . -78.3 138.75 38.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 212' ' ' ALA . 2.5 p-10 -36.94 128.52 0.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.839 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 59.1 p -109.76 109.47 20.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -154.46 142.33 20.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -156.41 105.47 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -144.87 136.82 25.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.5 t -134.1 110.2 9.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 50.97 -146.37 9.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.22 98.67 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.655 2.237 . . . . 0.0 112.345 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 80.1 p -174.4 126.22 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 30.5 p -103.22 132.55 49.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.453 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.3 m -90.3 121.2 32.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.799 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.4 t -141.8 128.9 20.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.819 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.72 124.42 0.98 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.478 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.3 m -82.29 101.84 10.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.862 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 61.4 p -99.52 42.31 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.85 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 122.68 45.0 0.32 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.442 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.6 t -49.65 136.74 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.329 . . . . 0.0 110.856 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 127' ' ' GLU . 1.2 pp20? -83.14 43.15 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.867 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 m -83.9 88.96 7.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -86.82 176.7 7.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.878 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.01 -173.58 29.67 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.497 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -61.65 -142.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.48 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.437 ' O ' ' CG ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -150.72 160.66 43.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.511 ' HB2' ' CD1' ' A' ' 211' ' ' PHE . 5.1 m-20 -162.29 117.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 tpp85 -65.84 -22.93 66.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -100.14 138.65 36.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.568 HD11 ' CE1' ' A' ' 181' ' ' PHE . 38.4 mt -121.46 157.8 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.928 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -125.7 119.28 27.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 29.5 t -101.46 148.12 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -141.58 -179.65 18.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.9 mmt 57.95 39.88 26.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 67.3 mt -97.04 158.24 15.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 21.2 t-20 -113.16 170.99 7.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -79.49 44.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -133.01 -40.75 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.448 ' CD ' ' SD ' ' A' ' 200' ' ' MET . 31.2 mt-30 -81.89 121.84 26.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.1 p -106.02 173.79 6.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -47.78 -46.51 30.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -53.84 -51.79 62.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -47.75 -68.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.575 HG13 ' CD1' ' A' ' 154' ' ' PHE . 96.8 t -47.16 -54.99 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.454 ' CD2' HD13 ' A' ' 160' ' ' ILE . 32.1 mt -52.18 -39.77 60.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -70.2 -38.68 75.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -85.08 -9.09 58.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.575 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -100.04 -38.94 8.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.1 tm0? -46.99 -47.01 54.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.627 0.727 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.5 Cg_exo -47.94 -20.34 2.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.263 . . . . 0.0 112.304 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -100.04 -43.35 6.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.65 156.37 27.53 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.8 t -74.75 96.9 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 111.129 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.454 HD13 ' CD2' ' A' ' 151' ' ' LEU . 41.9 mt -66.3 141.52 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.451 ' N ' HG22 ' A' ' 160' ' ' ILE . 74.6 m-20 -94.42 -54.39 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -141.52 141.76 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 43.2 t -133.97 143.61 48.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.8 m -148.96 154.08 38.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.169 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.435 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 58.0 t -124.9 142.94 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.121 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 59.1 mt -85.54 139.32 31.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -146.2 158.38 43.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -77.82 -166.89 28.72 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.47 -47.99 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.718 2.279 . . . . 0.0 112.331 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -70.26 -31.39 68.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 118.16 44.4 0.53 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 173' ' ' SER . 73.9 p -113.55 96.98 6.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 110.817 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 172' ' ' SER . 46.8 t -34.62 135.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.889 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -94.9 10.75 34.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 61.56 24.52 64.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.442 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 4.9 p -139.65 138.43 36.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 0.0 110.906 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -150.57 168.04 25.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -121.45 144.86 48.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.02 132.37 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -112.36 128.25 56.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.568 ' CE1' HD11 ' A' ' 136' ' ' LEU . 37.7 m-85 -100.27 162.51 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.0 p -67.09 -23.14 65.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.8 t -151.71 150.98 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.873 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.411 ' CG ' ' H ' ' A' ' 185' ' ' THR . 9.7 p80 -51.26 -57.45 8.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.411 ' H ' ' CG ' ' A' ' 184' ' ' HIS . 63.6 m -38.19 -66.6 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.08 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.3 OUTLIER -37.97 -51.09 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -57.29 -57.27 13.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.079 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -40.44 -43.41 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 191' ' ' ILE . . . -65.77 -68.48 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.082 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -35.57 -33.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 195' ' ' HIS . 83.3 mt -66.62 -70.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -62.04 -15.62 45.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.859 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -90.44 -22.7 21.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.077 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.463 HD21 ' NE2' ' A' ' 198' ' ' GLN . 75.7 mt -132.51 23.38 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.8 t60 -89.04 124.59 34.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.425 ' C ' ' HB3' ' A' ' 206' ' ' SER . . . 36.18 29.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.543 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 195' ' ' HIS . 76.4 p -100.14 -35.27 9.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.328 . . . . 0.0 110.846 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.463 ' NE2' HD21 ' A' ' 194' ' ' LEU . 22.4 mt-30 -100.28 155.05 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 25.7 m -129.18 81.51 2.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.448 ' SD ' ' CD ' ' A' ' 145' ' ' GLN . 14.9 mmt -45.67 141.03 4.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.547 0.689 . . . . 0.0 110.93 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.415 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 74.5 Cg_exo -47.97 153.05 2.83 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.708 2.272 . . . . 0.0 112.312 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 79.24 -41.79 2.29 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.446 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.15 140.06 31.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 111.064 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 25.2 t -94.8 -8.82 36.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.8 t -100.06 172.48 7.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.425 ' HB3' ' C ' ' A' ' 196' ' ' GLY . 19.4 m -97.96 145.93 25.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 8.6 tp -42.31 154.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 73.3 t -125.66 104.08 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.4 t -111.72 122.25 65.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -151.31 146.94 26.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 133' ' ' ASP . 34.2 m-85 -47.39 135.33 10.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -87.1 162.11 17.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.1 t0 64.41 42.4 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 27.2 p -64.93 130.55 43.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -104.1 106.08 16.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 217' ' ' GLU . 14.2 tptm -84.94 146.51 27.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 216' ' ' LYS . 7.6 mm-40 -100.46 124.99 46.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 87.7 p -98.93 91.66 5.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 69.65 65.4 2.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.98 173.32 14.65 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.739 2.292 . . . . 0.0 112.367 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.0 t -97.86 -49.35 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 51.3 p -117.33 156.18 28.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.514 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 m 55.56 44.39 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.859 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.0 t -161.41 140.99 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.09 179.12 27.45 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.459 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.2 m -81.79 83.13 7.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -47.75 119.1 2.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.62 137.63 5.86 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.53 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.2 p -63.48 137.31 58.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.07 91.1 3.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -62.59 97.89 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 61.73 41.23 12.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.87 119.5 6.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.474 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.45 89.32 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.472 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -54.5 6.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 0.0 110.902 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -48.83 159.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -118.97 40.02 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -125.91 152.09 46.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.8 mt -137.69 145.82 43.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -109.15 110.77 22.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.4 t -97.68 147.57 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -144.14 -175.81 17.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.519 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.2 mmt 56.45 48.24 17.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.5 mt -109.06 165.1 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -106.75 174.03 6.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -87.71 16.3 5.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -105.99 -22.92 12.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.475 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 16.3 mt-30 -82.25 149.67 27.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.8 p -130.94 172.69 11.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -50.54 -51.03 51.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -52.16 -52.79 49.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -42.53 -67.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.567 HG13 ' CD1' ' A' ' 154' ' ' PHE . 35.9 t -52.87 -51.28 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.136 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.1 mt -54.04 -32.17 53.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -79.61 -37.04 37.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.7 tp -84.35 -14.17 50.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.567 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.4 m-85 -100.22 -35.97 9.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.534 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 3.7 mt-30 -47.18 -49.0 53.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.549 0.69 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.5 Cg_exo -47.98 -17.13 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 72.2 m-85 -100.03 -34.14 10.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.9 169.59 42.55 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.481 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.38 107.75 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 111.126 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.7 mt -79.15 126.27 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -86.47 -65.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -114.65 126.02 54.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 16.7 t -133.15 127.11 33.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.3 m -146.38 149.66 34.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.403 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 77.7 t -114.53 137.89 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 27.2 mt -71.97 148.69 45.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 15.1 mtt85 -158.76 147.31 18.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.56 174.08 54.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.537 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.28 -56.41 2.94 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.397 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -82.74 42.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 40.81 73.05 0.21 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.459 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 173' ' ' SER . 8.3 t -128.29 94.5 3.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.88 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 172' ' ' SER . 1.1 t -35.28 117.35 0.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -81.39 3.64 23.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.1 24.69 76.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.51 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.78 154.78 41.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 110.866 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.403 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -156.45 176.07 13.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.02 124.14 34.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.83 134.72 60.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -114.99 144.28 43.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -118.9 161.13 20.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 17.3 t -59.16 -34.25 71.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.5 t -142.42 171.79 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.416 ' CG ' ' N ' ' A' ' 185' ' ' THR . 44.5 p-80 -64.76 -54.95 23.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.416 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 48.7 m -36.84 -63.92 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 185' ' ' THR . 23.8 mm-40 -37.8 -53.39 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -55.9 -59.13 5.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -40.26 -41.51 1.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -71.4 -63.73 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.68 -34.02 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.112 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 195' ' ' HIS . 72.5 mt -65.89 -71.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -59.15 -13.73 8.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -88.98 -32.05 17.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 32.5 mt -125.78 24.98 6.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.9 t60 -86.68 123.04 31.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 207' ' ' LEU . . . 34.56 32.94 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.455 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 195' ' ' HIS . 82.6 p -100.13 -35.14 9.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 110.874 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.21 155.8 17.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 90.2 m -132.61 77.51 1.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.475 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 11.5 mmt -39.92 139.13 1.0 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.601 0.715 . . . . 0.0 110.845 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.21 150.49 5.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.732 2.288 . . . . 0.0 112.358 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.48 -36.22 2.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -89.58 136.92 32.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.322 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 15.7 t -90.77 -10.87 41.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.847 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.9 t -99.51 172.08 7.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.4 m -99.82 154.79 18.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 196' ' ' GLY . 13.5 tp -54.36 138.16 40.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.454 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 54.1 t -108.09 117.09 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.1 t -123.23 124.8 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.454 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 14.6 ptpt -160.8 144.67 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -47.39 153.28 0.53 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.09 154.21 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.095 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 52.93 52.95 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 47.6 m -100.34 137.6 38.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -137.86 127.33 24.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 10.1 ttpp -129.24 41.77 3.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.67 -49.27 66.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 22.9 t -65.12 -53.11 50.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.828 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.83 161.66 9.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.61 169.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.5 t -87.62 -55.73 3.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.6 t -100.6 114.98 29.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.468 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.6 t -171.63 148.22 2.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.6 m -162.16 118.99 2.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -135.92 58.25 0.67 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.9 p -140.4 164.16 30.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.915 0.388 . . . . 0.0 110.845 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.2 m -138.57 132.06 30.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 141.86 117.26 1.3 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.505 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.0 m -56.34 144.05 32.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.364 . . . . 0.0 110.824 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.66 82.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.8 m -44.93 -45.07 10.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.416 ' HB3' ' NH1' ' A' ' 129' ' ' ARG . 12.2 ttp-105 -105.95 87.08 2.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.87 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.78 -42.01 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.477 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.92 133.76 12.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.518 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.21 74.13 0.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.826 0.346 . . . . 0.0 110.87 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -120.08 129.01 54.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -112.8 40.4 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -128.72 127.15 41.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 181' ' ' PHE . 65.8 mt -119.11 152.21 36.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -119.78 121.02 38.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.23 144.05 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.118 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -138.08 -172.41 12.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.5 mmt 54.05 51.48 14.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.333 . . . . 0.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.2 mt -111.06 155.42 22.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.459 ' ND2' ' HD2' ' A' ' 201' ' ' PRO . 3.2 p30 -91.58 159.49 15.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -81.95 42.67 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.412 ' HG2' ' CG ' ' A' ' 142' ' ' ASN . 6.2 pt20 -133.22 -35.02 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.413 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 34.0 mt-30 -71.12 150.27 45.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.0 p -119.59 -177.85 3.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -63.03 -46.88 85.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -54.71 -50.82 67.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -42.72 -47.68 5.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.57 HG13 ' CD1' ' A' ' 154' ' ' PHE . 95.8 t -70.31 -45.78 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.177 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.445 ' CD2' HD12 ' A' ' 160' ' ' ILE . 86.0 mt -57.57 -32.44 67.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.403 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 16.1 mmt180 -81.35 -35.39 30.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.2 tp -84.32 -16.09 44.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.57 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -100.18 -35.3 9.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.532 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 6.1 mt-30 -47.2 -49.04 53.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.6 0.714 . . . . 0.0 110.865 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.7 Cg_exo -47.96 -17.02 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.707 2.272 . . . . 0.0 112.303 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.475 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 71.3 m-85 -99.9 -36.53 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.62 163.38 35.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.528 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.62 104.84 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.445 HD12 ' CD2' ' A' ' 151' ' ' LEU . 62.2 mt -76.04 128.12 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -76.48 -54.33 6.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -147.07 145.3 29.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 43.1 t -133.74 148.0 51.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.94 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.0 m -151.49 151.5 31.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.161 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.42 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 68.4 t -122.63 146.98 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.19 139.99 30.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.472 ' HD3' ' N ' ' A' ' 173' ' ' SER . 6.7 mmt-85 -133.79 138.85 45.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.85 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -75.33 160.49 52.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.455 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.13 -37.75 18.47 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.259 . . . . 0.0 112.337 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -88.58 40.35 0.96 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 39.77 56.73 2.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.499 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 173' ' ' SER . 4.2 t -136.69 110.38 8.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.472 ' N ' ' HD3' ' A' ' 167' ' ' ARG . 22.6 t -35.46 137.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -97.3 26.88 4.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 49.55 30.57 13.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.48 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 7.1 p -149.79 149.47 30.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -160.03 161.18 33.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -113.71 133.26 55.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 70.4 t -122.81 126.09 73.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -108.63 123.18 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.421 ' CE1' HD13 ' A' ' 136' ' ' LEU . 34.6 m-85 -97.52 168.34 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 84.2 p -68.92 -36.72 78.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.8 m -135.25 171.79 13.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.409 ' H ' ' CD2' ' A' ' 184' ' ' HIS . 7.8 p80 -72.17 -44.71 62.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.4 m -52.24 -59.46 4.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -41.54 -49.68 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -58.05 -59.17 5.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -38.87 -47.37 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.42 -63.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.37 -39.37 1.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 195' ' ' HIS . 73.8 mt -60.99 -72.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -57.34 -12.95 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -87.5 -37.74 16.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.086 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 18.5 mt -120.22 23.53 10.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.0 t60 -83.36 123.03 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.7 33.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.9 p -100.31 -36.51 9.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.798 0.332 . . . . 0.0 110.859 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -100.4 160.66 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 37.9 m -134.16 81.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.413 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 15.9 mmt -41.38 137.47 1.68 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.56 0.695 . . . . 0.0 110.884 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.459 ' HD2' ' ND2' ' A' ' 142' ' ' ASN . 75.5 Cg_exo -48.74 147.06 10.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 0.0 112.317 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.65 -34.44 3.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.482 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.33 141.4 28.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.069 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 57.7 m -93.52 -12.81 28.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 66.7 m -99.53 157.17 16.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.9 m -78.36 172.13 14.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 196' ' ' GLY . 13.7 tp -71.97 140.15 48.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.2 t -106.24 106.72 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.7 t -117.99 120.3 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -159.54 156.29 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -56.23 131.85 49.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -47.66 -69.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -172.95 146.35 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.5 p -115.35 118.65 33.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.76 108.47 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -86.39 114.28 23.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -113.93 -51.25 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 67.5 p -163.41 175.99 10.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 145.56 73.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.53 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.52 131.76 12.51 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.713 2.276 . . . . 0.0 112.321 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 38.4 t -88.96 -53.91 4.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.905 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 72.1 p -38.98 -43.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.471 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.0 p -90.05 158.09 17.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.922 0.391 . . . . 0.0 110.862 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.1 m -77.73 170.55 16.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.3 72.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 t -122.46 113.95 20.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 82.1 p -137.4 114.79 11.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.827 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 169.91 -60.93 0.18 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.7 p -98.2 95.72 7.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 110.843 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -129.46 111.85 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 129' ' ' ARG . 5.6 p -93.42 136.42 33.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -34.89 -60.68 0.44 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.19 -131.65 2.92 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.504 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.9 61.17 7.48 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.472 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -111.92 83.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.0 110.872 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.76 114.43 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 183' ' ' SER . 16.5 ttm180 -100.6 32.35 3.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -117.96 140.77 49.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 mt -117.26 157.6 25.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -125.25 122.11 36.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.9 140.88 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -136.23 -176.98 14.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.466 ' HE2' ' CB ' ' A' ' 205' ' ' SER . 11.5 mmt 60.17 38.26 20.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.2 mt -99.02 154.61 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 144' ' ' GLN . 23.1 p30 -98.11 170.29 9.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -80.57 -0.18 36.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.409 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 57.0 mt-30 -102.05 32.68 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -134.99 154.18 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.4 p -132.25 167.0 20.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -54.41 -44.83 72.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -53.74 -45.9 70.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -50.3 -55.2 16.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.576 HG12 ' CD1' ' A' ' 154' ' ' PHE . 71.8 t -60.87 -46.3 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.469 HD23 ' CB ' ' A' ' 163' ' ' CYS . 35.1 mt -57.97 -39.09 77.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -70.08 -38.87 75.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.9 tp -84.05 -10.32 57.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.576 ' CD1' HG12 ' A' ' 150' ' ' VAL . 3.2 m-85 -100.17 -36.4 9.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.557 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -46.92 -47.03 53.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.638 0.732 . . . . 0.0 110.938 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.0 Cg_exo -47.99 -18.85 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.695 2.263 . . . . 0.0 112.314 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 75.8 m-85 -100.32 -38.07 8.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -172.49 162.7 34.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.8 t -76.41 103.4 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 111.102 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.463 HD13 ' CD2' ' A' ' 151' ' ' LEU . 20.7 mt -73.4 142.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.083 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -103.13 -61.62 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -114.18 119.31 36.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . 0.469 ' CB ' HD23 ' A' ' 151' ' ' LEU . 25.5 t -134.14 121.0 20.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -141.37 151.67 43.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.451 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 95.0 t -116.16 139.93 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 60.0 mt -79.51 147.06 32.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -151.25 170.46 19.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -100.43 171.6 23.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.97 -50.42 9.82 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.257 . . . . 0.0 112.361 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.14 -38.52 86.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.15 -39.36 1.63 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 63.9 m -41.98 146.61 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.82 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.9 t -79.47 143.43 34.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -85.86 12.83 8.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.78 76.01 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -139.37 153.79 47.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.862 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -161.94 157.46 23.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -109.2 144.65 37.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.461 HG11 ' CE1' ' A' ' 181' ' ' PHE . 59.0 t -134.86 126.62 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.13 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -113.8 123.94 51.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.461 ' CE1' HG11 ' A' ' 179' ' ' VAL . 49.2 m-85 -99.79 162.95 12.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.8 t -66.28 -37.34 85.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 134' ' ' ARG . 1.2 t -132.83 158.09 43.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.87 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.5 ' CG ' ' N ' ' A' ' 185' ' ' THR . 26.2 p-80 -59.24 -53.61 56.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.5 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 26.3 m -45.59 -52.73 10.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -47.27 -45.25 23.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.37 -59.27 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -40.19 -38.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -69.53 -63.84 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.071 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.32 -31.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 195' ' ' HIS . 74.7 mt -69.44 -71.51 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -56.73 -15.78 5.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.816 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -87.91 -34.93 17.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.503 HD11 ' CE1' ' A' ' 154' ' ' PHE . 26.0 mt -122.39 25.55 8.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.917 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.9 t60 -89.04 122.18 32.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.862 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.49 32.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 195' ' ' HIS . 60.3 p -100.14 -37.08 9.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.844 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.466 ' NE2' HD21 ' A' ' 207' ' ' LEU . 10.4 pt20 -100.37 161.77 13.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 27.0 m -131.19 84.59 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 16.9 mmt -39.19 139.2 0.81 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.555 0.693 . . . . 0.0 110.856 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.27 137.94 23.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.251 . . . . 0.0 112.331 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.0 3.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.43 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -69.93 139.36 52.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.1 m -92.82 -8.63 42.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.466 ' CB ' ' HE2' ' A' ' 140' ' ' MET . 4.6 t -99.94 170.89 8.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 25.0 m -100.14 145.05 28.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.466 HD21 ' NE2' ' A' ' 198' ' ' GLN . 10.9 tp -44.86 143.72 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.5 t -115.67 108.57 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.77 121.61 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.185 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -157.27 148.35 21.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -45.87 154.54 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.08 144.14 31.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.057 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 51.01 46.44 26.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.8 m -125.96 92.5 3.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -77.15 170.42 16.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.85 145.95 47.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -161.76 154.26 19.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 62.8 p -153.46 119.85 5.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 118.35 96.91 1.81 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.91 -28.06 9.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.357 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 66.2 m -118.5 145.27 45.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 30.2 p -101.34 157.31 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.49 179.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 t 57.28 42.18 25.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.8 p -51.28 -51.95 49.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.3 -43.45 2.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 t -81.98 108.71 15.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.8 p -47.84 118.65 2.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 172.31 104.84 0.18 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.0 p -57.53 146.94 28.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.853 0.359 . . . . 0.0 110.828 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.21 166.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 m -102.6 168.39 9.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.419 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 21.3 mtm105 -150.77 154.04 36.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 132.2 -60.55 0.67 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -149.63 92.68 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.502 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 163.06 9.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -133.93 119.81 19.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.1 mtm-85 -93.98 73.87 4.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.918 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 136' ' ' LEU . 13.3 tppt? -155.64 157.79 37.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.515 HD12 ' CE1' ' A' ' 181' ' ' PHE . 63.6 mt -139.2 135.57 34.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -102.45 117.13 34.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.9 t -106.53 145.43 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -140.03 -164.18 9.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.507 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.9 mmt 48.8 49.77 18.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.4 mt -110.31 153.31 25.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.597 HD22 ' N ' ' A' ' 201' ' ' PRO . 0.4 OUTLIER -95.12 173.96 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -90.38 42.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -134.4 -35.34 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.448 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 26.7 mt-30 -70.88 145.8 50.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.9 p -121.51 -178.53 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -64.69 -35.07 79.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -64.2 -35.67 81.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.56 -65.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.899 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 154' ' ' PHE . 92.8 t -53.72 -53.02 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.415 HD21 ' CB ' ' A' ' 163' ' ' CYS . 70.3 mt -52.46 -39.36 61.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -69.62 -39.5 77.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.5 tp -84.7 -9.28 58.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.571 ' CD1' HG12 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.98 -37.27 9.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.2 tm0? -47.29 -46.76 57.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.597 0.713 . . . . 0.0 110.934 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.3 Cg_exo -47.99 -17.18 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.307 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -100.27 -32.2 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.95 171.71 43.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.8 t -80.79 105.27 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.869 0.366 . . . . 0.0 111.072 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.441 HD11 ' CB ' ' A' ' 154' ' ' PHE . 47.5 mt -75.35 130.06 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.34 -61.31 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.838 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -146.37 145.25 30.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . 0.415 ' CB ' HD21 ' A' ' 151' ' ' LEU . 16.2 t -133.81 118.36 17.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.9 m -124.48 140.1 53.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.154 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.458 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 97.6 t -108.15 138.09 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.1 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.4 mt -77.32 148.22 35.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.461 ' HD3' ' CA ' ' A' ' 173' ' ' SER . 4.8 mmt85 -142.15 136.11 29.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -59.32 -164.08 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.468 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.59 -46.6 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.736 2.291 . . . . 0.0 112.34 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.69 41.12 1.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 53.84 60.95 7.62 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.534 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 173' ' ' SER . 72.1 m -131.71 90.77 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.849 0.357 . . . . 0.0 110.851 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.461 ' CA ' ' HD3' ' A' ' 167' ' ' ARG . 29.2 t -34.53 128.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.881 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -85.98 24.83 1.22 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.886 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 54.69 30.87 52.65 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.472 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 13.7 p -144.27 160.57 40.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 110.847 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -166.76 171.09 11.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -124.53 130.33 52.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.24 131.24 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -114.38 122.62 47.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.515 ' CE1' HD12 ' A' ' 136' ' ' LEU . 37.5 m-85 -94.95 163.96 13.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.8 p -70.46 -26.42 63.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.0 t -143.25 151.48 40.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.544 ' CG ' ' N ' ' A' ' 185' ' ' THR . 17.2 p80 -55.81 -51.62 66.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.544 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 66.4 m -43.03 -66.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.155 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.3 OUTLIER -37.2 -52.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -55.68 -59.26 5.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -38.7 -48.17 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.2 -63.28 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -40.09 -30.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.072 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 195' ' ' HIS . 72.5 mt -69.51 -71.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -64.63 -9.28 18.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -90.29 -25.59 20.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 24.6 mt -133.29 16.11 4.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 191' ' ' ILE . 2.0 t60 -87.89 126.45 35.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.854 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 45.66 20.15 0.37 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.526 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 60.4 p -100.38 -37.35 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.469 ' HG3' ' N ' ' A' ' 199' ' ' THR . 1.5 tt0 -100.44 156.26 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.469 ' N ' ' HG3' ' A' ' 198' ' ' GLN . 85.9 m -127.61 80.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.461 ' HE1' ' NE2' ' A' ' 198' ' ' GLN . 20.1 mmt -37.03 137.85 0.56 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.573 0.701 . . . . 0.0 110.859 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.597 ' N ' HD22 ' A' ' 142' ' ' ASN . 72.8 Cg_exo -47.21 154.29 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.7 2.267 . . . . 0.0 112.343 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.7 -45.92 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.498 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -79.14 136.08 37.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.086 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.4 t -87.48 -11.57 48.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 71.0 m -99.41 163.66 12.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.817 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 58.8 p -80.91 174.52 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.61 155.38 37.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.468 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 49.2 t -122.62 104.35 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 12.0 t -118.58 121.53 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.148 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.468 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 12.7 ptpt -159.15 146.5 17.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -40.76 142.98 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.43 163.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -58.44 101.7 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 20.8 p -91.82 146.94 23.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -165.72 110.99 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -145.76 153.31 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -161.46 154.01 20.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 46.4 t -145.72 132.34 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 153.97 -176.86 31.72 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 221' ' ' SER . 62.5 Cg_endo -76.91 42.27 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.665 2.243 . . . . 0.0 112.357 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 220' ' ' PRO . 60.6 p 37.17 40.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.3 t -69.83 -54.61 12.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.843 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 82.5 p -123.52 146.41 48.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.1 p -76.66 158.56 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.9 160.77 28.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.7 t -159.28 151.72 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 0.0 110.873 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.0 t -85.99 -60.79 1.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.859 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.72 124.86 0.92 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.532 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.1 t -90.84 126.55 36.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.855 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.64 41.65 3.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.6 m -110.3 153.03 25.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -112.02 99.74 8.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.42 138.81 2.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.489 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.47 -172.4 42.8 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.529 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -148.45 161.6 41.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 39.23 39.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -79.5 45.96 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -126.07 120.55 30.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.462 HD23 ' CD1' ' A' ' 191' ' ' ILE . 78.6 mt -106.97 154.67 20.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -121.59 115.26 22.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.36 149.3 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -142.73 -176.59 16.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.5 mmt 59.28 38.68 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.828 0.347 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 36.1 mt -98.98 153.65 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -105.27 164.88 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -77.61 47.6 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -133.77 -34.1 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.496 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 6.3 mt-30 -82.31 140.04 33.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.6 p -119.22 171.56 8.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -47.94 -51.92 21.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -54.93 26.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -43.14 -65.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.567 HG12 ' CE1' ' A' ' 154' ' ' PHE . 71.0 t -49.05 -62.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.466 ' CD2' HD12 ' A' ' 160' ' ' ILE . 29.4 mt -46.85 -37.3 8.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -69.9 -39.78 76.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.8 tp -83.83 -9.83 58.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 150' ' ' VAL . 3.2 m-85 -100.26 -36.19 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -46.99 -47.07 54.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.558 0.694 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.1 Cg_exo -47.94 -18.38 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.706 2.271 . . . . 0.0 112.329 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.44 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 76.4 m-85 -101.4 -45.33 5.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.05 156.72 27.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 83.1 t -74.86 95.34 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 111.12 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.466 HD12 ' CD2' ' A' ' 151' ' ' LEU . 40.3 mt -65.98 143.74 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.443 ' N ' HG21 ' A' ' 160' ' ' ILE . 0.9 OUTLIER -91.48 -59.7 2.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -138.69 137.15 36.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . 0.462 ' HB2' ' CD2' ' A' ' 151' ' ' LEU . 42.7 t -134.06 143.3 47.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 99.4 m -151.76 140.34 20.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.47 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 79.0 t -105.31 141.35 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 32.4 mt -81.57 142.2 33.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -150.92 170.89 18.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -97.17 -170.18 33.49 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.509 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.28 -20.36 12.69 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.673 2.249 . . . . 0.0 112.356 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.27 -31.72 21.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 132.07 -30.52 3.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 16.3 t -53.66 157.85 2.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 0.0 110.88 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.9 t -101.47 146.47 27.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.84 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -84.51 0.88 48.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 75.37 30.2 58.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.492 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.18 151.37 30.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -152.91 178.14 9.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -128.87 125.78 38.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.74 123.42 70.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.179 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.38 122.26 45.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.46 164.8 12.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.856 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.6 t -66.31 -35.76 81.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.1 t -137.65 168.12 20.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -66.15 -60.06 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.7 m -39.67 -52.74 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -47.3 -49.96 22.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -61.22 -55.97 25.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -39.97 -42.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -68.45 -64.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.52 -35.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.462 ' CD1' HD23 ' A' ' 136' ' ' LEU . 61.8 mt -67.15 -70.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -56.21 -13.59 2.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.44 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -89.62 -39.72 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.497 HD11 ' CE1' ' A' ' 154' ' ' PHE . 23.1 mt -118.23 29.19 7.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.3 t60 -96.32 122.54 39.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 42.36 24.15 0.2 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.531 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 195' ' ' HIS . 51.3 p -100.26 -37.44 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 0.0 110.877 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.472 ' NE2' ' HB3' ' A' ' 194' ' ' LEU . 1.9 pt20 -100.54 151.18 21.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 59.9 m -123.97 86.08 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.496 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 16.9 mmt -43.7 139.66 2.71 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.539 0.685 . . . . 0.0 110.895 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.67 151.14 5.38 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 82.31 -47.97 3.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.459 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -77.24 148.53 35.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.09 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 45.1 t -94.86 -17.76 21.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.2 m -100.07 164.71 11.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.921 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.0 p -79.13 -174.91 4.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.875 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.41 152.29 25.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -118.15 107.75 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.5 t -116.47 121.24 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.139 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -157.85 149.43 21.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -55.0 152.73 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -91.99 -41.49 10.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.099 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -136.26 126.12 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 215' ' ' ASP . 90.6 m -150.34 164.41 35.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 214' ' ' THR . 5.4 t70 -107.76 -60.36 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -109.36 156.5 19.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -82.08 130.27 35.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t 68.19 37.03 2.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.815 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 45.05 -152.15 0.72 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.76 133.49 13.71 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.627 2.218 . . . . 0.0 112.384 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.1 p -45.98 135.23 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 70.9 m -78.71 -60.4 2.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.816 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.975 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 t 63.15 42.17 7.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.2 m -124.93 124.92 43.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.54 -120.32 0.97 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.449 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.4 t -39.33 -44.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.851 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.2 t -72.24 155.02 40.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.807 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 152.42 154.96 6.86 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.506 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.3 m -78.26 139.14 38.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.21 37.38 3.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.7 m -69.15 92.96 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.877 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.92 117.4 19.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 131.29 159.24 9.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.33 121.93 0.8 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.526 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.75 79.37 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.842 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.48 138.86 46.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -125.48 48.35 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.495 ' HE2' ' CD1' ' A' ' 178' ' ' PHE . 48.2 tttt -137.04 136.23 38.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.8 mt -121.31 152.5 38.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -117.72 114.95 24.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.55 146.77 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -145.33 -178.99 21.31 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.4 mmt 55.59 48.23 19.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.47 ' CD2' HD12 ' A' ' 207' ' ' LEU . 42.4 mt -106.37 165.23 11.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -105.41 165.04 11.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.73 41.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -128.75 -35.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.35 152.97 36.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.7 p -129.23 178.9 6.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.411 ' HG3' ' CG2' ' A' ' 165' ' ' VAL . 5.2 mt-10 -57.02 -41.44 78.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.59 -55.03 38.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -43.2 -64.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.569 HG11 ' CE1' ' A' ' 154' ' ' PHE . 66.4 t -49.96 -60.76 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.461 ' CD2' HD11 ' A' ' 160' ' ' ILE . 35.8 mt -47.37 -37.61 11.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -69.48 -40.17 77.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.6 tp -83.81 -10.27 58.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.569 ' CE1' HG11 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.64 -35.54 9.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.0 tt0 -47.04 -46.96 55.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.601 0.715 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.2 Cg_exo -48.02 -17.13 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.621 2.214 . . . . 0.0 112.349 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.567 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 73.8 m-85 -100.63 -37.06 8.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.12 165.2 38.53 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.8 t -80.79 93.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.785 0.326 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.461 HD11 ' CD2' ' A' ' 151' ' ' LEU . 51.5 mt -65.37 129.31 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -77.77 -64.64 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -132.35 137.78 47.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . 0.439 ' CB ' HD23 ' A' ' 151' ' ' LEU . 42.8 t -134.07 139.21 45.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.1 m -144.44 153.88 42.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.153 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.411 ' CG2' ' HG3' ' A' ' 147' ' ' GLU . 81.6 t -113.41 147.69 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.163 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.0 mt -87.87 148.31 24.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -150.2 164.2 36.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.05 -153.18 30.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.499 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.09 -47.72 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.67 2.247 . . . . 0.0 112.303 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -86.87 43.73 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 46.57 39.08 10.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.454 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.0 m -102.89 119.46 38.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 110.823 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.1 t -58.83 133.68 56.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.841 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -89.99 11.64 19.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 67.68 25.69 73.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.65 153.36 41.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 110.868 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -156.34 159.21 38.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.495 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 49.1 m-85 -108.98 141.12 41.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.76 125.4 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.65 125.63 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -99.71 162.47 12.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.3 t -63.53 -30.7 71.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.0 m -141.39 168.95 18.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -68.23 -52.45 33.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 99.3 m -44.85 -61.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -40.04 -45.76 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.0 -54.44 34.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -43.36 -36.18 1.81 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.54 -59.72 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -45.61 -30.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.481 ' O ' ' N ' ' A' ' 195' ' ' HIS . 67.9 mt -68.43 -72.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -59.53 -17.3 31.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.567 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -80.51 -36.38 33.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.505 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 14.9 mt -123.28 23.05 9.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.2 t60 -87.24 124.34 33.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.87 30.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.525 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.08 -36.6 9.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.809 0.338 . . . . 0.0 110.872 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.37 159.55 15.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 30.0 m -134.47 81.04 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.175 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.6 mmt -41.55 140.28 1.35 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.584 0.707 . . . . 0.0 110.865 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.08 139.51 20.62 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.737 2.291 . . . . 0.0 112.328 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 90.47 -47.91 3.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.508 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -78.98 126.84 31.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.761 0.315 . . . . 0.0 111.147 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.8 t -83.26 -7.39 59.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.826 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.8 p -100.11 157.7 16.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -87.13 144.64 26.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.47 HD12 ' CD2' ' A' ' 141' ' ' LEU . 14.3 tp -44.57 144.63 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.943 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 63.6 t -112.74 114.61 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.5 t -125.5 119.59 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.128 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -158.43 150.6 21.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -49.72 148.51 2.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -84.85 163.28 19.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.114 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -61.31 86.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 15.1 t -89.57 44.91 1.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.146 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -141.14 109.11 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -65.57 -52.64 50.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -101.01 171.93 7.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 81.8 p -83.23 146.14 28.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -64.21 -146.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.515 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.96 122.18 7.06 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.668 2.245 . . . . 0.0 112.322 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.9 p -170.92 176.12 4.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 88.7 p -92.54 141.23 28.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.9 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 -179.951 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.8 t -134.98 167.35 21.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.923 0.392 . . . . 0.0 110.833 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.3 t -93.0 -61.58 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.815 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.08 51.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.9 p -93.9 134.5 36.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.358 . . . . 0.0 110.842 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 82.4 p -100.4 87.35 3.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.93 179.77 43.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.438 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.9 p -143.41 114.32 7.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.885 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -89.78 164.83 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.1 p -82.13 154.04 25.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -80.55 -54.19 5.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . 99.56 -42.99 1.88 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.519 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . -35.65 139.22 0.26 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.51 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 133' ' ' ASP . 17.9 ttt180 -122.07 -53.35 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.35 . . . . 0.0 110.867 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 132' ' ' ARG . 1.3 t70 -34.69 110.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -84.33 32.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 136' ' ' LEU . 2.9 tppp? -120.91 156.38 32.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.51 HD12 ' CE1' ' A' ' 181' ' ' PHE . 96.6 mt -136.32 144.94 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -112.92 122.48 47.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 t -113.05 144.45 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.21 -169.01 11.45 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.8 mmt 52.34 39.37 27.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.402 HD21 ' CD ' ' A' ' 145' ' ' GLN . 26.8 mt -100.26 145.51 28.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -89.64 -177.76 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.17 -7.24 59.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -99.99 29.4 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.936 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.418 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 59.8 mt-30 -127.04 105.56 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.946 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.1 p -103.08 166.32 10.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -43.8 -41.85 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -59.55 -48.11 82.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -50.52 -54.43 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.568 HG12 ' CD1' ' A' ' 154' ' ' PHE . 73.6 t -66.62 -55.93 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.441 ' CD2' HD11 ' A' ' 160' ' ' ILE . 73.6 mt -50.9 -33.61 24.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.422 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 15.2 mmm180 -77.65 -37.51 49.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.2 tp -84.31 -12.84 53.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.568 ' CD1' HG12 ' A' ' 150' ' ' VAL . 3.6 m-85 -100.46 -37.21 8.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.52 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 4.6 mt-30 -47.07 -49.31 51.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.541 0.686 . . . . 0.0 110.929 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.94 -17.19 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.717 2.278 . . . . 0.0 112.339 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 193' ' ' ALA . 73.3 m-85 -100.87 -39.98 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.77 155.67 27.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 69.6 t -71.43 93.9 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.441 HD11 ' CD2' ' A' ' 151' ' ' LEU . 75.1 mt -61.82 143.44 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -92.44 -59.53 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -140.5 144.44 36.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 3.7 t -134.02 133.14 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.7 m -137.2 125.75 23.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.464 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 58.8 t -96.95 151.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.4 mt -95.67 136.54 35.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.408 ' C ' ' HG3' ' A' ' 174' ' ' LYS . 18.2 mtt85 -125.71 135.42 52.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -59.16 -166.22 0.15 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.465 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.53 -48.76 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.14 -35.45 59.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.872 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 106.86 50.19 0.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 36.7 t -124.57 -75.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.7 m -174.99 153.5 1.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.408 ' HG3' ' C ' ' A' ' 167' ' ' ARG . 10.4 mttp -107.09 -4.46 18.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.84 24.86 70.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.32 160.07 42.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 110.898 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.45 158.39 20.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.426 ' HB3' ' NZ ' ' A' ' 135' ' ' LYS . 76.8 m-85 -112.27 132.98 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.407 HG11 ' N ' ' A' ' 180' ' ' LYS . 48.8 t -124.22 137.96 55.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.407 ' N ' HG11 ' A' ' 179' ' ' VAL . 23.9 ttmt -119.13 135.88 54.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.51 ' CE1' HD12 ' A' ' 136' ' ' LEU . 43.2 m-85 -107.94 167.93 9.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.5 t -71.44 -23.89 61.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.5 m -143.84 176.23 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.837 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -80.33 -42.23 23.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.812 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.4 m -53.56 -58.0 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -42.92 -47.3 5.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -59.65 -60.31 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.118 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -39.71 -41.67 1.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.39 -63.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.16 -32.69 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.127 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 195' ' ' HIS . 40.5 mt -66.34 -71.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.138 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -59.25 -10.98 3.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 157' ' ' PHE . . . -96.2 -24.44 16.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.424 HD21 ' NE2' ' A' ' 198' ' ' GLN . 30.2 mt -131.42 24.42 4.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 191' ' ' ILE . 2.4 t60 -90.6 119.8 31.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.69 33.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 195' ' ' HIS . 38.3 p -100.27 -38.07 8.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.826 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.424 ' NE2' HD21 ' A' ' 194' ' ' LEU . 18.3 mt-30 -100.53 163.2 12.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 26.3 m -129.93 84.58 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.418 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 21.4 mmt -40.52 137.9 1.29 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.612 0.72 . . . . 0.0 110.866 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.49 143.89 14.86 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.303 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 82.28 -40.15 2.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.507 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.66 138.85 35.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 90.9 p -92.42 -9.48 41.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.4 m -99.03 167.19 10.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.4 m -92.48 154.1 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 196' ' ' GLY . 11.6 tp -51.55 141.28 16.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.6 t -112.1 111.66 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.3 133.3 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -165.7 144.12 6.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -41.69 155.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' A' ' 135' ' ' LYS . . . -104.93 115.93 31.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.2 t70 70.5 53.99 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.7 m -126.7 127.5 45.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.155 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -161.44 166.59 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.897 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -64.16 112.31 2.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -72.05 -54.63 9.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.7 t -39.36 -47.99 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 106.29 -144.85 15.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.452 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.05 111.74 3.4 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.32 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.7 p -95.15 176.58 6.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 93.4 p -68.45 112.28 5.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.877 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.9 m -135.43 127.68 30.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.6 m -138.05 120.89 16.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.802 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.93 151.26 10.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.527 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.2 t -58.75 155.49 12.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.8 t -171.75 113.15 0.33 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -175.22 -138.93 2.9 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.513 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.1 m -141.41 144.45 34.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.832 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.87 174.48 11.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 m -71.31 122.67 20.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.406 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 19.4 mtm105 -111.29 117.53 33.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -103.73 -138.91 9.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.89 151.31 4.42 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.473 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.09 167.62 19.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 110.893 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -150.78 136.95 18.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.429 ' NH1' ' HB2' ' A' ' 134' ' ' ARG . 20.3 mtm105 -105.41 30.01 6.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.843 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -116.0 141.47 48.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.522 HD13 ' CE1' ' A' ' 181' ' ' PHE . 44.7 mt -120.09 153.78 35.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -120.44 120.13 35.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.69 147.62 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -141.04 -170.54 12.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.6 mmt 54.91 34.11 21.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.427 ' CD2' HD13 ' A' ' 207' ' ' LEU . 47.0 mt -93.31 153.52 18.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -106.95 165.58 11.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -77.32 46.9 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -133.81 -34.55 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -81.23 145.48 30.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 77.1 p -125.6 169.86 12.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -49.57 -46.84 49.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -54.61 -53.28 56.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -45.56 -65.69 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.568 HG13 ' CE1' ' A' ' 154' ' ' PHE . 95.2 t -48.9 -60.29 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.09 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.462 ' CD2' HD11 ' A' ' 160' ' ' ILE . 35.2 mt -47.53 -40.09 17.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -69.69 -39.42 76.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.1 tp -84.8 -9.1 58.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.573 ' CE1' ' CD1' ' A' ' 194' ' ' LEU . 3.2 m-85 -100.34 -37.32 8.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -47.29 -46.87 57.65 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 0.0 110.877 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.9 Cg_exo -48.0 -18.46 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.654 2.236 . . . . 0.0 112.366 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.565 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 75.5 m-85 -100.38 -47.32 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.57 164.77 33.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.51 104.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.462 HD11 ' CD2' ' A' ' 151' ' ' LEU . 45.1 mt -76.91 131.47 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.43 -64.38 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -122.37 132.21 54.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . 0.462 ' CB ' HD21 ' A' ' 151' ' ' LEU . 34.9 t -132.73 136.79 46.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 96.4 m -153.7 152.81 31.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.466 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 65.6 t -117.12 148.24 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.09 140.52 29.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -145.19 175.38 10.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -96.43 -155.17 30.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.07 -40.1 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.254 . . . . 0.0 112.312 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 171' ' ' GLY . 12.3 p-10 -107.05 70.94 0.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 170' ' ' ASP . . . 34.82 40.56 0.21 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.486 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -102.44 97.76 7.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 12.6 t -56.93 142.15 42.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -101.11 26.52 6.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 51.86 29.4 26.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 17.0 p -144.28 151.48 39.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.466 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -160.18 166.12 30.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -117.72 144.94 44.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 26.6 t -137.51 121.54 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -103.89 129.86 51.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.522 ' CE1' HD13 ' A' ' 136' ' ' LEU . 36.4 m-85 -103.66 164.73 11.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 88.2 p -63.49 -33.12 74.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.6 m -141.49 179.05 7.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -75.44 -51.85 12.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 31.0 m -48.83 -53.32 19.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.101 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -47.04 -47.98 22.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.419 ' HB3' ' CD1' ' A' ' 136' ' ' LEU . . . -62.37 -57.57 10.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.132 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -40.71 -40.67 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -67.36 -61.1 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.61 -31.67 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.095 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 195' ' ' HIS . 74.6 mt -67.5 -71.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.175 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -57.17 -13.64 3.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.565 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.72 -41.15 14.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.573 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 33.2 mt -113.51 16.26 18.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -83.03 126.21 32.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 37.94 28.43 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.541 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 195' ' ' HIS . 77.2 p -100.4 -39.61 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.351 . . . . 0.0 110.843 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.468 ' NE2' ' CE ' ' A' ' 200' ' ' MET . 6.6 pt20 -100.66 160.83 14.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 200' ' ' MET . 96.3 m -135.0 81.14 1.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.468 ' CE ' ' NE2' ' A' ' 198' ' ' GLN . 26.5 mmt -37.72 137.84 0.67 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.582 0.706 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.77 153.66 3.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 2.286 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 78.33 -42.88 2.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.509 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.62 138.23 35.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.9 t -87.22 -13.41 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 6.0 t -100.08 169.61 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 24.6 p -87.86 -174.81 4.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 141' ' ' LEU . 11.7 tp -86.86 122.67 31.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.53 109.48 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.101 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 36.4 t -118.22 124.81 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.083 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -164.33 150.6 10.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -46.5 163.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -89.14 152.55 21.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.08 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -42.08 123.8 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 13.8 t -126.04 159.93 31.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.084 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -77.25 96.29 4.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -84.11 145.85 28.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -126.49 42.05 3.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 90.7 p -107.98 171.98 7.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -146.35 159.54 27.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.69 171.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.619 2.212 . . . . 0.0 112.341 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.0 m -143.14 158.29 43.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.3 t -126.31 158.05 36.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.508 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 66.0 m -44.09 150.92 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.6 t -68.48 118.36 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 60.35 94.57 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.503 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.2 m -46.57 167.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.867 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.5 m -97.51 165.59 11.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.884 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 42.27 80.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.472 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.8 m -115.63 165.8 12.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.868 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -79.74 10.6 3.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.9 m -102.66 -41.33 6.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.89 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.81 130.88 4.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -133.87 170.17 22.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.446 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.27 -146.7 20.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.508 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.18 155.09 2.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.797 0.332 . . . . 0.0 110.879 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -94.87 -54.3 3.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.407 ' HB2' ' NH1' ' A' ' 134' ' ' ARG . 23.6 mtm105 48.28 36.1 6.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -133.52 109.82 9.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 181' ' ' PHE . 37.3 mt -96.41 150.52 20.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -116.13 113.27 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.86 143.71 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -140.02 -171.56 12.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.491 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.4 mmt 51.6 42.4 29.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 49.6 mt -102.19 157.33 16.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -99.17 168.12 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -84.14 37.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -127.62 -44.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -62.9 146.79 52.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 53.5 p -122.81 178.31 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.3 -48.19 81.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.876 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -54.18 -50.23 67.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -44.98 -68.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.572 HG11 ' CD1' ' A' ' 154' ' ' PHE . 46.9 t -49.04 -60.31 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.465 ' CD2' HG22 ' A' ' 160' ' ' ILE . 35.4 mt -46.48 -38.06 8.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -69.21 -40.4 78.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.93 -10.55 57.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.572 ' CD1' HG11 ' A' ' 150' ' ' VAL . 3.1 m-85 -98.83 -35.75 10.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.3 OUTLIER -47.18 -46.94 56.58 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.551 0.691 . . . . 0.0 110.908 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.6 Cg_exo -48.0 -16.95 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.639 2.226 . . . . 0.0 112.359 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 193' ' ' ALA . 72.7 m-85 -99.85 -46.83 5.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.1 174.49 36.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.5 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.4 t -87.6 102.32 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.465 HG22 ' CD2' ' A' ' 151' ' ' LEU . 23.7 mt -74.07 134.37 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.46 -60.36 2.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -139.9 142.26 36.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . 0.42 ' CB ' HD22 ' A' ' 151' ' ' LEU . 9.8 t -134.01 144.78 48.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.6 m -153.81 144.08 22.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.23 139.52 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 67.4 mt -76.94 139.63 40.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 20.2 mtt85 -143.78 163.18 34.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.98 -169.97 38.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.479 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.97 -46.62 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.672 2.248 . . . . 0.0 112.372 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -62.97 -40.1 96.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 125.73 43.66 0.28 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.505 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.0 t -126.49 122.08 34.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.809 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.2 t -61.87 142.24 57.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.848 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -89.63 17.9 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 59.46 28.95 65.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 6.2 p -145.93 156.43 43.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -160.47 172.1 17.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -126.61 124.01 38.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 85.7 t -115.9 130.58 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.408 ' O ' ' CG2' ' A' ' 160' ' ' ILE . 20.7 ttmt -111.9 131.22 55.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.454 ' CE1' HD11 ' A' ' 136' ' ' LEU . 40.9 m-85 -105.77 166.8 10.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.7 t -81.53 -3.14 52.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.0 m -162.96 149.76 12.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.858 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -59.84 -46.04 90.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.7 m -48.71 -61.14 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.108 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 181' ' ' PHE . 0.5 OUTLIER -42.33 -51.24 4.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -57.75 -56.84 16.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -38.62 -51.51 1.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.955 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.39 -61.21 2.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -40.99 -35.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 195' ' ' HIS . 63.4 mt -65.69 -69.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -62.25 -14.56 39.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.91 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -90.84 -25.03 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.497 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 76.9 mt -130.06 23.03 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -85.95 123.66 31.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 207' ' ' LEU . . . 34.15 39.46 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.478 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 22.6 p -100.09 -37.73 8.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -100.57 164.82 11.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 200' ' ' MET . 28.6 m -135.01 79.7 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.155 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 199' ' ' THR . 15.0 mmt -38.36 138.42 0.73 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.606 0.717 . . . . 0.0 110.853 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.27 145.18 11.74 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.42 -39.19 2.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.532 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -83.83 129.03 34.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.3 m -84.98 -7.51 59.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.8 t -99.3 170.4 8.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.1 m -99.94 151.97 20.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 196' ' ' GLY . 16.4 tp -53.19 137.82 33.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.62 119.34 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.01 117.52 49.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.073 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -158.05 153.01 25.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -52.7 139.97 24.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.09 162.18 22.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -54.16 113.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 82.4 p -101.35 108.17 19.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -122.5 168.61 11.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -106.18 -48.71 3.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -126.69 165.24 19.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.3 t -101.43 146.11 28.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 94.38 69.85 1.09 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.544 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.68 104.14 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.684 2.256 . . . . 0.0 112.314 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.3 t -69.0 84.04 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 59.7 p -49.46 142.7 7.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -105.63 163.65 12.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.1 p -67.77 157.23 35.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.15 134.45 2.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 m -99.87 148.64 24.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 71.3 m -96.77 163.1 13.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.14 -75.43 1.14 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.513 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.3 t -85.24 135.95 33.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.855 0.359 . . . . 0.0 110.864 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -100.56 145.09 28.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 t -72.12 145.1 48.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -43.03 143.9 0.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -116.66 175.05 15.54 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.27 151.26 38.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.506 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -128.18 130.03 47.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.898 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.18 119.29 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -84.12 44.34 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -119.56 142.29 48.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.8 mt -126.75 156.79 40.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -125.77 115.96 20.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.5 t -100.8 153.93 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.126 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -144.42 -172.88 15.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.0 mmt 51.11 50.14 19.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.418 ' HB2' ' C ' ' A' ' 175' ' ' GLY . 34.1 mt -107.71 154.97 20.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -99.43 171.06 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -86.26 28.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.89 -31.44 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.439 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 6.6 mt-30 -79.62 147.02 32.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.2 p -124.62 -176.61 3.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -62.69 -44.29 96.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -57.03 -45.16 83.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -52.33 -58.94 5.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.576 HG13 ' CD1' ' A' ' 154' ' ' PHE . 83.6 t -57.4 -50.49 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.464 ' CD2' HD13 ' A' ' 160' ' ' ILE . 33.9 mt -55.54 -39.49 70.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -70.05 -38.68 75.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.8 tp -84.22 -10.47 57.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.576 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.2 m-85 -100.15 -35.93 9.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.562 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.01 -46.92 54.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.601 0.715 . . . . 0.0 110.936 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.97 -17.13 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 193' ' ' ALA . 74.8 m-85 -101.66 -44.59 5.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.36 164.72 35.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.18 103.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.352 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.464 HD13 ' CD2' ' A' ' 151' ' ' LEU . 44.0 mt -75.25 137.79 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.97 -61.89 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.78 134.9 47.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . 0.447 ' CB ' HD21 ' A' ' 151' ' ' LEU . 36.7 t -134.08 135.12 43.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 80.4 m -147.76 145.3 28.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.109 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 77.3 t -112.56 148.02 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 40.6 mt -88.8 135.63 33.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.415 ' C ' ' HG3' ' A' ' 174' ' ' LYS . 64.7 mtm-85 -116.79 143.68 45.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -64.35 -178.31 5.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.541 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -46.08 -46.99 15.28 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.692 2.261 . . . . 0.0 112.322 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 171' ' ' GLY . 26.5 t70 -84.46 38.27 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.799 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 170' ' ' ASP . . . 34.22 61.43 0.53 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.522 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.51 -74.78 0.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.371 . . . . 0.0 110.862 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 t -167.79 143.67 3.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.834 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.415 ' HG3' ' C ' ' A' ' 167' ' ' ARG . 19.5 mttm -111.01 -4.38 15.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.418 ' C ' ' HB2' ' A' ' 141' ' ' LEU . . . 82.83 -3.33 83.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.472 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.3 169.0 16.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.835 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -164.67 173.59 11.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -123.94 132.39 53.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 64.1 t -125.61 131.58 71.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -117.45 113.11 21.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -86.26 166.35 15.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 95.6 p -68.47 -35.17 77.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -134.51 164.92 26.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -65.92 -50.97 62.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.91 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.4 m -48.96 -62.39 1.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.179 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -44.38 -42.05 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -59.39 -60.56 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -45.76 -50.28 14.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -50.28 -55.57 14.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.1 -35.68 59.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 58.3 mt -64.87 -68.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -57.88 -12.39 3.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 157' ' ' PHE . . . -91.08 -39.02 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.568 HD11 ' CE1' ' A' ' 154' ' ' PHE . 28.6 mt -115.2 25.68 10.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.8 t60 -88.72 122.62 32.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.61 33.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 195' ' ' HIS . 23.5 p -100.22 -38.33 8.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 110.866 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -100.52 162.47 12.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 47.5 m -132.75 84.1 2.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.439 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 14.6 mmt -39.93 137.92 1.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.568 0.699 . . . . 0.0 110.881 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.83 144.46 15.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.659 2.24 . . . . 0.0 112.332 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.34 -40.93 3.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.515 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -83.36 142.42 31.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 111.108 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 73.9 p -94.2 -12.65 27.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.7 m -98.94 157.94 15.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.7 m -78.27 174.94 10.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 196' ' ' GLY . 9.9 tp -73.97 145.6 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.926 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 57.3 t -113.46 111.51 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.6 t -122.27 123.6 69.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.093 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -161.81 149.56 14.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -47.25 142.49 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.95 94.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.02 43.77 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 13.3 t -85.22 42.11 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -42.07 149.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -106.4 42.26 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -44.18 136.36 3.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 36.0 t -72.18 164.33 26.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 168.25 74.43 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 42.66 1.15 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.676 2.251 . . . . 0.0 112.325 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 20.5 t -87.81 81.99 7.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.888 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 57.7 p -135.39 147.07 48.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.5 t -132.09 156.1 46.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.367 . . . . 0.0 110.839 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.1 m -146.85 138.87 24.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.819 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.67 73.49 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.471 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.5 m -124.84 86.04 2.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.837 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.2 m -72.52 144.98 47.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.96 -149.69 17.75 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.7 m -121.13 105.29 10.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.862 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -48.63 -46.23 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 77.6 p -119.8 149.62 41.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.857 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -106.55 -51.36 2.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 167.89 60.79 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.532 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.85 -88.23 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 53.6 37.01 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 110.885 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -103.72 146.68 28.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 78.9 mtm-85 -73.26 -31.53 64.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -96.0 140.63 30.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.46 HD22 ' CD1' ' A' ' 191' ' ' ILE . 18.9 mt -121.7 153.86 37.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -116.0 109.99 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.54 139.29 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -133.83 -173.05 13.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.452 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.468 ' HE3' ' CB ' ' A' ' 205' ' ' SER . 11.9 mmt 57.36 43.32 23.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 43.6 mt -102.23 156.89 17.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -96.23 161.32 14.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -81.98 43.12 0.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -134.38 -37.84 0.85 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.492 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 5.9 mt-30 -67.87 151.36 47.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.0 p -129.6 164.27 24.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -44.33 -48.52 9.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.24 -54.42 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -42.55 -67.79 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 154' ' ' PHE . 99.7 t -49.63 -61.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.439 ' CD2' HD13 ' A' ' 160' ' ' ILE . 34.2 mt -44.83 -38.25 4.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -69.45 -40.52 77.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.93 -9.38 58.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.53 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.2 m-85 -100.26 -35.81 9.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.564 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.13 -46.97 56.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.92 -16.67 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.325 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.568 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.4 m-85 -99.69 -41.95 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.22 168.02 37.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.62 134.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.153 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.439 HD13 ' CD2' ' A' ' 151' ' ' LEU . 75.4 mt -109.04 109.08 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.143 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' LYS . 18.5 m-20 -45.3 -61.28 1.73 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.875 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -157.88 148.43 20.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 20.6 t -133.74 135.61 44.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.8 m -139.44 141.9 37.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.69 135.06 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.25 144.55 42.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -150.39 148.76 29.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.34 163.55 35.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.472 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.26 -37.02 18.11 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.702 2.268 . . . . 0.0 112.357 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.25 39.03 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 42.88 53.09 5.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.532 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 173' ' ' SER . 22.5 p -121.59 90.01 3.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.902 0.382 . . . . 0.0 110.881 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 172' ' ' SER . 27.4 t -35.03 133.09 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.83 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.5 mttm -87.71 23.32 2.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.875 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 50.48 33.65 25.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 29.7 m -150.03 169.05 22.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 110.856 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -165.69 179.24 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -133.98 118.7 18.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.452 HG12 ' CE1' ' A' ' 181' ' ' PHE . 97.9 t -110.85 118.91 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 161' ' ' ASP . 13.4 ttmm -105.02 117.91 35.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.944 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.452 ' CE1' HG12 ' A' ' 179' ' ' VAL . 35.9 m-85 -93.29 154.14 18.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 m -57.4 -41.04 79.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -134.38 136.01 43.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.425 ' CD2' ' H ' ' A' ' 185' ' ' THR . 7.6 p-80 -38.57 -56.32 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.425 ' H ' ' CD2' ' A' ' 184' ' ' HIS . 94.3 m -37.53 -67.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -41.03 -43.62 2.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.0 -53.95 48.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -45.21 -46.93 12.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -60.94 -65.74 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.4 -38.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 195' ' ' HIS . 62.3 mt -61.63 -71.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.146 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -57.09 -13.14 2.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.568 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -90.94 -32.33 16.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.125 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.508 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 40.8 mt -122.43 20.64 10.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -86.53 123.96 32.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 41.52 28.36 0.36 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 82.9 p -100.53 -38.67 8.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.862 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.536 ' NE2' ' CD2' ' A' ' 207' ' ' LEU . 9.7 pt20 -100.58 146.0 27.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 200' ' ' MET . 86.9 m -123.91 80.25 1.79 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.147 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.492 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 14.1 mmt -34.58 138.1 0.34 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.558 0.694 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.63 151.58 7.43 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.733 2.289 . . . . 0.0 112.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.69 -43.9 2.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -78.84 136.33 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 111.097 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 70.1 m -86.49 -13.0 47.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.468 ' CB ' ' HE3' ' A' ' 140' ' ' MET . 23.1 m -100.08 161.24 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.3 p -85.27 -178.41 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.536 ' CD2' ' NE2' ' A' ' 198' ' ' GLN . 11.9 tp -82.71 123.49 29.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.4 t -92.24 106.04 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 14.6 t -113.27 117.43 55.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.16 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -157.46 150.6 23.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -54.68 152.61 6.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -94.24 -40.72 9.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -115.38 119.29 35.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 40.3 p -98.01 111.32 23.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -133.2 139.88 47.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -160.95 170.06 21.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -58.24 116.27 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 57.7 m -66.62 -51.55 55.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.823 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 129.21 93.26 0.71 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.45 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 116.65 4.25 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.3 t -48.3 102.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.2 t -103.62 99.43 9.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.446 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.2 t -171.25 153.52 3.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 110.915 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.1 m -91.89 144.66 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.27 70.32 0.27 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.514 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.9 m -81.66 113.94 20.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 110.838 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.7 p -154.27 149.89 27.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.784 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.3 137.39 5.77 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.4 p -78.39 126.55 30.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.819 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -83.0 -56.27 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.9 m -62.78 108.89 1.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -107.77 133.84 51.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 158.76 156.11 7.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.14 120.2 2.35 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -103.12 82.64 2.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -112.88 126.68 55.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.837 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -109.23 33.82 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.819 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -96.84 137.12 36.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 181' ' ' PHE . 58.1 mt -115.92 153.3 31.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -123.36 114.04 19.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.2 t -101.18 143.75 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.77 -173.85 13.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.6 mmt 57.8 37.46 27.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.446 ' CD2' ' OE1' ' A' ' 145' ' ' GLN . 24.3 mt -95.37 155.1 16.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -108.84 173.99 6.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.66 12.51 2.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -99.96 -22.61 15.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.451 ' CD ' ' SD ' ' A' ' 200' ' ' MET . 34.4 mt-30 -97.57 149.36 22.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 p -130.77 178.16 6.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -56.94 -49.24 76.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -52.23 -59.47 4.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -39.65 -67.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 154' ' ' PHE . 84.1 t -45.16 -60.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.466 ' CD2' HD12 ' A' ' 160' ' ' ILE . 33.9 mt -47.98 -40.31 22.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -69.57 -39.53 77.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -84.19 -10.04 58.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.571 ' CD1' HG12 ' A' ' 150' ' ' VAL . 3.2 m-85 -99.94 -36.2 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -47.11 -47.01 55.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.592 0.71 . . . . 0.0 110.919 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.2 Cg_exo -48.01 -17.13 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.695 2.263 . . . . 0.0 112.332 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 193' ' ' ALA . 74.2 m-85 -101.32 -48.15 4.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -156.3 160.43 30.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.88 93.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.117 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.466 HD12 ' CD2' ' A' ' 151' ' ' LEU . 63.5 mt -62.87 138.6 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -95.13 -62.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.28 132.92 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . 0.456 ' HB2' ' CD2' ' A' ' 151' ' ' LEU . 42.7 t -134.02 136.17 43.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 50.7 m -152.69 139.52 18.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.445 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 53.5 t -104.06 144.84 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 53.1 mt -84.61 145.05 28.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.921 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -141.31 178.49 7.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -103.82 -153.43 23.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.26 -46.86 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.692 2.261 . . . . 0.0 112.361 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -101.1 63.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 38.08 45.71 1.72 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.4 m -108.55 98.88 8.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.842 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.7 t -46.44 138.84 5.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.863 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -94.68 -0.62 54.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.74 10.79 86.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.35 148.13 50.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.835 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -153.37 166.15 33.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -120.83 136.06 55.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.928 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 81.2 t -130.51 124.31 56.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -107.9 129.65 55.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.559 ' CE1' HD13 ' A' ' 136' ' ' LEU . 28.4 m-85 -103.59 167.71 9.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.3 t -64.97 -32.31 73.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.3 t -143.19 175.94 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.569 ' CG ' ' N ' ' A' ' 185' ' ' THR . 4.4 p-80 -72.13 -49.63 34.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.569 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 89.4 m -43.79 -61.54 1.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -40.94 -51.31 3.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.466 ' CB ' HD22 ' A' ' 136' ' ' LEU . . . -56.6 -57.63 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.065 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -39.65 -47.24 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 190' ' ' ALA . . . -61.95 -67.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -36.53 -42.93 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 195' ' ' HIS . 77.7 mt -57.36 -74.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -57.05 -13.3 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.86 -35.79 18.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 21.5 mt -126.51 26.41 6.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.8 t60 -86.41 121.41 28.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 207' ' ' LEU . . . 33.86 32.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.51 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.38 -38.77 8.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.343 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -100.62 160.1 14.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 19.3 m -130.83 87.59 2.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.451 ' SD ' ' CD ' ' A' ' 145' ' ' GLN . 16.8 mmt -39.62 154.86 0.17 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.87 122.73 9.65 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 2.273 . . . . 0.0 112.305 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 111.97 -43.91 1.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -82.94 153.05 25.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 84.5 p -98.63 -12.8 20.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 64.8 m -100.14 164.96 11.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.852 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 67.5 m -87.49 161.28 17.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 196' ' ' GLY . 14.9 tp -57.09 141.65 45.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.447 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 55.8 t -110.28 107.12 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.1 t -118.24 114.52 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.447 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 17.6 ptpt -148.3 155.4 41.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -55.98 150.46 13.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.85 135.81 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -38.02 154.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 74.1 p -135.4 150.36 49.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.55 133.56 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -106.82 138.16 43.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -118.77 -43.31 2.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 24.8 p -62.29 -16.47 54.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 69.45 154.38 0.88 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.25 141.01 20.13 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.679 2.253 . . . . 0.0 112.361 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 86.4 p -68.09 90.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 50.7 m -76.65 172.77 12.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.533 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.441 -0.263 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 m -71.97 112.58 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.902 0.382 . . . . 0.0 110.865 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 t -148.83 141.09 24.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.82 69.01 1.08 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.514 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.1 t -85.02 41.36 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.0 t -128.08 156.28 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -173.18 -77.9 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 88.0 p -112.93 54.74 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -91.09 49.38 1.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.6 p -99.59 103.73 15.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.857 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -132.5 149.55 52.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.14 50.58 0.99 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.457 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 123.83 -130.52 7.67 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.465 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -149.51 171.07 17.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.848 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -164.78 129.34 2.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.829 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 74.3 mtm-85 -125.13 37.11 4.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -128.29 144.3 51.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.401 HD13 ' CD1' ' A' ' 181' ' ' PHE . 21.0 mt -125.06 144.93 50.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -112.64 114.76 27.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -103.85 146.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.133 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -142.34 -173.53 14.32 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.417 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.3 mmt 55.81 42.35 29.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.4 mt -103.35 154.87 18.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -98.12 165.82 11.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -82.48 39.93 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -128.53 -38.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -69.49 151.29 46.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.1 p -128.55 176.67 7.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -55.41 -44.62 76.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.861 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.83 -49.18 74.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.12 -69.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.574 HG12 ' CD1' ' A' ' 154' ' ' PHE . 74.6 t -49.96 -59.75 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.448 ' CD2' HD11 ' A' ' 160' ' ' ILE . 25.4 mt -47.34 -38.34 12.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -69.62 -40.13 76.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.1 tp -84.49 -8.96 58.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.574 ' CD1' HG12 ' A' ' 150' ' ' VAL . 3.1 m-85 -100.18 -37.24 9.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.2 tm0? -47.2 -46.89 56.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.645 0.736 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.97 -17.28 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.242 . . . . 0.0 112.361 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 193' ' ' ALA . 73.3 m-85 -99.88 -33.4 10.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.97 164.02 33.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.441 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 94.5 t -76.47 103.41 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.448 HD11 ' CD2' ' A' ' 151' ' ' LEU . 85.6 mt -72.37 133.99 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.428 ' N ' HG21 ' A' ' 160' ' ' ILE . 36.3 m-20 -81.51 -62.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -141.89 139.79 32.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . 0.442 ' CB ' HD21 ' A' ' 151' ' ' LEU . 45.0 t -134.04 141.11 47.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.6 m -146.7 139.44 25.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.458 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 87.3 t -105.6 136.63 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 49.9 mt -72.03 138.13 47.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -151.98 140.99 21.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -68.74 159.62 52.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.62 -35.67 13.09 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.661 2.241 . . . . 0.0 112.319 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -72.85 -38.97 66.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 121.03 40.1 0.57 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.446 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 t -116.75 112.28 20.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.839 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -55.91 131.13 46.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -90.63 26.26 2.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 55.94 38.94 77.01 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.482 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 22.7 p -156.17 149.76 24.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.805 0.336 . . . . 0.0 110.916 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -159.47 166.77 30.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.5 136.05 54.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.5 t -127.18 125.25 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -105.72 130.72 53.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.401 ' CD1' HD13 ' A' ' 136' ' ' LEU . 22.8 m-85 -106.29 158.83 16.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.7 t -53.21 -43.6 67.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.6 m -128.26 173.53 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.403 ' CD2' ' H ' ' A' ' 184' ' ' HIS . 7.7 p80 -71.8 -49.97 33.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.5 m -47.67 -63.62 1.01 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -40.25 -39.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.22 -65.76 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.105 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.424 ' C ' ' CD ' ' A' ' 188' ' ' GLN . 0.0 OUTLIER -43.39 -36.82 2.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.95 -61.87 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.44 -34.68 4.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 195' ' ' HIS . 45.1 mt -60.04 -71.83 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -55.59 -18.73 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 157' ' ' PHE . . . -79.05 -37.4 39.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.46 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 12.2 mt -126.51 28.26 5.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.5 t60 -84.81 120.98 27.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.04 34.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.452 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.3 -38.84 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.844 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -100.6 152.23 20.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 200' ' ' MET . 15.7 m -122.31 86.28 2.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 199' ' ' THR . 13.2 mmt -37.11 155.25 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 110.855 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.41 128.11 15.87 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.695 2.263 . . . . 0.0 112.372 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 103.51 -39.46 2.79 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.96 154.71 21.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.067 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.7 t -99.98 -14.96 18.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.1 m -100.12 161.54 13.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 66.9 m -88.64 158.27 18.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 14.3 tp -52.45 141.75 19.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 52.4 t -110.08 108.64 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.15 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 4.7 t -118.6 124.45 73.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -158.85 148.59 19.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -55.51 150.41 12.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -84.47 154.4 22.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.096 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -42.23 119.84 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.1 p -75.98 -34.82 59.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -173.56 176.91 2.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -83.2 -55.22 4.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -129.75 99.37 5.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 61.5 m -46.99 -56.16 6.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -118.86 146.2 18.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.522 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.67 -0.93 11.11 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.639 2.226 . . . . 0.0 112.35 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 75.1 p -52.5 170.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.7 m -86.39 -49.31 7.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.451 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.0 t -73.59 171.75 12.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -98.59 144.53 27.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.27 49.78 0.76 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.8 m -78.13 94.97 4.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 110.863 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 46.4 t -39.84 152.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.48 -178.61 9.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.462 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.9 t 55.68 44.89 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.788 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 128' ' ' SER . 11.9 pt-20 -92.12 -42.7 9.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.443 ' N ' ' HG3' ' A' ' 127' ' ' GLU . 35.7 t -107.0 140.24 40.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 41.53 38.44 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.89 -44.53 37.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 138.6 -162.02 25.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -133.19 118.25 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 0.0 110.873 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -149.86 128.31 12.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -95.16 32.71 1.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 136' ' ' LEU . 12.4 tppt? -125.85 157.5 37.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.449 HD13 ' CE1' ' A' ' 181' ' ' PHE . 88.7 mt -140.1 150.66 44.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -117.2 117.61 30.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.11 147.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.41 -170.5 11.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.52 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.4 mmt 51.68 51.19 17.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.778 0.323 . . . . 0.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 207' ' ' LEU . 43.5 mt -111.13 155.75 22.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -97.61 165.07 12.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -82.37 40.69 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -129.16 -40.05 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -69.43 144.65 53.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.3 p -122.91 171.27 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -48.43 -48.71 37.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.92 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.45 ' OE1' ' C ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -51.74 -51.41 56.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -46.6 -67.35 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.577 HG12 ' CD1' ' A' ' 154' ' ' PHE . 31.7 t -49.27 -62.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.469 ' CD2' HD12 ' A' ' 160' ' ' ILE . 25.0 mt -46.49 -38.35 9.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -69.51 -40.1 77.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.76 -10.2 58.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.577 ' CD1' HG12 ' A' ' 150' ' ' VAL . 3.2 m-85 -99.84 -35.73 9.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -47.1 -47.07 55.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.59 0.71 . . . . 0.0 110.897 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.99 -17.27 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.666 2.244 . . . . 0.0 112.365 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.563 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 74.1 m-85 -101.26 -47.16 4.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.97 166.14 34.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.503 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.5 t -80.6 101.8 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 0.0 111.14 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.469 HD12 ' CD2' ' A' ' 151' ' ' LEU . 38.5 mt -73.07 131.37 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.69 -64.17 1.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -130.77 140.98 50.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . 0.443 ' CB ' HD23 ' A' ' 151' ' ' LEU . 12.3 t -134.13 131.61 38.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.4 m -136.43 138.19 41.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.471 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 92.3 t -108.45 135.36 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 78.9 mt -67.88 147.11 52.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -158.02 148.02 20.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.66 168.06 41.32 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.468 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.16 -38.23 19.27 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.696 2.264 . . . . 0.0 112.335 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -101.74 41.82 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 48.85 58.1 8.0 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 41.3 t -115.06 88.61 2.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.876 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.9 t -41.97 121.4 1.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -79.79 9.61 5.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 67.68 20.61 72.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.3 m -143.49 164.43 30.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.792 0.33 . . . . 0.0 110.883 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -164.02 170.92 15.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.05 121.9 36.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 94.3 t -114.22 131.51 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -110.71 129.57 55.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.891 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.449 ' CE1' HD13 ' A' ' 136' ' ' LEU . 32.6 m-85 -102.47 165.23 11.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.7 p -67.32 -39.14 85.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.0 p -132.52 146.09 51.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.42 ' CG ' ' N ' ' A' ' 185' ' ' THR . 6.8 p80 -50.44 -50.41 52.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.42 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 85.9 m -48.66 -53.34 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -45.75 -50.42 13.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -59.89 -48.51 81.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.126 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.71 -43.41 17.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.41 -59.2 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.106 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.01 -36.81 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 195' ' ' HIS . 63.3 mt -61.37 -73.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.1 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -57.41 -12.05 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.563 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -85.09 -40.09 17.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.92 19.41 11.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.4 t60 -80.08 124.97 29.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.21 32.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.495 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 195' ' ' HIS . 58.8 p -100.38 -39.31 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.83 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -100.53 160.47 14.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 200' ' ' MET . 19.6 m -135.02 86.62 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 199' ' ' THR . 13.8 mmt -36.1 154.56 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.706 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.45 129.32 17.71 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.64 2.227 . . . . 0.0 112.359 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 101.66 -38.62 3.08 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.482 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.48 146.91 26.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.31 . . . . 0.0 111.081 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.8 t -93.39 -12.38 30.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 69.3 m -100.16 158.77 15.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.828 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 70.1 m -85.3 169.32 13.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.826 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.467 ' CD1' HD22 ' A' ' 141' ' ' LEU . 19.5 tp -65.87 128.12 34.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.1 113.86 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.9 t -123.19 124.08 69.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -162.3 148.61 13.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -48.04 141.22 6.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -63.14 164.88 7.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.03 103.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 40.5 p -89.26 109.21 20.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.96 174.62 5.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -144.01 142.16 30.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -113.5 -52.6 2.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 48.8 m -90.42 165.65 13.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -123.17 95.59 0.53 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.79 156.03 43.94 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.708 2.272 . . . . 0.0 112.368 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.0 t -159.9 134.17 7.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 60.4 p -146.91 134.73 21.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.471 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.7 m -138.99 128.38 24.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 110.828 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.1 p -124.53 160.25 28.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 136.7 -151.04 20.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.468 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 83.5 p -72.28 117.31 13.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.881 0.372 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.8 t -122.74 124.14 42.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.818 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 41.15 92.24 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.507 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.5 m -71.77 101.34 2.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -78.2 82.51 4.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.2 t 57.16 45.52 20.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -94.69 95.31 8.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -169.16 126.52 1.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.48 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.47 132.08 7.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.506 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 132' ' ' ARG . 18.9 mtm105 -97.31 95.69 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.96 150.76 46.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -107.26 11.07 29.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -100.06 139.11 36.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.509 HD12 ' CE1' ' A' ' 181' ' ' PHE . 36.0 mt -121.81 155.0 36.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 176' ' ' CYS . 44.7 t80 -124.42 112.79 17.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.52 152.66 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -146.16 174.93 25.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.4 mmt 57.48 46.01 18.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.336 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.473 ' CD2' ' OE1' ' A' ' 145' ' ' GLN . 60.2 mt -100.07 147.32 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 36.4 t30 -90.12 164.82 14.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.45 ' HA ' ' CB ' ' A' ' 173' ' ' SER . 19.1 pttt -66.98 -3.66 7.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.416 HE21 ' ND2' ' A' ' 142' ' ' ASN . 6.2 pt20 -109.31 43.71 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.496 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 74.1 mt-30 -135.21 109.24 8.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 p -104.08 170.74 7.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -52.86 -41.93 64.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.5 -47.32 86.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -48.03 -63.99 0.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.839 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 154' ' ' PHE . 94.9 t -58.49 -60.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.439 ' HA ' ' CD1' ' A' ' 160' ' ' ILE . 29.6 mt -44.4 -38.68 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -68.82 -41.11 79.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -84.0 -9.78 58.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.564 ' CD1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.14 -35.88 9.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.56 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.0 OUTLIER -47.18 -46.91 56.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 0.0 110.914 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -48.03 -16.75 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.652 2.235 . . . . 0.0 112.315 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 193' ' ' ALA . 72.4 m-85 -99.87 -42.1 6.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.73 171.16 42.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -80.48 102.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 151' ' ' LEU . 38.3 mt -72.13 151.34 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -103.13 -57.15 2.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.462 ' CG ' ' HB3' ' A' ' 180' ' ' LYS . 9.7 pt-20 -138.69 137.89 37.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 1.7 t -133.72 102.14 5.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.3 m -107.51 119.64 39.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.163 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.461 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 50.3 t -99.91 131.87 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.131 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.3 140.57 52.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -145.48 177.06 9.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.869 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -110.19 -161.43 18.42 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.31 -51.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.649 2.233 . . . . 0.0 112.355 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.79 -37.16 78.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 118.85 36.54 0.88 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 173' ' ' SER . 38.1 p -115.55 117.99 31.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.893 0.378 . . . . 0.0 110.874 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 143' ' ' LYS . 8.2 t -35.05 141.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.84 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -81.25 -18.56 45.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.45 -16.3 44.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.448 ' HB3' ' CE1' ' A' ' 137' ' ' PHE . 1.7 m -125.99 160.14 30.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 110.87 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.461 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -158.73 175.98 12.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -136.04 126.27 26.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.18 130.0 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.462 ' HB3' ' CG ' ' A' ' 162' ' ' GLU . 27.0 tttt -106.25 130.35 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.509 ' CE1' HD12 ' A' ' 136' ' ' LEU . 33.6 m-85 -104.0 160.63 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.4 t -72.43 -19.85 61.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.863 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -142.15 164.94 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.451 ' CG ' ' N ' ' A' ' 185' ' ' THR . 4.4 p-80 -75.39 -41.75 55.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.806 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.451 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 44.7 m -54.64 -59.76 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -41.12 -47.73 3.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 188' ' ' GLN . . . -60.79 -62.05 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.093 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 187' ' ' ALA . 1.8 mm-40 -35.44 -44.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.85 -63.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.054 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.36 -28.86 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.074 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.481 ' O ' ' N ' ' A' ' 195' ' ' HIS . 36.2 mt -70.71 -72.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.143 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -59.85 -17.14 34.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 157' ' ' PHE . . . -84.74 -25.8 28.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.129 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.5 mt -132.59 24.95 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.3 t60 -89.69 121.45 31.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.1 30.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 195' ' ' HIS . 60.6 p -100.25 -39.48 8.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.83 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.43 ' OE1' ' CD2' ' A' ' 207' ' ' LEU . 4.9 pt20 -100.66 163.98 12.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 200' ' ' MET . 29.3 m -134.82 81.3 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.496 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 13.9 mmt -37.03 156.01 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.698 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.473 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 54.1 Cg_endo -68.0 136.48 38.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.395 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.12 -35.95 4.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -89.36 150.85 22.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.5 t -100.08 -12.48 19.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.867 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.1 t -100.08 170.07 8.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -94.27 148.94 21.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.808 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.43 ' CD2' ' OE1' ' A' ' 198' ' ' GLN . 10.7 tp -45.68 151.4 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.97 104.29 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 6.6 t -115.94 116.41 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -155.35 148.36 24.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -49.08 140.82 8.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 213' ' ' ASP . . . -70.0 177.5 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.064 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 212' ' ' ALA . 4.5 p-10 -36.81 117.34 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 32.8 m -117.91 115.15 24.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -125.94 103.5 7.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -127.56 114.41 17.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -89.12 96.86 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 69.3 p -68.69 -60.8 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -120.98 100.15 0.74 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.1 120.6 2.56 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.728 2.285 . . . . 0.0 112.337 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.3 t -39.95 121.89 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.835 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 18.7 m -71.56 -49.63 38.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.475 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.833 0.349 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 1.009 HD21 ' HB1' ' A' ' 187' ' ' ALA . 9.0 mt -130.84 153.63 48.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -116.0 108.92 16.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.916 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.438 HG22 HG13 ' A' ' 209' ' ' VAL . 35.6 t -99.85 145.02 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.107 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.503 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -137.69 -170.44 11.88 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.497 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.4 mmt 52.39 53.01 13.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.403 HD21 HD11 ' A' ' 207' ' ' LEU . 56.1 mt -117.39 156.14 28.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -94.12 175.49 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.0 pttm -92.61 17.02 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -108.06 -13.69 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -90.09 152.11 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 95.9 p -131.96 166.23 22.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.457 ' HG3' HG23 ' A' ' 165' ' ' VAL . 29.5 mt-10 -45.77 -47.12 15.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -54.83 -53.76 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -43.03 -64.82 0.56 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.716 HG13 ' CE1' ' A' ' 154' ' ' PHE . 77.7 t -53.67 -63.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.776 HD21 ' CB ' ' A' ' 163' ' ' CYS . 31.4 mt -42.82 -36.98 1.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.28 -40.83 77.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -84.57 -8.6 58.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.924 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -99.89 -37.19 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 10.2 tm0? -47.31 -46.87 57.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.722 . . . . 0.0 110.902 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.89 -17.18 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.731 2.287 . . . . 0.0 112.363 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.489 ' CE1' ' HB1' ' A' ' 193' ' ' ALA . 75.2 m-85 -101.95 -35.07 9.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.84 161.31 30.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.512 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 80.9 t -75.03 97.98 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.924 HD11 ' CB ' ' A' ' 154' ' ' PHE . 36.5 mt -66.66 137.25 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.167 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -81.86 -61.43 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -139.54 143.57 37.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.776 ' CB ' HD21 ' A' ' 151' ' ' LEU . 10.6 t -134.02 135.78 43.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.83 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.523 ' O ' ' HB1' ' A' ' 177' ' ' ALA . 86.0 m -139.09 157.74 45.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.493 ' N ' HG22 ' A' ' 164' ' ' THR . 47.7 t -120.97 130.82 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 176' ' ' CYS . 60.3 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.0 mttm . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.802 0.334 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 71.44 21.76 78.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.52 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.401 ' HB2' HD12 ' A' ' 166' ' ' LEU . 3.2 m -136.55 159.78 40.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 164' ' ' THR . . . -158.1 161.67 37.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -112.23 121.73 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.469 HG11 ' HD2' ' A' ' 154' ' ' PHE . 38.7 t -119.15 122.94 70.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.573 ' O ' HG23 ' A' ' 160' ' ' ILE . 13.7 tttp -111.68 131.27 55.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' A' ' 187' ' ' ALA . 41.2 m-85 -101.7 166.68 10.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.3 t -66.81 -35.53 80.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.8 p -133.79 166.65 22.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -66.94 -55.25 15.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.4 m -43.73 -53.7 5.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -49.12 -48.1 44.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 1.009 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -59.81 -52.2 66.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.094 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.585 ' HA ' HD12 ' A' ' 191' ' ' ILE . 5.2 mm100 -46.42 -42.66 15.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.19 -63.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.73 -37.17 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 136' ' ' LEU . 54.1 mt -63.9 -72.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.106 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -57.48 -13.78 4.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.489 ' HB1' ' CE1' ' A' ' 157' ' ' PHE . . . -86.16 -40.24 15.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.689 HD13 ' CE1' ' A' ' 154' ' ' PHE . 18.1 mt -119.16 22.66 11.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.4 t60 -82.91 124.82 30.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.56 32.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.502 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 195' ' ' HIS . 54.4 p -100.19 -35.26 9.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.338 . . . . 0.0 110.849 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -100.27 161.1 13.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 12.9 m -134.6 77.14 1.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.163 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.0 mmt -39.43 138.45 0.94 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.597 0.713 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.39 146.73 9.78 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.12 -34.16 3.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.27 134.0 35.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.312 . . . . 0.0 111.133 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 80.4 p -90.25 -8.72 50.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.838 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 37.0 m -99.98 160.72 14.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.3 m -84.34 158.81 21.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 139' ' ' GLY . 13.4 tp -57.57 141.68 47.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.73 104.37 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.438 HG13 HG22 ' A' ' 138' ' ' VAL . 12.4 t -115.65 120.67 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.097 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -158.16 150.13 21.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.843 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.4 tttt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.838 0.351 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.987 HD21 ' HB1' ' A' ' 187' ' ' ALA . 44.3 mt -135.85 148.16 48.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -118.35 110.72 17.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.66 138.91 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.118 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.606 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -136.36 178.37 18.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.0 mmt 62.46 45.04 6.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 mt -102.73 153.81 19.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 28.2 t30 -108.2 169.58 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -78.45 45.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -132.11 -34.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -86.75 146.97 26.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.7 p -126.34 -177.56 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.641 ' HG3' HG23 ' A' ' 165' ' ' VAL . 18.0 mt-10 -58.73 -46.33 87.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -56.72 -53.19 60.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -42.53 -66.67 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.897 HG13 ' CE1' ' A' ' 154' ' ' PHE . 86.5 t -48.08 -63.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.754 HD21 ' HB2' ' A' ' 163' ' ' CYS . 33.4 mt -44.24 -40.77 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -69.01 -40.36 78.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.2 tp -84.21 -9.98 58.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.897 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.55 -35.6 9.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.36 -46.87 58.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 0.0 110.925 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.1 Cg_exo -47.95 -17.49 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.356 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -100.58 -46.29 5.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -161.2 160.92 32.58 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.474 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 159' ' ' VAL . 25.6 t -76.16 95.69 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.774 HD11 ' CB ' ' A' ' 154' ' ' PHE . 28.4 mt -63.85 142.92 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.099 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.68 -55.99 3.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -144.92 140.37 28.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.754 ' HB2' HD21 ' A' ' 151' ' ' LEU . 40.6 t -132.48 142.78 49.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.2 m -151.01 143.07 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.641 HG23 ' HG3' ' A' ' 147' ' ' GLU . 86.1 t -112.58 134.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttm . . . . . 0 C--O 1.23 0.031 0 CA-C-O 120.859 0.362 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 61.36 33.28 84.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.529 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 7.8 p -148.42 154.15 39.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -159.02 176.67 12.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -129.74 141.12 50.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.06 128.82 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.598 ' O ' HG23 ' A' ' 160' ' ' ILE . 18.9 ttmt -111.9 134.17 53.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.514 ' HE1' HD12 ' A' ' 136' ' ' LEU . 36.8 m-85 -108.96 164.86 12.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.4 t -69.31 -27.08 65.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.3 t -144.03 159.33 42.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.846 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -60.22 -57.49 12.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 99.9 m -38.82 -59.39 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -40.83 -52.75 2.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.987 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.97 -57.16 14.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.573 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.1 mm100 -37.91 -45.91 0.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 191' ' ' ILE . . . -66.16 -66.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -38.65 -27.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 188' ' ' GLN . 59.2 mt -74.3 -71.07 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -59.88 -12.27 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -89.84 -31.3 17.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.9 mt -125.91 21.63 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.3 t60 -83.72 124.55 30.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.438 ' C ' ' HB3' ' A' ' 206' ' ' SER . . . 34.62 31.92 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.463 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 195' ' ' HIS . 79.3 p -100.25 -36.09 9.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.894 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.739 ' OE1' HD22 ' A' ' 207' ' ' LEU . 1.1 pt20 -100.32 150.35 22.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 205' ' ' SER . 51.0 m -122.76 80.16 1.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.154 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 15.3 mmt -40.34 140.61 0.94 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.532 0.682 . . . . 0.0 110.899 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.471 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 74.5 Cg_exo -48.07 147.69 7.7 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.711 2.274 . . . . 0.0 112.306 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.09 -45.69 3.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.457 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -77.28 138.59 39.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.754 0.311 . . . . 0.0 111.085 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.5 t -91.62 -11.39 37.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 199' ' ' THR . 2.2 t -99.97 173.08 6.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.438 ' HB3' ' C ' ' A' ' 196' ' ' GLY . 59.0 m -99.67 150.87 21.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.739 HD22 ' OE1' ' A' ' 198' ' ' GLN . 14.1 tp -47.49 147.97 1.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.478 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 58.8 t -117.22 104.05 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.132 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 8.7 t -111.72 122.48 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.478 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 14.9 ptpt -161.43 150.25 15.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.958 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.559 ' HE2' ' CD1' ' A' ' 178' ' ' PHE . 71.3 tttt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.776 0.322 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 1.112 HD21 ' HB1' ' A' ' 187' ' ' ALA . 18.2 mt -124.25 156.3 37.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -126.68 112.95 16.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 30.4 t -97.14 148.23 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.44 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -142.31 -172.12 13.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.479 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.2 mmt 54.49 38.76 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.3 mt -95.22 160.93 14.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -100.91 -175.62 2.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -100.3 34.75 2.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -129.14 -30.98 2.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -77.79 145.77 36.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 55.1 p -119.79 -175.84 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.828 ' HG3' HG23 ' A' ' 165' ' ' VAL . 3.4 mp0 -68.53 -31.78 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -64.87 -48.39 74.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -48.39 -68.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.828 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.905 HG13 ' CE1' ' A' ' 154' ' ' PHE . 99.0 t -48.46 -53.95 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.837 HD21 ' HB2' ' A' ' 163' ' ' CYS . 38.9 mt -51.46 -40.68 59.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -69.27 -39.41 78.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.8 tp -84.31 -11.12 56.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.905 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -98.44 -36.21 10.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.57 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.06 -47.02 55.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.592 0.71 . . . . 0.0 110.921 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.5 Cg_exo -47.92 -16.77 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.355 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.411 ' HE2' HD11 ' A' ' 194' ' ' LEU . 72.3 m-85 -99.75 -35.28 9.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.38 164.38 37.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 159' ' ' VAL . 47.5 t -75.86 91.23 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 111.136 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.816 HD13 HD23 ' A' ' 151' ' ' LEU . 68.6 mt -59.54 132.81 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -84.94 -55.06 4.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.1 143.07 28.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.837 ' HB2' HD21 ' A' ' 151' ' ' LEU . 9.8 t -134.04 129.84 36.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.6 m -139.26 144.68 38.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.828 HG23 ' HG3' ' A' ' 147' ' ' GLU . 73.6 t -109.97 151.93 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.1 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.987 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.2 mttp . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.794 0.331 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.27 23.91 70.25 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.442 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 2.6 p -144.79 158.63 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.816 0.341 . . . . 0.0 110.925 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.47 175.1 11.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.128 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.559 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 81.8 m-85 -124.98 137.84 54.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.421 HG11 ' HD2' ' A' ' 154' ' ' PHE . 98.3 t -127.76 127.5 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -111.72 133.61 53.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.0 156.83 19.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.1 t -56.9 -28.87 62.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.845 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 t -140.9 177.35 8.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -76.64 -59.01 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.5 m -39.37 -54.39 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -44.78 -49.91 10.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 1.112 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -60.61 -57.11 14.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.09 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -38.65 -45.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.5 -62.17 1.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.07 -27.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.736 HD11 HD22 ' A' ' 136' ' ' LEU . 74.1 mt -76.77 -64.8 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -64.64 -7.9 12.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -99.26 -24.74 14.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.103 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.594 HD13 ' CE1' ' A' ' 154' ' ' PHE . 23.1 mt -132.36 27.12 4.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.2 t60 -93.04 122.43 35.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 36.39 31.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.461 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -99.23 -36.98 9.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.358 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.636 ' NE2' HD22 ' A' ' 207' ' ' LEU . 16.2 pt20 -100.35 165.06 11.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 205' ' ' SER . 18.4 m -134.96 85.82 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.474 ' CE ' ' OE1' ' A' ' 198' ' ' GLN . 14.2 mmt -44.95 139.78 3.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.706 . . . . 0.0 110.901 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -48.15 137.45 23.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.692 2.261 . . . . 0.0 112.326 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 91.21 -48.12 2.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.481 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -76.51 131.63 39.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.079 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.7 p -86.4 -7.39 58.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 199' ' ' THR . 4.7 t -99.71 171.45 7.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.4 m -100.08 143.19 30.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.636 HD22 ' NE2' ' A' ' 198' ' ' GLN . 14.8 tp -40.04 151.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.53 103.93 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.43 HG12 HG12 ' A' ' 191' ' ' ILE . 4.4 t -113.23 121.06 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -156.92 152.42 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.518 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 7.7 ttmt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.815 0.34 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.733 HD21 ' HB1' ' A' ' 187' ' ' ALA . 55.5 mt -112.32 139.34 47.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -109.23 116.01 31.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.13 146.36 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.545 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -140.13 179.86 18.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 mmt 57.3 48.23 15.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 110.879 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 48.9 mt -108.27 162.7 13.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -103.77 172.17 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -88.64 16.05 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -106.92 -18.21 13.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.976 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -87.77 147.92 24.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.951 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.3 p -124.77 -179.19 4.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.554 ' HG3' HG23 ' A' ' 165' ' ' VAL . 39.2 mp0 -63.21 -32.57 74.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -66.43 -48.02 71.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -50.92 -49.53 59.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.802 HG13 ' CE1' ' A' ' 154' ' ' PHE . 83.6 t -68.33 -50.35 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 mt -56.59 -32.24 65.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.421 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 11.7 mmm180 -81.24 -36.12 30.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.901 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.7 tp -85.01 -14.04 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.802 ' CE1' HG13 ' A' ' 150' ' ' VAL . 4.1 m-85 -100.05 -37.25 9.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 3.8 mt-30 -47.19 -48.91 54.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.635 0.731 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.8 Cg_exo -47.97 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.428 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.6 m-85 -100.43 -30.28 11.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 173.86 158.69 18.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.512 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.52 135.74 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 111.156 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.689 HD11 ' CB ' ' A' ' 154' ' ' PHE . 55.2 mt -111.75 125.22 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -69.89 -65.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -143.31 141.03 30.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 179' ' ' VAL . 44.1 t -132.22 108.43 9.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.8 m -109.66 128.13 55.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.154 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.554 HG23 ' HG3' ' A' ' 147' ' ' GLU . 73.4 t -91.91 135.91 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.165 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.0 mttm . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 58.38 24.17 55.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 17.9 m -147.77 165.08 31.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.842 0.353 . . . . 0.0 110.902 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.62 -179.06 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.518 ' CD1' ' HD3' ' A' ' 135' ' ' LYS . 57.7 m-85 -131.31 124.91 31.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.617 HG22 ' SG ' ' A' ' 163' ' ' CYS . 45.7 t -119.96 123.32 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -108.32 119.24 38.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.98 164.98 13.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.1 m -72.43 -32.37 66.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 t -133.37 160.28 37.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.827 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -64.72 -59.82 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 186' ' ' GLU . 53.0 m -38.68 -64.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.8 OUTLIER -36.6 -53.0 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.733 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.22 -59.8 4.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.101 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 187' ' ' ALA . 4.8 mm100 -37.3 -47.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 190' ' ' ALA . . . -62.47 -67.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -35.56 -38.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.051 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.632 HD11 HD22 ' A' ' 136' ' ' LEU . 93.1 mt -62.74 -73.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -55.33 -14.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.428 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.69 -41.08 14.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.43 30.54 7.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -99.51 122.98 43.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 45.75 20.16 0.39 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.46 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 60.7 p -100.04 -35.71 9.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -100.1 154.82 18.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 205' ' ' SER . 49.3 m -134.78 86.33 2.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 12.4 mmt -47.11 138.31 7.75 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.582 0.706 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -48.62 153.03 3.7 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.734 2.29 . . . . 0.0 112.331 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.55 -35.67 2.45 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.537 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.93 136.09 34.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.077 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 84.0 p -85.69 -13.93 46.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 199' ' ' THR . 7.7 m -100.0 157.72 16.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 6.1 p -79.81 -178.75 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 139' ' ' GLY . 15.7 tp -77.31 149.22 35.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.48 ' CG1' ' HE2' ' A' ' 210' ' ' LYS . 73.8 t -118.0 103.93 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.444 HG12 HG12 ' A' ' 191' ' ' ILE . 11.9 t -113.48 123.15 68.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.48 ' HE2' ' CG1' ' A' ' 208' ' ' VAL . 0.9 OUTLIER -159.96 148.48 17.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.4 tptt . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.845 HD21 ' HB1' ' A' ' 187' ' ' ALA . 38.4 mt -121.46 157.8 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.928 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -125.7 119.28 27.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 29.5 t -101.46 148.12 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -141.58 -179.65 18.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.9 mmt 57.95 39.88 26.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.454 ' CD2' HD11 ' A' ' 207' ' ' LEU . 67.3 mt -97.04 158.24 15.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 21.2 t-20 -113.16 170.99 7.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -79.49 44.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -133.01 -40.75 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.448 ' CD ' ' SD ' ' A' ' 200' ' ' MET . 31.2 mt-30 -81.89 121.84 26.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.1 p -106.02 173.79 6.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 165' ' ' VAL . 1.8 mp0 -47.78 -46.51 30.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -53.84 -51.79 62.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -47.75 -68.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.847 HG13 ' CE1' ' A' ' 154' ' ' PHE . 96.8 t -47.16 -54.99 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.795 HD21 ' HB2' ' A' ' 163' ' ' CYS . 32.1 mt -52.18 -39.77 60.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -70.2 -38.68 75.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.405 HD21 ' OE1' ' A' ' 198' ' ' GLN . 13.5 tp -85.08 -9.09 58.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.855 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -100.04 -38.94 8.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.1 tm0? -46.99 -47.01 54.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.627 0.727 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.5 Cg_exo -47.94 -20.34 2.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.263 . . . . 0.0 112.304 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -100.04 -43.35 6.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.65 156.37 27.53 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.8 t -74.75 96.9 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 111.129 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.855 HD11 ' CB ' ' A' ' 154' ' ' PHE . 41.9 mt -66.3 141.52 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -94.42 -54.39 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -141.52 141.76 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.795 ' HB2' HD21 ' A' ' 151' ' ' LEU . 43.2 t -133.97 143.61 48.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 165' ' ' VAL . 96.8 m -148.96 154.08 38.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.169 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.595 HG13 ' HB2' ' A' ' 177' ' ' ALA . 58.0 t -124.9 142.94 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.121 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.0 mttm . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.815 0.341 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 61.56 24.52 64.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.442 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 4.9 p -139.65 138.43 36.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 0.0 110.906 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.595 ' HB2' HG13 ' A' ' 165' ' ' VAL . . . -150.57 168.04 25.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -121.45 144.86 48.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.02 132.37 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.694 ' O ' HG23 ' A' ' 160' ' ' ILE . 23.5 ttmt -112.36 128.25 56.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.513 ' HE1' HD12 ' A' ' 136' ' ' LEU . 37.7 m-85 -100.27 162.51 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.0 p -67.09 -23.14 65.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.8 t -151.71 150.98 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.873 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -51.26 -57.45 8.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 186' ' ' GLU . 63.6 m -38.19 -66.6 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.08 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.3 OUTLIER -37.97 -51.09 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.845 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.29 -57.27 13.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.079 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.461 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.4 mm100 -40.44 -43.41 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 191' ' ' ILE . . . -65.77 -68.48 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.082 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -35.57 -33.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.575 HD11 HD22 ' A' ' 136' ' ' LEU . 83.3 mt -66.62 -70.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -62.04 -15.62 45.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.859 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -90.44 -22.7 21.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.077 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.733 HD22 ' NE2' ' A' ' 198' ' ' GLN . 75.7 mt -132.51 23.38 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.8 t60 -89.04 124.59 34.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.447 ' C ' ' HB3' ' A' ' 206' ' ' SER . . . 36.18 29.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.543 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 195' ' ' HIS . 76.4 p -100.14 -35.27 9.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.328 . . . . 0.0 110.846 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.733 ' NE2' HD22 ' A' ' 194' ' ' LEU . 22.4 mt-30 -100.28 155.05 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 205' ' ' SER . 25.7 m -129.18 81.51 2.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.448 ' SD ' ' CD ' ' A' ' 145' ' ' GLN . 14.9 mmt -45.67 141.03 4.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.547 0.689 . . . . 0.0 110.93 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.415 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 74.5 Cg_exo -47.97 153.05 2.83 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.708 2.272 . . . . 0.0 112.312 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 79.24 -41.79 2.29 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.446 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.15 140.06 31.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 111.064 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 25.2 t -94.8 -8.82 36.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 199' ' ' THR . 2.8 t -100.06 172.48 7.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.447 ' HB3' ' C ' ' A' ' 196' ' ' GLY . 19.4 m -97.96 145.93 25.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.454 HD11 ' CD2' ' A' ' 141' ' ' LEU . 8.6 tp -42.31 154.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.934 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 73.3 t -125.66 104.08 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.4 t -111.72 122.25 65.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -151.31 146.94 26.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 1.034 HD21 ' HB1' ' A' ' 187' ' ' ALA . 19.8 mt -137.69 145.82 43.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -109.15 110.77 22.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.4 t -97.68 147.57 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.661 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -144.14 -175.81 17.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.519 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.2 mmt 56.45 48.24 17.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.5 mt -109.06 165.1 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -106.75 174.03 6.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -87.71 16.3 5.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -105.99 -22.92 12.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.475 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 16.3 mt-30 -82.25 149.67 27.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.8 p -130.94 172.69 11.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -50.54 -51.03 51.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -52.16 -52.79 49.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -42.53 -67.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.556 HG13 ' CE1' ' A' ' 154' ' ' PHE . 35.9 t -52.87 -51.28 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.136 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.677 HD21 ' CB ' ' A' ' 163' ' ' CYS . 39.1 mt -54.04 -32.17 53.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -79.61 -37.04 37.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.7 tp -84.35 -14.17 50.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.802 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.4 m-85 -100.22 -35.97 9.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.534 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 3.7 mt-30 -47.18 -49.0 53.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.549 0.69 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.5 Cg_exo -47.98 -17.13 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.425 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.2 m-85 -100.03 -34.14 10.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.9 169.59 42.55 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.481 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.38 107.75 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 111.126 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.802 HD11 ' CB ' ' A' ' 154' ' ' PHE . 82.7 mt -79.15 126.27 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.4 ' HB2' ' CD ' ' A' ' 180' ' ' LYS . 3.2 m-20 -86.47 -65.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -114.65 126.02 54.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.677 ' CB ' HD21 ' A' ' 151' ' ' LEU . 16.7 t -133.15 127.11 33.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.3 m -146.38 149.66 34.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.407 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 77.7 t -114.53 137.89 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 176' ' ' CYS . 27.2 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.8 mttt . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.803 0.335 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.1 24.69 76.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.51 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.411 ' HB2' HD12 ' A' ' 166' ' ' LEU . 1.8 m -146.78 154.78 41.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 110.866 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -156.45 176.07 13.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.02 124.14 34.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.469 HG11 ' HD2' ' A' ' 154' ' ' PHE . 39.1 t -117.83 134.72 60.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 160' ' ' ILE . 30.6 ttmt -114.99 144.28 43.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -118.9 161.13 20.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 17.3 t -59.16 -34.25 71.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.5 t -142.42 171.79 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.416 ' CG ' ' N ' ' A' ' 185' ' ' THR . 44.5 p-80 -64.76 -54.95 23.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.416 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 48.7 m -36.84 -63.92 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 185' ' ' THR . 23.8 mm-40 -37.8 -53.39 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 1.034 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -55.9 -59.13 5.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -40.26 -41.51 1.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -71.4 -63.73 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.68 -34.02 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.112 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 136' ' ' LEU . 72.5 mt -65.89 -71.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -59.15 -13.73 8.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.425 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -88.98 -32.05 17.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.442 HD13 ' CE1' ' A' ' 154' ' ' PHE . 32.5 mt -125.78 24.98 6.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.9 t60 -86.68 123.04 31.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.56 32.94 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.455 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 195' ' ' HIS . 82.6 p -100.13 -35.14 9.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 110.874 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.21 155.8 17.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 205' ' ' SER . 90.2 m -132.61 77.51 1.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.475 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 11.5 mmt -39.92 139.13 1.0 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.601 0.715 . . . . 0.0 110.845 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.21 150.49 5.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.732 2.288 . . . . 0.0 112.358 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.48 -36.22 2.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -89.58 136.92 32.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.322 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 15.7 t -90.77 -10.87 41.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.847 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 199' ' ' THR . 4.9 t -99.51 172.08 7.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.4 m -99.82 154.79 18.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 139' ' ' GLY . 13.5 tp -54.36 138.16 40.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.468 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 54.1 t -108.09 117.09 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.1 t -123.23 124.8 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.468 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 14.6 ptpt -160.8 144.67 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.5 tptt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.786 0.327 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.732 HD22 HD11 ' A' ' 191' ' ' ILE . 65.8 mt -119.11 152.21 36.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -119.78 121.02 38.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.23 144.05 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.118 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -138.08 -172.41 12.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.5 mmt 54.05 51.48 14.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.333 . . . . 0.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.2 mt -111.06 155.42 22.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.462 ' ND2' ' HD2' ' A' ' 201' ' ' PRO . 3.2 p30 -91.58 159.49 15.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -81.95 42.67 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.425 ' HG2' ' CG ' ' A' ' 142' ' ' ASN . 6.2 pt20 -133.22 -35.02 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -71.12 150.27 45.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.0 p -119.59 -177.85 3.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.411 ' HG3' HG23 ' A' ' 165' ' ' VAL . 21.9 mt-10 -63.03 -46.88 85.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -54.71 -50.82 67.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -42.72 -47.68 5.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.624 HG13 ' CE1' ' A' ' 154' ' ' PHE . 95.8 t -70.31 -45.78 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.177 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 163' ' ' CYS . 86.0 mt -57.57 -32.44 67.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.403 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 16.1 mmt180 -81.35 -35.39 30.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.2 tp -84.32 -16.09 44.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.717 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -100.18 -35.3 9.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.532 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 6.1 mt-30 -47.2 -49.04 53.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.6 0.714 . . . . 0.0 110.865 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.7 Cg_exo -47.96 -17.02 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.707 2.272 . . . . 0.0 112.303 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -99.9 -36.53 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.62 163.38 35.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.528 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.62 104.84 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.717 HD11 ' CB ' ' A' ' 154' ' ' PHE . 62.2 mt -76.04 128.12 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -76.48 -54.33 6.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -147.07 145.3 29.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.595 ' HB2' HD21 ' A' ' 151' ' ' LEU . 43.1 t -133.74 148.0 51.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.439 ' O ' ' HB1' ' A' ' 177' ' ' ALA . 24.0 m -151.49 151.5 31.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.161 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 177' ' ' ALA . 68.4 t -122.63 146.98 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.755 HD12 ' SG ' ' A' ' 176' ' ' CYS . 79.3 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.809 0.338 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 49.55 30.57 13.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.48 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.755 ' SG ' HD12 ' A' ' 166' ' ' LEU . 7.1 p -149.79 149.47 30.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 164' ' ' THR . . . -160.03 161.18 33.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -113.71 133.26 55.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 70.4 t -122.81 126.09 73.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 160' ' ' ILE . 15.6 tttp -108.63 123.18 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -97.52 168.34 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.866 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 84.2 p -68.92 -36.72 78.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.8 m -135.25 171.79 13.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -72.17 -44.71 62.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.4 m -52.24 -59.46 4.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -41.54 -49.68 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -58.05 -59.17 5.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -38.87 -47.37 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.42 -63.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.37 -39.37 1.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.732 HD11 HD22 ' A' ' 136' ' ' LEU . 73.8 mt -60.99 -72.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -57.34 -12.95 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -87.5 -37.74 16.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.086 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 154' ' ' PHE . 18.5 mt -120.22 23.53 10.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.0 t60 -83.36 123.03 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.7 33.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.9 p -100.31 -36.51 9.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.798 0.332 . . . . 0.0 110.859 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -100.4 160.66 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 37.9 m -134.16 81.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 15.9 mmt -41.38 137.47 1.68 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.56 0.695 . . . . 0.0 110.884 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.462 ' HD2' ' ND2' ' A' ' 142' ' ' ASN . 75.5 Cg_exo -48.74 147.06 10.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 0.0 112.317 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.65 -34.44 3.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.482 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.33 141.4 28.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.069 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 57.7 m -93.52 -12.81 28.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 66.7 m -99.53 157.17 16.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.9 m -78.36 172.13 14.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 196' ' ' GLY . 13.7 tp -71.97 140.15 48.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.2 t -106.24 106.72 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.7 t -117.99 120.3 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -159.54 156.29 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.926 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 tptt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.808 0.337 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.665 ' CD2' HD11 ' A' ' 191' ' ' ILE . 54.8 mt -117.26 157.6 25.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -125.25 122.11 36.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.9 140.88 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -136.23 -176.98 14.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.5 mmt 60.17 38.26 20.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.2 mt -99.02 154.61 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 144' ' ' GLN . 23.1 p30 -98.11 170.29 9.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -80.57 -0.18 36.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.409 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 57.0 mt-30 -102.05 32.68 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -134.99 154.18 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.4 p -132.25 167.0 20.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.558 ' CG ' HG23 ' A' ' 165' ' ' VAL . 50.1 mt-10 -54.41 -44.83 72.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -53.74 -45.9 70.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -50.3 -55.2 16.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.786 HG13 ' CE1' ' A' ' 154' ' ' PHE . 71.8 t -60.87 -46.3 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.901 HD21 ' CB ' ' A' ' 163' ' ' CYS . 35.1 mt -57.97 -39.09 77.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -70.08 -38.87 75.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.9 tp -84.05 -10.32 57.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.888 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.17 -36.4 9.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.557 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -46.92 -47.03 53.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.638 0.732 . . . . 0.0 110.938 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.0 Cg_exo -47.99 -18.85 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.695 2.263 . . . . 0.0 112.314 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.406 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 75.8 m-85 -100.32 -38.07 8.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -172.49 162.7 34.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.8 t -76.41 103.4 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 111.102 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.888 HD11 ' CB ' ' A' ' 154' ' ' PHE . 20.7 mt -73.4 142.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.083 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -103.13 -61.62 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -114.18 119.31 36.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.901 ' CB ' HD21 ' A' ' 151' ' ' LEU . 25.5 t -134.14 121.0 20.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -141.37 151.67 43.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.558 HG23 ' CG ' ' A' ' 147' ' ' GLU . 95.0 t -116.16 139.93 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 60.0 mt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 mttm . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.872 0.368 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.78 76.01 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -139.37 153.79 47.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.862 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.476 ' HB2' HG13 ' A' ' 165' ' ' VAL . . . -161.94 157.46 23.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -109.2 144.65 37.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.615 HG11 ' HD2' ' A' ' 154' ' ' PHE . 59.0 t -134.86 126.62 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.13 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 160' ' ' ILE . 11.6 tttp -113.8 123.94 51.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -99.79 162.95 12.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.8 t -66.28 -37.34 85.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 t -132.83 158.09 43.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.87 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.5 ' CG ' ' N ' ' A' ' 185' ' ' THR . 26.2 p-80 -59.24 -53.61 56.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.5 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 26.3 m -45.59 -52.73 10.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -47.27 -45.25 23.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.533 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -64.37 -59.27 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.407 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.2 mm100 -40.19 -38.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -69.53 -63.84 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.071 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.32 -31.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.665 HD11 ' CD2' ' A' ' 136' ' ' LEU . 74.7 mt -69.44 -71.51 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -56.73 -15.78 5.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.816 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.406 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -87.91 -34.93 17.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.471 ' HB3' ' NE2' ' A' ' 198' ' ' GLN . 26.0 mt -122.39 25.55 8.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.917 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.9 t60 -89.04 122.18 32.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.862 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.49 32.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 195' ' ' HIS . 60.3 p -100.14 -37.08 9.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.844 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.697 ' NE2' HD22 ' A' ' 207' ' ' LEU . 10.4 pt20 -100.37 161.77 13.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 205' ' ' SER . 27.0 m -131.19 84.59 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 16.9 mmt -39.19 139.2 0.81 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.555 0.693 . . . . 0.0 110.856 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.27 137.94 23.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.251 . . . . 0.0 112.331 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.0 3.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.43 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -69.93 139.36 52.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.1 m -92.82 -8.63 42.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 199' ' ' THR . 4.6 t -99.94 170.89 8.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 25.0 m -100.14 145.05 28.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.697 HD22 ' NE2' ' A' ' 198' ' ' GLN . 10.9 tp -44.86 143.72 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.5 t -115.67 108.57 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.42 HG12 HG12 ' A' ' 191' ' ' ILE . 15.8 t -115.77 121.61 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -157.27 148.35 21.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.977 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 136' ' ' LEU . 13.3 tppt? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.867 0.365 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.834 ' CD2' HD11 ' A' ' 191' ' ' ILE . 63.6 mt -139.2 135.57 34.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -102.45 117.13 34.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 209' ' ' VAL . 5.9 t -106.53 145.43 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.124 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.552 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -140.03 -164.18 9.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.507 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.9 mmt 48.8 49.77 18.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.668 HD23 ' HG3' ' A' ' 200' ' ' MET . 58.4 mt -110.31 153.31 25.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.406 ' CG ' ' O ' ' A' ' 201' ' ' PRO . 0.4 OUTLIER -95.12 173.96 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -90.38 42.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -134.4 -35.34 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.448 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 26.7 mt-30 -70.88 145.8 50.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.9 p -121.51 -178.53 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.58 ' HG3' HG23 ' A' ' 165' ' ' VAL . 6.1 mp0 -64.69 -35.07 79.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -64.2 -35.67 81.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.56 -65.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.899 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.85 HG13 ' CE1' ' A' ' 154' ' ' PHE . 92.8 t -53.72 -53.02 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 163' ' ' CYS . 70.3 mt -52.46 -39.36 61.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -69.62 -39.5 77.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.5 tp -84.7 -9.28 58.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.89 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -99.98 -37.27 9.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.2 tm0? -47.29 -46.76 57.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.597 0.713 . . . . 0.0 110.934 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.3 Cg_exo -47.99 -17.18 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.307 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.431 ' HE2' HD11 ' A' ' 194' ' ' LEU . 73.6 m-85 -100.27 -32.2 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.95 171.71 43.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.8 t -80.79 105.27 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.869 0.366 . . . . 0.0 111.072 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.89 HD11 ' CB ' ' A' ' 154' ' ' PHE . 47.5 mt -75.35 130.06 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.34 -61.31 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.838 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -146.37 145.25 30.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.732 ' CB ' HD21 ' A' ' 151' ' ' LEU . 16.2 t -133.81 118.36 17.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.9 m -124.48 140.1 53.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.154 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.58 HG23 ' HG3' ' A' ' 147' ' ' GLU . 97.6 t -108.15 138.09 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.1 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.589 HD12 ' SG ' ' A' ' 176' ' ' CYS . 37.4 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.789 0.328 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 54.69 30.87 52.65 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.472 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.589 ' SG ' HD12 ' A' ' 166' ' ' LEU . 13.7 p -144.27 160.57 40.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 110.847 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -166.76 171.09 11.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -124.53 130.33 52.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.24 131.24 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -114.38 122.62 47.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.546 ' CE1' HD12 ' A' ' 136' ' ' LEU . 37.5 m-85 -94.95 163.96 13.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.8 p -70.46 -26.42 63.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.0 t -143.25 151.48 40.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.544 ' CG ' ' N ' ' A' ' 185' ' ' THR . 17.2 p80 -55.81 -51.62 66.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.544 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 66.4 m -43.03 -66.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.155 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.3 OUTLIER -37.2 -52.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.577 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -55.68 -59.26 5.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.545 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.3 mm100 -38.7 -48.17 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.2 -63.28 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -40.09 -30.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.072 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.834 HD11 ' CD2' ' A' ' 136' ' ' LEU . 72.5 mt -69.51 -71.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -64.63 -9.28 18.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -90.29 -25.59 20.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.431 HD11 ' HE2' ' A' ' 157' ' ' PHE . 24.6 mt -133.29 16.11 4.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 191' ' ' ILE . 2.0 t60 -87.89 126.45 35.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.854 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 45.66 20.15 0.37 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.526 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 60.4 p -100.38 -37.35 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 199' ' ' THR . 6.5 tt0 -100.44 156.26 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 205' ' ' SER . 85.9 m -127.61 80.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.668 ' HG3' HD23 ' A' ' 141' ' ' LEU . 20.1 mmt -37.03 137.85 0.56 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.573 0.701 . . . . 0.0 110.859 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.406 ' O ' ' CG ' ' A' ' 142' ' ' ASN . 72.8 Cg_exo -47.21 154.29 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.7 2.267 . . . . 0.0 112.343 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.7 -45.92 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.498 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -79.14 136.08 37.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.086 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.4 t -87.48 -11.57 48.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 199' ' ' THR . 71.0 m -99.41 163.66 12.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.817 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 58.8 p -80.91 174.52 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 139' ' ' GLY . 20.1 tp -74.61 155.38 37.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.486 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 49.2 t -122.62 104.35 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 138' ' ' VAL . 12.0 t -118.58 121.53 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.148 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.486 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 12.7 ptpt -159.15 146.5 17.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.4 tttp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.813 0.34 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.761 HD11 ' HB1' ' A' ' 187' ' ' ALA . 78.6 mt -106.97 154.67 20.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -121.59 115.26 22.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.36 149.3 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -142.73 -176.59 16.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.5 mmt 59.28 38.68 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.828 0.347 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 36.1 mt -98.98 153.65 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -105.27 164.88 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -77.61 47.6 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -133.77 -34.1 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -82.31 140.04 33.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.6 p -119.22 171.56 8.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -47.94 -51.92 21.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -54.93 26.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -43.14 -65.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.573 HG13 ' CE1' ' A' ' 154' ' ' PHE . 71.0 t -49.05 -62.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.885 HD21 ' CB ' ' A' ' 163' ' ' CYS . 29.4 mt -46.85 -37.3 8.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -69.9 -39.78 76.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.8 tp -83.83 -9.83 58.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.861 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.26 -36.19 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -46.99 -47.07 54.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.558 0.694 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.1 Cg_exo -47.94 -18.38 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.706 2.271 . . . . 0.0 112.329 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -101.4 -45.33 5.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.05 156.72 27.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 83.1 t -74.86 95.34 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 111.12 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.861 HD11 ' CB ' ' A' ' 154' ' ' PHE . 40.3 mt -65.98 143.74 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.48 -59.7 2.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -138.69 137.15 36.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.885 ' CB ' HD21 ' A' ' 151' ' ' LEU . 42.7 t -134.06 143.3 47.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 99.4 m -151.76 140.34 20.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.477 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 79.0 t -105.31 141.35 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 42.1 mttm . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.799 0.333 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 75.37 30.2 58.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.492 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.18 151.37 30.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -152.91 178.14 9.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -128.87 125.78 38.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.74 123.42 70.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.179 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -106.38 122.26 45.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.46 164.8 12.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.856 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.6 t -66.31 -35.76 81.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.1 t -137.65 168.12 20.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -66.15 -60.06 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.7 m -39.67 -52.74 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -47.3 -49.96 22.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.761 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -61.22 -55.97 25.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -39.97 -42.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -68.45 -64.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.52 -35.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.631 HD11 HD22 ' A' ' 136' ' ' LEU . 61.8 mt -67.15 -70.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -56.21 -13.59 2.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -89.62 -39.72 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.469 ' HB3' ' NE2' ' A' ' 198' ' ' GLN . 23.1 mt -118.23 29.19 7.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.3 t60 -96.32 122.54 39.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 42.36 24.15 0.2 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.531 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 195' ' ' HIS . 51.3 p -100.26 -37.44 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 0.0 110.877 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.469 ' NE2' ' HB3' ' A' ' 194' ' ' LEU . 1.9 pt20 -100.54 151.18 21.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 205' ' ' SER . 59.9 m -123.97 86.08 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 16.9 mmt -43.7 139.66 2.71 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.539 0.685 . . . . 0.0 110.895 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.67 151.14 5.38 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 82.31 -47.97 3.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.459 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -77.24 148.53 35.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.09 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 45.1 t -94.86 -17.76 21.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 199' ' ' THR . 4.2 m -100.07 164.71 11.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.921 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.0 p -79.13 -174.91 4.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.875 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 139' ' ' GLY . 13.1 tp -83.41 152.29 25.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -118.15 107.75 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.5 t -116.47 121.24 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.139 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -157.85 149.43 21.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.506 ' HE2' ' CD1' ' A' ' 178' ' ' PHE . 48.2 tttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.913 HD21 ' HB1' ' A' ' 187' ' ' ALA . 28.8 mt -121.31 152.5 38.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -117.72 114.95 24.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.55 146.77 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -145.33 -178.99 21.31 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.482 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.4 mmt 55.59 48.23 19.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.529 ' CD2' HD11 ' A' ' 207' ' ' LEU . 42.4 mt -106.37 165.23 11.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -105.41 165.04 11.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.73 41.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -128.75 -35.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.35 152.97 36.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.7 p -129.23 178.9 6.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.768 ' HG3' HG23 ' A' ' 165' ' ' VAL . 5.2 mt-10 -57.02 -41.44 78.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.59 -55.03 38.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -43.2 -64.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.595 HG13 ' CE1' ' A' ' 154' ' ' PHE . 66.4 t -49.96 -60.76 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.868 HD21 ' CB ' ' A' ' 163' ' ' CYS . 35.8 mt -47.37 -37.61 11.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -69.48 -40.17 77.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.6 tp -83.81 -10.27 58.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.872 ' HB3' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -99.64 -35.54 9.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.0 tt0 -47.04 -46.96 55.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.601 0.715 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.2 Cg_exo -48.02 -17.13 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.621 2.214 . . . . 0.0 112.349 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.455 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 73.8 m-85 -100.63 -37.06 8.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.12 165.2 38.53 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.8 t -80.79 93.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.785 0.326 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.872 HD11 ' HB3' ' A' ' 154' ' ' PHE . 51.5 mt -65.37 129.31 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -77.77 -64.64 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -132.35 137.78 47.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.868 ' CB ' HD21 ' A' ' 151' ' ' LEU . 42.8 t -134.07 139.21 45.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.1 m -144.44 153.88 42.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.153 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.768 HG23 ' HG3' ' A' ' 147' ' ' GLU . 81.6 t -113.41 147.69 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.163 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.0 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.3 mttm . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.833 0.349 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 67.68 25.69 73.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.65 153.36 41.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 110.868 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -156.34 159.21 38.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.506 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 49.1 m-85 -108.98 141.12 41.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.76 125.4 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.673 ' O ' HG23 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -108.65 125.63 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -99.71 162.47 12.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.3 t -63.53 -30.7 71.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.0 m -141.39 168.95 18.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -68.23 -52.45 33.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 99.3 m -44.85 -61.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -40.04 -45.76 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.913 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -64.0 -54.44 34.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.541 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.5 mm100 -43.36 -36.18 1.81 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.54 -59.72 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -45.61 -30.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 188' ' ' GLN . 67.9 mt -68.43 -72.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -59.53 -17.3 31.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.455 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -80.51 -36.38 33.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.553 HD13 ' CE1' ' A' ' 154' ' ' PHE . 14.9 mt -123.28 23.05 9.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.2 t60 -87.24 124.34 33.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.87 30.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.525 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.08 -36.6 9.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.809 0.338 . . . . 0.0 110.872 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.783 ' OE1' HD22 ' A' ' 207' ' ' LEU . 1.6 pt20 -100.37 159.55 15.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 30.0 m -134.47 81.04 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.175 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.6 mmt -41.55 140.28 1.35 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.584 0.707 . . . . 0.0 110.865 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.08 139.51 20.62 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.737 2.291 . . . . 0.0 112.328 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 90.47 -47.91 3.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.508 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -78.98 126.84 31.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.761 0.315 . . . . 0.0 111.147 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.8 t -83.26 -7.39 59.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.826 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.8 p -100.11 157.7 16.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -87.13 144.64 26.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.783 HD22 ' OE1' ' A' ' 198' ' ' GLN . 14.3 tp -44.57 144.63 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.943 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 63.6 t -112.74 114.61 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.5 t -125.5 119.59 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.128 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -158.43 150.6 21.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.989 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 178' ' ' PHE . 2.9 tppp? . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.807 0.337 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.628 ' CD2' HD11 ' A' ' 191' ' ' ILE . 96.6 mt -136.32 144.94 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -112.92 122.48 47.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 t -113.05 144.45 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.21 -169.01 11.45 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.8 mmt 52.34 39.37 27.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.8 mt -100.26 145.51 28.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -89.64 -177.76 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.17 -7.24 59.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -99.99 29.4 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.936 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.418 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 59.8 mt-30 -127.04 105.56 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.946 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.1 p -103.08 166.32 10.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.475 ' HG3' HG23 ' A' ' 165' ' ' VAL . 5.4 mp0 -43.8 -41.85 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -59.55 -48.11 82.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -50.52 -54.43 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.685 HG13 ' CE1' ' A' ' 154' ' ' PHE . 73.6 t -66.62 -55.93 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.618 HD23 HD13 ' A' ' 160' ' ' ILE . 73.6 mt -50.9 -33.61 24.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.422 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 15.2 mmm180 -77.65 -37.51 49.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.2 tp -84.31 -12.84 53.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.868 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.6 m-85 -100.46 -37.21 8.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.52 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 4.6 mt-30 -47.07 -49.31 51.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.541 0.686 . . . . 0.0 110.929 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.94 -17.19 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.717 2.278 . . . . 0.0 112.339 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.515 ' CE1' ' HB1' ' A' ' 193' ' ' ALA . 73.3 m-85 -100.87 -39.98 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.77 155.67 27.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 69.6 t -71.43 93.9 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.868 HD11 ' CB ' ' A' ' 154' ' ' PHE . 75.1 mt -61.82 143.44 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -92.44 -59.53 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -140.5 144.44 36.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.524 ' CB ' HD21 ' A' ' 151' ' ' LEU . 3.7 t -134.02 133.14 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.7 m -137.2 125.75 23.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.475 HG23 ' HG3' ' A' ' 147' ' ' GLU . 58.8 t -96.95 151.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.496 HD11 ' HE1' ' A' ' 178' ' ' PHE . 38.4 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.4 mttp . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.832 0.349 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.84 24.86 70.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.32 160.07 42.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 110.898 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.45 158.39 20.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.496 ' HE1' HD11 ' A' ' 166' ' ' LEU . 76.8 m-85 -112.27 132.98 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.22 137.96 55.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 160' ' ' ILE . 23.9 ttmt -119.13 135.88 54.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.603 ' HE1' HD12 ' A' ' 136' ' ' LEU . 43.2 m-85 -107.94 167.93 9.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.5 t -71.44 -23.89 61.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.5 m -143.84 176.23 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.837 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -80.33 -42.23 23.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.812 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.4 m -53.56 -58.0 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -42.92 -47.3 5.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.617 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -59.65 -60.31 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -39.71 -41.67 1.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.39 -63.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.16 -32.69 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.127 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.628 HD11 ' CD2' ' A' ' 136' ' ' LEU . 40.5 mt -66.34 -71.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.138 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -59.25 -10.98 3.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.515 ' HB1' ' CE1' ' A' ' 157' ' ' PHE . . . -96.2 -24.44 16.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.47 HD21 ' HE2' ' A' ' 157' ' ' PHE . 30.2 mt -131.42 24.42 4.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 191' ' ' ILE . 2.4 t60 -90.6 119.8 31.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.69 33.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 195' ' ' HIS . 38.3 p -100.27 -38.07 8.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.826 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -100.53 163.2 12.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 205' ' ' SER . 26.3 m -129.93 84.58 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.418 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 21.4 mmt -40.52 137.9 1.29 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.612 0.72 . . . . 0.0 110.866 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.49 143.89 14.86 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.303 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 82.28 -40.15 2.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.507 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.66 138.85 35.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 90.9 p -92.42 -9.48 41.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 199' ' ' THR . 49.4 m -99.03 167.19 10.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.4 m -92.48 154.1 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 196' ' ' GLY . 11.6 tp -51.55 141.28 16.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.6 t -112.1 111.66 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.3 133.3 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -165.7 144.12 6.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.936 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.872 0.368 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.796 HD21 ' HB1' ' A' ' 187' ' ' ALA . 44.7 mt -120.09 153.78 35.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -120.44 120.13 35.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.69 147.62 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -141.04 -170.54 12.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.6 mmt 54.91 34.11 21.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.563 ' CD2' HD11 ' A' ' 207' ' ' LEU . 47.0 mt -93.31 153.52 18.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -106.95 165.58 11.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -77.32 46.9 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -133.81 -34.55 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -81.23 145.48 30.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 77.1 p -125.6 169.86 12.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.468 ' HG3' HG23 ' A' ' 165' ' ' VAL . 9.9 mt-10 -49.57 -46.84 49.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -54.61 -53.28 56.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -45.56 -65.69 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.885 HG13 ' CE1' ' A' ' 154' ' ' PHE . 95.2 t -48.9 -60.29 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.09 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.925 HD21 ' CB ' ' A' ' 163' ' ' CYS . 35.2 mt -47.53 -40.09 17.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -69.69 -39.42 76.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.458 HD21 HD22 ' A' ' 194' ' ' LEU . 13.1 tp -84.8 -9.1 58.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.885 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.2 m-85 -100.34 -37.32 8.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -47.29 -46.87 57.65 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 0.0 110.877 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.9 Cg_exo -48.0 -18.46 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.654 2.236 . . . . 0.0 112.366 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.457 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 75.5 m-85 -100.38 -47.32 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.57 164.77 33.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.51 104.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.83 HD11 ' HB3' ' A' ' 154' ' ' PHE . 45.1 mt -76.91 131.47 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.43 -64.38 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -122.37 132.21 54.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.925 ' CB ' HD21 ' A' ' 151' ' ' LEU . 34.9 t -132.73 136.79 46.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 165' ' ' VAL . 96.4 m -153.7 152.81 31.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.57 HG22 ' CB ' ' A' ' 177' ' ' ALA . 65.6 t -117.12 148.24 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.2 mttm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.828 0.347 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 51.86 29.4 26.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 17.0 p -144.28 151.48 39.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.57 ' CB ' HG22 ' A' ' 165' ' ' VAL . . . -160.18 166.12 30.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -117.72 144.94 44.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 26.6 t -137.51 121.54 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.731 ' O ' HG23 ' A' ' 160' ' ' ILE . 23.1 ttmt -103.89 129.86 51.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.412 ' HE1' HD12 ' A' ' 136' ' ' LEU . 36.4 m-85 -103.66 164.73 11.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 88.2 p -63.49 -33.12 74.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.6 m -141.49 179.05 7.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -75.44 -51.85 12.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 31.0 m -48.83 -53.32 19.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.101 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -47.04 -47.98 22.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.796 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -62.37 -57.57 10.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.132 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.574 ' HA ' HD12 ' A' ' 191' ' ' ILE . 5.1 mm100 -40.71 -40.67 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -67.36 -61.1 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.61 -31.67 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.095 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.684 HD11 HD22 ' A' ' 136' ' ' LEU . 74.6 mt -67.5 -71.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.175 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -57.17 -13.64 3.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.457 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.72 -41.15 14.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 154' ' ' PHE . 33.2 mt -113.51 16.26 18.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -83.03 126.21 32.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 37.94 28.43 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.541 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 195' ' ' HIS . 77.2 p -100.4 -39.61 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.351 . . . . 0.0 110.843 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.759 ' NE2' HD22 ' A' ' 207' ' ' LEU . 11.5 pt20 -100.66 160.83 14.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 205' ' ' SER . 96.3 m -135.0 81.14 1.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.41 ' C ' ' O ' ' A' ' 199' ' ' THR . 26.5 mmt -37.72 137.84 0.67 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.582 0.706 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.77 153.66 3.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 2.286 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 78.33 -42.88 2.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.509 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.62 138.23 35.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.9 t -87.22 -13.41 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 199' ' ' THR . 6.0 t -100.08 169.61 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 24.6 p -87.86 -174.81 4.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.759 HD22 ' NE2' ' A' ' 198' ' ' GLN . 11.7 tp -86.86 122.67 31.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.53 109.48 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.101 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 36.4 t -118.22 124.81 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.083 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -164.33 150.6 10.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.6 tttt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.749 0.309 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.978 HD21 ' HB1' ' A' ' 187' ' ' ALA . 37.3 mt -96.41 150.52 20.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -116.13 113.27 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.86 143.71 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.679 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -140.02 -171.56 12.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.491 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.4 mmt 51.6 42.4 29.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 49.6 mt -102.19 157.33 16.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -99.17 168.12 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -84.14 37.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -127.62 -44.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -62.9 146.79 52.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 53.5 p -122.81 178.31 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' A' ' 165' ' ' VAL . 13.0 mt-10 -58.3 -48.19 81.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -54.18 -50.23 67.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -44.98 -68.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.69 HG13 ' CE1' ' A' ' 154' ' ' PHE . 46.9 t -49.04 -60.31 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.751 HD23 HD13 ' A' ' 160' ' ' ILE . 35.4 mt -46.48 -38.06 8.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -69.21 -40.4 78.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.93 -10.55 57.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.731 ' CE1' HD13 ' A' ' 194' ' ' LEU . 3.1 m-85 -98.83 -35.75 10.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.3 OUTLIER -47.18 -46.94 56.58 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.551 0.691 . . . . 0.0 110.908 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.6 Cg_exo -48.0 -16.95 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.639 2.226 . . . . 0.0 112.359 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.48 ' CE1' ' HB1' ' A' ' 193' ' ' ALA . 72.7 m-85 -99.85 -46.83 5.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.409 ' HA3' ' CG ' ' A' ' 186' ' ' GLU . . . -160.1 174.49 36.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.5 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.4 t -87.6 102.32 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.751 HD13 HD23 ' A' ' 151' ' ' LEU . 23.7 mt -74.07 134.37 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.46 -60.36 2.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -139.9 142.26 36.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.719 ' HB2' HD21 ' A' ' 151' ' ' LEU . 9.8 t -134.01 144.78 48.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.6 m -153.81 144.08 22.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.485 HG23 ' HG3' ' A' ' 147' ' ' GLU . 58.0 t -112.23 139.52 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 67.4 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.1 mttt . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.843 0.354 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 59.46 28.95 65.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 6.2 p -145.93 156.43 43.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -160.47 172.1 17.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -126.61 124.01 38.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 85.7 t -115.9 130.58 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.693 ' O ' HG23 ' A' ' 160' ' ' ILE . 20.7 ttmt -111.9 131.22 55.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 186' ' ' GLU . 40.9 m-85 -105.77 166.8 10.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.7 t -81.53 -3.14 52.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.0 m -162.96 149.76 12.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.858 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -59.84 -46.04 90.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.7 m -48.71 -61.14 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.108 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 181' ' ' PHE . 0.5 OUTLIER -42.33 -51.24 4.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.978 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.75 -56.84 16.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.098 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -38.62 -51.51 1.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.955 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.39 -61.21 2.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -40.99 -35.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.786 HD11 HD22 ' A' ' 136' ' ' LEU . 63.4 mt -65.69 -69.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -62.25 -14.56 39.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.91 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.48 ' HB1' ' CE1' ' A' ' 157' ' ' PHE . . . -90.84 -25.03 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.731 HD13 ' CE1' ' A' ' 154' ' ' PHE . 76.9 mt -130.06 23.03 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -85.95 123.66 31.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.15 39.46 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.478 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 22.6 p -100.09 -37.73 8.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -100.57 164.82 11.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 205' ' ' SER . 28.6 m -135.01 79.7 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.155 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 199' ' ' THR . 15.0 mmt -38.36 138.42 0.73 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.606 0.717 . . . . 0.0 110.853 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.27 145.18 11.74 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.42 -39.19 2.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.532 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -83.83 129.03 34.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.3 m -84.98 -7.51 59.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 199' ' ' THR . 9.8 t -99.3 170.4 8.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.1 m -99.94 151.97 20.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 139' ' ' GLY . 16.4 tp -53.19 137.82 33.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.62 119.34 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.01 117.52 49.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.073 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -158.05 153.01 25.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.1 tptm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.803 0.335 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.732 ' CD2' HD11 ' A' ' 191' ' ' ILE . 43.8 mt -126.75 156.79 40.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -125.77 115.96 20.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 139' ' ' GLY . 84.5 t -100.8 153.93 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.126 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.434 ' N ' HG12 ' A' ' 138' ' ' VAL . . . -144.42 -172.88 15.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.0 mmt 51.11 50.14 19.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HB2' ' C ' ' A' ' 175' ' ' GLY . 34.1 mt -107.71 154.97 20.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -99.43 171.06 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -86.26 28.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.89 -31.44 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -79.62 147.02 32.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.2 p -124.62 -176.61 3.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -62.69 -44.29 96.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -57.03 -45.16 83.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -52.33 -58.94 5.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.792 HG13 ' CE1' ' A' ' 154' ' ' PHE . 83.6 t -57.4 -50.49 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.868 HD21 ' CB ' ' A' ' 163' ' ' CYS . 33.9 mt -55.54 -39.49 70.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -70.05 -38.68 75.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.8 tp -84.22 -10.47 57.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.799 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.15 -35.93 9.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.562 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.01 -46.92 54.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.601 0.715 . . . . 0.0 110.936 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.97 -17.13 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -101.66 -44.59 5.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.36 164.72 35.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.18 103.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.352 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.799 HD11 ' CB ' ' A' ' 154' ' ' PHE . 44.0 mt -75.25 137.79 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.97 -61.89 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.78 134.9 47.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.868 ' CB ' HD21 ' A' ' 151' ' ' LEU . 36.7 t -134.08 135.12 43.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 80.4 m -147.76 145.3 28.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.109 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.47 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 77.3 t -112.56 148.02 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.912 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.5 mttm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.833 0.349 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.421 ' C ' ' HB2' ' A' ' 141' ' ' LEU . . . 82.83 -3.33 83.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.472 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.3 169.0 16.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.835 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -164.67 173.59 11.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -123.94 132.39 53.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 64.1 t -125.61 131.58 71.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -117.45 113.11 21.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -86.26 166.35 15.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 95.6 p -68.47 -35.17 77.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -134.51 164.92 26.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -65.92 -50.97 62.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.91 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.4 m -48.96 -62.39 1.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.179 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -44.38 -42.05 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -59.39 -60.56 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.787 ' HA ' HD12 ' A' ' 191' ' ' ILE . 6.3 mt-30 -45.76 -50.28 14.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -50.28 -55.57 14.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.1 -35.68 59.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.787 HD12 ' HA ' ' A' ' 188' ' ' GLN . 58.3 mt -64.87 -68.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.146 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -57.88 -12.39 3.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -91.08 -39.02 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.704 HD13 ' CE1' ' A' ' 154' ' ' PHE . 28.6 mt -115.2 25.68 10.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.8 t60 -88.72 122.62 32.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.61 33.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 195' ' ' HIS . 23.5 p -100.22 -38.33 8.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 110.866 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -100.52 162.47 12.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 47.5 m -132.75 84.1 2.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.6 mmt -39.93 137.92 1.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.568 0.699 . . . . 0.0 110.881 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.83 144.46 15.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.659 2.24 . . . . 0.0 112.332 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.34 -40.93 3.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.515 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -83.36 142.42 31.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 111.108 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 73.9 p -94.2 -12.65 27.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.7 m -98.94 157.94 15.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.7 m -78.27 174.94 10.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 196' ' ' GLY . 9.9 tp -73.97 145.6 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.926 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 57.3 t -113.46 111.51 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.6 t -122.27 123.6 69.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.093 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -161.81 149.56 14.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.94 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.846 0.355 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.698 HD21 ' HB1' ' A' ' 187' ' ' ALA . 18.9 mt -121.7 153.86 37.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -116.0 109.99 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.54 139.29 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -133.83 -173.05 13.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.452 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.9 mmt 57.36 43.32 23.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.403 ' CD2' HD11 ' A' ' 207' ' ' LEU . 43.6 mt -102.23 156.89 17.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -96.23 161.32 14.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -81.98 43.12 0.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -134.38 -37.84 0.85 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -67.87 151.36 47.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.0 p -129.6 164.27 24.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.413 ' HG3' HG23 ' A' ' 165' ' ' VAL . 4.7 mp0 -44.33 -48.52 9.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.24 -54.42 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -42.55 -67.79 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.834 HG13 ' CE1' ' A' ' 154' ' ' PHE . 99.7 t -49.63 -61.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 155' ' ' GLN . 34.2 mt -44.83 -38.25 4.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -69.45 -40.52 77.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.93 -9.38 58.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.883 ' HB3' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.26 -35.81 9.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.564 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.13 -46.97 56.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.92 -16.67 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.325 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.453 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.4 m-85 -99.69 -41.95 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.22 168.02 37.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.62 134.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.153 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.883 HD11 ' HB3' ' A' ' 154' ' ' PHE . 75.4 mt -109.04 109.08 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.143 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' LYS . 18.5 m-20 -45.3 -61.28 1.73 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.875 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -157.88 148.43 20.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 20.6 t -133.74 135.61 44.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.8 m -139.44 141.9 37.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.413 HG23 ' HG3' ' A' ' 147' ' ' GLU . 98.3 t -104.69 135.06 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.548 HD11 ' HE2' ' A' ' 178' ' ' PHE . 95.9 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.5 mttm . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.833 0.349 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 50.48 33.65 25.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 29.7 m -150.03 169.05 22.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 110.856 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -165.69 179.24 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.548 ' HE2' HD11 ' A' ' 166' ' ' LEU . 91.5 m-85 -133.98 118.7 18.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.9 t -110.85 118.91 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 161' ' ' ASP . 13.4 ttmm -105.02 117.91 35.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.944 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -93.29 154.14 18.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 m -57.4 -41.04 79.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -134.38 136.01 43.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 187' ' ' ALA . 4.9 p80 -38.57 -56.32 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 184' ' ' HIS . 94.3 m -37.53 -67.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -41.03 -43.62 2.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.698 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -62.0 -53.95 48.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.623 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.3 mm100 -45.21 -46.93 12.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -60.94 -65.74 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.4 -38.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.661 HD11 HD22 ' A' ' 136' ' ' LEU . 62.3 mt -61.63 -71.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.146 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -57.09 -13.14 2.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.453 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -90.94 -32.33 16.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.125 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.684 HD13 ' CE1' ' A' ' 154' ' ' PHE . 40.8 mt -122.43 20.64 10.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -86.53 123.96 32.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 41.52 28.36 0.36 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 82.9 p -100.53 -38.67 8.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.862 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.689 ' NE2' HD22 ' A' ' 207' ' ' LEU . 9.7 pt20 -100.58 146.0 27.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 205' ' ' SER . 86.9 m -123.91 80.25 1.79 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.147 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.446 ' C ' ' O ' ' A' ' 199' ' ' THR . 14.1 mmt -34.58 138.1 0.34 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.558 0.694 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.63 151.58 7.43 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.733 2.289 . . . . 0.0 112.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.69 -43.9 2.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -78.84 136.33 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 111.097 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 70.1 m -86.49 -13.0 47.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 199' ' ' THR . 23.1 m -100.08 161.24 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.3 p -85.27 -178.41 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.689 HD22 ' NE2' ' A' ' 198' ' ' GLN . 11.9 tp -82.71 123.49 29.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.4 t -92.24 106.04 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 14.6 t -113.27 117.43 55.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.16 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -157.46 150.6 23.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.1 tttt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.827 0.346 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 1.015 HD21 ' HB1' ' A' ' 187' ' ' ALA . 58.1 mt -115.92 153.3 31.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -123.36 114.04 19.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.2 t -101.18 143.75 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.77 -173.85 13.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.6 mmt 57.8 37.46 27.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.446 ' CD2' ' OE1' ' A' ' 145' ' ' GLN . 24.3 mt -95.37 155.1 16.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -108.84 173.99 6.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.66 12.51 2.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -99.96 -22.61 15.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.451 ' CD ' ' SD ' ' A' ' 200' ' ' MET . 34.4 mt-30 -97.57 149.36 22.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 p -130.77 178.16 6.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.42 ' HG3' HG23 ' A' ' 165' ' ' VAL . 13.7 mt-10 -56.94 -49.24 76.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -52.23 -59.47 4.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -39.65 -67.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.773 HG13 ' CE1' ' A' ' 154' ' ' PHE . 84.1 t -45.16 -60.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.907 HD21 ' HB2' ' A' ' 163' ' ' CYS . 33.9 mt -47.98 -40.31 22.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -69.57 -39.53 77.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -84.19 -10.04 58.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.845 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -99.94 -36.2 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -47.11 -47.01 55.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.592 0.71 . . . . 0.0 110.919 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.2 Cg_exo -48.01 -17.13 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.695 2.263 . . . . 0.0 112.332 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.447 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 74.2 m-85 -101.32 -48.15 4.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -156.3 160.43 30.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.88 93.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.117 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.845 HD11 ' CB ' ' A' ' 154' ' ' PHE . 63.5 mt -62.87 138.6 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -95.13 -62.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.28 132.92 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.907 ' HB2' HD21 ' A' ' 151' ' ' LEU . 42.7 t -134.02 136.17 43.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 50.7 m -152.69 139.52 18.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 53.5 t -104.06 144.84 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 53.1 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.921 179.957 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.74 10.79 86.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.35 148.13 50.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.835 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -153.37 166.15 33.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -120.83 136.06 55.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.928 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 81.2 t -130.51 124.31 56.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -107.9 129.65 55.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.429 ' CE1' HD12 ' A' ' 136' ' ' LEU . 28.4 m-85 -103.59 167.71 9.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.3 t -64.97 -32.31 73.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.3 t -143.19 175.94 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.569 ' CG ' ' N ' ' A' ' 185' ' ' THR . 2.7 p80 -72.13 -49.63 34.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.569 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 89.4 m -43.79 -61.54 1.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -40.94 -51.31 3.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 1.015 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -56.6 -57.63 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.065 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -39.65 -47.24 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 190' ' ' ALA . . . -61.95 -67.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -36.53 -42.93 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.507 HD11 HD22 ' A' ' 136' ' ' LEU . 77.7 mt -57.36 -74.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -57.05 -13.3 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.447 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.86 -35.79 18.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 21.5 mt -126.51 26.41 6.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.8 t60 -86.41 121.41 28.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 207' ' ' LEU . . . 33.86 32.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.51 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.38 -38.77 8.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.343 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.62 160.1 14.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 205' ' ' SER . 19.3 m -130.83 87.59 2.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.451 ' SD ' ' CD ' ' A' ' 145' ' ' GLN . 16.8 mmt -39.62 154.86 0.17 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.87 122.73 9.65 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 2.273 . . . . 0.0 112.305 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 111.97 -43.91 1.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -82.94 153.05 25.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 84.5 p -98.63 -12.8 20.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 199' ' ' THR . 64.8 m -100.14 164.96 11.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.852 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 67.5 m -87.49 161.28 17.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 196' ' ' GLY . 14.9 tp -57.09 141.65 45.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.457 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 55.8 t -110.28 107.12 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.1 t -118.24 114.52 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.457 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 17.6 ptpt -148.3 155.4 41.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.765 0.317 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 1.019 HD21 ' HB1' ' A' ' 187' ' ' ALA . 21.0 mt -125.06 144.93 50.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -112.64 114.76 27.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -103.85 146.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.133 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -142.34 -173.53 14.32 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.417 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.3 mmt 55.81 42.35 29.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.4 mt -103.35 154.87 18.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -98.12 165.82 11.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -82.48 39.93 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -128.53 -38.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -69.49 151.29 46.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.1 p -128.55 176.67 7.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -55.41 -44.62 76.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.861 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.83 -49.18 74.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.12 -69.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.748 HG13 ' CE1' ' A' ' 154' ' ' PHE . 74.6 t -49.96 -59.75 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.866 HD21 ' CB ' ' A' ' 163' ' ' CYS . 25.4 mt -47.34 -38.34 12.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -69.62 -40.13 76.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.1 tp -84.49 -8.96 58.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.748 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -100.18 -37.24 9.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.2 tm0? -47.2 -46.89 56.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.645 0.736 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.97 -17.28 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.242 . . . . 0.0 112.361 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.706 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 73.3 m-85 -99.88 -33.4 10.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.97 164.02 33.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.441 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 94.5 t -76.47 103.41 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 154' ' ' PHE . 85.6 mt -72.37 133.99 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -81.51 -62.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -141.89 139.79 32.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.866 ' CB ' HD21 ' A' ' 151' ' ' LEU . 45.0 t -134.04 141.11 47.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.6 m -146.7 139.44 25.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 87.3 t -105.6 136.63 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.569 HD12 ' SG ' ' A' ' 176' ' ' CYS . 49.9 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.0 mttt . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.794 0.33 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 55.94 38.94 77.01 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.482 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.569 ' SG ' HD12 ' A' ' 166' ' ' LEU . 22.7 p -156.17 149.76 24.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.805 0.336 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -159.47 166.77 30.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.5 136.05 54.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.482 HG22 ' SG ' ' A' ' 163' ' ' CYS . 10.5 t -127.18 125.25 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.615 ' O ' HG23 ' A' ' 160' ' ' ILE . 30.9 tttm -105.72 130.72 53.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.405 ' CE1' HD12 ' A' ' 136' ' ' LEU . 22.8 m-85 -106.29 158.83 16.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.7 t -53.21 -43.6 67.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.6 m -128.26 173.53 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.464 ' O ' ' HB3' ' A' ' 187' ' ' ALA . 29.5 p-80 -71.8 -49.97 33.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.5 m -47.67 -63.62 1.01 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -40.25 -39.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 1.019 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -63.22 -65.76 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.424 ' C ' ' CD ' ' A' ' 188' ' ' GLN . 0.0 OUTLIER -43.39 -36.82 2.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.95 -61.87 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.44 -34.68 4.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.509 HD11 HD22 ' A' ' 136' ' ' LEU . 45.1 mt -60.04 -71.83 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -55.59 -18.73 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.706 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -79.05 -37.4 39.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.46 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 12.2 mt -126.51 28.26 5.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.5 t60 -84.81 120.98 27.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.04 34.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.452 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.3 -38.84 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.844 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -100.6 152.23 20.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 200' ' ' MET . 15.7 m -122.31 86.28 2.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 199' ' ' THR . 13.2 mmt -37.11 155.25 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 110.855 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.41 128.11 15.87 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.695 2.263 . . . . 0.0 112.372 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 103.51 -39.46 2.79 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.96 154.71 21.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.067 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.7 t -99.98 -14.96 18.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.1 m -100.12 161.54 13.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 66.9 m -88.64 158.27 18.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 139' ' ' GLY . 14.3 tp -52.45 141.75 19.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 52.4 t -110.08 108.64 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.15 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.492 HG12 HG12 ' A' ' 191' ' ' ILE . 4.7 t -118.6 124.45 73.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -158.85 148.59 19.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.461 ' CZ ' HD12 ' A' ' 191' ' ' ILE . 68.4 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.763 0.316 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.788 ' CD2' HD11 ' A' ' 191' ' ' ILE . 88.7 mt -140.1 150.66 44.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -117.2 117.61 30.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.11 147.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.49 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -139.41 -170.5 11.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.52 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.4 mmt 51.68 51.19 17.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.778 0.323 . . . . 0.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.462 HD22 ' OE1' ' A' ' 145' ' ' GLN . 43.5 mt -111.13 155.75 22.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -97.61 165.07 12.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -82.37 40.69 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -129.16 -40.05 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.462 ' OE1' HD22 ' A' ' 141' ' ' LEU . 62.9 mt-30 -69.43 144.65 53.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.3 p -122.91 171.27 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.566 ' HG3' HG23 ' A' ' 165' ' ' VAL . 12.9 mp0 -48.43 -48.71 37.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.45 ' OE1' ' C ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -51.74 -51.41 56.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -46.6 -67.35 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.601 HG13 ' CE1' ' A' ' 154' ' ' PHE . 31.7 t -49.27 -62.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 163' ' ' CYS . 25.0 mt -46.49 -38.35 9.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -69.51 -40.1 77.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.76 -10.2 58.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.825 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -99.84 -35.73 9.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -47.1 -47.07 55.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.59 0.71 . . . . 0.0 110.897 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.99 -17.27 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.666 2.244 . . . . 0.0 112.365 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.492 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 74.1 m-85 -101.26 -47.16 4.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.97 166.14 34.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.503 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.5 t -80.6 101.8 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 0.0 111.14 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.825 HD11 ' CB ' ' A' ' 154' ' ' PHE . 38.5 mt -73.07 131.37 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.69 -64.17 1.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -130.77 140.98 50.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.813 ' CB ' HD21 ' A' ' 151' ' ' LEU . 12.3 t -134.13 131.61 38.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.4 m -136.43 138.19 41.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.566 HG23 ' HG3' ' A' ' 147' ' ' GLU . 92.3 t -108.45 135.36 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 176' ' ' CYS . 78.9 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.802 0.334 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 67.68 20.61 72.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.673 ' HB2' HD12 ' A' ' 166' ' ' LEU . 21.3 m -143.49 164.43 30.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.792 0.33 . . . . 0.0 110.883 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -164.02 170.92 15.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.05 121.9 36.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 94.3 t -114.22 131.51 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.704 ' O ' HG23 ' A' ' 160' ' ' ILE . 24.9 ttpt -110.71 129.57 55.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.891 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -102.47 165.23 11.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.7 p -67.32 -39.14 85.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.0 p -132.52 146.09 51.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.42 ' CG ' ' N ' ' A' ' 185' ' ' THR . 6.8 p80 -50.44 -50.41 52.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.42 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 85.9 m -48.66 -53.34 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -45.75 -50.42 13.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -59.89 -48.51 81.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.126 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.596 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.3 mm100 -46.71 -43.41 17.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.41 -59.2 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.106 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.01 -36.81 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.788 HD11 ' CD2' ' A' ' 136' ' ' LEU . 63.3 mt -61.37 -73.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.1 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -57.41 -12.05 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.492 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -85.09 -40.09 17.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.92 19.41 11.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.4 t60 -80.08 124.97 29.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.21 32.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.495 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 195' ' ' HIS . 58.8 p -100.38 -39.31 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.83 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -100.53 160.47 14.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 205' ' ' SER . 19.6 m -135.02 86.62 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 199' ' ' THR . 13.8 mmt -36.1 154.56 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.706 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.45 129.32 17.71 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.64 2.227 . . . . 0.0 112.359 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 101.66 -38.62 3.08 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.482 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.48 146.91 26.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.31 . . . . 0.0 111.081 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.8 t -93.39 -12.38 30.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 199' ' ' THR . 69.3 m -100.16 158.77 15.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.828 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 70.1 m -85.3 169.32 13.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.826 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 139' ' ' GLY . 19.5 tp -65.87 128.12 34.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.1 113.86 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.9 t -123.19 124.08 69.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -162.3 148.61 13.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.98 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.6 tttp . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.796 0.331 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.964 HD21 ' HB1' ' A' ' 187' ' ' ALA . 36.0 mt -121.81 155.0 36.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE1' ' HB3' ' A' ' 176' ' ' CYS . 44.7 t80 -124.42 112.79 17.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.52 152.66 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -146.16 174.93 25.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.4 mmt 57.48 46.01 18.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.336 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.507 ' CD2' HD11 ' A' ' 207' ' ' LEU . 60.2 mt -100.07 147.32 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.437 HD21 ' HA ' ' A' ' 142' ' ' ASN . 0.7 OUTLIER -90.12 164.82 14.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -66.98 -3.66 7.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -109.31 43.71 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.496 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 74.1 mt-30 -135.21 109.24 8.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 p -104.08 170.74 7.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -52.86 -41.93 64.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.5 -47.32 86.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -48.03 -63.99 0.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.839 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.858 HG13 ' CE1' ' A' ' 154' ' ' PHE . 94.9 t -58.49 -60.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.662 HD23 HD13 ' A' ' 160' ' ' ILE . 29.6 mt -44.4 -38.68 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -68.82 -41.11 79.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.461 HD21 HE22 ' A' ' 198' ' ' GLN . 13.5 tp -84.0 -9.78 58.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.858 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.14 -35.88 9.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.56 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.0 OUTLIER -47.18 -46.91 56.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 0.0 110.914 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -48.03 -16.75 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.652 2.235 . . . . 0.0 112.315 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.406 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.4 m-85 -99.87 -42.1 6.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.73 171.16 42.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -80.48 102.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.848 HD11 ' CB ' ' A' ' 154' ' ' PHE . 38.3 mt -72.13 151.34 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -103.13 -57.15 2.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.479 ' CG ' ' HB3' ' A' ' 180' ' ' LYS . 9.7 pt-20 -138.69 137.89 37.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' CYS . . . . . 0.66 ' CB ' HD21 ' A' ' 151' ' ' LEU . 1.7 t -133.72 102.14 5.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.3 m -107.51 119.64 39.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.163 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.467 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 50.3 t -99.91 131.87 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.131 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.9 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.997 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.1 mttt . . . . . 0 CA--C 1.525 0.015 0 CA-C-O 120.812 0.339 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.45 -16.3 44.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.46 ' HB3' ' CE1' ' A' ' 137' ' ' PHE . 1.7 m -125.99 160.14 30.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 110.87 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -158.73 175.98 12.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -136.04 126.27 26.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.18 130.0 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.479 ' HB3' ' CG ' ' A' ' 162' ' ' GLU . 27.0 tttt -106.25 130.35 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.41 ' HE1' HD12 ' A' ' 136' ' ' LEU . 33.6 m-85 -104.0 160.63 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.4 t -72.43 -19.85 61.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.863 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -142.15 164.94 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.451 ' CG ' ' N ' ' A' ' 185' ' ' THR . 2.7 p80 -75.39 -41.75 55.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.806 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.451 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 44.7 m -54.64 -59.76 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -41.12 -47.73 3.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.964 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -60.79 -62.05 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.093 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 187' ' ' ALA . 4.5 mm100 -35.44 -44.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.85 -63.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.054 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.36 -28.86 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.074 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.556 HD11 HD22 ' A' ' 136' ' ' LEU . 36.2 mt -70.71 -72.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.143 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -59.85 -17.14 34.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.406 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -84.74 -25.8 28.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.129 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.418 HD13 ' CE1' ' A' ' 154' ' ' PHE . 25.5 mt -132.59 24.95 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.3 t60 -89.69 121.45 31.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.1 30.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 195' ' ' HIS . 60.6 p -100.25 -39.48 8.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.83 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.829 ' OE1' HD22 ' A' ' 207' ' ' LEU . 4.9 pt20 -100.66 163.98 12.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 205' ' ' SER . 29.3 m -134.82 81.3 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.496 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 13.9 mmt -37.03 156.01 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.698 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.0 136.48 38.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.395 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.12 -35.95 4.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -89.36 150.85 22.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.5 t -100.08 -12.48 19.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.867 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.593 ' O ' HG23 ' A' ' 199' ' ' THR . 7.1 t -100.08 170.07 8.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -94.27 148.94 21.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.808 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.829 HD22 ' OE1' ' A' ' 198' ' ' GLN . 10.7 tp -45.68 151.4 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.97 104.29 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 191' ' ' ILE . 6.6 t -115.94 116.41 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -155.35 148.36 24.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.1 m -39.71 107.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -74.32 139.59 44.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 67.08 179.36 11.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 92.6 p -167.45 176.4 6.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.6 m -151.57 143.82 24.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -172.6 -174.49 39.9 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.493 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 57.9 m -57.45 149.81 20.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.0 110.855 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -139.63 109.26 6.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.3 p -66.44 166.91 11.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -80.19 130.04 34.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.806 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.58 -39.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.84 169.96 29.9 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.468 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -115.5 117.87 31.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.767 0.318 . . . . 0.0 110.912 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -89.85 104.23 16.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -88.86 30.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -112.41 157.21 21.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 1.009 HD21 ' HB1' ' A' ' 187' ' ' ALA . 9.0 mt -130.84 153.63 48.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -116.0 108.92 16.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.916 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.438 HG22 HG13 ' A' ' 209' ' ' VAL . 35.6 t -99.85 145.02 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.107 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.503 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -137.69 -170.44 11.88 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.497 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.4 mmt 52.39 53.01 13.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.403 HD21 HD11 ' A' ' 207' ' ' LEU . 56.1 mt -117.39 156.14 28.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -94.12 175.49 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.0 pttm -92.61 17.02 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -108.06 -13.69 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -90.09 152.11 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 95.9 p -131.96 166.23 22.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.457 ' HG3' HG23 ' A' ' 165' ' ' VAL . 29.5 mt-10 -45.77 -47.12 15.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -54.83 -53.76 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -43.03 -64.82 0.56 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.716 HG13 ' CE1' ' A' ' 154' ' ' PHE . 77.7 t -53.67 -63.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.776 HD21 ' CB ' ' A' ' 163' ' ' CYS . 31.4 mt -42.82 -36.98 1.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.28 -40.83 77.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -84.57 -8.6 58.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.924 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -99.89 -37.19 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 10.2 tm0? -47.31 -46.87 57.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.722 . . . . 0.0 110.902 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.89 -17.18 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.731 2.287 . . . . 0.0 112.363 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.489 ' CE1' ' HB1' ' A' ' 193' ' ' ALA . 75.2 m-85 -101.95 -35.07 9.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.84 161.31 30.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.512 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 80.9 t -75.03 97.98 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.924 HD11 ' CB ' ' A' ' 154' ' ' PHE . 36.5 mt -66.66 137.25 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.167 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -81.86 -61.43 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -139.54 143.57 37.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.776 ' CB ' HD21 ' A' ' 151' ' ' LEU . 10.6 t -134.02 135.78 43.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.83 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.523 ' O ' ' HB1' ' A' ' 177' ' ' ALA . 86.0 m -139.09 157.74 45.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.493 ' N ' HG22 ' A' ' 164' ' ' THR . 47.7 t -120.97 130.82 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 176' ' ' CYS . 60.3 mt -72.84 147.97 44.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -148.23 165.58 30.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -100.12 -161.83 28.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.487 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.07 -50.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.664 2.243 . . . . 0.0 112.299 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.64 -39.56 88.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 121.28 39.83 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.521 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 70.2 m -121.99 118.12 28.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 110.863 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.0 t -50.01 136.57 18.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -84.5 11.24 9.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 71.44 21.76 78.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.52 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.401 ' HB2' HD12 ' A' ' 166' ' ' LEU . 3.2 m -136.55 159.78 40.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 164' ' ' THR . . . -158.1 161.67 37.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -112.23 121.73 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.469 HG11 ' HD2' ' A' ' 154' ' ' PHE . 38.7 t -119.15 122.94 70.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.573 ' O ' HG23 ' A' ' 160' ' ' ILE . 13.7 tttp -111.68 131.27 55.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' A' ' 187' ' ' ALA . 41.2 m-85 -101.7 166.68 10.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.3 t -66.81 -35.53 80.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.8 p -133.79 166.65 22.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -66.94 -55.25 15.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.4 m -43.73 -53.7 5.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -49.12 -48.1 44.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 1.009 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -59.81 -52.2 66.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.094 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.585 ' HA ' HD12 ' A' ' 191' ' ' ILE . 5.2 mm100 -46.42 -42.66 15.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.19 -63.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.73 -37.17 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 136' ' ' LEU . 54.1 mt -63.9 -72.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.106 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -57.48 -13.78 4.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.489 ' HB1' ' CE1' ' A' ' 157' ' ' PHE . . . -86.16 -40.24 15.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.689 HD13 ' CE1' ' A' ' 154' ' ' PHE . 18.1 mt -119.16 22.66 11.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.4 t60 -82.91 124.82 30.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.56 32.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.502 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 195' ' ' HIS . 54.4 p -100.19 -35.26 9.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.338 . . . . 0.0 110.849 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -100.27 161.1 13.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 12.9 m -134.6 77.14 1.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.163 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.0 mmt -39.43 138.45 0.94 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.597 0.713 . . . . 0.0 110.868 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.39 146.73 9.78 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.12 -34.16 3.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.27 134.0 35.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.312 . . . . 0.0 111.133 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 80.4 p -90.25 -8.72 50.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.838 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 37.0 m -99.98 160.72 14.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.3 m -84.34 158.81 21.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 139' ' ' GLY . 13.4 tp -57.57 141.68 47.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.73 104.37 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.438 HG13 HG22 ' A' ' 138' ' ' VAL . 12.4 t -115.65 120.67 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.097 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -158.16 150.13 21.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.843 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -47.99 147.35 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.11 -36.56 77.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.108 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.56 78.51 1.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 39.1 p -59.04 -73.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -118.59 46.76 1.76 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.88 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -118.15 87.07 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -112.72 110.15 20.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.2 t -78.72 96.48 5.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.82 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 172.55 147.27 5.73 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.1 133.2 13.33 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.664 2.243 . . . . 0.0 112.372 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.0 t -77.05 -46.22 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 m -96.9 -59.94 1.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.494 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 53.7 m 61.17 41.77 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.863 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 79.4 p -73.44 120.77 19.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.808 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 154.55 126.12 1.03 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.507 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.5 m -161.3 152.38 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.362 . . . . 0.0 110.892 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -121.68 140.13 52.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -129.2 -179.3 15.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.546 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 t -87.12 88.1 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 110.907 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -111.44 86.87 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t -60.06 123.26 16.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.82 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -57.91 117.87 4.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.45 51.78 0.38 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 117.7 123.3 3.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.538 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.454 ' HD3' ' N ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -113.49 70.09 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.926 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 132' ' ' ARG . 13.7 m-20 -34.49 -44.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 134' ' ' ARG . 20.2 mtm105 59.23 29.64 19.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -114.66 154.08 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.987 HD21 ' HB1' ' A' ' 187' ' ' ALA . 44.3 mt -135.85 148.16 48.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -118.35 110.72 17.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.66 138.91 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.118 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.606 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -136.36 178.37 18.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.0 mmt 62.46 45.04 6.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 mt -102.73 153.81 19.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 28.2 t30 -108.2 169.58 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -78.45 45.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -132.11 -34.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -86.75 146.97 26.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.7 p -126.34 -177.56 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.641 ' HG3' HG23 ' A' ' 165' ' ' VAL . 18.0 mt-10 -58.73 -46.33 87.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -56.72 -53.19 60.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -42.53 -66.67 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.897 HG13 ' CE1' ' A' ' 154' ' ' PHE . 86.5 t -48.08 -63.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.754 HD21 ' HB2' ' A' ' 163' ' ' CYS . 33.4 mt -44.24 -40.77 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -69.01 -40.36 78.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.2 tp -84.21 -9.98 58.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.897 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.55 -35.6 9.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.36 -46.87 58.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 0.0 110.925 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.1 Cg_exo -47.95 -17.49 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.356 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -100.58 -46.29 5.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -161.2 160.92 32.58 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.474 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 159' ' ' VAL . 25.6 t -76.16 95.69 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.774 HD11 ' CB ' ' A' ' 154' ' ' PHE . 28.4 mt -63.85 142.92 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.099 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.68 -55.99 3.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -144.92 140.37 28.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.754 ' HB2' HD21 ' A' ' 151' ' ' LEU . 40.6 t -132.48 142.78 49.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.2 m -151.01 143.07 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.641 HG23 ' HG3' ' A' ' 147' ' ' GLU . 86.1 t -112.58 134.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.62 144.04 39.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -132.32 174.59 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -101.25 -158.98 27.17 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.35 -18.48 13.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.678 2.252 . . . . 0.0 112.355 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -125.56 32.82 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 172' ' ' SER . . . 81.88 -38.92 2.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 171' ' ' GLY . 16.9 t -35.66 102.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.869 0.366 . . . . 0.0 110.822 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.3 t -55.36 139.59 42.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -83.32 13.94 3.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 61.36 33.28 84.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.529 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 7.8 p -148.42 154.15 39.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -159.02 176.67 12.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -129.74 141.12 50.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.06 128.82 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.598 ' O ' HG23 ' A' ' 160' ' ' ILE . 18.9 ttmt -111.9 134.17 53.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.514 ' HE1' HD12 ' A' ' 136' ' ' LEU . 36.8 m-85 -108.96 164.86 12.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.4 t -69.31 -27.08 65.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.3 t -144.03 159.33 42.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.846 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -60.22 -57.49 12.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 99.9 m -38.82 -59.39 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -40.83 -52.75 2.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.987 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.97 -57.16 14.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.573 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.1 mm100 -37.91 -45.91 0.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 191' ' ' ILE . . . -66.16 -66.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -38.65 -27.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 188' ' ' GLN . 59.2 mt -74.3 -71.07 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -59.88 -12.27 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -89.84 -31.3 17.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.9 mt -125.91 21.63 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.3 t60 -83.72 124.55 30.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.438 ' C ' ' HB3' ' A' ' 206' ' ' SER . . . 34.62 31.92 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.463 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 195' ' ' HIS . 79.3 p -100.25 -36.09 9.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.894 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.739 ' OE1' HD22 ' A' ' 207' ' ' LEU . 1.1 pt20 -100.32 150.35 22.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 205' ' ' SER . 51.0 m -122.76 80.16 1.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.154 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 15.3 mmt -40.34 140.61 0.94 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.532 0.682 . . . . 0.0 110.899 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.471 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 74.5 Cg_exo -48.07 147.69 7.7 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.711 2.274 . . . . 0.0 112.306 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.09 -45.69 3.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.457 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -77.28 138.59 39.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.754 0.311 . . . . 0.0 111.085 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.5 t -91.62 -11.39 37.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 199' ' ' THR . 2.2 t -99.97 173.08 6.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.438 ' HB3' ' C ' ' A' ' 196' ' ' GLY . 59.0 m -99.67 150.87 21.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.739 HD22 ' OE1' ' A' ' 198' ' ' GLN . 14.1 tp -47.49 147.97 1.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.478 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 58.8 t -117.22 104.05 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.132 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 8.7 t -111.72 122.48 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.478 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 14.9 ptpt -161.43 150.25 15.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -50.2 136.95 18.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -57.31 152.08 14.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.111 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -39.28 141.48 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 12.7 t -161.8 135.12 6.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -168.39 119.72 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -75.58 135.41 40.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.923 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -114.11 -52.42 2.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.5 t -41.48 158.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -172.4 -166.63 31.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.521 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.04 -43.21 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.705 2.27 . . . . 0.0 112.294 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 46.0 m -115.61 121.64 43.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 70.6 m -62.54 115.51 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.504 179.987 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.9 p 42.92 42.54 3.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.833 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.2 t -48.8 -47.86 41.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.92 136.69 2.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.44 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.3 m -145.19 115.57 7.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.823 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.3 m -93.38 -49.92 5.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.99 61.79 6.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.483 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 94.4 p -127.5 95.18 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 110.866 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -58.2 127.53 32.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 87.3 p -168.36 143.47 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -99.81 -44.09 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.29 -149.77 49.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.489 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.05 171.55 55.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.427 ' NH1' ' HB3' ' A' ' 184' ' ' HIS . 13.5 mmt180 -102.91 113.93 27.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.866 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.68 121.58 6.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 10.2 mtm-85 -97.09 26.54 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.559 ' HE2' ' CD1' ' A' ' 178' ' ' PHE . 71.3 tttt -112.28 137.97 49.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 1.112 HD21 ' HB1' ' A' ' 187' ' ' ALA . 18.2 mt -124.25 156.3 37.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -126.68 112.95 16.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 30.4 t -97.14 148.23 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.44 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -142.31 -172.12 13.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.479 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.2 mmt 54.49 38.76 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.3 mt -95.22 160.93 14.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -100.91 -175.62 2.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -100.3 34.75 2.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -129.14 -30.98 2.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -77.79 145.77 36.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 55.1 p -119.79 -175.84 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.828 ' HG3' HG23 ' A' ' 165' ' ' VAL . 3.4 mp0 -68.53 -31.78 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -64.87 -48.39 74.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -48.39 -68.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.828 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.905 HG13 ' CE1' ' A' ' 154' ' ' PHE . 99.0 t -48.46 -53.95 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.837 HD21 ' HB2' ' A' ' 163' ' ' CYS . 38.9 mt -51.46 -40.68 59.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -69.27 -39.41 78.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.8 tp -84.31 -11.12 56.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.905 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -98.44 -36.21 10.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.57 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.06 -47.02 55.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.592 0.71 . . . . 0.0 110.921 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.5 Cg_exo -47.92 -16.77 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.355 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.411 ' HE2' HD11 ' A' ' 194' ' ' LEU . 72.3 m-85 -99.75 -35.28 9.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.38 164.38 37.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 159' ' ' VAL . 47.5 t -75.86 91.23 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 111.136 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.816 HD13 HD23 ' A' ' 151' ' ' LEU . 68.6 mt -59.54 132.81 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -84.94 -55.06 4.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.1 143.07 28.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.837 ' HB2' HD21 ' A' ' 151' ' ' LEU . 9.8 t -134.04 129.84 36.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.6 m -139.26 144.68 38.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.828 HG23 ' HG3' ' A' ' 147' ' ' GLU . 73.6 t -109.97 151.93 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.1 mt -88.2 142.16 27.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.403 ' C ' ' NZ ' ' A' ' 174' ' ' LYS . 53.0 mtt180 -153.77 155.06 35.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.52 -162.72 31.92 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.516 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.89 -45.89 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.72 2.28 . . . . 0.0 112.383 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.13 -42.85 99.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 125.51 41.73 0.34 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.535 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.8 p -110.78 146.65 36.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 110.892 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.1 t -79.97 124.5 28.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.403 ' NZ ' ' C ' ' A' ' 167' ' ' ARG . 38.2 mttp -78.24 8.05 5.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.27 23.91 70.25 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.442 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 2.6 p -144.79 158.63 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.816 0.341 . . . . 0.0 110.925 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.47 175.1 11.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.128 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.559 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 81.8 m-85 -124.98 137.84 54.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.421 HG11 ' HD2' ' A' ' 154' ' ' PHE . 98.3 t -127.76 127.5 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -111.72 133.61 53.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.0 156.83 19.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.1 t -56.9 -28.87 62.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.845 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 t -140.9 177.35 8.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.427 ' HB3' ' NH1' ' A' ' 132' ' ' ARG . 12.5 t60 -76.64 -59.01 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.5 m -39.37 -54.39 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -44.78 -49.91 10.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 1.112 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -60.61 -57.11 14.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.09 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -38.65 -45.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.5 -62.17 1.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.07 -27.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.736 HD11 HD22 ' A' ' 136' ' ' LEU . 74.1 mt -76.77 -64.8 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -64.64 -7.9 12.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -99.26 -24.74 14.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.103 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.594 HD13 ' CE1' ' A' ' 154' ' ' PHE . 23.1 mt -132.36 27.12 4.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.2 t60 -93.04 122.43 35.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 36.39 31.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.461 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -99.23 -36.98 9.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.358 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.636 ' NE2' HD22 ' A' ' 207' ' ' LEU . 16.2 pt20 -100.35 165.06 11.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 205' ' ' SER . 18.4 m -134.96 85.82 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.474 ' CE ' ' OE1' ' A' ' 198' ' ' GLN . 14.2 mmt -44.95 139.78 3.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.706 . . . . 0.0 110.901 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -48.15 137.45 23.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.692 2.261 . . . . 0.0 112.326 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 91.21 -48.12 2.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.481 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -76.51 131.63 39.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.079 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.7 p -86.4 -7.39 58.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 199' ' ' THR . 4.7 t -99.71 171.45 7.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.4 m -100.08 143.19 30.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.636 HD22 ' NE2' ' A' ' 198' ' ' GLN . 14.8 tp -40.04 151.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.53 103.93 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.43 HG12 HG12 ' A' ' 191' ' ' ILE . 4.4 t -113.23 121.06 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -156.92 152.42 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -51.5 139.22 20.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.05 -42.66 80.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.11 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -156.83 163.63 38.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.3 t -162.9 169.85 19.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.153 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -123.57 79.7 1.72 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -56.92 127.74 33.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -109.54 113.97 27.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.6 t -121.43 155.29 35.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 165.86 74.59 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.57 -45.92 15.45 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.711 2.274 . . . . 0.0 112.337 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.5 m -138.67 160.47 39.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 17.6 t -139.35 117.89 12.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.478 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 96.5 p -78.82 140.03 38.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.869 0.366 . . . . 0.0 110.843 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.8 p -64.89 114.57 4.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.824 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.91 -145.92 8.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.436 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 t -82.56 136.42 34.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 110.856 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.7 p -103.21 -53.37 2.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 170.03 144.52 4.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 m -49.11 -57.42 6.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.866 0.365 . . . . 0.0 110.826 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -148.31 152.3 36.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.4 m -120.82 45.4 2.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.883 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -110.04 115.42 29.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 163.32 -84.84 0.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.43 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -140.72 93.34 0.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -46.12 130.91 10.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.28 118.58 22.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.903 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 181' ' ' PHE . 21.9 ttm105 -124.69 42.5 3.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.518 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 7.7 ttmt -117.75 139.5 50.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.733 HD21 ' HB1' ' A' ' 187' ' ' ALA . 55.5 mt -112.32 139.34 47.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -109.23 116.01 31.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.13 146.36 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.545 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -140.13 179.86 18.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 mmt 57.3 48.23 15.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 110.879 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 48.9 mt -108.27 162.7 13.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -103.77 172.17 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -88.64 16.05 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -106.92 -18.21 13.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.976 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -87.77 147.92 24.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.951 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.3 p -124.77 -179.19 4.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.554 ' HG3' HG23 ' A' ' 165' ' ' VAL . 39.2 mp0 -63.21 -32.57 74.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -66.43 -48.02 71.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -50.92 -49.53 59.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.802 HG13 ' CE1' ' A' ' 154' ' ' PHE . 83.6 t -68.33 -50.35 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 mt -56.59 -32.24 65.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.421 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 11.7 mmm180 -81.24 -36.12 30.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.901 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.7 tp -85.01 -14.04 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.802 ' CE1' HG13 ' A' ' 150' ' ' VAL . 4.1 m-85 -100.05 -37.25 9.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 3.8 mt-30 -47.19 -48.91 54.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.635 0.731 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.8 Cg_exo -47.97 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.428 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.6 m-85 -100.43 -30.28 11.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 173.86 158.69 18.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.512 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.52 135.74 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 111.156 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.689 HD11 ' CB ' ' A' ' 154' ' ' PHE . 55.2 mt -111.75 125.22 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -69.89 -65.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -143.31 141.03 30.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 179' ' ' VAL . 44.1 t -132.22 108.43 9.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.8 m -109.66 128.13 55.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.154 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.554 HG23 ' HG3' ' A' ' 147' ' ' GLU . 73.4 t -91.91 135.91 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.165 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 47.1 mt -76.16 142.95 41.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -154.04 171.67 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -104.12 -171.97 25.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.0 -9.28 17.98 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.673 2.249 . . . . 0.0 112.341 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -90.92 -37.29 13.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 132.06 -19.19 4.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.459 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 12.8 t -67.9 170.66 7.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.3 t -106.53 144.38 33.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -83.97 20.34 1.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 58.38 24.17 55.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 17.9 m -147.77 165.08 31.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.842 0.353 . . . . 0.0 110.902 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.62 -179.06 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.518 ' CD1' ' HD3' ' A' ' 135' ' ' LYS . 57.7 m-85 -131.31 124.91 31.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.617 HG22 ' SG ' ' A' ' 163' ' ' CYS . 45.7 t -119.96 123.32 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -108.32 119.24 38.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.496 ' O ' ' CD ' ' A' ' 134' ' ' ARG . 30.5 m-85 -92.98 164.98 13.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.1 m -72.43 -32.37 66.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 t -133.37 160.28 37.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.827 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -64.72 -59.82 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 186' ' ' GLU . 53.0 m -38.68 -64.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.8 OUTLIER -36.6 -53.0 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.733 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.22 -59.8 4.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.101 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 187' ' ' ALA . 4.8 mm100 -37.3 -47.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 190' ' ' ALA . . . -62.47 -67.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -35.56 -38.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.051 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.632 HD11 HD22 ' A' ' 136' ' ' LEU . 93.1 mt -62.74 -73.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -55.33 -14.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.428 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.69 -41.08 14.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.43 30.54 7.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -99.51 122.98 43.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 45.75 20.16 0.39 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.46 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 60.7 p -100.04 -35.71 9.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -100.1 154.82 18.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 205' ' ' SER . 49.3 m -134.78 86.33 2.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 12.4 mmt -47.11 138.31 7.75 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.582 0.706 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -48.62 153.03 3.7 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.734 2.29 . . . . 0.0 112.331 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.55 -35.67 2.45 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.537 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.93 136.09 34.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.077 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 84.0 p -85.69 -13.93 46.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 199' ' ' THR . 7.7 m -100.0 157.72 16.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 6.1 p -79.81 -178.75 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 139' ' ' GLY . 15.7 tp -77.31 149.22 35.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.48 ' CG1' ' HE2' ' A' ' 210' ' ' LYS . 73.8 t -118.0 103.93 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.444 HG12 HG12 ' A' ' 191' ' ' ILE . 11.9 t -113.48 123.15 68.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.48 ' HE2' ' CG1' ' A' ' 208' ' ' VAL . 0.9 OUTLIER -159.96 148.48 17.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -47.68 157.36 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 213' ' ' ASP . . . -78.3 138.75 38.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 212' ' ' ALA . 2.5 p-10 -36.94 128.52 0.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.839 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 59.1 p -109.76 109.47 20.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -154.46 142.33 20.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -156.41 105.47 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -144.87 136.82 25.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.5 t -134.1 110.2 9.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 50.97 -146.37 9.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.22 98.67 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.655 2.237 . . . . 0.0 112.345 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 80.1 p -174.4 126.22 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 30.5 p -103.22 132.55 49.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.453 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.3 m -90.3 121.2 32.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.799 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.4 t -141.8 128.9 20.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.819 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.72 124.42 0.98 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.478 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.3 m -82.29 101.84 10.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.862 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 61.4 p -99.52 42.31 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.85 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 122.68 45.0 0.32 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.442 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.6 t -49.65 136.74 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.329 . . . . 0.0 110.856 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.44 ' O ' ' CD ' ' A' ' 127' ' ' GLU . 1.2 pp20? -83.14 43.15 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.867 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 m -83.9 88.96 7.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -86.82 176.7 7.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.878 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.01 -173.58 29.67 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.497 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -61.65 -142.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.48 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.437 ' O ' ' CG ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -150.72 160.66 43.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.516 ' HB2' ' CD1' ' A' ' 211' ' ' PHE . 5.1 m-20 -162.29 117.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 tpp85 -65.84 -22.93 66.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -100.14 138.65 36.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.845 HD21 ' HB1' ' A' ' 187' ' ' ALA . 38.4 mt -121.46 157.8 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.928 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -125.7 119.28 27.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 29.5 t -101.46 148.12 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -141.58 -179.65 18.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.9 mmt 57.95 39.88 26.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.454 ' CD2' HD11 ' A' ' 207' ' ' LEU . 67.3 mt -97.04 158.24 15.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 21.2 t-20 -113.16 170.99 7.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -79.49 44.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -133.01 -40.75 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.448 ' CD ' ' SD ' ' A' ' 200' ' ' MET . 31.2 mt-30 -81.89 121.84 26.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.1 p -106.02 173.79 6.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 165' ' ' VAL . 1.8 mp0 -47.78 -46.51 30.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -53.84 -51.79 62.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -47.75 -68.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.847 HG13 ' CE1' ' A' ' 154' ' ' PHE . 96.8 t -47.16 -54.99 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.795 HD21 ' HB2' ' A' ' 163' ' ' CYS . 32.1 mt -52.18 -39.77 60.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -70.2 -38.68 75.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.405 HD21 ' OE1' ' A' ' 198' ' ' GLN . 13.5 tp -85.08 -9.09 58.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.855 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -100.04 -38.94 8.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.1 tm0? -46.99 -47.01 54.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.627 0.727 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.5 Cg_exo -47.94 -20.34 2.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.263 . . . . 0.0 112.304 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -100.04 -43.35 6.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.65 156.37 27.53 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.8 t -74.75 96.9 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 111.129 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.855 HD11 ' CB ' ' A' ' 154' ' ' PHE . 41.9 mt -66.3 141.52 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -94.42 -54.39 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -141.52 141.76 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.795 ' HB2' HD21 ' A' ' 151' ' ' LEU . 43.2 t -133.97 143.61 48.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 165' ' ' VAL . 96.8 m -148.96 154.08 38.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.169 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.595 HG13 ' HB2' ' A' ' 177' ' ' ALA . 58.0 t -124.9 142.94 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.121 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 59.1 mt -85.54 139.32 31.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -146.2 158.38 43.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -77.82 -166.89 28.72 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.47 -47.99 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.718 2.279 . . . . 0.0 112.331 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -70.26 -31.39 68.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 118.16 44.4 0.53 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 173' ' ' SER . 73.9 p -113.55 96.98 6.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 110.817 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 172' ' ' SER . 46.8 t -34.62 135.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.889 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -94.9 10.75 34.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 61.56 24.52 64.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.442 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 4.9 p -139.65 138.43 36.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 0.0 110.906 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.595 ' HB2' HG13 ' A' ' 165' ' ' VAL . . . -150.57 168.04 25.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -121.45 144.86 48.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.02 132.37 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.694 ' O ' HG23 ' A' ' 160' ' ' ILE . 23.5 ttmt -112.36 128.25 56.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.513 ' HE1' HD12 ' A' ' 136' ' ' LEU . 37.7 m-85 -100.27 162.51 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.0 p -67.09 -23.14 65.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.8 t -151.71 150.98 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.873 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -51.26 -57.45 8.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 186' ' ' GLU . 63.6 m -38.19 -66.6 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.08 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.3 OUTLIER -37.97 -51.09 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.845 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.29 -57.27 13.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.079 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.461 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.4 mm100 -40.44 -43.41 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 191' ' ' ILE . . . -65.77 -68.48 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.082 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -35.57 -33.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.575 HD11 HD22 ' A' ' 136' ' ' LEU . 83.3 mt -66.62 -70.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -62.04 -15.62 45.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.859 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -90.44 -22.7 21.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.077 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.733 HD22 ' NE2' ' A' ' 198' ' ' GLN . 75.7 mt -132.51 23.38 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.8 t60 -89.04 124.59 34.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.447 ' C ' ' HB3' ' A' ' 206' ' ' SER . . . 36.18 29.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.543 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 195' ' ' HIS . 76.4 p -100.14 -35.27 9.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.328 . . . . 0.0 110.846 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.733 ' NE2' HD22 ' A' ' 194' ' ' LEU . 22.4 mt-30 -100.28 155.05 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 205' ' ' SER . 25.7 m -129.18 81.51 2.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.448 ' SD ' ' CD ' ' A' ' 145' ' ' GLN . 14.9 mmt -45.67 141.03 4.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.547 0.689 . . . . 0.0 110.93 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.415 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 74.5 Cg_exo -47.97 153.05 2.83 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.708 2.272 . . . . 0.0 112.312 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 79.24 -41.79 2.29 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.446 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.15 140.06 31.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 111.064 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 25.2 t -94.8 -8.82 36.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 199' ' ' THR . 2.8 t -100.06 172.48 7.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.447 ' HB3' ' C ' ' A' ' 196' ' ' GLY . 19.4 m -97.96 145.93 25.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.454 HD11 ' CD2' ' A' ' 141' ' ' LEU . 8.6 tp -42.31 154.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.934 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 73.3 t -125.66 104.08 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.4 t -111.72 122.25 65.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -151.31 146.94 26.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 133' ' ' ASP . 34.2 m-85 -47.39 135.33 10.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -87.1 162.11 17.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.1 t0 64.41 42.4 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 27.2 p -64.93 130.55 43.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -104.1 106.08 16.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' A' ' 217' ' ' GLU . 14.2 tptm -84.94 146.51 27.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.422 ' N ' ' HG3' ' A' ' 216' ' ' LYS . 7.6 mm-40 -100.46 124.99 46.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 87.7 p -98.93 91.66 5.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 69.65 65.4 2.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.98 173.32 14.65 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.739 2.292 . . . . 0.0 112.367 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.0 t -97.86 -49.35 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 51.3 p -117.33 156.18 28.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.514 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 m 55.56 44.39 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.859 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.0 t -161.41 140.99 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.09 179.12 27.45 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.459 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.2 m -81.79 83.13 7.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -47.75 119.1 2.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.62 137.63 5.86 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.53 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.2 p -63.48 137.31 58.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.07 91.1 3.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -62.59 97.89 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 61.73 41.23 12.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.87 119.5 6.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.474 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.45 89.32 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.472 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -54.5 6.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 0.0 110.902 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -48.83 159.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -118.97 40.02 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -125.91 152.09 46.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 1.034 HD21 ' HB1' ' A' ' 187' ' ' ALA . 19.8 mt -137.69 145.82 43.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -109.15 110.77 22.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.4 t -97.68 147.57 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.661 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -144.14 -175.81 17.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.519 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.2 mmt 56.45 48.24 17.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.5 mt -109.06 165.1 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -106.75 174.03 6.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -87.71 16.3 5.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -105.99 -22.92 12.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.475 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 16.3 mt-30 -82.25 149.67 27.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.8 p -130.94 172.69 11.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -50.54 -51.03 51.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -52.16 -52.79 49.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -42.53 -67.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.556 HG13 ' CE1' ' A' ' 154' ' ' PHE . 35.9 t -52.87 -51.28 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.136 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.677 HD21 ' CB ' ' A' ' 163' ' ' CYS . 39.1 mt -54.04 -32.17 53.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -79.61 -37.04 37.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.7 tp -84.35 -14.17 50.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.802 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.4 m-85 -100.22 -35.97 9.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.534 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 3.7 mt-30 -47.18 -49.0 53.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.549 0.69 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.5 Cg_exo -47.98 -17.13 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.425 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.2 m-85 -100.03 -34.14 10.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.9 169.59 42.55 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.481 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.38 107.75 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 111.126 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.802 HD11 ' CB ' ' A' ' 154' ' ' PHE . 82.7 mt -79.15 126.27 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.4 ' HB2' ' CD ' ' A' ' 180' ' ' LYS . 3.2 m-20 -86.47 -65.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -114.65 126.02 54.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.677 ' CB ' HD21 ' A' ' 151' ' ' LEU . 16.7 t -133.15 127.11 33.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.3 m -146.38 149.66 34.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.407 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 77.7 t -114.53 137.89 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 176' ' ' CYS . 27.2 mt -71.97 148.69 45.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 15.1 mtt85 -158.76 147.31 18.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.56 174.08 54.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.537 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.28 -56.41 2.94 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.397 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -82.74 42.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 40.81 73.05 0.21 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.459 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 173' ' ' SER . 8.3 t -128.29 94.5 3.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.88 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 172' ' ' SER . 1.1 t -35.28 117.35 0.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -81.39 3.64 23.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.1 24.69 76.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.51 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.411 ' HB2' HD12 ' A' ' 166' ' ' LEU . 1.8 m -146.78 154.78 41.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 110.866 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -156.45 176.07 13.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.02 124.14 34.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.469 HG11 ' HD2' ' A' ' 154' ' ' PHE . 39.1 t -117.83 134.72 60.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 160' ' ' ILE . 30.6 ttmt -114.99 144.28 43.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -118.9 161.13 20.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 17.3 t -59.16 -34.25 71.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.5 t -142.42 171.79 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.416 ' CG ' ' N ' ' A' ' 185' ' ' THR . 44.5 p-80 -64.76 -54.95 23.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.416 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 48.7 m -36.84 -63.92 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 185' ' ' THR . 23.8 mm-40 -37.8 -53.39 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 1.034 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -55.9 -59.13 5.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -40.26 -41.51 1.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -71.4 -63.73 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.68 -34.02 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.112 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 136' ' ' LEU . 72.5 mt -65.89 -71.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -59.15 -13.73 8.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.425 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -88.98 -32.05 17.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.442 HD13 ' CE1' ' A' ' 154' ' ' PHE . 32.5 mt -125.78 24.98 6.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.9 t60 -86.68 123.04 31.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.56 32.94 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.455 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 195' ' ' HIS . 82.6 p -100.13 -35.14 9.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 110.874 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.21 155.8 17.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 205' ' ' SER . 90.2 m -132.61 77.51 1.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.475 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 11.5 mmt -39.92 139.13 1.0 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.601 0.715 . . . . 0.0 110.845 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.21 150.49 5.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.732 2.288 . . . . 0.0 112.358 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.48 -36.22 2.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -89.58 136.92 32.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.322 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 15.7 t -90.77 -10.87 41.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.847 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 199' ' ' THR . 4.9 t -99.51 172.08 7.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.4 m -99.82 154.79 18.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 139' ' ' GLY . 13.5 tp -54.36 138.16 40.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.468 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 54.1 t -108.09 117.09 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.1 t -123.23 124.8 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.468 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 14.6 ptpt -160.8 144.67 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -47.39 153.28 0.53 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.09 154.21 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.095 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 52.93 52.95 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 47.6 m -100.34 137.6 38.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -137.86 127.33 24.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 10.1 ttpp -129.24 41.77 3.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.67 -49.27 66.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 22.9 t -65.12 -53.11 50.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.828 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.83 161.66 9.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.61 169.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.5 t -87.62 -55.73 3.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.6 t -100.6 114.98 29.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.468 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.6 t -171.63 148.22 2.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.6 m -162.16 118.99 2.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -135.92 58.25 0.67 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.9 p -140.4 164.16 30.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.915 0.388 . . . . 0.0 110.845 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.2 m -138.57 132.06 30.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 141.86 117.26 1.3 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.505 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.0 m -56.34 144.05 32.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.364 . . . . 0.0 110.824 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.66 82.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.8 m -44.93 -45.07 10.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.429 ' HB3' ' NH1' ' A' ' 129' ' ' ARG . 12.2 ttp-105 -105.95 87.08 2.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.87 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.78 -42.01 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.477 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.92 133.76 12.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.518 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.21 74.13 0.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.826 0.346 . . . . 0.0 110.87 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -120.08 129.01 54.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -112.8 40.4 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -128.72 127.15 41.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.732 HD22 HD11 ' A' ' 191' ' ' ILE . 65.8 mt -119.11 152.21 36.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -119.78 121.02 38.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.23 144.05 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.118 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -138.08 -172.41 12.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.5 mmt 54.05 51.48 14.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.333 . . . . 0.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.2 mt -111.06 155.42 22.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.462 ' ND2' ' HD2' ' A' ' 201' ' ' PRO . 3.2 p30 -91.58 159.49 15.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -81.95 42.67 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.425 ' HG2' ' CG ' ' A' ' 142' ' ' ASN . 6.2 pt20 -133.22 -35.02 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -71.12 150.27 45.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.0 p -119.59 -177.85 3.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.411 ' HG3' HG23 ' A' ' 165' ' ' VAL . 21.9 mt-10 -63.03 -46.88 85.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -54.71 -50.82 67.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -42.72 -47.68 5.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.624 HG13 ' CE1' ' A' ' 154' ' ' PHE . 95.8 t -70.31 -45.78 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.177 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 163' ' ' CYS . 86.0 mt -57.57 -32.44 67.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.403 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 16.1 mmt180 -81.35 -35.39 30.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.2 tp -84.32 -16.09 44.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.717 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -100.18 -35.3 9.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.532 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 6.1 mt-30 -47.2 -49.04 53.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.6 0.714 . . . . 0.0 110.865 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.7 Cg_exo -47.96 -17.02 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.707 2.272 . . . . 0.0 112.303 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -99.9 -36.53 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.62 163.38 35.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.528 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.62 104.84 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.717 HD11 ' CB ' ' A' ' 154' ' ' PHE . 62.2 mt -76.04 128.12 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -76.48 -54.33 6.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -147.07 145.3 29.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.595 ' HB2' HD21 ' A' ' 151' ' ' LEU . 43.1 t -133.74 148.0 51.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.439 ' O ' ' HB1' ' A' ' 177' ' ' ALA . 24.0 m -151.49 151.5 31.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.161 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 177' ' ' ALA . 68.4 t -122.63 146.98 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.755 HD12 ' SG ' ' A' ' 176' ' ' CYS . 79.3 mt -87.19 139.99 30.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.491 ' HD3' ' N ' ' A' ' 173' ' ' SER . 6.7 mmt-85 -133.79 138.85 45.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.85 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -75.33 160.49 52.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.455 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.13 -37.75 18.47 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.259 . . . . 0.0 112.337 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -88.58 40.35 0.96 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 39.77 56.73 2.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.499 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 173' ' ' SER . 4.2 t -136.69 110.38 8.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.491 ' N ' ' HD3' ' A' ' 167' ' ' ARG . 22.6 t -35.46 137.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -97.3 26.88 4.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 49.55 30.57 13.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.48 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.755 ' SG ' HD12 ' A' ' 166' ' ' LEU . 7.1 p -149.79 149.47 30.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 164' ' ' THR . . . -160.03 161.18 33.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -113.71 133.26 55.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 70.4 t -122.81 126.09 73.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 160' ' ' ILE . 15.6 tttp -108.63 123.18 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -97.52 168.34 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.866 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 84.2 p -68.92 -36.72 78.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.8 m -135.25 171.79 13.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -72.17 -44.71 62.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.4 m -52.24 -59.46 4.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -41.54 -49.68 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -58.05 -59.17 5.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -38.87 -47.37 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.42 -63.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.37 -39.37 1.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.732 HD11 HD22 ' A' ' 136' ' ' LEU . 73.8 mt -60.99 -72.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -57.34 -12.95 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -87.5 -37.74 16.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.086 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 154' ' ' PHE . 18.5 mt -120.22 23.53 10.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.0 t60 -83.36 123.03 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.7 33.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.9 p -100.31 -36.51 9.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.798 0.332 . . . . 0.0 110.859 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -100.4 160.66 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 37.9 m -134.16 81.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 15.9 mmt -41.38 137.47 1.68 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.56 0.695 . . . . 0.0 110.884 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.462 ' HD2' ' ND2' ' A' ' 142' ' ' ASN . 75.5 Cg_exo -48.74 147.06 10.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 0.0 112.317 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.65 -34.44 3.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.482 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.33 141.4 28.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.069 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 57.7 m -93.52 -12.81 28.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 66.7 m -99.53 157.17 16.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.9 m -78.36 172.13 14.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 196' ' ' GLY . 13.7 tp -71.97 140.15 48.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.2 t -106.24 106.72 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.7 t -117.99 120.3 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -159.54 156.29 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -56.23 131.85 49.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -47.66 -69.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -172.95 146.35 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.5 p -115.35 118.65 33.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.76 108.47 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -86.39 114.28 23.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -113.93 -51.25 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 67.5 p -163.41 175.99 10.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 145.56 73.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.53 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.52 131.76 12.51 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.713 2.276 . . . . 0.0 112.321 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 38.4 t -88.96 -53.91 4.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.905 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 72.1 p -38.98 -43.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.471 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.0 p -90.05 158.09 17.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.922 0.391 . . . . 0.0 110.862 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.1 m -77.73 170.55 16.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.3 72.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 t -122.46 113.95 20.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 82.1 p -137.4 114.79 11.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.827 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 169.91 -60.93 0.18 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.7 p -98.2 95.72 7.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 110.843 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -129.46 111.85 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 129' ' ' ARG . 5.6 p -93.42 136.42 33.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -34.89 -60.68 0.44 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.19 -131.65 2.92 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.504 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.9 61.17 7.48 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.472 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -111.92 83.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.0 110.872 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.76 114.43 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 183' ' ' SER . 16.5 ttm180 -100.6 32.35 3.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -117.96 140.77 49.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.665 ' CD2' HD11 ' A' ' 191' ' ' ILE . 54.8 mt -117.26 157.6 25.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -125.25 122.11 36.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.9 140.88 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -136.23 -176.98 14.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.5 mmt 60.17 38.26 20.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.2 mt -99.02 154.61 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 144' ' ' GLN . 23.1 p30 -98.11 170.29 9.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -80.57 -0.18 36.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.409 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 57.0 mt-30 -102.05 32.68 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -134.99 154.18 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.4 p -132.25 167.0 20.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.558 ' CG ' HG23 ' A' ' 165' ' ' VAL . 50.1 mt-10 -54.41 -44.83 72.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -53.74 -45.9 70.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -50.3 -55.2 16.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.786 HG13 ' CE1' ' A' ' 154' ' ' PHE . 71.8 t -60.87 -46.3 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.901 HD21 ' CB ' ' A' ' 163' ' ' CYS . 35.1 mt -57.97 -39.09 77.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -70.08 -38.87 75.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.9 tp -84.05 -10.32 57.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.888 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.17 -36.4 9.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.557 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -46.92 -47.03 53.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.638 0.732 . . . . 0.0 110.938 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.0 Cg_exo -47.99 -18.85 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.695 2.263 . . . . 0.0 112.314 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.406 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 75.8 m-85 -100.32 -38.07 8.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -172.49 162.7 34.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.8 t -76.41 103.4 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 111.102 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.888 HD11 ' CB ' ' A' ' 154' ' ' PHE . 20.7 mt -73.4 142.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.083 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -103.13 -61.62 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -114.18 119.31 36.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.901 ' CB ' HD21 ' A' ' 151' ' ' LEU . 25.5 t -134.14 121.0 20.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -141.37 151.67 43.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.558 HG23 ' CG ' ' A' ' 147' ' ' GLU . 95.0 t -116.16 139.93 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 60.0 mt -79.51 147.06 32.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -151.25 170.46 19.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -100.43 171.6 23.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.97 -50.42 9.82 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.257 . . . . 0.0 112.361 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.14 -38.52 86.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.15 -39.36 1.63 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 63.9 m -41.98 146.61 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.82 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.9 t -79.47 143.43 34.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -85.86 12.83 8.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.78 76.01 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -139.37 153.79 47.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.862 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.476 ' HB2' HG13 ' A' ' 165' ' ' VAL . . . -161.94 157.46 23.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -109.2 144.65 37.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.615 HG11 ' HD2' ' A' ' 154' ' ' PHE . 59.0 t -134.86 126.62 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.13 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 160' ' ' ILE . 11.6 tttp -113.8 123.94 51.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -99.79 162.95 12.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.8 t -66.28 -37.34 85.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 134' ' ' ARG . 1.2 t -132.83 158.09 43.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.87 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.5 ' CG ' ' N ' ' A' ' 185' ' ' THR . 26.2 p-80 -59.24 -53.61 56.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.5 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 26.3 m -45.59 -52.73 10.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -47.27 -45.25 23.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.533 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -64.37 -59.27 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.407 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.2 mm100 -40.19 -38.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -69.53 -63.84 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.071 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.32 -31.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.665 HD11 ' CD2' ' A' ' 136' ' ' LEU . 74.7 mt -69.44 -71.51 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -56.73 -15.78 5.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.816 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.406 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -87.91 -34.93 17.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.471 ' HB3' ' NE2' ' A' ' 198' ' ' GLN . 26.0 mt -122.39 25.55 8.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.917 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.9 t60 -89.04 122.18 32.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.862 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.49 32.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 195' ' ' HIS . 60.3 p -100.14 -37.08 9.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.844 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.697 ' NE2' HD22 ' A' ' 207' ' ' LEU . 10.4 pt20 -100.37 161.77 13.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 205' ' ' SER . 27.0 m -131.19 84.59 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 16.9 mmt -39.19 139.2 0.81 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.555 0.693 . . . . 0.0 110.856 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.27 137.94 23.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.251 . . . . 0.0 112.331 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.0 3.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.43 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -69.93 139.36 52.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.1 m -92.82 -8.63 42.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 199' ' ' THR . 4.6 t -99.94 170.89 8.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 25.0 m -100.14 145.05 28.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.697 HD22 ' NE2' ' A' ' 198' ' ' GLN . 10.9 tp -44.86 143.72 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.5 t -115.67 108.57 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.42 HG12 HG12 ' A' ' 191' ' ' ILE . 15.8 t -115.77 121.61 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -157.27 148.35 21.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -45.87 154.54 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.08 144.14 31.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.057 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 51.01 46.44 26.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.8 m -125.96 92.5 3.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -77.15 170.42 16.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.85 145.95 47.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -161.76 154.26 19.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 62.8 p -153.46 119.85 5.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 118.35 96.91 1.81 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.91 -28.06 9.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.357 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 66.2 m -118.5 145.27 45.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 30.2 p -101.34 157.31 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.49 179.967 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 t 57.28 42.18 25.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.8 p -51.28 -51.95 49.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.3 -43.45 2.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 t -81.98 108.71 15.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.8 p -47.84 118.65 2.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 172.31 104.84 0.18 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.0 p -57.53 146.94 28.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.853 0.359 . . . . 0.0 110.828 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.6 OUTLIER -45.21 166.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 m -102.6 168.39 9.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.429 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 21.3 mtm105 -150.77 154.04 36.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 132.2 -60.55 0.67 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -149.63 92.68 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.502 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 163.06 9.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -133.93 119.81 19.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.1 mtm-85 -93.98 73.87 4.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.918 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 136' ' ' LEU . 13.3 tppt? -155.64 157.79 37.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.834 ' CD2' HD11 ' A' ' 191' ' ' ILE . 63.6 mt -139.2 135.57 34.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -102.45 117.13 34.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 209' ' ' VAL . 5.9 t -106.53 145.43 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.124 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.552 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -140.03 -164.18 9.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.507 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.9 mmt 48.8 49.77 18.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.668 HD23 ' HG3' ' A' ' 200' ' ' MET . 58.4 mt -110.31 153.31 25.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.406 ' CG ' ' O ' ' A' ' 201' ' ' PRO . 0.4 OUTLIER -95.12 173.96 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -90.38 42.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -134.4 -35.34 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.448 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 26.7 mt-30 -70.88 145.8 50.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.9 p -121.51 -178.53 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.58 ' HG3' HG23 ' A' ' 165' ' ' VAL . 6.1 mp0 -64.69 -35.07 79.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -64.2 -35.67 81.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.56 -65.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.899 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.85 HG13 ' CE1' ' A' ' 154' ' ' PHE . 92.8 t -53.72 -53.02 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 163' ' ' CYS . 70.3 mt -52.46 -39.36 61.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -69.62 -39.5 77.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.5 tp -84.7 -9.28 58.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.89 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -99.98 -37.27 9.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.2 tm0? -47.29 -46.76 57.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.597 0.713 . . . . 0.0 110.934 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.3 Cg_exo -47.99 -17.18 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.307 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' HE2' HD11 ' A' ' 194' ' ' LEU . 73.6 m-85 -100.27 -32.2 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.95 171.71 43.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.8 t -80.79 105.27 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.869 0.366 . . . . 0.0 111.072 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.89 HD11 ' CB ' ' A' ' 154' ' ' PHE . 47.5 mt -75.35 130.06 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.34 -61.31 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.838 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -146.37 145.25 30.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.732 ' CB ' HD21 ' A' ' 151' ' ' LEU . 16.2 t -133.81 118.36 17.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.9 m -124.48 140.1 53.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.154 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.58 HG23 ' HG3' ' A' ' 147' ' ' GLU . 97.6 t -108.15 138.09 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.1 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.589 HD12 ' SG ' ' A' ' 176' ' ' CYS . 37.4 mt -77.32 148.22 35.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.482 ' HD3' ' N ' ' A' ' 173' ' ' SER . 4.8 mmt85 -142.15 136.11 29.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -59.32 -164.08 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.468 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.59 -46.6 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.736 2.291 . . . . 0.0 112.34 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.69 41.12 1.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 53.84 60.95 7.62 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.534 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 173' ' ' SER . 72.1 m -131.71 90.77 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.849 0.357 . . . . 0.0 110.851 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.482 ' N ' ' HD3' ' A' ' 167' ' ' ARG . 29.2 t -34.53 128.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.881 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -85.98 24.83 1.22 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.886 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 54.69 30.87 52.65 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.472 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.589 ' SG ' HD12 ' A' ' 166' ' ' LEU . 13.7 p -144.27 160.57 40.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 110.847 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -166.76 171.09 11.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -124.53 130.33 52.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.24 131.24 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -114.38 122.62 47.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.546 ' CE1' HD12 ' A' ' 136' ' ' LEU . 37.5 m-85 -94.95 163.96 13.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.8 p -70.46 -26.42 63.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.0 t -143.25 151.48 40.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.544 ' CG ' ' N ' ' A' ' 185' ' ' THR . 17.2 p80 -55.81 -51.62 66.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.544 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 66.4 m -43.03 -66.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.155 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.3 OUTLIER -37.2 -52.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.577 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -55.68 -59.26 5.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.545 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.3 mm100 -38.7 -48.17 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.2 -63.28 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -40.09 -30.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.072 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.834 HD11 ' CD2' ' A' ' 136' ' ' LEU . 72.5 mt -69.51 -71.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -64.63 -9.28 18.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -90.29 -25.59 20.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.431 HD11 ' HE2' ' A' ' 157' ' ' PHE . 24.6 mt -133.29 16.11 4.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 191' ' ' ILE . 2.0 t60 -87.89 126.45 35.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.854 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 45.66 20.15 0.37 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.526 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 60.4 p -100.38 -37.35 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 199' ' ' THR . 6.5 tt0 -100.44 156.26 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 205' ' ' SER . 85.9 m -127.61 80.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.668 ' HG3' HD23 ' A' ' 141' ' ' LEU . 20.1 mmt -37.03 137.85 0.56 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.573 0.701 . . . . 0.0 110.859 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.406 ' O ' ' CG ' ' A' ' 142' ' ' ASN . 72.8 Cg_exo -47.21 154.29 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.7 2.267 . . . . 0.0 112.343 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.7 -45.92 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.498 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -79.14 136.08 37.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.086 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.4 t -87.48 -11.57 48.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 199' ' ' THR . 71.0 m -99.41 163.66 12.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.817 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 58.8 p -80.91 174.52 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 139' ' ' GLY . 20.1 tp -74.61 155.38 37.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.486 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 49.2 t -122.62 104.35 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 138' ' ' VAL . 12.0 t -118.58 121.53 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.148 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.486 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 12.7 ptpt -159.15 146.5 17.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -40.76 142.98 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.43 163.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -58.44 101.7 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 20.8 p -91.82 146.94 23.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -165.72 110.99 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -145.76 153.31 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -161.46 154.01 20.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 46.4 t -145.72 132.34 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 153.97 -176.86 31.72 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 221' ' ' SER . 62.5 Cg_endo -76.91 42.27 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.665 2.243 . . . . 0.0 112.357 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 220' ' ' PRO . 60.6 p 37.17 40.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.3 t -69.83 -54.61 12.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.843 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 82.5 p -123.52 146.41 48.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.1 p -76.66 158.56 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.9 160.77 28.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.7 t -159.28 151.72 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 0.0 110.873 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.0 t -85.99 -60.79 1.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.859 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.72 124.86 0.92 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.532 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.1 t -90.84 126.55 36.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.855 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.64 41.65 3.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.6 m -110.3 153.03 25.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -112.02 99.74 8.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.42 138.81 2.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.489 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.47 -172.4 42.8 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.529 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -148.45 161.6 41.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 39.23 39.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -79.5 45.96 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -126.07 120.55 30.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.761 HD11 ' HB1' ' A' ' 187' ' ' ALA . 78.6 mt -106.97 154.67 20.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -121.59 115.26 22.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.36 149.3 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -142.73 -176.59 16.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.5 mmt 59.28 38.68 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.828 0.347 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 36.1 mt -98.98 153.65 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -105.27 164.88 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -77.61 47.6 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -133.77 -34.1 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -82.31 140.04 33.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.6 p -119.22 171.56 8.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -47.94 -51.92 21.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -54.93 26.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -43.14 -65.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.573 HG13 ' CE1' ' A' ' 154' ' ' PHE . 71.0 t -49.05 -62.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.885 HD21 ' CB ' ' A' ' 163' ' ' CYS . 29.4 mt -46.85 -37.3 8.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -69.9 -39.78 76.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.8 tp -83.83 -9.83 58.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.861 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.26 -36.19 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -46.99 -47.07 54.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.558 0.694 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.1 Cg_exo -47.94 -18.38 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.706 2.271 . . . . 0.0 112.329 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -101.4 -45.33 5.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.05 156.72 27.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 83.1 t -74.86 95.34 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 111.12 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.861 HD11 ' CB ' ' A' ' 154' ' ' PHE . 40.3 mt -65.98 143.74 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.48 -59.7 2.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -138.69 137.15 36.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.885 ' CB ' HD21 ' A' ' 151' ' ' LEU . 42.7 t -134.06 143.3 47.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 99.4 m -151.76 140.34 20.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.477 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 79.0 t -105.31 141.35 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 32.4 mt -81.57 142.2 33.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -150.92 170.89 18.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -97.17 -170.18 33.49 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.509 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.28 -20.36 12.69 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.673 2.249 . . . . 0.0 112.356 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.27 -31.72 21.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 132.07 -30.52 3.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 16.3 t -53.66 157.85 2.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 0.0 110.88 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.9 t -101.47 146.47 27.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.84 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -84.51 0.88 48.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 75.37 30.2 58.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.492 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.18 151.37 30.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -152.91 178.14 9.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -128.87 125.78 38.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.74 123.42 70.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.179 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -106.38 122.26 45.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.46 164.8 12.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.856 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.6 t -66.31 -35.76 81.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.1 t -137.65 168.12 20.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -66.15 -60.06 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.7 m -39.67 -52.74 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -47.3 -49.96 22.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.761 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -61.22 -55.97 25.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -39.97 -42.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -68.45 -64.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.52 -35.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.631 HD11 HD22 ' A' ' 136' ' ' LEU . 61.8 mt -67.15 -70.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -56.21 -13.59 2.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -89.62 -39.72 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.469 ' HB3' ' NE2' ' A' ' 198' ' ' GLN . 23.1 mt -118.23 29.19 7.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.3 t60 -96.32 122.54 39.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 42.36 24.15 0.2 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.531 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 195' ' ' HIS . 51.3 p -100.26 -37.44 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 0.0 110.877 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.469 ' NE2' ' HB3' ' A' ' 194' ' ' LEU . 1.9 pt20 -100.54 151.18 21.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 205' ' ' SER . 59.9 m -123.97 86.08 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 16.9 mmt -43.7 139.66 2.71 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.539 0.685 . . . . 0.0 110.895 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.67 151.14 5.38 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 82.31 -47.97 3.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.459 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -77.24 148.53 35.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.09 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 45.1 t -94.86 -17.76 21.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 199' ' ' THR . 4.2 m -100.07 164.71 11.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.921 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.0 p -79.13 -174.91 4.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.875 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 139' ' ' GLY . 13.1 tp -83.41 152.29 25.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -118.15 107.75 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.5 t -116.47 121.24 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.139 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -157.85 149.43 21.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -55.0 152.73 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -91.99 -41.49 10.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.099 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -136.26 126.12 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.603 HG22 ' N ' ' A' ' 215' ' ' ASP . 90.6 m -150.34 164.41 35.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.603 ' N ' HG22 ' A' ' 214' ' ' THR . 5.4 t70 -107.76 -60.36 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -109.36 156.5 19.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -82.08 130.27 35.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t 68.19 37.03 2.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.815 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 45.05 -152.15 0.72 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.76 133.49 13.71 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.627 2.218 . . . . 0.0 112.384 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.1 p -45.98 135.23 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 70.9 m -78.71 -60.4 2.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.816 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.975 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 t 63.15 42.17 7.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.2 m -124.93 124.92 43.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.54 -120.32 0.97 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.449 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.4 t -39.33 -44.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.851 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.2 t -72.24 155.02 40.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.807 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 152.42 154.96 6.86 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.506 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.3 m -78.26 139.14 38.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.21 37.38 3.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.7 m -69.15 92.96 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.877 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.92 117.4 19.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 131.29 159.24 9.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.33 121.93 0.8 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.526 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.75 79.37 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.842 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' OD2' HG21 ' A' ' 214' ' ' THR . 0.4 OUTLIER -110.48 138.86 46.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -125.48 48.35 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.506 ' HE2' ' CD1' ' A' ' 178' ' ' PHE . 48.2 tttt -137.04 136.23 38.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.913 HD21 ' HB1' ' A' ' 187' ' ' ALA . 28.8 mt -121.31 152.5 38.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -117.72 114.95 24.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.55 146.77 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -145.33 -178.99 21.31 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.482 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.4 mmt 55.59 48.23 19.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.529 ' CD2' HD11 ' A' ' 207' ' ' LEU . 42.4 mt -106.37 165.23 11.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -105.41 165.04 11.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.73 41.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -128.75 -35.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.35 152.97 36.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.7 p -129.23 178.9 6.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.768 ' HG3' HG23 ' A' ' 165' ' ' VAL . 5.2 mt-10 -57.02 -41.44 78.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.59 -55.03 38.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -43.2 -64.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.595 HG13 ' CE1' ' A' ' 154' ' ' PHE . 66.4 t -49.96 -60.76 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.868 HD21 ' CB ' ' A' ' 163' ' ' CYS . 35.8 mt -47.37 -37.61 11.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -69.48 -40.17 77.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.6 tp -83.81 -10.27 58.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.872 ' HB3' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -99.64 -35.54 9.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.0 tt0 -47.04 -46.96 55.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.601 0.715 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.2 Cg_exo -48.02 -17.13 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.621 2.214 . . . . 0.0 112.349 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.455 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 73.8 m-85 -100.63 -37.06 8.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.12 165.2 38.53 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.8 t -80.79 93.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.785 0.326 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.872 HD11 ' HB3' ' A' ' 154' ' ' PHE . 51.5 mt -65.37 129.31 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -77.77 -64.64 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -132.35 137.78 47.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.868 ' CB ' HD21 ' A' ' 151' ' ' LEU . 42.8 t -134.07 139.21 45.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.1 m -144.44 153.88 42.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.153 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.768 HG23 ' HG3' ' A' ' 147' ' ' GLU . 81.6 t -113.41 147.69 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.163 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.0 mt -87.87 148.31 24.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -150.2 164.2 36.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.05 -153.18 30.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.499 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.09 -47.72 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.67 2.247 . . . . 0.0 112.303 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -86.87 43.73 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 46.57 39.08 10.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.454 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.0 m -102.89 119.46 38.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 110.823 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.1 t -58.83 133.68 56.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.841 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -89.99 11.64 19.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 67.68 25.69 73.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.65 153.36 41.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 110.868 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -156.34 159.21 38.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.506 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 49.1 m-85 -108.98 141.12 41.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.76 125.4 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.673 ' O ' HG23 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -108.65 125.63 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -99.71 162.47 12.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.3 t -63.53 -30.7 71.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.0 m -141.39 168.95 18.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -68.23 -52.45 33.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 99.3 m -44.85 -61.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -40.04 -45.76 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.913 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -64.0 -54.44 34.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.541 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.5 mm100 -43.36 -36.18 1.81 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.54 -59.72 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -45.61 -30.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 188' ' ' GLN . 67.9 mt -68.43 -72.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -59.53 -17.3 31.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.455 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -80.51 -36.38 33.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.553 HD13 ' CE1' ' A' ' 154' ' ' PHE . 14.9 mt -123.28 23.05 9.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.2 t60 -87.24 124.34 33.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.87 30.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.525 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.08 -36.6 9.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.809 0.338 . . . . 0.0 110.872 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.783 ' OE1' HD22 ' A' ' 207' ' ' LEU . 1.6 pt20 -100.37 159.55 15.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 30.0 m -134.47 81.04 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.175 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.6 mmt -41.55 140.28 1.35 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.584 0.707 . . . . 0.0 110.865 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.08 139.51 20.62 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.737 2.291 . . . . 0.0 112.328 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 90.47 -47.91 3.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.508 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -78.98 126.84 31.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.761 0.315 . . . . 0.0 111.147 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.8 t -83.26 -7.39 59.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.826 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.8 p -100.11 157.7 16.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -87.13 144.64 26.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.783 HD22 ' OE1' ' A' ' 198' ' ' GLN . 14.3 tp -44.57 144.63 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.943 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 63.6 t -112.74 114.61 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.5 t -125.5 119.59 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.128 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -158.43 150.6 21.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -49.72 148.51 2.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -84.85 163.28 19.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.114 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -61.31 86.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 214' ' ' THR . 15.1 t -89.57 44.91 1.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.146 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -141.14 109.11 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -65.57 -52.64 50.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -101.01 171.93 7.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 81.8 p -83.23 146.14 28.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -64.21 -146.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.515 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.96 122.18 7.06 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.668 2.245 . . . . 0.0 112.322 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.9 p -170.92 176.12 4.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 88.7 p -92.54 141.23 28.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.9 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 -179.951 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.8 t -134.98 167.35 21.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.923 0.392 . . . . 0.0 110.833 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.3 t -93.0 -61.58 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.815 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.08 51.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.9 p -93.9 134.5 36.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.358 . . . . 0.0 110.842 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 82.4 p -100.4 87.35 3.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.93 179.77 43.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.438 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.9 p -143.41 114.32 7.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.885 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -89.78 164.83 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.1 p -82.13 154.04 25.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -80.55 -54.19 5.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . 99.56 -42.99 1.88 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.519 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . -35.65 139.22 0.26 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.51 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 133' ' ' ASP . 17.9 ttt180 -122.07 -53.35 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.35 . . . . 0.0 110.867 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 132' ' ' ARG . 1.3 t70 -34.69 110.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -84.33 32.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.549 ' CG ' ' HB3' ' A' ' 212' ' ' ALA . 2.9 tppp? -120.91 156.38 32.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.628 ' CD2' HD11 ' A' ' 191' ' ' ILE . 96.6 mt -136.32 144.94 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -112.92 122.48 47.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 t -113.05 144.45 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.21 -169.01 11.45 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.8 mmt 52.34 39.37 27.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.8 mt -100.26 145.51 28.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -89.64 -177.76 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.17 -7.24 59.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -99.99 29.4 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.936 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.418 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 59.8 mt-30 -127.04 105.56 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.946 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.1 p -103.08 166.32 10.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.475 ' HG3' HG23 ' A' ' 165' ' ' VAL . 5.4 mp0 -43.8 -41.85 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -59.55 -48.11 82.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -50.52 -54.43 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.685 HG13 ' CE1' ' A' ' 154' ' ' PHE . 73.6 t -66.62 -55.93 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.618 HD23 HD13 ' A' ' 160' ' ' ILE . 73.6 mt -50.9 -33.61 24.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.422 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 15.2 mmm180 -77.65 -37.51 49.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.2 tp -84.31 -12.84 53.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.868 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.6 m-85 -100.46 -37.21 8.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.52 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 4.6 mt-30 -47.07 -49.31 51.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.541 0.686 . . . . 0.0 110.929 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.94 -17.19 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.717 2.278 . . . . 0.0 112.339 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.515 ' CE1' ' HB1' ' A' ' 193' ' ' ALA . 73.3 m-85 -100.87 -39.98 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.77 155.67 27.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 69.6 t -71.43 93.9 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.868 HD11 ' CB ' ' A' ' 154' ' ' PHE . 75.1 mt -61.82 143.44 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -92.44 -59.53 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -140.5 144.44 36.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.524 ' CB ' HD21 ' A' ' 151' ' ' LEU . 3.7 t -134.02 133.14 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.7 m -137.2 125.75 23.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.475 HG23 ' HG3' ' A' ' 147' ' ' GLU . 58.8 t -96.95 151.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.496 HD11 ' HE1' ' A' ' 178' ' ' PHE . 38.4 mt -95.67 136.54 35.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.427 ' C ' ' HG3' ' A' ' 174' ' ' LYS . 18.2 mtt85 -125.71 135.42 52.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -59.16 -166.22 0.15 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.465 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.53 -48.76 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.14 -35.45 59.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.872 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 106.86 50.19 0.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 36.7 t -124.57 -75.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.7 m -174.99 153.5 1.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.427 ' HG3' ' C ' ' A' ' 167' ' ' ARG . 10.4 mttp -107.09 -4.46 18.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.84 24.86 70.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.32 160.07 42.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 110.898 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.45 158.39 20.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.496 ' HE1' HD11 ' A' ' 166' ' ' LEU . 76.8 m-85 -112.27 132.98 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.22 137.96 55.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 160' ' ' ILE . 23.9 ttmt -119.13 135.88 54.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.603 ' HE1' HD12 ' A' ' 136' ' ' LEU . 43.2 m-85 -107.94 167.93 9.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.5 t -71.44 -23.89 61.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.5 m -143.84 176.23 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.837 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -80.33 -42.23 23.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.812 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.4 m -53.56 -58.0 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -42.92 -47.3 5.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.617 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -59.65 -60.31 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -39.71 -41.67 1.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.39 -63.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.16 -32.69 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.127 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.628 HD11 ' CD2' ' A' ' 136' ' ' LEU . 40.5 mt -66.34 -71.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.138 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -59.25 -10.98 3.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.515 ' HB1' ' CE1' ' A' ' 157' ' ' PHE . . . -96.2 -24.44 16.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.47 HD21 ' HE2' ' A' ' 157' ' ' PHE . 30.2 mt -131.42 24.42 4.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 191' ' ' ILE . 2.4 t60 -90.6 119.8 31.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.69 33.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 195' ' ' HIS . 38.3 p -100.27 -38.07 8.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.826 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -100.53 163.2 12.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 205' ' ' SER . 26.3 m -129.93 84.58 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.418 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 21.4 mmt -40.52 137.9 1.29 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.612 0.72 . . . . 0.0 110.866 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.49 143.89 14.86 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.303 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 82.28 -40.15 2.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.507 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.66 138.85 35.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 90.9 p -92.42 -9.48 41.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 199' ' ' THR . 49.4 m -99.03 167.19 10.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.4 m -92.48 154.1 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 196' ' ' GLY . 11.6 tp -51.55 141.28 16.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.6 t -112.1 111.66 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.3 133.3 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -165.7 144.12 6.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -41.69 155.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.549 ' HB3' ' CG ' ' A' ' 135' ' ' LYS . . . -104.93 115.93 31.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.2 t70 70.5 53.99 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.7 m -126.7 127.5 45.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.155 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -161.44 166.59 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.897 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -64.16 112.31 2.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -72.05 -54.63 9.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.7 t -39.36 -47.99 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 106.29 -144.85 15.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.452 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.05 111.74 3.4 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.32 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.7 p -95.15 176.58 6.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 93.4 p -68.45 112.28 5.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.877 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.9 m -135.43 127.68 30.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.6 m -138.05 120.89 16.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.802 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.93 151.26 10.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.527 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.2 t -58.75 155.49 12.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.8 t -171.75 113.15 0.33 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -175.22 -138.93 2.9 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.513 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.1 m -141.41 144.45 34.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.832 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.87 174.48 11.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 m -71.31 122.67 20.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.419 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 19.4 mtm105 -111.29 117.53 33.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -103.73 -138.91 9.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.89 151.31 4.42 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.473 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.09 167.62 19.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 110.893 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -150.78 136.95 18.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.437 ' HB2' ' NH1' ' A' ' 134' ' ' ARG . 20.3 mtm105 -105.41 30.01 6.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.843 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -116.0 141.47 48.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.796 HD21 ' HB1' ' A' ' 187' ' ' ALA . 44.7 mt -120.09 153.78 35.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -120.44 120.13 35.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.69 147.62 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -141.04 -170.54 12.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.6 mmt 54.91 34.11 21.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.563 ' CD2' HD11 ' A' ' 207' ' ' LEU . 47.0 mt -93.31 153.52 18.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -106.95 165.58 11.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -77.32 46.9 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -133.81 -34.55 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -81.23 145.48 30.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 77.1 p -125.6 169.86 12.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.468 ' HG3' HG23 ' A' ' 165' ' ' VAL . 9.9 mt-10 -49.57 -46.84 49.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -54.61 -53.28 56.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -45.56 -65.69 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.885 HG13 ' CE1' ' A' ' 154' ' ' PHE . 95.2 t -48.9 -60.29 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.09 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.925 HD21 ' CB ' ' A' ' 163' ' ' CYS . 35.2 mt -47.53 -40.09 17.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -69.69 -39.42 76.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.458 HD21 HD22 ' A' ' 194' ' ' LEU . 13.1 tp -84.8 -9.1 58.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.885 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.2 m-85 -100.34 -37.32 8.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -47.29 -46.87 57.65 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 0.0 110.877 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.9 Cg_exo -48.0 -18.46 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.654 2.236 . . . . 0.0 112.366 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.457 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 75.5 m-85 -100.38 -47.32 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.57 164.77 33.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.51 104.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.83 HD11 ' HB3' ' A' ' 154' ' ' PHE . 45.1 mt -76.91 131.47 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.43 -64.38 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -122.37 132.21 54.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.925 ' CB ' HD21 ' A' ' 151' ' ' LEU . 34.9 t -132.73 136.79 46.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 165' ' ' VAL . 96.4 m -153.7 152.81 31.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.57 HG22 ' CB ' ' A' ' 177' ' ' ALA . 65.6 t -117.12 148.24 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.09 140.52 29.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -145.19 175.38 10.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -96.43 -155.17 30.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.07 -40.1 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.254 . . . . 0.0 112.312 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 171' ' ' GLY . 12.3 p-10 -107.05 70.94 0.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 170' ' ' ASP . . . 34.82 40.56 0.21 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.486 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -102.44 97.76 7.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 12.6 t -56.93 142.15 42.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -101.11 26.52 6.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 51.86 29.4 26.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 17.0 p -144.28 151.48 39.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.57 ' CB ' HG22 ' A' ' 165' ' ' VAL . . . -160.18 166.12 30.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -117.72 144.94 44.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 26.6 t -137.51 121.54 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.731 ' O ' HG23 ' A' ' 160' ' ' ILE . 23.1 ttmt -103.89 129.86 51.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.412 ' HE1' HD12 ' A' ' 136' ' ' LEU . 36.4 m-85 -103.66 164.73 11.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 88.2 p -63.49 -33.12 74.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.6 m -141.49 179.05 7.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -75.44 -51.85 12.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 31.0 m -48.83 -53.32 19.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.101 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -47.04 -47.98 22.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.796 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -62.37 -57.57 10.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.132 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.574 ' HA ' HD12 ' A' ' 191' ' ' ILE . 5.1 mm100 -40.71 -40.67 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -67.36 -61.1 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.61 -31.67 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.095 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.684 HD11 HD22 ' A' ' 136' ' ' LEU . 74.6 mt -67.5 -71.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.175 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -57.17 -13.64 3.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.457 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.72 -41.15 14.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 154' ' ' PHE . 33.2 mt -113.51 16.26 18.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -83.03 126.21 32.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 37.94 28.43 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.541 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 195' ' ' HIS . 77.2 p -100.4 -39.61 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.351 . . . . 0.0 110.843 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.759 ' NE2' HD22 ' A' ' 207' ' ' LEU . 11.5 pt20 -100.66 160.83 14.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 205' ' ' SER . 96.3 m -135.0 81.14 1.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.41 ' C ' ' O ' ' A' ' 199' ' ' THR . 26.5 mmt -37.72 137.84 0.67 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.582 0.706 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.77 153.66 3.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 2.286 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 78.33 -42.88 2.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.509 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.62 138.23 35.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.9 t -87.22 -13.41 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 199' ' ' THR . 6.0 t -100.08 169.61 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 24.6 p -87.86 -174.81 4.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.759 HD22 ' NE2' ' A' ' 198' ' ' GLN . 11.7 tp -86.86 122.67 31.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.53 109.48 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.101 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 36.4 t -118.22 124.81 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.083 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -164.33 150.6 10.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -46.5 163.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -89.14 152.55 21.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.08 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -42.08 123.8 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 13.8 t -126.04 159.93 31.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.084 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -77.25 96.29 4.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -84.11 145.85 28.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -126.49 42.05 3.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 90.7 p -107.98 171.98 7.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -146.35 159.54 27.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.69 171.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.619 2.212 . . . . 0.0 112.341 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.0 m -143.14 158.29 43.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.3 t -126.31 158.05 36.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.508 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 66.0 m -44.09 150.92 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.6 t -68.48 118.36 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 60.35 94.57 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.503 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.2 m -46.57 167.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.867 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.5 m -97.51 165.59 11.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.884 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 42.27 80.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.472 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.8 m -115.63 165.8 12.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.868 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -79.74 10.6 3.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.9 m -102.66 -41.33 6.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.89 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.81 130.88 4.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -133.87 170.17 22.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.446 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.27 -146.7 20.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.508 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.18 155.09 2.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.797 0.332 . . . . 0.0 110.879 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -94.87 -54.3 3.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.42 ' HB2' ' NH1' ' A' ' 134' ' ' ARG . 23.6 mtm105 48.28 36.1 6.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -133.52 109.82 9.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.978 HD21 ' HB1' ' A' ' 187' ' ' ALA . 37.3 mt -96.41 150.52 20.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -116.13 113.27 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.86 143.71 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.679 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -140.02 -171.56 12.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.491 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.4 mmt 51.6 42.4 29.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 49.6 mt -102.19 157.33 16.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -99.17 168.12 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -84.14 37.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -127.62 -44.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -62.9 146.79 52.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 53.5 p -122.81 178.31 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' A' ' 165' ' ' VAL . 13.0 mt-10 -58.3 -48.19 81.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -54.18 -50.23 67.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -44.98 -68.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.69 HG13 ' CE1' ' A' ' 154' ' ' PHE . 46.9 t -49.04 -60.31 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.751 HD23 HD13 ' A' ' 160' ' ' ILE . 35.4 mt -46.48 -38.06 8.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -69.21 -40.4 78.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.93 -10.55 57.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.731 ' CE1' HD13 ' A' ' 194' ' ' LEU . 3.1 m-85 -98.83 -35.75 10.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.3 OUTLIER -47.18 -46.94 56.58 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.551 0.691 . . . . 0.0 110.908 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.6 Cg_exo -48.0 -16.95 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.639 2.226 . . . . 0.0 112.359 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.48 ' CE1' ' HB1' ' A' ' 193' ' ' ALA . 72.7 m-85 -99.85 -46.83 5.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.409 ' HA3' ' CG ' ' A' ' 186' ' ' GLU . . . -160.1 174.49 36.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.5 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.4 t -87.6 102.32 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.751 HD13 HD23 ' A' ' 151' ' ' LEU . 23.7 mt -74.07 134.37 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.46 -60.36 2.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -139.9 142.26 36.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.719 ' HB2' HD21 ' A' ' 151' ' ' LEU . 9.8 t -134.01 144.78 48.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.6 m -153.81 144.08 22.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.485 HG23 ' HG3' ' A' ' 147' ' ' GLU . 58.0 t -112.23 139.52 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 67.4 mt -76.94 139.63 40.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 20.2 mtt85 -143.78 163.18 34.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.98 -169.97 38.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.479 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.97 -46.62 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.672 2.248 . . . . 0.0 112.372 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -62.97 -40.1 96.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 125.73 43.66 0.28 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.505 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.0 t -126.49 122.08 34.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.809 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.2 t -61.87 142.24 57.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.848 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -89.63 17.9 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 59.46 28.95 65.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 6.2 p -145.93 156.43 43.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -160.47 172.1 17.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -126.61 124.01 38.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 85.7 t -115.9 130.58 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.693 ' O ' HG23 ' A' ' 160' ' ' ILE . 20.7 ttmt -111.9 131.22 55.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 186' ' ' GLU . 40.9 m-85 -105.77 166.8 10.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.7 t -81.53 -3.14 52.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.0 m -162.96 149.76 12.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.858 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -59.84 -46.04 90.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.7 m -48.71 -61.14 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.108 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 181' ' ' PHE . 0.5 OUTLIER -42.33 -51.24 4.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.978 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.75 -56.84 16.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.098 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -38.62 -51.51 1.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.955 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.39 -61.21 2.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -40.99 -35.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.786 HD11 HD22 ' A' ' 136' ' ' LEU . 63.4 mt -65.69 -69.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -62.25 -14.56 39.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.91 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.48 ' HB1' ' CE1' ' A' ' 157' ' ' PHE . . . -90.84 -25.03 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.731 HD13 ' CE1' ' A' ' 154' ' ' PHE . 76.9 mt -130.06 23.03 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -85.95 123.66 31.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.15 39.46 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.478 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 22.6 p -100.09 -37.73 8.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -100.57 164.82 11.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 205' ' ' SER . 28.6 m -135.01 79.7 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.155 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 199' ' ' THR . 15.0 mmt -38.36 138.42 0.73 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.606 0.717 . . . . 0.0 110.853 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.27 145.18 11.74 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.42 -39.19 2.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.532 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -83.83 129.03 34.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.3 m -84.98 -7.51 59.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 199' ' ' THR . 9.8 t -99.3 170.4 8.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.1 m -99.94 151.97 20.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 139' ' ' GLY . 16.4 tp -53.19 137.82 33.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.62 119.34 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.01 117.52 49.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.073 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -158.05 153.01 25.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -52.7 139.97 24.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.09 162.18 22.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -54.16 113.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 82.4 p -101.35 108.17 19.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -122.5 168.61 11.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -106.18 -48.71 3.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -126.69 165.24 19.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.3 t -101.43 146.11 28.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 94.38 69.85 1.09 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.544 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.68 104.14 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.684 2.256 . . . . 0.0 112.314 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.3 t -69.0 84.04 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 59.7 p -49.46 142.7 7.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -105.63 163.65 12.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.1 p -67.77 157.23 35.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.15 134.45 2.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 m -99.87 148.64 24.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 71.3 m -96.77 163.1 13.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.14 -75.43 1.14 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.513 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.3 t -85.24 135.95 33.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.855 0.359 . . . . 0.0 110.864 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -100.56 145.09 28.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 t -72.12 145.1 48.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -43.03 143.9 0.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -116.66 175.05 15.54 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.27 151.26 38.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.506 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -128.18 130.03 47.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.898 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.18 119.29 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -84.12 44.34 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -119.56 142.29 48.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.732 ' CD2' HD11 ' A' ' 191' ' ' ILE . 43.8 mt -126.75 156.79 40.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -125.77 115.96 20.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 139' ' ' GLY . 84.5 t -100.8 153.93 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.126 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.434 ' N ' HG12 ' A' ' 138' ' ' VAL . . . -144.42 -172.88 15.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.0 mmt 51.11 50.14 19.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HB2' ' C ' ' A' ' 175' ' ' GLY . 34.1 mt -107.71 154.97 20.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -99.43 171.06 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -86.26 28.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.89 -31.44 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -79.62 147.02 32.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.2 p -124.62 -176.61 3.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -62.69 -44.29 96.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -57.03 -45.16 83.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -52.33 -58.94 5.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.792 HG13 ' CE1' ' A' ' 154' ' ' PHE . 83.6 t -57.4 -50.49 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.868 HD21 ' CB ' ' A' ' 163' ' ' CYS . 33.9 mt -55.54 -39.49 70.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -70.05 -38.68 75.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.8 tp -84.22 -10.47 57.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.799 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.15 -35.93 9.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.562 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.01 -46.92 54.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.601 0.715 . . . . 0.0 110.936 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.97 -17.13 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -101.66 -44.59 5.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.36 164.72 35.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.18 103.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.352 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.799 HD11 ' CB ' ' A' ' 154' ' ' PHE . 44.0 mt -75.25 137.79 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.97 -61.89 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.78 134.9 47.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.868 ' CB ' HD21 ' A' ' 151' ' ' LEU . 36.7 t -134.08 135.12 43.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 80.4 m -147.76 145.3 28.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.109 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.47 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 77.3 t -112.56 148.02 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 40.6 mt -88.8 135.63 33.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.43 ' C ' ' HG3' ' A' ' 174' ' ' LYS . 64.7 mtm-85 -116.79 143.68 45.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -64.35 -178.31 5.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.541 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -46.08 -46.99 15.28 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.692 2.261 . . . . 0.0 112.322 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 171' ' ' GLY . 26.5 t70 -84.46 38.27 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.799 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 170' ' ' ASP . . . 34.22 61.43 0.53 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.522 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.51 -74.78 0.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.371 . . . . 0.0 110.862 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 t -167.79 143.67 3.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.834 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.43 ' HG3' ' C ' ' A' ' 167' ' ' ARG . 19.5 mttm -111.01 -4.38 15.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.421 ' C ' ' HB2' ' A' ' 141' ' ' LEU . . . 82.83 -3.33 83.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.472 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.3 169.0 16.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.835 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -164.67 173.59 11.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -123.94 132.39 53.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 64.1 t -125.61 131.58 71.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -117.45 113.11 21.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -86.26 166.35 15.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 95.6 p -68.47 -35.17 77.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -134.51 164.92 26.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -65.92 -50.97 62.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.91 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.4 m -48.96 -62.39 1.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.179 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -44.38 -42.05 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -59.39 -60.56 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.787 ' HA ' HD12 ' A' ' 191' ' ' ILE . 6.3 mt-30 -45.76 -50.28 14.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -50.28 -55.57 14.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.1 -35.68 59.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.787 HD12 ' HA ' ' A' ' 188' ' ' GLN . 58.3 mt -64.87 -68.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.146 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -57.88 -12.39 3.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -91.08 -39.02 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.704 HD13 ' CE1' ' A' ' 154' ' ' PHE . 28.6 mt -115.2 25.68 10.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.8 t60 -88.72 122.62 32.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.61 33.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 195' ' ' HIS . 23.5 p -100.22 -38.33 8.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 110.866 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -100.52 162.47 12.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 47.5 m -132.75 84.1 2.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.6 mmt -39.93 137.92 1.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.568 0.699 . . . . 0.0 110.881 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.83 144.46 15.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.659 2.24 . . . . 0.0 112.332 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.34 -40.93 3.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.515 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -83.36 142.42 31.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 111.108 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 73.9 p -94.2 -12.65 27.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.7 m -98.94 157.94 15.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.7 m -78.27 174.94 10.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 196' ' ' GLY . 9.9 tp -73.97 145.6 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.926 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 57.3 t -113.46 111.51 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.6 t -122.27 123.6 69.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.093 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -161.81 149.56 14.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -47.25 142.49 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.95 94.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.02 43.77 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 214' ' ' THR . 13.3 t -85.22 42.11 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -42.07 149.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -106.4 42.26 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -44.18 136.36 3.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 36.0 t -72.18 164.33 26.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 168.25 74.43 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 42.66 1.15 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.676 2.251 . . . . 0.0 112.325 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 20.5 t -87.81 81.99 7.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.888 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 57.7 p -135.39 147.07 48.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.5 t -132.09 156.1 46.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.367 . . . . 0.0 110.839 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.1 m -146.85 138.87 24.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.819 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.67 73.49 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.471 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.5 m -124.84 86.04 2.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.837 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.2 m -72.52 144.98 47.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.96 -149.69 17.75 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.7 m -121.13 105.29 10.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.862 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -48.63 -46.23 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 77.6 p -119.8 149.62 41.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.857 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -106.55 -51.36 2.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 167.89 60.79 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.532 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.85 -88.23 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 53.6 37.01 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 110.885 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -103.72 146.68 28.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 78.9 mtm-85 -73.26 -31.53 64.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -96.0 140.63 30.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.698 HD21 ' HB1' ' A' ' 187' ' ' ALA . 18.9 mt -121.7 153.86 37.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -116.0 109.99 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.54 139.29 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -133.83 -173.05 13.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.452 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.9 mmt 57.36 43.32 23.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.403 ' CD2' HD11 ' A' ' 207' ' ' LEU . 43.6 mt -102.23 156.89 17.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -96.23 161.32 14.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -81.98 43.12 0.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -134.38 -37.84 0.85 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -67.87 151.36 47.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.0 p -129.6 164.27 24.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.413 ' HG3' HG23 ' A' ' 165' ' ' VAL . 4.7 mp0 -44.33 -48.52 9.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.24 -54.42 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -42.55 -67.79 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.834 HG13 ' CE1' ' A' ' 154' ' ' PHE . 99.7 t -49.63 -61.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 155' ' ' GLN . 34.2 mt -44.83 -38.25 4.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -69.45 -40.52 77.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.93 -9.38 58.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.883 ' HB3' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.26 -35.81 9.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.564 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.13 -46.97 56.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.92 -16.67 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.325 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.453 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.4 m-85 -99.69 -41.95 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.22 168.02 37.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.62 134.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.153 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.883 HD11 ' HB3' ' A' ' 154' ' ' PHE . 75.4 mt -109.04 109.08 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.143 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' LYS . 18.5 m-20 -45.3 -61.28 1.73 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.875 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -157.88 148.43 20.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 20.6 t -133.74 135.61 44.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.8 m -139.44 141.9 37.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.413 HG23 ' HG3' ' A' ' 147' ' ' GLU . 98.3 t -104.69 135.06 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.548 HD11 ' HE2' ' A' ' 178' ' ' PHE . 95.9 mt -75.25 144.55 42.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -150.39 148.76 29.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.34 163.55 35.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.472 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.26 -37.02 18.11 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.702 2.268 . . . . 0.0 112.357 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.25 39.03 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 42.88 53.09 5.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.532 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 173' ' ' SER . 22.5 p -121.59 90.01 3.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.902 0.382 . . . . 0.0 110.881 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 172' ' ' SER . 27.4 t -35.03 133.09 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.83 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.5 mttm -87.71 23.32 2.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.875 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 50.48 33.65 25.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 29.7 m -150.03 169.05 22.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 110.856 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -165.69 179.24 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.548 ' HE2' HD11 ' A' ' 166' ' ' LEU . 91.5 m-85 -133.98 118.7 18.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.9 t -110.85 118.91 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 161' ' ' ASP . 13.4 ttmm -105.02 117.91 35.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.944 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -93.29 154.14 18.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 m -57.4 -41.04 79.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -134.38 136.01 43.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 187' ' ' ALA . 4.9 p80 -38.57 -56.32 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 184' ' ' HIS . 94.3 m -37.53 -67.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -41.03 -43.62 2.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.698 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -62.0 -53.95 48.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.623 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.3 mm100 -45.21 -46.93 12.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -60.94 -65.74 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.4 -38.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.661 HD11 HD22 ' A' ' 136' ' ' LEU . 62.3 mt -61.63 -71.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.146 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -57.09 -13.14 2.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.453 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -90.94 -32.33 16.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.125 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.684 HD13 ' CE1' ' A' ' 154' ' ' PHE . 40.8 mt -122.43 20.64 10.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -86.53 123.96 32.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 41.52 28.36 0.36 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 82.9 p -100.53 -38.67 8.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.862 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.689 ' NE2' HD22 ' A' ' 207' ' ' LEU . 9.7 pt20 -100.58 146.0 27.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 205' ' ' SER . 86.9 m -123.91 80.25 1.79 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.147 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.446 ' C ' ' O ' ' A' ' 199' ' ' THR . 14.1 mmt -34.58 138.1 0.34 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.558 0.694 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.63 151.58 7.43 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.733 2.289 . . . . 0.0 112.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.69 -43.9 2.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -78.84 136.33 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 111.097 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 70.1 m -86.49 -13.0 47.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 199' ' ' THR . 23.1 m -100.08 161.24 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.3 p -85.27 -178.41 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.689 HD22 ' NE2' ' A' ' 198' ' ' GLN . 11.9 tp -82.71 123.49 29.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.4 t -92.24 106.04 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 14.6 t -113.27 117.43 55.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.16 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -157.46 150.6 23.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -54.68 152.61 6.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -94.24 -40.72 9.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -115.38 119.29 35.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 40.3 p -98.01 111.32 23.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -133.2 139.88 47.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -160.95 170.06 21.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -58.24 116.27 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 57.7 m -66.62 -51.55 55.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.823 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 129.21 93.26 0.71 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.45 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 116.65 4.25 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.3 t -48.3 102.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.2 t -103.62 99.43 9.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.446 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.2 t -171.25 153.52 3.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 110.915 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.1 m -91.89 144.66 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.27 70.32 0.27 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.514 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.9 m -81.66 113.94 20.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 110.838 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.7 p -154.27 149.89 27.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.784 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.3 137.39 5.77 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.4 p -78.39 126.55 30.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.819 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -83.0 -56.27 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.9 m -62.78 108.89 1.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -107.77 133.84 51.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 158.76 156.11 7.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.14 120.2 2.35 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -103.12 82.64 2.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -112.88 126.68 55.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.837 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -109.23 33.82 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.819 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -96.84 137.12 36.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 1.015 HD21 ' HB1' ' A' ' 187' ' ' ALA . 58.1 mt -115.92 153.3 31.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -123.36 114.04 19.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.2 t -101.18 143.75 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.77 -173.85 13.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.6 mmt 57.8 37.46 27.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.446 ' CD2' ' OE1' ' A' ' 145' ' ' GLN . 24.3 mt -95.37 155.1 16.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -108.84 173.99 6.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.66 12.51 2.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -99.96 -22.61 15.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.451 ' CD ' ' SD ' ' A' ' 200' ' ' MET . 34.4 mt-30 -97.57 149.36 22.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 p -130.77 178.16 6.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.42 ' HG3' HG23 ' A' ' 165' ' ' VAL . 13.7 mt-10 -56.94 -49.24 76.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -52.23 -59.47 4.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -39.65 -67.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.773 HG13 ' CE1' ' A' ' 154' ' ' PHE . 84.1 t -45.16 -60.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.907 HD21 ' HB2' ' A' ' 163' ' ' CYS . 33.9 mt -47.98 -40.31 22.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -69.57 -39.53 77.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -84.19 -10.04 58.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.845 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -99.94 -36.2 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -47.11 -47.01 55.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.592 0.71 . . . . 0.0 110.919 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.2 Cg_exo -48.01 -17.13 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.695 2.263 . . . . 0.0 112.332 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.447 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 74.2 m-85 -101.32 -48.15 4.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -156.3 160.43 30.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.88 93.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.117 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.845 HD11 ' CB ' ' A' ' 154' ' ' PHE . 63.5 mt -62.87 138.6 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -95.13 -62.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.28 132.92 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.907 ' HB2' HD21 ' A' ' 151' ' ' LEU . 42.7 t -134.02 136.17 43.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 50.7 m -152.69 139.52 18.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 53.5 t -104.06 144.84 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 53.1 mt -84.61 145.05 28.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.921 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -141.31 178.49 7.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -103.82 -153.43 23.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.26 -46.86 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.692 2.261 . . . . 0.0 112.361 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -101.1 63.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 38.08 45.71 1.72 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.4 m -108.55 98.88 8.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.842 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.7 t -46.44 138.84 5.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.863 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -94.68 -0.62 54.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.74 10.79 86.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.35 148.13 50.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.835 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -153.37 166.15 33.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -120.83 136.06 55.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.928 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 81.2 t -130.51 124.31 56.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -107.9 129.65 55.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.429 ' CE1' HD12 ' A' ' 136' ' ' LEU . 28.4 m-85 -103.59 167.71 9.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.3 t -64.97 -32.31 73.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.3 t -143.19 175.94 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.569 ' CG ' ' N ' ' A' ' 185' ' ' THR . 2.7 p80 -72.13 -49.63 34.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.569 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 89.4 m -43.79 -61.54 1.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -40.94 -51.31 3.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 1.015 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -56.6 -57.63 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.065 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -39.65 -47.24 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 190' ' ' ALA . . . -61.95 -67.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -36.53 -42.93 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.507 HD11 HD22 ' A' ' 136' ' ' LEU . 77.7 mt -57.36 -74.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -57.05 -13.3 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.447 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.86 -35.79 18.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 21.5 mt -126.51 26.41 6.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.8 t60 -86.41 121.41 28.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 207' ' ' LEU . . . 33.86 32.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.51 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.38 -38.77 8.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.343 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.62 160.1 14.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 205' ' ' SER . 19.3 m -130.83 87.59 2.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.451 ' SD ' ' CD ' ' A' ' 145' ' ' GLN . 16.8 mmt -39.62 154.86 0.17 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.87 122.73 9.65 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 2.273 . . . . 0.0 112.305 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 111.97 -43.91 1.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -82.94 153.05 25.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 84.5 p -98.63 -12.8 20.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 199' ' ' THR . 64.8 m -100.14 164.96 11.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.852 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 67.5 m -87.49 161.28 17.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 196' ' ' GLY . 14.9 tp -57.09 141.65 45.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.457 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 55.8 t -110.28 107.12 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.1 t -118.24 114.52 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.457 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 17.6 ptpt -148.3 155.4 41.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -55.98 150.46 13.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.85 135.81 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -38.02 154.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 74.1 p -135.4 150.36 49.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.55 133.56 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -106.82 138.16 43.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -118.77 -43.31 2.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 24.8 p -62.29 -16.47 54.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 69.45 154.38 0.88 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.25 141.01 20.13 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.679 2.253 . . . . 0.0 112.361 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 86.4 p -68.09 90.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 50.7 m -76.65 172.77 12.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.533 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.441 -0.263 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 m -71.97 112.58 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.902 0.382 . . . . 0.0 110.865 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 t -148.83 141.09 24.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.82 69.01 1.08 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.514 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.1 t -85.02 41.36 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.0 t -128.08 156.28 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -173.18 -77.9 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 88.0 p -112.93 54.74 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -91.09 49.38 1.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.6 p -99.59 103.73 15.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.857 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -132.5 149.55 52.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.14 50.58 0.99 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.457 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 123.83 -130.52 7.67 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.465 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -149.51 171.07 17.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.848 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -164.78 129.34 2.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.829 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 74.3 mtm-85 -125.13 37.11 4.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -128.29 144.3 51.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 1.019 HD21 ' HB1' ' A' ' 187' ' ' ALA . 21.0 mt -125.06 144.93 50.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -112.64 114.76 27.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -103.85 146.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.133 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -142.34 -173.53 14.32 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.417 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.3 mmt 55.81 42.35 29.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.4 mt -103.35 154.87 18.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -98.12 165.82 11.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -82.48 39.93 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -128.53 -38.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -69.49 151.29 46.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.1 p -128.55 176.67 7.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -55.41 -44.62 76.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.861 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.83 -49.18 74.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.12 -69.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.748 HG13 ' CE1' ' A' ' 154' ' ' PHE . 74.6 t -49.96 -59.75 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.866 HD21 ' CB ' ' A' ' 163' ' ' CYS . 25.4 mt -47.34 -38.34 12.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -69.62 -40.13 76.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.1 tp -84.49 -8.96 58.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.748 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -100.18 -37.24 9.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.2 tm0? -47.2 -46.89 56.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.645 0.736 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.97 -17.28 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.242 . . . . 0.0 112.361 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.706 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 73.3 m-85 -99.88 -33.4 10.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.97 164.02 33.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.441 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 94.5 t -76.47 103.41 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 154' ' ' PHE . 85.6 mt -72.37 133.99 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -81.51 -62.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -141.89 139.79 32.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.866 ' CB ' HD21 ' A' ' 151' ' ' LEU . 45.0 t -134.04 141.11 47.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.6 m -146.7 139.44 25.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 87.3 t -105.6 136.63 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.569 HD12 ' SG ' ' A' ' 176' ' ' CYS . 49.9 mt -72.03 138.13 47.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -151.98 140.99 21.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -68.74 159.62 52.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.62 -35.67 13.09 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.661 2.241 . . . . 0.0 112.319 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -72.85 -38.97 66.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 121.03 40.1 0.57 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.446 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 t -116.75 112.28 20.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.839 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -55.91 131.13 46.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -90.63 26.26 2.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 55.94 38.94 77.01 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.482 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.569 ' SG ' HD12 ' A' ' 166' ' ' LEU . 22.7 p -156.17 149.76 24.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.805 0.336 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -159.47 166.77 30.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.5 136.05 54.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.482 HG22 ' SG ' ' A' ' 163' ' ' CYS . 10.5 t -127.18 125.25 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.615 ' O ' HG23 ' A' ' 160' ' ' ILE . 30.9 tttm -105.72 130.72 53.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.405 ' CE1' HD12 ' A' ' 136' ' ' LEU . 22.8 m-85 -106.29 158.83 16.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.7 t -53.21 -43.6 67.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.6 m -128.26 173.53 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.464 ' O ' ' HB3' ' A' ' 187' ' ' ALA . 29.5 p-80 -71.8 -49.97 33.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.5 m -47.67 -63.62 1.01 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -40.25 -39.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 1.019 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -63.22 -65.76 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.424 ' C ' ' CD ' ' A' ' 188' ' ' GLN . 0.0 OUTLIER -43.39 -36.82 2.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.95 -61.87 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.44 -34.68 4.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.509 HD11 HD22 ' A' ' 136' ' ' LEU . 45.1 mt -60.04 -71.83 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -55.59 -18.73 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.706 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -79.05 -37.4 39.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.46 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 12.2 mt -126.51 28.26 5.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.5 t60 -84.81 120.98 27.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.04 34.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.452 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.3 -38.84 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.844 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -100.6 152.23 20.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 200' ' ' MET . 15.7 m -122.31 86.28 2.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 199' ' ' THR . 13.2 mmt -37.11 155.25 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 110.855 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.41 128.11 15.87 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.695 2.263 . . . . 0.0 112.372 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 103.51 -39.46 2.79 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.96 154.71 21.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.067 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.7 t -99.98 -14.96 18.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.1 m -100.12 161.54 13.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 66.9 m -88.64 158.27 18.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 139' ' ' GLY . 14.3 tp -52.45 141.75 19.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 52.4 t -110.08 108.64 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.15 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.492 HG12 HG12 ' A' ' 191' ' ' ILE . 4.7 t -118.6 124.45 73.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -158.85 148.59 19.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.461 ' CZ ' HD12 ' A' ' 191' ' ' ILE . 68.4 m-85 -55.51 150.41 12.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -84.47 154.4 22.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.096 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -42.23 119.84 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.1 p -75.98 -34.82 59.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -173.56 176.91 2.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -83.2 -55.22 4.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -129.75 99.37 5.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 61.5 m -46.99 -56.16 6.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -118.86 146.2 18.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.522 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.67 -0.93 11.11 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.639 2.226 . . . . 0.0 112.35 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 75.1 p -52.5 170.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.7 m -86.39 -49.31 7.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.451 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.0 t -73.59 171.75 12.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -98.59 144.53 27.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.27 49.78 0.76 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.8 m -78.13 94.97 4.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 110.863 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 46.4 t -39.84 152.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.48 -178.61 9.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.462 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.9 t 55.68 44.89 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.788 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 128' ' ' SER . 11.9 pt-20 -92.12 -42.7 9.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.451 ' N ' ' HG3' ' A' ' 127' ' ' GLU . 35.7 t -107.0 140.24 40.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 41.53 38.44 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.89 -44.53 37.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 138.6 -162.02 25.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -133.19 118.25 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 0.0 110.873 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -149.86 128.31 12.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -95.16 32.71 1.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -125.85 157.5 37.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.788 ' CD2' HD11 ' A' ' 191' ' ' ILE . 88.7 mt -140.1 150.66 44.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -117.2 117.61 30.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.11 147.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.49 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -139.41 -170.5 11.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.52 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.4 mmt 51.68 51.19 17.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.778 0.323 . . . . 0.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.462 HD22 ' OE1' ' A' ' 145' ' ' GLN . 43.5 mt -111.13 155.75 22.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -97.61 165.07 12.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -82.37 40.69 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -129.16 -40.05 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.462 ' OE1' HD22 ' A' ' 141' ' ' LEU . 62.9 mt-30 -69.43 144.65 53.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.3 p -122.91 171.27 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.566 ' HG3' HG23 ' A' ' 165' ' ' VAL . 12.9 mp0 -48.43 -48.71 37.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.45 ' OE1' ' C ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -51.74 -51.41 56.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -46.6 -67.35 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.601 HG13 ' CE1' ' A' ' 154' ' ' PHE . 31.7 t -49.27 -62.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 163' ' ' CYS . 25.0 mt -46.49 -38.35 9.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -69.51 -40.1 77.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.76 -10.2 58.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.825 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -99.84 -35.73 9.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -47.1 -47.07 55.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.59 0.71 . . . . 0.0 110.897 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.99 -17.27 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.666 2.244 . . . . 0.0 112.365 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.492 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 74.1 m-85 -101.26 -47.16 4.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.97 166.14 34.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.503 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.5 t -80.6 101.8 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 0.0 111.14 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.825 HD11 ' CB ' ' A' ' 154' ' ' PHE . 38.5 mt -73.07 131.37 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.69 -64.17 1.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -130.77 140.98 50.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.813 ' CB ' HD21 ' A' ' 151' ' ' LEU . 12.3 t -134.13 131.61 38.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.4 m -136.43 138.19 41.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.566 HG23 ' HG3' ' A' ' 147' ' ' GLU . 92.3 t -108.45 135.36 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 176' ' ' CYS . 78.9 mt -67.88 147.11 52.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -158.02 148.02 20.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.66 168.06 41.32 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.468 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.16 -38.23 19.27 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.696 2.264 . . . . 0.0 112.335 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -101.74 41.82 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 48.85 58.1 8.0 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 41.3 t -115.06 88.61 2.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.876 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.9 t -41.97 121.4 1.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -79.79 9.61 5.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 67.68 20.61 72.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.673 ' HB2' HD12 ' A' ' 166' ' ' LEU . 21.3 m -143.49 164.43 30.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.792 0.33 . . . . 0.0 110.883 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -164.02 170.92 15.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.05 121.9 36.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 94.3 t -114.22 131.51 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.704 ' O ' HG23 ' A' ' 160' ' ' ILE . 24.9 ttpt -110.71 129.57 55.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.891 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -102.47 165.23 11.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.7 p -67.32 -39.14 85.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.0 p -132.52 146.09 51.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.42 ' CG ' ' N ' ' A' ' 185' ' ' THR . 6.8 p80 -50.44 -50.41 52.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.42 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 85.9 m -48.66 -53.34 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -45.75 -50.42 13.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -59.89 -48.51 81.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.126 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.596 ' HA ' HD12 ' A' ' 191' ' ' ILE . 4.3 mm100 -46.71 -43.41 17.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.41 -59.2 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.106 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.01 -36.81 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.788 HD11 ' CD2' ' A' ' 136' ' ' LEU . 63.3 mt -61.37 -73.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.1 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -57.41 -12.05 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.492 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -85.09 -40.09 17.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.92 19.41 11.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.4 t60 -80.08 124.97 29.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.21 32.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.495 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 195' ' ' HIS . 58.8 p -100.38 -39.31 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.83 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -100.53 160.47 14.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 205' ' ' SER . 19.6 m -135.02 86.62 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 199' ' ' THR . 13.8 mmt -36.1 154.56 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.706 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.45 129.32 17.71 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.64 2.227 . . . . 0.0 112.359 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 101.66 -38.62 3.08 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.482 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.48 146.91 26.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.31 . . . . 0.0 111.081 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.8 t -93.39 -12.38 30.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 199' ' ' THR . 69.3 m -100.16 158.77 15.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.828 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 70.1 m -85.3 169.32 13.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.826 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 139' ' ' GLY . 19.5 tp -65.87 128.12 34.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.1 113.86 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.9 t -123.19 124.08 69.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -162.3 148.61 13.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -48.04 141.22 6.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -63.14 164.88 7.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.03 103.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 40.5 p -89.26 109.21 20.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.96 174.62 5.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -144.01 142.16 30.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -113.5 -52.6 2.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 48.8 m -90.42 165.65 13.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -123.17 95.59 0.53 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.79 156.03 43.94 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.708 2.272 . . . . 0.0 112.368 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.0 t -159.9 134.17 7.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 60.4 p -146.91 134.73 21.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.471 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.7 m -138.99 128.38 24.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 110.828 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.1 p -124.53 160.25 28.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 136.7 -151.04 20.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.468 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 83.5 p -72.28 117.31 13.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.881 0.372 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.8 t -122.74 124.14 42.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.818 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 41.15 92.24 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.507 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.5 m -71.77 101.34 2.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -78.2 82.51 4.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.2 t 57.16 45.52 20.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -94.69 95.31 8.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.466 ' O ' HG21 ' A' ' 214' ' ' THR . . . -169.16 126.52 1.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.48 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.47 132.08 7.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.506 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.425 ' HB2' ' NH1' ' A' ' 132' ' ' ARG . 18.9 mtm105 -97.31 95.69 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.96 150.76 46.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -107.26 11.07 29.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -100.06 139.11 36.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.964 HD21 ' HB1' ' A' ' 187' ' ' ALA . 36.0 mt -121.81 155.0 36.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE1' ' HB3' ' A' ' 176' ' ' CYS . 44.7 t80 -124.42 112.79 17.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.52 152.66 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -146.16 174.93 25.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.4 mmt 57.48 46.01 18.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.336 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.507 ' CD2' HD11 ' A' ' 207' ' ' LEU . 60.2 mt -100.07 147.32 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.437 HD21 ' HA ' ' A' ' 142' ' ' ASN . 0.7 OUTLIER -90.12 164.82 14.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.46 ' HA ' ' CB ' ' A' ' 173' ' ' SER . 19.1 pttt -66.98 -3.66 7.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -109.31 43.71 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.496 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 74.1 mt-30 -135.21 109.24 8.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 p -104.08 170.74 7.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -52.86 -41.93 64.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.5 -47.32 86.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -48.03 -63.99 0.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.839 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.858 HG13 ' CE1' ' A' ' 154' ' ' PHE . 94.9 t -58.49 -60.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.662 HD23 HD13 ' A' ' 160' ' ' ILE . 29.6 mt -44.4 -38.68 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -68.82 -41.11 79.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.461 HD21 HE22 ' A' ' 198' ' ' GLN . 13.5 tp -84.0 -9.78 58.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.858 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.14 -35.88 9.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.56 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.0 OUTLIER -47.18 -46.91 56.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 0.0 110.914 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -48.03 -16.75 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.652 2.235 . . . . 0.0 112.315 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.406 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.4 m-85 -99.87 -42.1 6.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.73 171.16 42.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -80.48 102.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.848 HD11 ' CB ' ' A' ' 154' ' ' PHE . 38.3 mt -72.13 151.34 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -103.13 -57.15 2.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.479 ' CG ' ' HB3' ' A' ' 180' ' ' LYS . 9.7 pt-20 -138.69 137.89 37.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' CYS . . . . . 0.66 ' CB ' HD21 ' A' ' 151' ' ' LEU . 1.7 t -133.72 102.14 5.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.3 m -107.51 119.64 39.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.163 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.467 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 50.3 t -99.91 131.87 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.131 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.3 140.57 52.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -145.48 177.06 9.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.869 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -110.19 -161.43 18.42 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.31 -51.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.649 2.233 . . . . 0.0 112.355 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.79 -37.16 78.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 118.85 36.54 0.88 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 173' ' ' SER . 38.1 p -115.55 117.99 31.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.893 0.378 . . . . 0.0 110.874 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.46 ' CB ' ' HA ' ' A' ' 143' ' ' LYS . 8.2 t -35.05 141.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.84 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -81.25 -18.56 45.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.45 -16.3 44.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.46 ' HB3' ' CE1' ' A' ' 137' ' ' PHE . 1.7 m -125.99 160.14 30.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 110.87 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -158.73 175.98 12.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -136.04 126.27 26.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.18 130.0 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.479 ' HB3' ' CG ' ' A' ' 162' ' ' GLU . 27.0 tttt -106.25 130.35 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.41 ' HE1' HD12 ' A' ' 136' ' ' LEU . 33.6 m-85 -104.0 160.63 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.4 t -72.43 -19.85 61.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.863 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -142.15 164.94 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.451 ' CG ' ' N ' ' A' ' 185' ' ' THR . 2.7 p80 -75.39 -41.75 55.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.806 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.451 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 44.7 m -54.64 -59.76 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -41.12 -47.73 3.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.964 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -60.79 -62.05 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.093 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 187' ' ' ALA . 4.5 mm100 -35.44 -44.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.85 -63.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.054 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.36 -28.86 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.074 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.556 HD11 HD22 ' A' ' 136' ' ' LEU . 36.2 mt -70.71 -72.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.143 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -59.85 -17.14 34.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.406 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -84.74 -25.8 28.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.129 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.418 HD13 ' CE1' ' A' ' 154' ' ' PHE . 25.5 mt -132.59 24.95 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.3 t60 -89.69 121.45 31.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.1 30.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 195' ' ' HIS . 60.6 p -100.25 -39.48 8.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.83 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.829 ' OE1' HD22 ' A' ' 207' ' ' LEU . 4.9 pt20 -100.66 163.98 12.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 205' ' ' SER . 29.3 m -134.82 81.3 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.496 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 13.9 mmt -37.03 156.01 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.698 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.0 136.48 38.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.395 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.12 -35.95 4.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -89.36 150.85 22.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.5 t -100.08 -12.48 19.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.867 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.593 ' O ' HG23 ' A' ' 199' ' ' THR . 7.1 t -100.08 170.07 8.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -94.27 148.94 21.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.808 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.829 HD22 ' OE1' ' A' ' 198' ' ' GLN . 10.7 tp -45.68 151.4 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.97 104.29 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 191' ' ' ILE . 6.6 t -115.94 116.41 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -155.35 148.36 24.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -49.08 140.82 8.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 213' ' ' ASP . . . -70.0 177.5 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.064 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 212' ' ' ALA . 4.5 p-10 -36.81 117.34 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 130' ' ' GLY . 32.8 m -117.91 115.15 24.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -125.94 103.5 7.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -127.56 114.41 17.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -89.12 96.86 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 69.3 p -68.69 -60.8 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -120.98 100.15 0.74 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.1 120.6 2.56 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.728 2.285 . . . . 0.0 112.337 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.3 t -39.95 121.89 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.835 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 18.7 m -71.56 -49.63 38.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.475 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.833 0.349 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 1.009 HD21 ' HB1' ' A' ' 187' ' ' ALA . 9.0 mt -130.84 153.63 48.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -116.0 108.92 16.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.916 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.438 HG22 HG13 ' A' ' 209' ' ' VAL . 35.6 t -99.85 145.02 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.107 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.503 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -137.69 -170.44 11.88 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.497 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.4 mmt 52.39 53.01 13.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.403 HD21 HD11 ' A' ' 207' ' ' LEU . 56.1 mt -117.39 156.14 28.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -94.12 175.49 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.0 pttm -92.61 17.02 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -108.06 -13.69 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.491 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 20.4 mt-30 -90.09 152.11 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 95.9 p -131.96 166.23 22.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.457 ' HG3' HG23 ' A' ' 165' ' ' VAL . 29.5 mt-10 -45.77 -47.12 15.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -54.83 -53.76 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -43.03 -64.82 0.56 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.716 HG13 ' CE1' ' A' ' 154' ' ' PHE . 77.7 t -53.67 -63.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.776 HD21 ' CB ' ' A' ' 163' ' ' CYS . 31.4 mt -42.82 -36.98 1.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.28 -40.83 77.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -84.57 -8.6 58.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.924 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -99.89 -37.19 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 10.2 tm0? -47.31 -46.87 57.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.722 . . . . 0.0 110.902 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.89 -17.18 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.731 2.287 . . . . 0.0 112.363 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.489 ' CE1' ' HB1' ' A' ' 193' ' ' ALA . 75.2 m-85 -101.95 -35.07 9.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.84 161.31 30.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.512 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 80.9 t -75.03 97.98 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.924 HD11 ' CB ' ' A' ' 154' ' ' PHE . 36.5 mt -66.66 137.25 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.167 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -81.86 -61.43 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -139.54 143.57 37.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.776 ' CB ' HD21 ' A' ' 151' ' ' LEU . 10.6 t -134.02 135.78 43.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.83 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.523 ' O ' ' HB1' ' A' ' 177' ' ' ALA . 86.0 m -139.09 157.74 45.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.493 ' N ' HG22 ' A' ' 164' ' ' THR . 47.7 t -120.97 130.82 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 176' ' ' CYS . 60.3 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.0 mttm . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.802 0.334 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 71.44 21.76 78.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.52 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.401 ' HB2' HD12 ' A' ' 166' ' ' LEU . 3.2 m -136.55 159.78 40.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 164' ' ' THR . . . -158.1 161.67 37.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -112.23 121.73 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.469 HG11 ' HD2' ' A' ' 154' ' ' PHE . 38.7 t -119.15 122.94 70.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.573 ' O ' HG23 ' A' ' 160' ' ' ILE . 13.7 tttp -111.68 131.27 55.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' A' ' 187' ' ' ALA . 41.2 m-85 -101.7 166.68 10.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.3 t -66.81 -35.53 80.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.8 p -133.79 166.65 22.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -66.94 -55.25 15.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.4 m -43.73 -53.7 5.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -49.12 -48.1 44.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 1.009 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -59.81 -52.2 66.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.094 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.585 ' HA ' HD12 ' A' ' 191' ' ' ILE . 2.8 mm-40 -46.42 -42.66 15.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.19 -63.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.73 -37.17 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 136' ' ' LEU . 54.1 mt -63.9 -72.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.106 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -57.48 -13.78 4.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.489 ' HB1' ' CE1' ' A' ' 157' ' ' PHE . . . -86.16 -40.24 15.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.689 HD13 ' CE1' ' A' ' 154' ' ' PHE . 18.1 mt -119.16 22.66 11.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.4 t60 -82.91 124.82 30.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.56 32.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.502 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 195' ' ' HIS . 54.4 p -100.19 -35.26 9.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.338 . . . . 0.0 110.849 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -100.27 161.1 13.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 12.9 m -134.6 77.14 1.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.163 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.491 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 14.0 mmt -39.43 138.45 0.94 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.597 0.713 . . . . 0.0 110.868 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.39 146.73 9.78 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.12 -34.16 3.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.27 134.0 35.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.312 . . . . 0.0 111.133 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 80.4 p -90.25 -8.72 50.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.838 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 37.0 m -99.98 160.72 14.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.3 m -84.34 158.81 21.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 139' ' ' GLY . 13.4 tp -57.57 141.68 47.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.73 104.37 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.438 HG13 HG22 ' A' ' 138' ' ' VAL . 12.4 t -115.65 120.67 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.097 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -158.16 150.13 21.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.843 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.4 tttt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.838 0.351 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.987 HD21 ' HB1' ' A' ' 187' ' ' ALA . 44.3 mt -135.85 148.16 48.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -118.35 110.72 17.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.66 138.91 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.118 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.606 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -136.36 178.37 18.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.0 mmt 62.46 45.04 6.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 mt -102.73 153.81 19.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 28.2 t30 -108.2 169.58 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -78.45 45.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -132.11 -34.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.513 ' NE2' ' CE ' ' A' ' 200' ' ' MET . 6.7 mt-30 -86.75 146.97 26.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.7 p -126.34 -177.56 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.641 ' HG3' HG23 ' A' ' 165' ' ' VAL . 18.0 mt-10 -58.73 -46.33 87.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -56.72 -53.19 60.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -42.53 -66.67 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.897 HG13 ' CE1' ' A' ' 154' ' ' PHE . 86.5 t -48.08 -63.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.754 HD21 ' HB2' ' A' ' 163' ' ' CYS . 33.4 mt -44.24 -40.77 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -69.01 -40.36 78.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.2 tp -84.21 -9.98 58.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.897 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.55 -35.6 9.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.36 -46.87 58.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 0.0 110.925 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.1 Cg_exo -47.95 -17.49 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.356 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -100.58 -46.29 5.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -161.2 160.92 32.58 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.474 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 159' ' ' VAL . 25.6 t -76.16 95.69 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.774 HD11 ' CB ' ' A' ' 154' ' ' PHE . 28.4 mt -63.85 142.92 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.099 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.68 -55.99 3.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -144.92 140.37 28.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.754 ' HB2' HD21 ' A' ' 151' ' ' LEU . 40.6 t -132.48 142.78 49.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.2 m -151.01 143.07 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.641 HG23 ' HG3' ' A' ' 147' ' ' GLU . 86.1 t -112.58 134.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttm . . . . . 0 C--O 1.23 0.031 0 CA-C-O 120.859 0.362 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 61.36 33.28 84.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.529 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 7.8 p -148.42 154.15 39.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -159.02 176.67 12.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -129.74 141.12 50.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.06 128.82 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.598 ' O ' HG23 ' A' ' 160' ' ' ILE . 18.9 ttmt -111.9 134.17 53.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.514 ' HE1' HD12 ' A' ' 136' ' ' LEU . 36.8 m-85 -108.96 164.86 12.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.4 t -69.31 -27.08 65.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.3 t -144.03 159.33 42.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.846 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -60.22 -57.49 12.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 99.9 m -38.82 -59.39 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -40.83 -52.75 2.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.987 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.97 -57.16 14.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.573 ' HA ' HD12 ' A' ' 191' ' ' ILE . 3.7 mm-40 -37.91 -45.91 0.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 191' ' ' ILE . . . -66.16 -66.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -38.65 -27.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 188' ' ' GLN . 59.2 mt -74.3 -71.07 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -59.88 -12.27 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -89.84 -31.3 17.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.9 mt -125.91 21.63 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.3 t60 -83.72 124.55 30.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.438 ' C ' ' HB3' ' A' ' 206' ' ' SER . . . 34.62 31.92 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.463 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 195' ' ' HIS . 79.3 p -100.25 -36.09 9.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.894 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.739 ' OE1' HD22 ' A' ' 207' ' ' LEU . 1.1 pt20 -100.32 150.35 22.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 205' ' ' SER . 51.0 m -122.76 80.16 1.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.154 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.513 ' CE ' ' NE2' ' A' ' 145' ' ' GLN . 15.3 mmt -40.34 140.61 0.94 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.532 0.682 . . . . 0.0 110.899 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.471 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 74.5 Cg_exo -48.07 147.69 7.7 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.711 2.274 . . . . 0.0 112.306 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.09 -45.69 3.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.457 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -77.28 138.59 39.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.754 0.311 . . . . 0.0 111.085 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.5 t -91.62 -11.39 37.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 199' ' ' THR . 2.2 t -99.97 173.08 6.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.438 ' HB3' ' C ' ' A' ' 196' ' ' GLY . 59.0 m -99.67 150.87 21.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.739 HD22 ' OE1' ' A' ' 198' ' ' GLN . 14.1 tp -47.49 147.97 1.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.478 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 58.8 t -117.22 104.05 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.132 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 8.7 t -111.72 122.48 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.478 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 14.9 ptpt -161.43 150.25 15.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.559 ' HE2' ' CD1' ' A' ' 178' ' ' PHE . 71.3 tttt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.776 0.322 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 1.112 HD21 ' HB1' ' A' ' 187' ' ' ALA . 18.2 mt -124.25 156.3 37.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -126.68 112.95 16.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 30.4 t -97.14 148.23 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.44 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -142.31 -172.12 13.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.479 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.2 mmt 54.49 38.76 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.3 mt -95.22 160.93 14.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -100.91 -175.62 2.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -100.3 34.75 2.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -129.14 -30.98 2.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -77.79 145.77 36.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 55.1 p -119.79 -175.84 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.828 ' HG3' HG23 ' A' ' 165' ' ' VAL . 3.4 mp0 -68.53 -31.78 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -64.87 -48.39 74.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -48.39 -68.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.828 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.905 HG13 ' CE1' ' A' ' 154' ' ' PHE . 99.0 t -48.46 -53.95 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.837 HD21 ' HB2' ' A' ' 163' ' ' CYS . 38.9 mt -51.46 -40.68 59.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -69.27 -39.41 78.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.8 tp -84.31 -11.12 56.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.905 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -98.44 -36.21 10.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.57 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.06 -47.02 55.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.592 0.71 . . . . 0.0 110.921 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.5 Cg_exo -47.92 -16.77 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.355 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.411 ' HE2' HD11 ' A' ' 194' ' ' LEU . 72.3 m-85 -99.75 -35.28 9.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.38 164.38 37.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 159' ' ' VAL . 47.5 t -75.86 91.23 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 111.136 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.816 HD13 HD23 ' A' ' 151' ' ' LEU . 68.6 mt -59.54 132.81 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -84.94 -55.06 4.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.1 143.07 28.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.837 ' HB2' HD21 ' A' ' 151' ' ' LEU . 9.8 t -134.04 129.84 36.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.6 m -139.26 144.68 38.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.828 HG23 ' HG3' ' A' ' 147' ' ' GLU . 73.6 t -109.97 151.93 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.1 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.987 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.2 mttp . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.794 0.331 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.27 23.91 70.25 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.442 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 2.6 p -144.79 158.63 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.816 0.341 . . . . 0.0 110.925 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.47 175.1 11.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.128 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.559 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 81.8 m-85 -124.98 137.84 54.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.421 HG11 ' HD2' ' A' ' 154' ' ' PHE . 98.3 t -127.76 127.5 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -111.72 133.61 53.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.0 156.83 19.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.1 t -56.9 -28.87 62.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.845 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 t -140.9 177.35 8.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -76.64 -59.01 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.5 m -39.37 -54.39 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -44.78 -49.91 10.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 1.112 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -60.61 -57.11 14.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.09 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -38.65 -45.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.5 -62.17 1.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.07 -27.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.736 HD11 HD22 ' A' ' 136' ' ' LEU . 74.1 mt -76.77 -64.8 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -64.64 -7.9 12.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -99.26 -24.74 14.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.103 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.594 HD13 ' CE1' ' A' ' 154' ' ' PHE . 23.1 mt -132.36 27.12 4.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.2 t60 -93.04 122.43 35.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 36.39 31.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.461 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -99.23 -36.98 9.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.358 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.636 ' NE2' HD22 ' A' ' 207' ' ' LEU . 16.2 pt20 -100.35 165.06 11.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 205' ' ' SER . 18.4 m -134.96 85.82 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.474 ' CE ' ' OE1' ' A' ' 198' ' ' GLN . 14.2 mmt -44.95 139.78 3.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.706 . . . . 0.0 110.901 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -48.15 137.45 23.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.692 2.261 . . . . 0.0 112.326 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 91.21 -48.12 2.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.481 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -76.51 131.63 39.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.079 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.7 p -86.4 -7.39 58.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 199' ' ' THR . 4.7 t -99.71 171.45 7.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.4 m -100.08 143.19 30.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.636 HD22 ' NE2' ' A' ' 198' ' ' GLN . 14.8 tp -40.04 151.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.53 103.93 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.43 HG12 HG12 ' A' ' 191' ' ' ILE . 4.4 t -113.23 121.06 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -156.92 152.42 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.518 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 7.7 ttmt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.815 0.34 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.733 HD21 ' HB1' ' A' ' 187' ' ' ALA . 55.5 mt -112.32 139.34 47.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -109.23 116.01 31.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.13 146.36 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.545 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -140.13 179.86 18.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 mmt 57.3 48.23 15.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 110.879 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 48.9 mt -108.27 162.7 13.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -103.77 172.17 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -88.64 16.05 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -106.92 -18.21 13.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.976 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -87.77 147.92 24.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.951 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.3 p -124.77 -179.19 4.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.554 ' HG3' HG23 ' A' ' 165' ' ' VAL . 39.2 mp0 -63.21 -32.57 74.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -66.43 -48.02 71.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -50.92 -49.53 59.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.802 HG13 ' CE1' ' A' ' 154' ' ' PHE . 83.6 t -68.33 -50.35 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 mt -56.59 -32.24 65.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.421 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 11.7 mmm180 -81.24 -36.12 30.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.901 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.7 tp -85.01 -14.04 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.802 ' CE1' HG13 ' A' ' 150' ' ' VAL . 4.1 m-85 -100.05 -37.25 9.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 3.7 mt-30 -47.19 -48.91 54.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.635 0.731 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.8 Cg_exo -47.97 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.428 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.6 m-85 -100.43 -30.28 11.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 173.86 158.69 18.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.512 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.52 135.74 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 111.156 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.689 HD11 ' CB ' ' A' ' 154' ' ' PHE . 55.2 mt -111.75 125.22 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -69.89 -65.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -143.31 141.03 30.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 179' ' ' VAL . 44.1 t -132.22 108.43 9.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.8 m -109.66 128.13 55.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.154 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.554 HG23 ' HG3' ' A' ' 147' ' ' GLU . 73.4 t -91.91 135.91 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.165 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.0 mttm . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 58.38 24.17 55.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 17.9 m -147.77 165.08 31.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.842 0.353 . . . . 0.0 110.902 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.62 -179.06 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.518 ' CD1' ' HD3' ' A' ' 135' ' ' LYS . 57.7 m-85 -131.31 124.91 31.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.617 HG22 ' SG ' ' A' ' 163' ' ' CYS . 45.7 t -119.96 123.32 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -108.32 119.24 38.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -92.98 164.98 13.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.1 m -72.43 -32.37 66.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 t -133.37 160.28 37.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.827 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -64.72 -59.82 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 186' ' ' GLU . 53.0 m -38.68 -64.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.8 OUTLIER -36.6 -53.0 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.733 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.22 -59.8 4.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.101 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 187' ' ' ALA . 1.5 mm-40 -37.3 -47.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 190' ' ' ALA . . . -62.47 -67.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -35.56 -38.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.051 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.632 HD11 HD22 ' A' ' 136' ' ' LEU . 93.1 mt -62.74 -73.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -55.33 -14.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.428 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.69 -41.08 14.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.43 30.54 7.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -99.51 122.98 43.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 45.75 20.16 0.39 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.46 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 60.7 p -100.04 -35.71 9.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -100.1 154.82 18.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 205' ' ' SER . 49.3 m -134.78 86.33 2.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 12.4 mmt -47.11 138.31 7.75 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.582 0.706 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -48.62 153.03 3.7 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.734 2.29 . . . . 0.0 112.331 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.55 -35.67 2.45 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.537 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.93 136.09 34.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.077 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 84.0 p -85.69 -13.93 46.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 199' ' ' THR . 7.7 m -100.0 157.72 16.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 6.1 p -79.81 -178.75 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 139' ' ' GLY . 15.7 tp -77.31 149.22 35.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.48 ' CG1' ' HE2' ' A' ' 210' ' ' LYS . 73.8 t -118.0 103.93 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.444 HG12 HG12 ' A' ' 191' ' ' ILE . 11.9 t -113.48 123.15 68.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.48 ' HE2' ' CG1' ' A' ' 208' ' ' VAL . 0.9 OUTLIER -159.96 148.48 17.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.4 tptt . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.845 HD21 ' HB1' ' A' ' 187' ' ' ALA . 38.4 mt -121.46 157.8 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.928 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -125.7 119.28 27.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 29.5 t -101.46 148.12 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -141.58 -179.65 18.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.9 mmt 57.95 39.88 26.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.454 ' CD2' HD11 ' A' ' 207' ' ' LEU . 67.3 mt -97.04 158.24 15.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 21.2 t-20 -113.16 170.99 7.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -79.49 44.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -133.01 -40.75 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.448 ' CD ' ' SD ' ' A' ' 200' ' ' MET . 31.2 mt-30 -81.89 121.84 26.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.1 p -106.02 173.79 6.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 165' ' ' VAL . 1.8 mp0 -47.78 -46.51 30.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -53.84 -51.79 62.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -47.75 -68.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.847 HG13 ' CE1' ' A' ' 154' ' ' PHE . 96.8 t -47.16 -54.99 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.795 HD21 ' HB2' ' A' ' 163' ' ' CYS . 32.1 mt -52.18 -39.77 60.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -70.2 -38.68 75.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.405 HD21 ' OE1' ' A' ' 198' ' ' GLN . 13.5 tp -85.08 -9.09 58.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.855 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -100.04 -38.94 8.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.1 tm0? -46.99 -47.01 54.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.627 0.727 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.5 Cg_exo -47.94 -20.34 2.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.263 . . . . 0.0 112.304 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -100.04 -43.35 6.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.65 156.37 27.53 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.8 t -74.75 96.9 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 111.129 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.855 HD11 ' CB ' ' A' ' 154' ' ' PHE . 41.9 mt -66.3 141.52 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -94.42 -54.39 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -141.52 141.76 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.795 ' HB2' HD21 ' A' ' 151' ' ' LEU . 43.2 t -133.97 143.61 48.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 165' ' ' VAL . 96.8 m -148.96 154.08 38.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.169 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.595 HG13 ' HB2' ' A' ' 177' ' ' ALA . 58.0 t -124.9 142.94 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.121 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.0 mttm . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.815 0.341 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 61.56 24.52 64.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.442 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 4.9 p -139.65 138.43 36.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 0.0 110.906 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.595 ' HB2' HG13 ' A' ' 165' ' ' VAL . . . -150.57 168.04 25.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -121.45 144.86 48.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.02 132.37 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.694 ' O ' HG23 ' A' ' 160' ' ' ILE . 23.5 ttmt -112.36 128.25 56.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.513 ' HE1' HD12 ' A' ' 136' ' ' LEU . 37.7 m-85 -100.27 162.51 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.0 p -67.09 -23.14 65.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.8 t -151.71 150.98 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.873 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -51.26 -57.45 8.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 186' ' ' GLU . 63.6 m -38.19 -66.6 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.08 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.3 OUTLIER -37.97 -51.09 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.845 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.29 -57.27 13.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.079 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.461 ' HA ' HD12 ' A' ' 191' ' ' ILE . 0.7 OUTLIER -40.44 -43.41 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 191' ' ' ILE . . . -65.77 -68.48 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.082 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -35.57 -33.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.575 HD11 HD22 ' A' ' 136' ' ' LEU . 83.3 mt -66.62 -70.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -62.04 -15.62 45.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.859 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -90.44 -22.7 21.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.077 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.733 HD22 ' NE2' ' A' ' 198' ' ' GLN . 75.7 mt -132.51 23.38 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.8 t60 -89.04 124.59 34.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.447 ' C ' ' HB3' ' A' ' 206' ' ' SER . . . 36.18 29.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.543 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 195' ' ' HIS . 76.4 p -100.14 -35.27 9.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.328 . . . . 0.0 110.846 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.733 ' NE2' HD22 ' A' ' 194' ' ' LEU . 22.4 mt-30 -100.28 155.05 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 205' ' ' SER . 25.7 m -129.18 81.51 2.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.448 ' SD ' ' CD ' ' A' ' 145' ' ' GLN . 14.9 mmt -45.67 141.03 4.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.547 0.689 . . . . 0.0 110.93 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.415 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 74.5 Cg_exo -47.97 153.05 2.83 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.708 2.272 . . . . 0.0 112.312 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 79.24 -41.79 2.29 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.446 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.15 140.06 31.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 111.064 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 25.2 t -94.8 -8.82 36.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 199' ' ' THR . 2.8 t -100.06 172.48 7.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.447 ' HB3' ' C ' ' A' ' 196' ' ' GLY . 19.4 m -97.96 145.93 25.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.454 HD11 ' CD2' ' A' ' 141' ' ' LEU . 8.6 tp -42.31 154.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.934 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 73.3 t -125.66 104.08 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.4 t -111.72 122.25 65.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -151.31 146.94 26.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 1.034 HD21 ' HB1' ' A' ' 187' ' ' ALA . 19.8 mt -137.69 145.82 43.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -109.15 110.77 22.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.4 t -97.68 147.57 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.661 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -144.14 -175.81 17.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.519 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.2 mmt 56.45 48.24 17.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.5 mt -109.06 165.1 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -106.75 174.03 6.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -87.71 16.3 5.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -105.99 -22.92 12.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.475 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 16.3 mt-30 -82.25 149.67 27.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.8 p -130.94 172.69 11.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -50.54 -51.03 51.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -52.16 -52.79 49.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -42.53 -67.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.556 HG13 ' CE1' ' A' ' 154' ' ' PHE . 35.9 t -52.87 -51.28 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.136 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.677 HD21 ' CB ' ' A' ' 163' ' ' CYS . 39.1 mt -54.04 -32.17 53.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -79.61 -37.04 37.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.7 tp -84.35 -14.17 50.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.802 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.4 m-85 -100.22 -35.97 9.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.534 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 3.7 mt-30 -47.18 -49.0 53.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.549 0.69 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.5 Cg_exo -47.98 -17.13 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.425 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.2 m-85 -100.03 -34.14 10.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.9 169.59 42.55 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.481 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.38 107.75 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 111.126 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.802 HD11 ' CB ' ' A' ' 154' ' ' PHE . 82.7 mt -79.15 126.27 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.4 ' HB2' ' CD ' ' A' ' 180' ' ' LYS . 3.2 m-20 -86.47 -65.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -114.65 126.02 54.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.677 ' CB ' HD21 ' A' ' 151' ' ' LEU . 16.7 t -133.15 127.11 33.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.3 m -146.38 149.66 34.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.407 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 77.7 t -114.53 137.89 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 176' ' ' CYS . 27.2 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.8 mttt . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.803 0.335 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.1 24.69 76.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.51 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.411 ' HB2' HD12 ' A' ' 166' ' ' LEU . 1.8 m -146.78 154.78 41.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 110.866 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -156.45 176.07 13.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.02 124.14 34.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.469 HG11 ' HD2' ' A' ' 154' ' ' PHE . 39.1 t -117.83 134.72 60.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 160' ' ' ILE . 30.6 ttmt -114.99 144.28 43.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -118.9 161.13 20.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 17.3 t -59.16 -34.25 71.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.5 t -142.42 171.79 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.416 ' CG ' ' N ' ' A' ' 185' ' ' THR . 44.5 p-80 -64.76 -54.95 23.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.416 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 48.7 m -36.84 -63.92 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 185' ' ' THR . 23.8 mm-40 -37.8 -53.39 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 1.034 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -55.9 -59.13 5.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -40.26 -41.51 1.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -71.4 -63.73 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.68 -34.02 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.112 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 136' ' ' LEU . 72.5 mt -65.89 -71.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -59.15 -13.73 8.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.425 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -88.98 -32.05 17.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.442 HD13 ' CE1' ' A' ' 154' ' ' PHE . 32.5 mt -125.78 24.98 6.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.9 t60 -86.68 123.04 31.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.56 32.94 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.455 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 195' ' ' HIS . 82.6 p -100.13 -35.14 9.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 110.874 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.21 155.8 17.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 205' ' ' SER . 90.2 m -132.61 77.51 1.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.475 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 11.5 mmt -39.92 139.13 1.0 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.601 0.715 . . . . 0.0 110.845 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.21 150.49 5.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.732 2.288 . . . . 0.0 112.358 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.48 -36.22 2.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -89.58 136.92 32.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.322 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 15.7 t -90.77 -10.87 41.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.847 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 199' ' ' THR . 4.9 t -99.51 172.08 7.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.4 m -99.82 154.79 18.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 139' ' ' GLY . 13.5 tp -54.36 138.16 40.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.468 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 54.1 t -108.09 117.09 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.1 t -123.23 124.8 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.468 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 14.6 ptpt -160.8 144.67 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.5 tptt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.786 0.327 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.732 HD22 HD11 ' A' ' 191' ' ' ILE . 65.8 mt -119.11 152.21 36.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -119.78 121.02 38.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.23 144.05 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.118 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -138.08 -172.41 12.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.5 mmt 54.05 51.48 14.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.333 . . . . 0.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.2 mt -111.06 155.42 22.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.462 ' ND2' ' HD2' ' A' ' 201' ' ' PRO . 3.2 p30 -91.58 159.49 15.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -81.95 42.67 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.425 ' HG2' ' CG ' ' A' ' 142' ' ' ASN . 6.2 pt20 -133.22 -35.02 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.413 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 34.0 mt-30 -71.12 150.27 45.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.0 p -119.59 -177.85 3.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.411 ' HG3' HG23 ' A' ' 165' ' ' VAL . 21.9 mt-10 -63.03 -46.88 85.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -54.71 -50.82 67.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -42.72 -47.68 5.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.624 HG13 ' CE1' ' A' ' 154' ' ' PHE . 95.8 t -70.31 -45.78 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.177 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 163' ' ' CYS . 86.0 mt -57.57 -32.44 67.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.403 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 16.1 mmt180 -81.35 -35.39 30.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.2 tp -84.32 -16.09 44.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.717 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -100.18 -35.3 9.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.532 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 6.1 mt-30 -47.2 -49.04 53.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.6 0.714 . . . . 0.0 110.865 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.7 Cg_exo -47.96 -17.02 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.707 2.272 . . . . 0.0 112.303 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -99.9 -36.53 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.62 163.38 35.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.528 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.62 104.84 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.717 HD11 ' CB ' ' A' ' 154' ' ' PHE . 62.2 mt -76.04 128.12 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -76.48 -54.33 6.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -147.07 145.3 29.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.595 ' HB2' HD21 ' A' ' 151' ' ' LEU . 43.1 t -133.74 148.0 51.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.439 ' O ' ' HB1' ' A' ' 177' ' ' ALA . 24.0 m -151.49 151.5 31.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.161 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 177' ' ' ALA . 68.4 t -122.63 146.98 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.755 HD12 ' SG ' ' A' ' 176' ' ' CYS . 79.3 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.809 0.338 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 49.55 30.57 13.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.48 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.755 ' SG ' HD12 ' A' ' 166' ' ' LEU . 7.1 p -149.79 149.47 30.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 164' ' ' THR . . . -160.03 161.18 33.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -113.71 133.26 55.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 70.4 t -122.81 126.09 73.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 160' ' ' ILE . 15.6 tttp -108.63 123.18 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -97.52 168.34 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.866 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 84.2 p -68.92 -36.72 78.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.8 m -135.25 171.79 13.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.495 ' H ' ' CD2' ' A' ' 184' ' ' HIS . 7.8 p80 -72.17 -44.71 62.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.4 m -52.24 -59.46 4.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -41.54 -49.68 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -58.05 -59.17 5.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -38.87 -47.37 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.42 -63.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.37 -39.37 1.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.732 HD11 HD22 ' A' ' 136' ' ' LEU . 73.8 mt -60.99 -72.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -57.34 -12.95 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -87.5 -37.74 16.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.086 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 154' ' ' PHE . 18.5 mt -120.22 23.53 10.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.0 t60 -83.36 123.03 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.7 33.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.9 p -100.31 -36.51 9.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.798 0.332 . . . . 0.0 110.859 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.55 HE21 HD22 ' A' ' 194' ' ' LEU . 31.7 mt-30 -100.4 160.66 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 37.9 m -134.16 81.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.413 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 15.9 mmt -41.38 137.47 1.68 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.56 0.695 . . . . 0.0 110.884 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.462 ' HD2' ' ND2' ' A' ' 142' ' ' ASN . 75.5 Cg_exo -48.74 147.06 10.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 0.0 112.317 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.65 -34.44 3.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.482 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.33 141.4 28.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.069 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 57.7 m -93.52 -12.81 28.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 66.7 m -99.53 157.17 16.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.9 m -78.36 172.13 14.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 196' ' ' GLY . 13.7 tp -71.97 140.15 48.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.2 t -106.24 106.72 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.7 t -117.99 120.3 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -159.54 156.29 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.926 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 tptt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.808 0.337 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.665 ' CD2' HD11 ' A' ' 191' ' ' ILE . 54.8 mt -117.26 157.6 25.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -125.25 122.11 36.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.9 140.88 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -136.23 -176.98 14.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.5 mmt 60.17 38.26 20.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.2 mt -99.02 154.61 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 144' ' ' GLN . 23.1 p30 -98.11 170.29 9.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -80.57 -0.18 36.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.409 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 57.0 mt-30 -102.05 32.68 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -134.99 154.18 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.4 p -132.25 167.0 20.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.558 ' CG ' HG23 ' A' ' 165' ' ' VAL . 50.1 mt-10 -54.41 -44.83 72.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -53.74 -45.9 70.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -50.3 -55.2 16.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.786 HG13 ' CE1' ' A' ' 154' ' ' PHE . 71.8 t -60.87 -46.3 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.901 HD21 ' CB ' ' A' ' 163' ' ' CYS . 35.1 mt -57.97 -39.09 77.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -70.08 -38.87 75.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.9 tp -84.05 -10.32 57.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.888 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.17 -36.4 9.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.557 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -46.92 -47.03 53.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.638 0.732 . . . . 0.0 110.938 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.0 Cg_exo -47.99 -18.85 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.695 2.263 . . . . 0.0 112.314 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.406 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 75.8 m-85 -100.32 -38.07 8.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -172.49 162.7 34.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.8 t -76.41 103.4 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 111.102 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.888 HD11 ' CB ' ' A' ' 154' ' ' PHE . 20.7 mt -73.4 142.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.083 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -103.13 -61.62 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -114.18 119.31 36.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.901 ' CB ' HD21 ' A' ' 151' ' ' LEU . 25.5 t -134.14 121.0 20.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -141.37 151.67 43.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.558 HG23 ' CG ' ' A' ' 147' ' ' GLU . 95.0 t -116.16 139.93 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 60.0 mt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 mttm . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.872 0.368 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.78 76.01 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -139.37 153.79 47.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.862 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.476 ' HB2' HG13 ' A' ' 165' ' ' VAL . . . -161.94 157.46 23.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -109.2 144.65 37.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.615 HG11 ' HD2' ' A' ' 154' ' ' PHE . 59.0 t -134.86 126.62 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.13 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 160' ' ' ILE . 11.6 tttp -113.8 123.94 51.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -99.79 162.95 12.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.8 t -66.28 -37.34 85.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 t -132.83 158.09 43.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.87 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.5 ' CG ' ' N ' ' A' ' 185' ' ' THR . 26.2 p-80 -59.24 -53.61 56.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.5 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 26.3 m -45.59 -52.73 10.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -47.27 -45.25 23.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.533 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -64.37 -59.27 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.407 ' HA ' HD12 ' A' ' 191' ' ' ILE . 1.8 mm-40 -40.19 -38.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -69.53 -63.84 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.071 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.32 -31.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.665 HD11 ' CD2' ' A' ' 136' ' ' LEU . 74.7 mt -69.44 -71.51 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -56.73 -15.78 5.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.816 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.406 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -87.91 -34.93 17.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.471 ' HB3' ' NE2' ' A' ' 198' ' ' GLN . 26.0 mt -122.39 25.55 8.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.917 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.9 t60 -89.04 122.18 32.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.862 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.49 32.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 195' ' ' HIS . 60.3 p -100.14 -37.08 9.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.844 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.697 ' NE2' HD22 ' A' ' 207' ' ' LEU . 10.4 pt20 -100.37 161.77 13.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 205' ' ' SER . 27.0 m -131.19 84.59 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 16.9 mmt -39.19 139.2 0.81 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.555 0.693 . . . . 0.0 110.856 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.27 137.94 23.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.251 . . . . 0.0 112.331 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.0 3.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.43 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -69.93 139.36 52.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.1 m -92.82 -8.63 42.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 199' ' ' THR . 4.6 t -99.94 170.89 8.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 25.0 m -100.14 145.05 28.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.697 HD22 ' NE2' ' A' ' 198' ' ' GLN . 10.9 tp -44.86 143.72 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.5 t -115.67 108.57 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.42 HG12 HG12 ' A' ' 191' ' ' ILE . 15.8 t -115.77 121.61 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -157.27 148.35 21.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.977 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 136' ' ' LEU . 13.3 tppt? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.867 0.365 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.834 ' CD2' HD11 ' A' ' 191' ' ' ILE . 63.6 mt -139.2 135.57 34.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -102.45 117.13 34.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 209' ' ' VAL . 5.9 t -106.53 145.43 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.124 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.552 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -140.03 -164.18 9.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.507 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.9 mmt 48.8 49.77 18.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.668 HD23 ' HG3' ' A' ' 200' ' ' MET . 58.4 mt -110.31 153.31 25.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.645 HD21 ' N ' ' A' ' 201' ' ' PRO . 0.4 OUTLIER -95.12 173.96 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -90.38 42.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -134.4 -35.34 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.448 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 26.7 mt-30 -70.88 145.8 50.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.9 p -121.51 -178.53 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.58 ' HG3' HG23 ' A' ' 165' ' ' VAL . 6.1 mp0 -64.69 -35.07 79.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -64.2 -35.67 81.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.56 -65.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.899 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.85 HG13 ' CE1' ' A' ' 154' ' ' PHE . 92.8 t -53.72 -53.02 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 163' ' ' CYS . 70.3 mt -52.46 -39.36 61.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -69.62 -39.5 77.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.5 tp -84.7 -9.28 58.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.89 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -99.98 -37.27 9.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.2 tm0? -47.29 -46.76 57.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.597 0.713 . . . . 0.0 110.934 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.3 Cg_exo -47.99 -17.18 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.307 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.431 ' HE2' HD11 ' A' ' 194' ' ' LEU . 73.6 m-85 -100.27 -32.2 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.95 171.71 43.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.8 t -80.79 105.27 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.869 0.366 . . . . 0.0 111.072 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.89 HD11 ' CB ' ' A' ' 154' ' ' PHE . 47.5 mt -75.35 130.06 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.34 -61.31 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.838 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -146.37 145.25 30.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.732 ' CB ' HD21 ' A' ' 151' ' ' LEU . 16.2 t -133.81 118.36 17.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.9 m -124.48 140.1 53.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.154 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.58 HG23 ' HG3' ' A' ' 147' ' ' GLU . 97.6 t -108.15 138.09 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.1 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.589 HD12 ' SG ' ' A' ' 176' ' ' CYS . 37.4 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.789 0.328 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 54.69 30.87 52.65 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.472 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.589 ' SG ' HD12 ' A' ' 166' ' ' LEU . 13.7 p -144.27 160.57 40.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 110.847 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -166.76 171.09 11.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -124.53 130.33 52.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.24 131.24 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -114.38 122.62 47.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.546 ' CE1' HD12 ' A' ' 136' ' ' LEU . 37.5 m-85 -94.95 163.96 13.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.8 p -70.46 -26.42 63.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.0 t -143.25 151.48 40.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.544 ' CG ' ' N ' ' A' ' 185' ' ' THR . 17.2 p80 -55.81 -51.62 66.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.544 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 66.4 m -43.03 -66.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.155 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.3 OUTLIER -37.2 -52.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.577 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -55.68 -59.26 5.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.545 ' HA ' HD12 ' A' ' 191' ' ' ILE . 1.8 mm-40 -38.7 -48.17 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.2 -63.28 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -40.09 -30.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.072 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.834 HD11 ' CD2' ' A' ' 136' ' ' LEU . 72.5 mt -69.51 -71.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -64.63 -9.28 18.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -90.29 -25.59 20.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.431 HD11 ' HE2' ' A' ' 157' ' ' PHE . 24.6 mt -133.29 16.11 4.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 191' ' ' ILE . 2.0 t60 -87.89 126.45 35.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.854 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 45.66 20.15 0.37 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.526 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 60.4 p -100.38 -37.35 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 199' ' ' THR . 1.5 tt0 -100.44 156.26 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 205' ' ' SER . 85.9 m -127.61 80.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.668 ' HG3' HD23 ' A' ' 141' ' ' LEU . 20.1 mmt -37.03 137.85 0.56 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.573 0.701 . . . . 0.0 110.859 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.645 ' N ' HD21 ' A' ' 142' ' ' ASN . 72.8 Cg_exo -47.21 154.29 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.7 2.267 . . . . 0.0 112.343 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.7 -45.92 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.498 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -79.14 136.08 37.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.086 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.4 t -87.48 -11.57 48.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 199' ' ' THR . 71.0 m -99.41 163.66 12.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.817 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 58.8 p -80.91 174.52 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 139' ' ' GLY . 20.1 tp -74.61 155.38 37.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.486 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 49.2 t -122.62 104.35 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 138' ' ' VAL . 12.0 t -118.58 121.53 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.148 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.486 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 12.7 ptpt -159.15 146.5 17.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.4 tttp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.813 0.34 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.761 HD11 ' HB1' ' A' ' 187' ' ' ALA . 78.6 mt -106.97 154.67 20.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -121.59 115.26 22.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.36 149.3 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -142.73 -176.59 16.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.5 mmt 59.28 38.68 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.828 0.347 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 36.1 mt -98.98 153.65 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -105.27 164.88 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -77.61 47.6 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -133.77 -34.1 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.496 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 6.3 mt-30 -82.31 140.04 33.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.6 p -119.22 171.56 8.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -47.94 -51.92 21.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -54.93 26.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -43.14 -65.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.573 HG13 ' CE1' ' A' ' 154' ' ' PHE . 71.0 t -49.05 -62.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.885 HD21 ' CB ' ' A' ' 163' ' ' CYS . 29.4 mt -46.85 -37.3 8.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -69.9 -39.78 76.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.8 tp -83.83 -9.83 58.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.861 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.26 -36.19 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -46.99 -47.07 54.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.558 0.694 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.1 Cg_exo -47.94 -18.38 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.706 2.271 . . . . 0.0 112.329 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -101.4 -45.33 5.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.05 156.72 27.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 83.1 t -74.86 95.34 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 111.12 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.861 HD11 ' CB ' ' A' ' 154' ' ' PHE . 40.3 mt -65.98 143.74 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.48 -59.7 2.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -138.69 137.15 36.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.885 ' CB ' HD21 ' A' ' 151' ' ' LEU . 42.7 t -134.06 143.3 47.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 99.4 m -151.76 140.34 20.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.477 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 79.0 t -105.31 141.35 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 42.1 mttm . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.799 0.333 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 75.37 30.2 58.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.492 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.18 151.37 30.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -152.91 178.14 9.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -128.87 125.78 38.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.74 123.42 70.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.179 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -106.38 122.26 45.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.46 164.8 12.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.856 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.6 t -66.31 -35.76 81.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.1 t -137.65 168.12 20.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -66.15 -60.06 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.7 m -39.67 -52.74 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -47.3 -49.96 22.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.761 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -61.22 -55.97 25.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -39.97 -42.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -68.45 -64.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.52 -35.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.631 HD11 HD22 ' A' ' 136' ' ' LEU . 61.8 mt -67.15 -70.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -56.21 -13.59 2.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -89.62 -39.72 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.469 ' HB3' ' NE2' ' A' ' 198' ' ' GLN . 23.1 mt -118.23 29.19 7.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.3 t60 -96.32 122.54 39.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 42.36 24.15 0.2 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.531 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 195' ' ' HIS . 51.3 p -100.26 -37.44 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 0.0 110.877 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.469 ' NE2' ' HB3' ' A' ' 194' ' ' LEU . 1.9 pt20 -100.54 151.18 21.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 205' ' ' SER . 59.9 m -123.97 86.08 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.496 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 16.9 mmt -43.7 139.66 2.71 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.539 0.685 . . . . 0.0 110.895 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.67 151.14 5.38 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 82.31 -47.97 3.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.459 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -77.24 148.53 35.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.09 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 45.1 t -94.86 -17.76 21.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 199' ' ' THR . 4.2 m -100.07 164.71 11.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.921 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.0 p -79.13 -174.91 4.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.875 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 139' ' ' GLY . 13.1 tp -83.41 152.29 25.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -118.15 107.75 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.5 t -116.47 121.24 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.139 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -157.85 149.43 21.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.506 ' HE2' ' CD1' ' A' ' 178' ' ' PHE . 48.2 tttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.913 HD21 ' HB1' ' A' ' 187' ' ' ALA . 28.8 mt -121.31 152.5 38.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -117.72 114.95 24.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.55 146.77 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -145.33 -178.99 21.31 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.482 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.4 mmt 55.59 48.23 19.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.529 ' CD2' HD11 ' A' ' 207' ' ' LEU . 42.4 mt -106.37 165.23 11.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -105.41 165.04 11.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.73 41.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -128.75 -35.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.35 152.97 36.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.7 p -129.23 178.9 6.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.768 ' HG3' HG23 ' A' ' 165' ' ' VAL . 5.2 mt-10 -57.02 -41.44 78.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.59 -55.03 38.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -43.2 -64.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.595 HG13 ' CE1' ' A' ' 154' ' ' PHE . 66.4 t -49.96 -60.76 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.868 HD21 ' CB ' ' A' ' 163' ' ' CYS . 35.8 mt -47.37 -37.61 11.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -69.48 -40.17 77.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.6 tp -83.81 -10.27 58.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.872 ' HB3' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -99.64 -35.54 9.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.0 tt0 -47.04 -46.96 55.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.601 0.715 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.2 Cg_exo -48.02 -17.13 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.621 2.214 . . . . 0.0 112.349 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.455 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 73.8 m-85 -100.63 -37.06 8.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.12 165.2 38.53 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.8 t -80.79 93.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.785 0.326 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.872 HD11 ' HB3' ' A' ' 154' ' ' PHE . 51.5 mt -65.37 129.31 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -77.77 -64.64 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -132.35 137.78 47.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.868 ' CB ' HD21 ' A' ' 151' ' ' LEU . 42.8 t -134.07 139.21 45.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.1 m -144.44 153.88 42.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.153 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.768 HG23 ' HG3' ' A' ' 147' ' ' GLU . 81.6 t -113.41 147.69 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.163 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.0 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.3 mttm . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.833 0.349 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 67.68 25.69 73.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.65 153.36 41.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 110.868 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -156.34 159.21 38.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.506 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 49.1 m-85 -108.98 141.12 41.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.76 125.4 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.673 ' O ' HG23 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -108.65 125.63 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -99.71 162.47 12.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.3 t -63.53 -30.7 71.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.0 m -141.39 168.95 18.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -68.23 -52.45 33.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 99.3 m -44.85 -61.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -40.04 -45.76 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.913 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -64.0 -54.44 34.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.541 ' HA ' HD12 ' A' ' 191' ' ' ILE . 1.2 mm-40 -43.36 -36.18 1.81 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.54 -59.72 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -45.61 -30.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 188' ' ' GLN . 67.9 mt -68.43 -72.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -59.53 -17.3 31.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.455 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -80.51 -36.38 33.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.553 HD13 ' CE1' ' A' ' 154' ' ' PHE . 14.9 mt -123.28 23.05 9.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.2 t60 -87.24 124.34 33.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.87 30.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.525 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.08 -36.6 9.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.809 0.338 . . . . 0.0 110.872 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.783 ' OE1' HD22 ' A' ' 207' ' ' LEU . 1.6 pt20 -100.37 159.55 15.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 30.0 m -134.47 81.04 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.175 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.6 mmt -41.55 140.28 1.35 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.584 0.707 . . . . 0.0 110.865 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.08 139.51 20.62 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.737 2.291 . . . . 0.0 112.328 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 90.47 -47.91 3.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.508 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -78.98 126.84 31.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.761 0.315 . . . . 0.0 111.147 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.8 t -83.26 -7.39 59.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.826 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.8 p -100.11 157.7 16.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -87.13 144.64 26.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.783 HD22 ' OE1' ' A' ' 198' ' ' GLN . 14.3 tp -44.57 144.63 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.943 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 63.6 t -112.74 114.61 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.5 t -125.5 119.59 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.128 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -158.43 150.6 21.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.989 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 178' ' ' PHE . 2.9 tppp? . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.807 0.337 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.628 ' CD2' HD11 ' A' ' 191' ' ' ILE . 96.6 mt -136.32 144.94 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -112.92 122.48 47.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 t -113.05 144.45 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.21 -169.01 11.45 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.8 mmt 52.34 39.37 27.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.8 mt -100.26 145.51 28.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -89.64 -177.76 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.17 -7.24 59.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -99.99 29.4 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.936 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.418 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 59.8 mt-30 -127.04 105.56 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.946 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.1 p -103.08 166.32 10.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.475 ' HG3' HG23 ' A' ' 165' ' ' VAL . 5.4 mp0 -43.8 -41.85 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -59.55 -48.11 82.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -50.52 -54.43 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.685 HG13 ' CE1' ' A' ' 154' ' ' PHE . 73.6 t -66.62 -55.93 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.618 HD23 HD13 ' A' ' 160' ' ' ILE . 73.6 mt -50.9 -33.61 24.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.422 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 15.2 mmm180 -77.65 -37.51 49.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.2 tp -84.31 -12.84 53.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.868 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.6 m-85 -100.46 -37.21 8.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.52 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 4.6 mt-30 -47.07 -49.31 51.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.541 0.686 . . . . 0.0 110.929 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.94 -17.19 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.717 2.278 . . . . 0.0 112.339 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.515 ' CE1' ' HB1' ' A' ' 193' ' ' ALA . 73.3 m-85 -100.87 -39.98 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.77 155.67 27.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 69.6 t -71.43 93.9 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.868 HD11 ' CB ' ' A' ' 154' ' ' PHE . 75.1 mt -61.82 143.44 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -92.44 -59.53 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -140.5 144.44 36.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.524 ' CB ' HD21 ' A' ' 151' ' ' LEU . 3.7 t -134.02 133.14 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.7 m -137.2 125.75 23.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.475 HG23 ' HG3' ' A' ' 147' ' ' GLU . 58.8 t -96.95 151.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.496 HD11 ' HE1' ' A' ' 178' ' ' PHE . 38.4 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.4 mttp . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.832 0.349 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.84 24.86 70.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.32 160.07 42.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 110.898 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.45 158.39 20.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.496 ' HE1' HD11 ' A' ' 166' ' ' LEU . 76.8 m-85 -112.27 132.98 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.22 137.96 55.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 160' ' ' ILE . 23.9 ttmt -119.13 135.88 54.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.603 ' HE1' HD12 ' A' ' 136' ' ' LEU . 43.2 m-85 -107.94 167.93 9.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.5 t -71.44 -23.89 61.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.5 m -143.84 176.23 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.837 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.409 ' CD2' ' H ' ' A' ' 184' ' ' HIS . 10.2 p80 -80.33 -42.23 23.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.812 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.4 m -53.56 -58.0 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -42.92 -47.3 5.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.617 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -59.65 -60.31 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -39.71 -41.67 1.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.39 -63.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.16 -32.69 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.127 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.628 HD11 ' CD2' ' A' ' 136' ' ' LEU . 40.5 mt -66.34 -71.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.138 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -59.25 -10.98 3.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.515 ' HB1' ' CE1' ' A' ' 157' ' ' PHE . . . -96.2 -24.44 16.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.526 HD22 HE22 ' A' ' 198' ' ' GLN . 30.2 mt -131.42 24.42 4.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 191' ' ' ILE . 2.4 t60 -90.6 119.8 31.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.69 33.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 195' ' ' HIS . 38.3 p -100.27 -38.07 8.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.826 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.526 HE22 HD22 ' A' ' 194' ' ' LEU . 18.3 mt-30 -100.53 163.2 12.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 205' ' ' SER . 26.3 m -129.93 84.58 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.418 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 21.4 mmt -40.52 137.9 1.29 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.612 0.72 . . . . 0.0 110.866 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.49 143.89 14.86 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.303 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 82.28 -40.15 2.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.507 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.66 138.85 35.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 90.9 p -92.42 -9.48 41.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 199' ' ' THR . 49.4 m -99.03 167.19 10.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.4 m -92.48 154.1 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 196' ' ' GLY . 11.6 tp -51.55 141.28 16.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.6 t -112.1 111.66 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.3 133.3 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -165.7 144.12 6.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.936 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.872 0.368 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.796 HD21 ' HB1' ' A' ' 187' ' ' ALA . 44.7 mt -120.09 153.78 35.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -120.44 120.13 35.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.69 147.62 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -141.04 -170.54 12.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.6 mmt 54.91 34.11 21.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.563 ' CD2' HD11 ' A' ' 207' ' ' LEU . 47.0 mt -93.31 153.52 18.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -106.95 165.58 11.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -77.32 46.9 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -133.81 -34.55 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -81.23 145.48 30.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 77.1 p -125.6 169.86 12.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.468 ' HG3' HG23 ' A' ' 165' ' ' VAL . 9.9 mt-10 -49.57 -46.84 49.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -54.61 -53.28 56.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -45.56 -65.69 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.885 HG13 ' CE1' ' A' ' 154' ' ' PHE . 95.2 t -48.9 -60.29 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.09 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.925 HD21 ' CB ' ' A' ' 163' ' ' CYS . 35.2 mt -47.53 -40.09 17.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -69.69 -39.42 76.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.458 HD21 HD22 ' A' ' 194' ' ' LEU . 13.1 tp -84.8 -9.1 58.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.885 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.2 m-85 -100.34 -37.32 8.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -47.29 -46.87 57.65 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 0.0 110.877 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.9 Cg_exo -48.0 -18.46 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.654 2.236 . . . . 0.0 112.366 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.457 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 75.5 m-85 -100.38 -47.32 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.57 164.77 33.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.51 104.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.83 HD11 ' HB3' ' A' ' 154' ' ' PHE . 45.1 mt -76.91 131.47 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.43 -64.38 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -122.37 132.21 54.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.925 ' CB ' HD21 ' A' ' 151' ' ' LEU . 34.9 t -132.73 136.79 46.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 165' ' ' VAL . 96.4 m -153.7 152.81 31.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.57 HG22 ' CB ' ' A' ' 177' ' ' ALA . 65.6 t -117.12 148.24 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.2 mttm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.828 0.347 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 51.86 29.4 26.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 17.0 p -144.28 151.48 39.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.57 ' CB ' HG22 ' A' ' 165' ' ' VAL . . . -160.18 166.12 30.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -117.72 144.94 44.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 26.6 t -137.51 121.54 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.731 ' O ' HG23 ' A' ' 160' ' ' ILE . 23.1 ttmt -103.89 129.86 51.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.412 ' HE1' HD12 ' A' ' 136' ' ' LEU . 36.4 m-85 -103.66 164.73 11.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 88.2 p -63.49 -33.12 74.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.6 m -141.49 179.05 7.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -75.44 -51.85 12.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 31.0 m -48.83 -53.32 19.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.101 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -47.04 -47.98 22.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.796 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -62.37 -57.57 10.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.132 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.574 ' HA ' HD12 ' A' ' 191' ' ' ILE . 2.3 mm-40 -40.71 -40.67 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -67.36 -61.1 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.61 -31.67 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.095 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.684 HD11 HD22 ' A' ' 136' ' ' LEU . 74.6 mt -67.5 -71.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.175 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -57.17 -13.64 3.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.457 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.72 -41.15 14.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 154' ' ' PHE . 33.2 mt -113.51 16.26 18.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -83.03 126.21 32.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 37.94 28.43 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.541 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 195' ' ' HIS . 77.2 p -100.4 -39.61 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.351 . . . . 0.0 110.843 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.616 ' OE1' HD22 ' A' ' 207' ' ' LEU . 6.6 pt20 -100.66 160.83 14.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 205' ' ' SER . 96.3 m -135.0 81.14 1.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.468 ' CE ' ' NE2' ' A' ' 198' ' ' GLN . 26.5 mmt -37.72 137.84 0.67 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.582 0.706 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.77 153.66 3.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 2.286 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 78.33 -42.88 2.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.509 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.62 138.23 35.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.9 t -87.22 -13.41 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 199' ' ' THR . 6.0 t -100.08 169.61 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 24.6 p -87.86 -174.81 4.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.616 HD22 ' OE1' ' A' ' 198' ' ' GLN . 11.7 tp -86.86 122.67 31.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.53 109.48 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.101 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 36.4 t -118.22 124.81 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.083 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -164.33 150.6 10.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.6 tttt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.749 0.309 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.978 HD21 ' HB1' ' A' ' 187' ' ' ALA . 37.3 mt -96.41 150.52 20.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -116.13 113.27 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.86 143.71 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.679 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -140.02 -171.56 12.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.491 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.4 mmt 51.6 42.4 29.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 49.6 mt -102.19 157.33 16.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -99.17 168.12 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -84.14 37.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -127.62 -44.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -62.9 146.79 52.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 53.5 p -122.81 178.31 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' A' ' 165' ' ' VAL . 13.0 mt-10 -58.3 -48.19 81.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -54.18 -50.23 67.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -44.98 -68.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.69 HG13 ' CE1' ' A' ' 154' ' ' PHE . 46.9 t -49.04 -60.31 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.751 HD23 HD13 ' A' ' 160' ' ' ILE . 35.4 mt -46.48 -38.06 8.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -69.21 -40.4 78.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.93 -10.55 57.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.731 ' CE1' HD13 ' A' ' 194' ' ' LEU . 3.1 m-85 -98.83 -35.75 10.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.3 OUTLIER -47.18 -46.94 56.58 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.551 0.691 . . . . 0.0 110.908 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.6 Cg_exo -48.0 -16.95 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.639 2.226 . . . . 0.0 112.359 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.48 ' CE1' ' HB1' ' A' ' 193' ' ' ALA . 72.7 m-85 -99.85 -46.83 5.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.409 ' HA3' ' CG ' ' A' ' 186' ' ' GLU . . . -160.1 174.49 36.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.5 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.4 t -87.6 102.32 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.751 HD13 HD23 ' A' ' 151' ' ' LEU . 23.7 mt -74.07 134.37 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.46 -60.36 2.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -139.9 142.26 36.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.719 ' HB2' HD21 ' A' ' 151' ' ' LEU . 9.8 t -134.01 144.78 48.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.6 m -153.81 144.08 22.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.485 HG23 ' HG3' ' A' ' 147' ' ' GLU . 58.0 t -112.23 139.52 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 67.4 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.1 mttt . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.843 0.354 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 59.46 28.95 65.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 6.2 p -145.93 156.43 43.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -160.47 172.1 17.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -126.61 124.01 38.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 85.7 t -115.9 130.58 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.693 ' O ' HG23 ' A' ' 160' ' ' ILE . 20.7 ttmt -111.9 131.22 55.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 186' ' ' GLU . 40.9 m-85 -105.77 166.8 10.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.7 t -81.53 -3.14 52.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.0 m -162.96 149.76 12.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.858 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -59.84 -46.04 90.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.7 m -48.71 -61.14 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.108 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 181' ' ' PHE . 0.5 OUTLIER -42.33 -51.24 4.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.978 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.75 -56.84 16.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.098 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -38.62 -51.51 1.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.955 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.39 -61.21 2.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -40.99 -35.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.786 HD11 HD22 ' A' ' 136' ' ' LEU . 63.4 mt -65.69 -69.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -62.25 -14.56 39.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.91 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.48 ' HB1' ' CE1' ' A' ' 157' ' ' PHE . . . -90.84 -25.03 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.731 HD13 ' CE1' ' A' ' 154' ' ' PHE . 76.9 mt -130.06 23.03 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -85.95 123.66 31.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.15 39.46 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.478 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 22.6 p -100.09 -37.73 8.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -100.57 164.82 11.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 205' ' ' SER . 28.6 m -135.01 79.7 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.155 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 199' ' ' THR . 15.0 mmt -38.36 138.42 0.73 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.606 0.717 . . . . 0.0 110.853 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.27 145.18 11.74 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.42 -39.19 2.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.532 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -83.83 129.03 34.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.3 m -84.98 -7.51 59.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 199' ' ' THR . 9.8 t -99.3 170.4 8.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.1 m -99.94 151.97 20.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 139' ' ' GLY . 16.4 tp -53.19 137.82 33.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.62 119.34 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.01 117.52 49.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.073 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -158.05 153.01 25.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.1 tptm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.803 0.335 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.732 ' CD2' HD11 ' A' ' 191' ' ' ILE . 43.8 mt -126.75 156.79 40.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -125.77 115.96 20.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 139' ' ' GLY . 84.5 t -100.8 153.93 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.126 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.434 ' N ' HG12 ' A' ' 138' ' ' VAL . . . -144.42 -172.88 15.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.0 mmt 51.11 50.14 19.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HB2' ' C ' ' A' ' 175' ' ' GLY . 34.1 mt -107.71 154.97 20.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -99.43 171.06 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -86.26 28.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.89 -31.44 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.439 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 6.6 mt-30 -79.62 147.02 32.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.2 p -124.62 -176.61 3.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -62.69 -44.29 96.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -57.03 -45.16 83.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -52.33 -58.94 5.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.792 HG13 ' CE1' ' A' ' 154' ' ' PHE . 83.6 t -57.4 -50.49 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.868 HD21 ' CB ' ' A' ' 163' ' ' CYS . 33.9 mt -55.54 -39.49 70.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -70.05 -38.68 75.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.8 tp -84.22 -10.47 57.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.799 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.15 -35.93 9.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.562 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.01 -46.92 54.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.601 0.715 . . . . 0.0 110.936 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.97 -17.13 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -101.66 -44.59 5.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.36 164.72 35.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.18 103.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.352 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.799 HD11 ' CB ' ' A' ' 154' ' ' PHE . 44.0 mt -75.25 137.79 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.97 -61.89 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.78 134.9 47.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.868 ' CB ' HD21 ' A' ' 151' ' ' LEU . 36.7 t -134.08 135.12 43.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 80.4 m -147.76 145.3 28.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.109 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.47 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 77.3 t -112.56 148.02 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.912 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.5 mttm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.833 0.349 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.421 ' C ' ' HB2' ' A' ' 141' ' ' LEU . . . 82.83 -3.33 83.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.472 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.3 169.0 16.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.835 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -164.67 173.59 11.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -123.94 132.39 53.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 64.1 t -125.61 131.58 71.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -117.45 113.11 21.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -86.26 166.35 15.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 95.6 p -68.47 -35.17 77.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -134.51 164.92 26.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -65.92 -50.97 62.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.91 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.4 m -48.96 -62.39 1.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.179 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -44.38 -42.05 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -59.39 -60.56 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.787 ' HA ' HD12 ' A' ' 191' ' ' ILE . 7.2 mt-30 -45.76 -50.28 14.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -50.28 -55.57 14.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.1 -35.68 59.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.787 HD12 ' HA ' ' A' ' 188' ' ' GLN . 58.3 mt -64.87 -68.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.146 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -57.88 -12.39 3.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -91.08 -39.02 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.704 HD13 ' CE1' ' A' ' 154' ' ' PHE . 28.6 mt -115.2 25.68 10.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.8 t60 -88.72 122.62 32.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.61 33.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 195' ' ' HIS . 23.5 p -100.22 -38.33 8.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 110.866 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -100.52 162.47 12.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 47.5 m -132.75 84.1 2.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.439 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 14.6 mmt -39.93 137.92 1.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.568 0.699 . . . . 0.0 110.881 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.83 144.46 15.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.659 2.24 . . . . 0.0 112.332 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.34 -40.93 3.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.515 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -83.36 142.42 31.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 111.108 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 73.9 p -94.2 -12.65 27.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.7 m -98.94 157.94 15.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.7 m -78.27 174.94 10.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 196' ' ' GLY . 9.9 tp -73.97 145.6 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.926 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 57.3 t -113.46 111.51 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.6 t -122.27 123.6 69.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.093 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -161.81 149.56 14.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.94 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.846 0.355 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.698 HD21 ' HB1' ' A' ' 187' ' ' ALA . 18.9 mt -121.7 153.86 37.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -116.0 109.99 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.54 139.29 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -133.83 -173.05 13.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.452 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.9 mmt 57.36 43.32 23.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.403 ' CD2' HD11 ' A' ' 207' ' ' LEU . 43.6 mt -102.23 156.89 17.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -96.23 161.32 14.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -81.98 43.12 0.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -134.38 -37.84 0.85 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.492 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 5.9 mt-30 -67.87 151.36 47.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.0 p -129.6 164.27 24.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.413 ' HG3' HG23 ' A' ' 165' ' ' VAL . 4.7 mp0 -44.33 -48.52 9.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.24 -54.42 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -42.55 -67.79 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.834 HG13 ' CE1' ' A' ' 154' ' ' PHE . 99.7 t -49.63 -61.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 155' ' ' GLN . 34.2 mt -44.83 -38.25 4.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -69.45 -40.52 77.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.93 -9.38 58.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.883 ' HB3' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.26 -35.81 9.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.564 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.13 -46.97 56.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.92 -16.67 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.325 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.453 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.4 m-85 -99.69 -41.95 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.22 168.02 37.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.62 134.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.153 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.883 HD11 ' HB3' ' A' ' 154' ' ' PHE . 75.4 mt -109.04 109.08 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.143 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' LYS . 18.5 m-20 -45.3 -61.28 1.73 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.875 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -157.88 148.43 20.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 20.6 t -133.74 135.61 44.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.8 m -139.44 141.9 37.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.413 HG23 ' HG3' ' A' ' 147' ' ' GLU . 98.3 t -104.69 135.06 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.548 HD11 ' HE2' ' A' ' 178' ' ' PHE . 95.9 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.5 mttm . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.833 0.349 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 50.48 33.65 25.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 29.7 m -150.03 169.05 22.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 110.856 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -165.69 179.24 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.548 ' HE2' HD11 ' A' ' 166' ' ' LEU . 91.5 m-85 -133.98 118.7 18.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.9 t -110.85 118.91 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 161' ' ' ASP . 13.4 ttmm -105.02 117.91 35.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.944 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -93.29 154.14 18.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 m -57.4 -41.04 79.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -134.38 136.01 43.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 187' ' ' ALA . 7.6 p-80 -38.57 -56.32 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.425 ' H ' ' CD2' ' A' ' 184' ' ' HIS . 94.3 m -37.53 -67.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -41.03 -43.62 2.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.698 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -62.0 -53.95 48.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.623 ' HA ' HD12 ' A' ' 191' ' ' ILE . 0.1 OUTLIER -45.21 -46.93 12.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -60.94 -65.74 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.4 -38.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.661 HD11 HD22 ' A' ' 136' ' ' LEU . 62.3 mt -61.63 -71.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.146 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -57.09 -13.14 2.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.453 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -90.94 -32.33 16.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.125 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.684 HD13 ' CE1' ' A' ' 154' ' ' PHE . 40.8 mt -122.43 20.64 10.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -86.53 123.96 32.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 41.52 28.36 0.36 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 82.9 p -100.53 -38.67 8.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.862 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.689 ' NE2' HD22 ' A' ' 207' ' ' LEU . 9.7 pt20 -100.58 146.0 27.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 205' ' ' SER . 86.9 m -123.91 80.25 1.79 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.147 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.492 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 14.1 mmt -34.58 138.1 0.34 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.558 0.694 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.63 151.58 7.43 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.733 2.289 . . . . 0.0 112.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.69 -43.9 2.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -78.84 136.33 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 111.097 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 70.1 m -86.49 -13.0 47.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 199' ' ' THR . 23.1 m -100.08 161.24 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.3 p -85.27 -178.41 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.689 HD22 ' NE2' ' A' ' 198' ' ' GLN . 11.9 tp -82.71 123.49 29.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.4 t -92.24 106.04 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 14.6 t -113.27 117.43 55.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.16 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -157.46 150.6 23.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.1 tttt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.827 0.346 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 1.015 HD21 ' HB1' ' A' ' 187' ' ' ALA . 58.1 mt -115.92 153.3 31.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -123.36 114.04 19.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.2 t -101.18 143.75 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.77 -173.85 13.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.6 mmt 57.8 37.46 27.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.446 ' CD2' ' OE1' ' A' ' 145' ' ' GLN . 24.3 mt -95.37 155.1 16.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -108.84 173.99 6.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.66 12.51 2.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -99.96 -22.61 15.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.451 ' CD ' ' SD ' ' A' ' 200' ' ' MET . 34.4 mt-30 -97.57 149.36 22.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 p -130.77 178.16 6.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.42 ' HG3' HG23 ' A' ' 165' ' ' VAL . 13.7 mt-10 -56.94 -49.24 76.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -52.23 -59.47 4.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -39.65 -67.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.773 HG13 ' CE1' ' A' ' 154' ' ' PHE . 84.1 t -45.16 -60.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.907 HD21 ' HB2' ' A' ' 163' ' ' CYS . 33.9 mt -47.98 -40.31 22.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -69.57 -39.53 77.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.426 HD21 HE22 ' A' ' 198' ' ' GLN . 13.5 tp -84.19 -10.04 58.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.845 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -99.94 -36.2 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -47.11 -47.01 55.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.592 0.71 . . . . 0.0 110.919 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.2 Cg_exo -48.01 -17.13 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.695 2.263 . . . . 0.0 112.332 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.447 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 74.2 m-85 -101.32 -48.15 4.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -156.3 160.43 30.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.88 93.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.117 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.845 HD11 ' CB ' ' A' ' 154' ' ' PHE . 63.5 mt -62.87 138.6 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -95.13 -62.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.28 132.92 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.907 ' HB2' HD21 ' A' ' 151' ' ' LEU . 42.7 t -134.02 136.17 43.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 50.7 m -152.69 139.52 18.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 53.5 t -104.06 144.84 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 53.1 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.921 179.957 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.74 10.79 86.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.35 148.13 50.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.835 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -153.37 166.15 33.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -120.83 136.06 55.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.928 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 81.2 t -130.51 124.31 56.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -107.9 129.65 55.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.429 ' CE1' HD12 ' A' ' 136' ' ' LEU . 28.4 m-85 -103.59 167.71 9.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.3 t -64.97 -32.31 73.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.3 t -143.19 175.94 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.569 ' CG ' ' N ' ' A' ' 185' ' ' THR . 4.4 p-80 -72.13 -49.63 34.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.569 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 89.4 m -43.79 -61.54 1.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -40.94 -51.31 3.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 1.015 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -56.6 -57.63 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.065 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -39.65 -47.24 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 190' ' ' ALA . . . -61.95 -67.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -36.53 -42.93 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.507 HD11 HD22 ' A' ' 136' ' ' LEU . 77.7 mt -57.36 -74.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -57.05 -13.3 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.447 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.86 -35.79 18.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 21.5 mt -126.51 26.41 6.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.8 t60 -86.41 121.41 28.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 207' ' ' LEU . . . 33.86 32.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.51 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.38 -38.77 8.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.343 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.426 HE22 HD21 ' A' ' 153' ' ' LEU . 33.2 mt-30 -100.62 160.1 14.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 205' ' ' SER . 19.3 m -130.83 87.59 2.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.451 ' SD ' ' CD ' ' A' ' 145' ' ' GLN . 16.8 mmt -39.62 154.86 0.17 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.87 122.73 9.65 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 2.273 . . . . 0.0 112.305 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 111.97 -43.91 1.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -82.94 153.05 25.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 84.5 p -98.63 -12.8 20.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 199' ' ' THR . 64.8 m -100.14 164.96 11.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.852 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 67.5 m -87.49 161.28 17.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 196' ' ' GLY . 14.9 tp -57.09 141.65 45.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.457 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 55.8 t -110.28 107.12 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.1 t -118.24 114.52 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.457 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 17.6 ptpt -148.3 155.4 41.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.765 0.317 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 1.019 HD21 ' HB1' ' A' ' 187' ' ' ALA . 21.0 mt -125.06 144.93 50.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -112.64 114.76 27.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -103.85 146.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.133 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -142.34 -173.53 14.32 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.417 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.3 mmt 55.81 42.35 29.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.4 mt -103.35 154.87 18.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -98.12 165.82 11.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -82.48 39.93 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -128.53 -38.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -69.49 151.29 46.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.1 p -128.55 176.67 7.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -55.41 -44.62 76.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.861 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.83 -49.18 74.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.12 -69.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.748 HG13 ' CE1' ' A' ' 154' ' ' PHE . 74.6 t -49.96 -59.75 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.866 HD21 ' CB ' ' A' ' 163' ' ' CYS . 25.4 mt -47.34 -38.34 12.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -69.62 -40.13 76.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.1 tp -84.49 -8.96 58.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.748 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -100.18 -37.24 9.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.2 tm0? -47.2 -46.89 56.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.645 0.736 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.97 -17.28 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.242 . . . . 0.0 112.361 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.706 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 73.3 m-85 -99.88 -33.4 10.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.97 164.02 33.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.441 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 94.5 t -76.47 103.41 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 154' ' ' PHE . 85.6 mt -72.37 133.99 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -81.51 -62.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -141.89 139.79 32.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.866 ' CB ' HD21 ' A' ' 151' ' ' LEU . 45.0 t -134.04 141.11 47.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.6 m -146.7 139.44 25.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 87.3 t -105.6 136.63 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.569 HD12 ' SG ' ' A' ' 176' ' ' CYS . 49.9 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.0 mttt . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.794 0.33 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 55.94 38.94 77.01 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.482 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.569 ' SG ' HD12 ' A' ' 166' ' ' LEU . 22.7 p -156.17 149.76 24.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.805 0.336 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -159.47 166.77 30.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.5 136.05 54.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.482 HG22 ' SG ' ' A' ' 163' ' ' CYS . 10.5 t -127.18 125.25 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.615 ' O ' HG23 ' A' ' 160' ' ' ILE . 30.9 tttm -105.72 130.72 53.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.405 ' CE1' HD12 ' A' ' 136' ' ' LEU . 22.8 m-85 -106.29 158.83 16.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.7 t -53.21 -43.6 67.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.6 m -128.26 173.53 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.492 ' H ' ' CD2' ' A' ' 184' ' ' HIS . 7.7 p80 -71.8 -49.97 33.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.5 m -47.67 -63.62 1.01 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -40.25 -39.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 1.019 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -63.22 -65.76 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.424 ' C ' ' CD ' ' A' ' 188' ' ' GLN . 0.0 OUTLIER -43.39 -36.82 2.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.95 -61.87 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.44 -34.68 4.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.509 HD11 HD22 ' A' ' 136' ' ' LEU . 45.1 mt -60.04 -71.83 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -55.59 -18.73 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.706 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -79.05 -37.4 39.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.46 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 12.2 mt -126.51 28.26 5.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.5 t60 -84.81 120.98 27.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.04 34.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.452 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.3 -38.84 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.844 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -100.6 152.23 20.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 200' ' ' MET . 15.7 m -122.31 86.28 2.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 199' ' ' THR . 13.2 mmt -37.11 155.25 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 110.855 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.41 128.11 15.87 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.695 2.263 . . . . 0.0 112.372 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 103.51 -39.46 2.79 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.96 154.71 21.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.067 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.7 t -99.98 -14.96 18.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.1 m -100.12 161.54 13.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 66.9 m -88.64 158.27 18.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 139' ' ' GLY . 14.3 tp -52.45 141.75 19.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 52.4 t -110.08 108.64 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.15 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.492 HG12 HG12 ' A' ' 191' ' ' ILE . 4.7 t -118.6 124.45 73.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -158.85 148.59 19.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.461 ' CZ ' HD12 ' A' ' 191' ' ' ILE . 68.4 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.763 0.316 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.788 ' CD2' HD11 ' A' ' 191' ' ' ILE . 88.7 mt -140.1 150.66 44.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -117.2 117.61 30.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.11 147.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.49 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -139.41 -170.5 11.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.52 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.4 mmt 51.68 51.19 17.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.778 0.323 . . . . 0.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.462 HD22 ' OE1' ' A' ' 145' ' ' GLN . 43.5 mt -111.13 155.75 22.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -97.61 165.07 12.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -82.37 40.69 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -129.16 -40.05 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.462 ' OE1' HD22 ' A' ' 141' ' ' LEU . 62.9 mt-30 -69.43 144.65 53.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.3 p -122.91 171.27 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.566 ' HG3' HG23 ' A' ' 165' ' ' VAL . 12.9 mp0 -48.43 -48.71 37.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.45 ' OE1' ' C ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -51.74 -51.41 56.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -46.6 -67.35 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.601 HG13 ' CE1' ' A' ' 154' ' ' PHE . 31.7 t -49.27 -62.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 163' ' ' CYS . 25.0 mt -46.49 -38.35 9.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -69.51 -40.1 77.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.76 -10.2 58.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.825 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -99.84 -35.73 9.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -47.1 -47.07 55.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.59 0.71 . . . . 0.0 110.897 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.99 -17.27 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.666 2.244 . . . . 0.0 112.365 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.492 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 74.1 m-85 -101.26 -47.16 4.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.97 166.14 34.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.503 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.5 t -80.6 101.8 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 0.0 111.14 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.825 HD11 ' CB ' ' A' ' 154' ' ' PHE . 38.5 mt -73.07 131.37 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.69 -64.17 1.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -130.77 140.98 50.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.813 ' CB ' HD21 ' A' ' 151' ' ' LEU . 12.3 t -134.13 131.61 38.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.4 m -136.43 138.19 41.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.566 HG23 ' HG3' ' A' ' 147' ' ' GLU . 92.3 t -108.45 135.36 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 176' ' ' CYS . 78.9 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.802 0.334 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 67.68 20.61 72.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.673 ' HB2' HD12 ' A' ' 166' ' ' LEU . 21.3 m -143.49 164.43 30.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.792 0.33 . . . . 0.0 110.883 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -164.02 170.92 15.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.05 121.9 36.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 94.3 t -114.22 131.51 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.704 ' O ' HG23 ' A' ' 160' ' ' ILE . 24.9 ttpt -110.71 129.57 55.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.891 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -102.47 165.23 11.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.7 p -67.32 -39.14 85.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.0 p -132.52 146.09 51.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.42 ' CG ' ' N ' ' A' ' 185' ' ' THR . 6.8 p80 -50.44 -50.41 52.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.42 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 85.9 m -48.66 -53.34 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -45.75 -50.42 13.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -59.89 -48.51 81.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.126 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.596 ' HA ' HD12 ' A' ' 191' ' ' ILE . 0.9 OUTLIER -46.71 -43.41 17.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.41 -59.2 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.106 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.01 -36.81 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.788 HD11 ' CD2' ' A' ' 136' ' ' LEU . 63.3 mt -61.37 -73.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.1 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -57.41 -12.05 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.492 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -85.09 -40.09 17.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.92 19.41 11.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.4 t60 -80.08 124.97 29.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.21 32.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.495 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 195' ' ' HIS . 58.8 p -100.38 -39.31 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.83 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -100.53 160.47 14.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 205' ' ' SER . 19.6 m -135.02 86.62 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 199' ' ' THR . 13.8 mmt -36.1 154.56 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.706 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.45 129.32 17.71 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.64 2.227 . . . . 0.0 112.359 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 101.66 -38.62 3.08 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.482 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.48 146.91 26.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.31 . . . . 0.0 111.081 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.8 t -93.39 -12.38 30.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 199' ' ' THR . 69.3 m -100.16 158.77 15.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.828 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 70.1 m -85.3 169.32 13.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.826 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 139' ' ' GLY . 19.5 tp -65.87 128.12 34.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.1 113.86 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.9 t -123.19 124.08 69.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -162.3 148.61 13.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.98 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.6 tttp . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.796 0.331 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.964 HD21 ' HB1' ' A' ' 187' ' ' ALA . 36.0 mt -121.81 155.0 36.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE1' ' HB3' ' A' ' 176' ' ' CYS . 44.7 t80 -124.42 112.79 17.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.52 152.66 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -146.16 174.93 25.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.4 mmt 57.48 46.01 18.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.336 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.507 ' CD2' HD11 ' A' ' 207' ' ' LEU . 60.2 mt -100.07 147.32 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 36.4 t30 -90.12 164.82 14.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -66.98 -3.66 7.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.427 HE21 ' ND2' ' A' ' 142' ' ' ASN . 6.2 pt20 -109.31 43.71 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.496 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 74.1 mt-30 -135.21 109.24 8.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 p -104.08 170.74 7.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -52.86 -41.93 64.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.5 -47.32 86.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -48.03 -63.99 0.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.839 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.858 HG13 ' CE1' ' A' ' 154' ' ' PHE . 94.9 t -58.49 -60.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.662 HD23 HD13 ' A' ' 160' ' ' ILE . 29.6 mt -44.4 -38.68 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -68.82 -41.11 79.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.461 HD21 HE22 ' A' ' 198' ' ' GLN . 13.5 tp -84.0 -9.78 58.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.858 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.14 -35.88 9.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.56 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.0 OUTLIER -47.18 -46.91 56.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 0.0 110.914 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -48.03 -16.75 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.652 2.235 . . . . 0.0 112.315 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.406 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.4 m-85 -99.87 -42.1 6.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.73 171.16 42.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -80.48 102.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.848 HD11 ' CB ' ' A' ' 154' ' ' PHE . 38.3 mt -72.13 151.34 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -103.13 -57.15 2.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.479 ' CG ' ' HB3' ' A' ' 180' ' ' LYS . 9.7 pt-20 -138.69 137.89 37.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' CYS . . . . . 0.66 ' CB ' HD21 ' A' ' 151' ' ' LEU . 1.7 t -133.72 102.14 5.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.3 m -107.51 119.64 39.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.163 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.467 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 50.3 t -99.91 131.87 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.131 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.9 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.997 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.1 mttt . . . . . 0 CA--C 1.525 0.015 0 CA-C-O 120.812 0.339 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.45 -16.3 44.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.46 ' HB3' ' CE1' ' A' ' 137' ' ' PHE . 1.7 m -125.99 160.14 30.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 110.87 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -158.73 175.98 12.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -136.04 126.27 26.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.18 130.0 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.479 ' HB3' ' CG ' ' A' ' 162' ' ' GLU . 27.0 tttt -106.25 130.35 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.41 ' HE1' HD12 ' A' ' 136' ' ' LEU . 33.6 m-85 -104.0 160.63 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.4 t -72.43 -19.85 61.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.863 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -142.15 164.94 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.451 ' CG ' ' N ' ' A' ' 185' ' ' THR . 4.4 p-80 -75.39 -41.75 55.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.806 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.451 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 44.7 m -54.64 -59.76 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -41.12 -47.73 3.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.964 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -60.79 -62.05 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.093 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 187' ' ' ALA . 1.8 mm-40 -35.44 -44.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.85 -63.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.054 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.36 -28.86 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.074 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.556 HD11 HD22 ' A' ' 136' ' ' LEU . 36.2 mt -70.71 -72.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.143 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -59.85 -17.14 34.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.406 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -84.74 -25.8 28.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.129 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.418 HD13 ' CE1' ' A' ' 154' ' ' PHE . 25.5 mt -132.59 24.95 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.3 t60 -89.69 121.45 31.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.1 30.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 195' ' ' HIS . 60.6 p -100.25 -39.48 8.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.83 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.829 ' OE1' HD22 ' A' ' 207' ' ' LEU . 4.9 pt20 -100.66 163.98 12.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 205' ' ' SER . 29.3 m -134.82 81.3 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.496 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 13.9 mmt -37.03 156.01 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.698 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.473 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 54.1 Cg_endo -68.0 136.48 38.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.395 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.12 -35.95 4.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -89.36 150.85 22.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.5 t -100.08 -12.48 19.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.867 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.593 ' O ' HG23 ' A' ' 199' ' ' THR . 7.1 t -100.08 170.07 8.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -94.27 148.94 21.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.808 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.829 HD22 ' OE1' ' A' ' 198' ' ' GLN . 10.7 tp -45.68 151.4 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.97 104.29 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 191' ' ' ILE . 6.6 t -115.94 116.41 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -155.35 148.36 24.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 69.1 m -39.71 107.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 97.1 p -74.32 139.59 44.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 67.08 179.36 11.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.479 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 92.6 p -167.45 176.4 6.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.6 m -151.57 143.82 24.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -172.6 -174.49 39.9 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.493 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 57.9 m -57.45 149.81 20.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.0 110.855 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -139.63 109.26 6.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.3 p -66.44 166.91 11.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -80.19 130.04 34.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.806 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.58 -39.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.84 169.96 29.9 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.468 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -115.5 117.87 31.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.767 0.318 . . . . 0.0 110.912 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -89.85 104.23 16.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -88.86 30.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -112.41 157.21 21.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 1.009 HD21 ' HB1' ' A' ' 187' ' ' ALA . 9.0 mt -130.84 153.63 48.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -116.0 108.92 16.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.916 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.438 HG22 HG13 ' A' ' 209' ' ' VAL . 35.6 t -99.85 145.02 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.107 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.503 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -137.69 -170.44 11.88 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.497 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.4 mmt 52.39 53.01 13.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.403 HD21 HD11 ' A' ' 207' ' ' LEU . 56.1 mt -117.39 156.14 28.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -94.12 175.49 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.0 pttm -92.61 17.02 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -108.06 -13.69 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.491 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 20.4 mt-30 -90.09 152.11 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 95.9 p -131.96 166.23 22.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.457 ' HG3' HG23 ' A' ' 165' ' ' VAL . 29.5 mt-10 -45.77 -47.12 15.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -54.83 -53.76 51.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -43.03 -64.82 0.56 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.716 HG13 ' CE1' ' A' ' 154' ' ' PHE . 77.7 t -53.67 -63.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.776 HD21 ' CB ' ' A' ' 163' ' ' CYS . 31.4 mt -42.82 -36.98 1.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.28 -40.83 77.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -84.57 -8.6 58.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.924 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -99.89 -37.19 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 10.2 tm0? -47.31 -46.87 57.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.722 . . . . 0.0 110.902 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.89 -17.18 0.7 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.731 2.287 . . . . 0.0 112.363 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.489 ' CE1' ' HB1' ' A' ' 193' ' ' ALA . 75.2 m-85 -101.95 -35.07 9.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.84 161.31 30.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.512 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 80.9 t -75.03 97.98 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.924 HD11 ' CB ' ' A' ' 154' ' ' PHE . 36.5 mt -66.66 137.25 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.167 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -81.86 -61.43 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -139.54 143.57 37.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.776 ' CB ' HD21 ' A' ' 151' ' ' LEU . 10.6 t -134.02 135.78 43.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.83 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.523 ' O ' ' HB1' ' A' ' 177' ' ' ALA . 86.0 m -139.09 157.74 45.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.493 ' N ' HG22 ' A' ' 164' ' ' THR . 47.7 t -120.97 130.82 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 176' ' ' CYS . 60.3 mt -72.84 147.97 44.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -148.23 165.58 30.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -100.12 -161.83 28.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.487 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.07 -50.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.664 2.243 . . . . 0.0 112.299 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.64 -39.56 88.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 121.28 39.83 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.521 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 70.2 m -121.99 118.12 28.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.386 . . . . 0.0 110.863 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.0 t -50.01 136.57 18.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -84.5 11.24 9.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 71.44 21.76 78.64 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.52 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.401 ' HB2' HD12 ' A' ' 166' ' ' LEU . 3.2 m -136.55 159.78 40.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.523 ' HB1' ' O ' ' A' ' 164' ' ' THR . . . -158.1 161.67 37.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -112.23 121.73 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.469 HG11 ' HD2' ' A' ' 154' ' ' PHE . 38.7 t -119.15 122.94 70.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.573 ' O ' HG23 ' A' ' 160' ' ' ILE . 13.7 tttp -111.68 131.27 55.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.902 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' A' ' 187' ' ' ALA . 41.2 m-85 -101.7 166.68 10.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.3 t -66.81 -35.53 80.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.8 p -133.79 166.65 22.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -66.94 -55.25 15.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.4 m -43.73 -53.7 5.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -49.12 -48.1 44.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 1.009 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -59.81 -52.2 66.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.094 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.585 ' HA ' HD12 ' A' ' 191' ' ' ILE . 2.8 mm-40 -46.42 -42.66 15.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.897 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.19 -63.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.73 -37.17 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 136' ' ' LEU . 54.1 mt -63.9 -72.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.106 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -57.48 -13.78 4.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.489 ' HB1' ' CE1' ' A' ' 157' ' ' PHE . . . -86.16 -40.24 15.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.689 HD13 ' CE1' ' A' ' 154' ' ' PHE . 18.1 mt -119.16 22.66 11.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.4 t60 -82.91 124.82 30.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.56 32.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.502 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 195' ' ' HIS . 54.4 p -100.19 -35.26 9.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.338 . . . . 0.0 110.849 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -100.27 161.1 13.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 12.9 m -134.6 77.14 1.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.163 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.491 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 14.0 mmt -39.43 138.45 0.94 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.597 0.713 . . . . 0.0 110.868 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.39 146.73 9.78 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.269 . . . . 0.0 112.343 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.12 -34.16 3.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.27 134.0 35.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.312 . . . . 0.0 111.133 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 80.4 p -90.25 -8.72 50.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.838 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 37.0 m -99.98 160.72 14.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 5.3 m -84.34 158.81 21.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 139' ' ' GLY . 13.4 tp -57.57 141.68 47.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.73 104.37 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.438 HG13 HG22 ' A' ' 138' ' ' VAL . 12.4 t -115.65 120.67 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.097 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -158.16 150.13 21.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.843 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -47.99 147.35 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.11 -36.56 77.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.108 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.56 78.51 1.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 39.1 p -59.04 -73.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -118.59 46.76 1.76 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.88 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -118.15 87.07 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -112.72 110.15 20.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.2 t -78.72 96.48 5.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.82 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 172.55 147.27 5.73 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.524 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.1 133.2 13.33 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.664 2.243 . . . . 0.0 112.372 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.0 t -77.05 -46.22 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 m -96.9 -59.94 1.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.494 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 53.7 m 61.17 41.77 13.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.863 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 79.4 p -73.44 120.77 19.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.808 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 154.55 126.12 1.03 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.507 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.5 m -161.3 152.38 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.362 . . . . 0.0 110.892 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -121.68 140.13 52.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -129.2 -179.3 15.87 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.546 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 t -87.12 88.1 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 110.907 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -111.44 86.87 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.0 t -60.06 123.26 16.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.82 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -57.91 117.87 4.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.45 51.78 0.38 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 117.7 123.3 3.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.538 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.454 ' N ' ' HD3' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -113.49 70.09 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.926 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 132' ' ' ARG . 13.7 m-20 -34.49 -44.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 134' ' ' ARG . 20.2 mtm105 59.23 29.64 19.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -114.66 154.08 29.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.987 HD21 ' HB1' ' A' ' 187' ' ' ALA . 44.3 mt -135.85 148.16 48.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -118.35 110.72 17.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.66 138.91 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.118 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.606 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -136.36 178.37 18.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.0 mmt 62.46 45.04 6.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 mt -102.73 153.81 19.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 28.2 t30 -108.2 169.58 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -78.45 45.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -132.11 -34.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.513 ' NE2' ' CE ' ' A' ' 200' ' ' MET . 6.7 mt-30 -86.75 146.97 26.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 83.7 p -126.34 -177.56 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.641 ' HG3' HG23 ' A' ' 165' ' ' VAL . 18.0 mt-10 -58.73 -46.33 87.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -56.72 -53.19 60.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -42.53 -66.67 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.897 HG13 ' CE1' ' A' ' 154' ' ' PHE . 86.5 t -48.08 -63.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.168 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.754 HD21 ' HB2' ' A' ' 163' ' ' CYS . 33.4 mt -44.24 -40.77 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.6 mmp_? -69.01 -40.36 78.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.2 tp -84.21 -9.98 58.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.897 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.55 -35.6 9.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.36 -46.87 58.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 0.0 110.925 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.1 Cg_exo -47.95 -17.49 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.356 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -100.58 -46.29 5.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -161.2 160.92 32.58 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.474 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 159' ' ' VAL . 25.6 t -76.16 95.69 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.774 HD11 ' CB ' ' A' ' 154' ' ' PHE . 28.4 mt -63.85 142.92 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.099 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.68 -55.99 3.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -144.92 140.37 28.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.754 ' HB2' HD21 ' A' ' 151' ' ' LEU . 40.6 t -132.48 142.78 49.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.2 m -151.01 143.07 24.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.641 HG23 ' HG3' ' A' ' 147' ' ' GLU . 86.1 t -112.58 134.15 56.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.62 144.04 39.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.959 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -132.32 174.59 10.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -101.25 -158.98 27.17 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.35 -18.48 13.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.678 2.252 . . . . 0.0 112.355 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -125.56 32.82 5.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 172' ' ' SER . . . 81.88 -38.92 2.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 171' ' ' GLY . 16.9 t -35.66 102.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.869 0.366 . . . . 0.0 110.822 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.3 t -55.36 139.59 42.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -83.32 13.94 3.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 61.36 33.28 84.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.529 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 7.8 p -148.42 154.15 39.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -159.02 176.67 12.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -129.74 141.12 50.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.5 t -134.06 128.82 53.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.598 ' O ' HG23 ' A' ' 160' ' ' ILE . 18.9 ttmt -111.9 134.17 53.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.514 ' HE1' HD12 ' A' ' 136' ' ' LEU . 36.8 m-85 -108.96 164.86 12.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.4 t -69.31 -27.08 65.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.3 t -144.03 159.33 42.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.846 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -60.22 -57.49 12.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 99.9 m -38.82 -59.39 0.96 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.159 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -40.83 -52.75 2.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.987 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.97 -57.16 14.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.573 ' HA ' HD12 ' A' ' 191' ' ' ILE . 3.7 mm-40 -37.91 -45.91 0.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.954 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 191' ' ' ILE . . . -66.16 -66.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -38.65 -27.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 188' ' ' GLN . 59.2 mt -74.3 -71.07 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -59.88 -12.27 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.83 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -89.84 -31.3 17.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.9 mt -125.91 21.63 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.3 t60 -83.72 124.55 30.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.438 ' C ' ' HB3' ' A' ' 206' ' ' SER . . . 34.62 31.92 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.463 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 195' ' ' HIS . 79.3 p -100.25 -36.09 9.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.894 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.739 ' OE1' HD22 ' A' ' 207' ' ' LEU . 1.1 pt20 -100.32 150.35 22.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 205' ' ' SER . 51.0 m -122.76 80.16 1.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.154 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.513 ' CE ' ' NE2' ' A' ' 145' ' ' GLN . 15.3 mmt -40.34 140.61 0.94 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.532 0.682 . . . . 0.0 110.899 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.471 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 74.5 Cg_exo -48.07 147.69 7.7 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.711 2.274 . . . . 0.0 112.306 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.09 -45.69 3.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.457 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -77.28 138.59 39.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.754 0.311 . . . . 0.0 111.085 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.5 t -91.62 -11.39 37.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 199' ' ' THR . 2.2 t -99.97 173.08 6.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.438 ' HB3' ' C ' ' A' ' 196' ' ' GLY . 59.0 m -99.67 150.87 21.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.815 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.739 HD22 ' OE1' ' A' ' 198' ' ' GLN . 14.1 tp -47.49 147.97 1.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.919 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.478 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 58.8 t -117.22 104.05 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.132 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 8.7 t -111.72 122.48 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.478 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 14.9 ptpt -161.43 150.25 15.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -50.2 136.95 18.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -57.31 152.08 14.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.111 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -39.28 141.48 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 12.7 t -161.8 135.12 6.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -168.39 119.72 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -75.58 135.41 40.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.923 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -114.11 -52.42 2.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.5 t -41.48 158.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -172.4 -166.63 31.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.521 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.04 -43.21 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.705 2.27 . . . . 0.0 112.294 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 46.0 m -115.61 121.64 43.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 70.6 m -62.54 115.51 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.504 179.987 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.9 p 42.92 42.54 3.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.833 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.2 t -48.8 -47.86 41.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.92 136.69 2.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.44 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.3 m -145.19 115.57 7.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.823 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.3 m -93.38 -49.92 5.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.99 61.79 6.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.483 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 94.4 p -127.5 95.18 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 110.866 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -58.2 127.53 32.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 87.3 p -168.36 143.47 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -99.81 -44.09 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.29 -149.77 49.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.489 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.05 171.55 55.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.427 ' NH1' ' HB3' ' A' ' 184' ' ' HIS . 13.5 mmt180 -102.91 113.93 27.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.866 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.68 121.58 6.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 10.2 mtm-85 -97.09 26.54 4.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.559 ' HE2' ' CD1' ' A' ' 178' ' ' PHE . 71.3 tttt -112.28 137.97 49.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 1.112 HD21 ' HB1' ' A' ' 187' ' ' ALA . 18.2 mt -124.25 156.3 37.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -126.68 112.95 16.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 30.4 t -97.14 148.23 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.44 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -142.31 -172.12 13.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.479 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.2 mmt 54.49 38.76 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.815 0.34 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.3 mt -95.22 160.93 14.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -100.91 -175.62 2.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -100.3 34.75 2.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -129.14 -30.98 2.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -77.79 145.77 36.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 55.1 p -119.79 -175.84 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.828 ' HG3' HG23 ' A' ' 165' ' ' VAL . 3.4 mp0 -68.53 -31.78 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -64.87 -48.39 74.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -48.39 -68.5 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.828 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.905 HG13 ' CE1' ' A' ' 154' ' ' PHE . 99.0 t -48.46 -53.95 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.837 HD21 ' HB2' ' A' ' 163' ' ' CYS . 38.9 mt -51.46 -40.68 59.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -69.27 -39.41 78.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.8 tp -84.31 -11.12 56.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.905 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -98.44 -36.21 10.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.57 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.06 -47.02 55.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.592 0.71 . . . . 0.0 110.921 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.5 Cg_exo -47.92 -16.77 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.355 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.411 ' HE2' HD11 ' A' ' 194' ' ' LEU . 72.3 m-85 -99.75 -35.28 9.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.38 164.38 37.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 159' ' ' VAL . 47.5 t -75.86 91.23 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 111.136 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.816 HD13 HD23 ' A' ' 151' ' ' LEU . 68.6 mt -59.54 132.81 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -84.94 -55.06 4.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.1 143.07 28.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.837 ' HB2' HD21 ' A' ' 151' ' ' LEU . 9.8 t -134.04 129.84 36.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.6 m -139.26 144.68 38.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.828 HG23 ' HG3' ' A' ' 147' ' ' GLU . 73.6 t -109.97 151.93 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.1 mt -88.2 142.16 27.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.403 ' C ' ' NZ ' ' A' ' 174' ' ' LYS . 53.0 mtt180 -153.77 155.06 35.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -82.52 -162.72 31.92 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.516 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.89 -45.89 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.72 2.28 . . . . 0.0 112.383 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.13 -42.85 99.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 125.51 41.73 0.34 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.535 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.8 p -110.78 146.65 36.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 110.892 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.1 t -79.97 124.5 28.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.403 ' NZ ' ' C ' ' A' ' 167' ' ' ARG . 38.2 mttp -78.24 8.05 5.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.27 23.91 70.25 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.442 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 2.6 p -144.79 158.63 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.816 0.341 . . . . 0.0 110.925 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.47 175.1 11.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.128 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.559 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 81.8 m-85 -124.98 137.84 54.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.421 HG11 ' HD2' ' A' ' 154' ' ' PHE . 98.3 t -127.76 127.5 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -111.72 133.61 53.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.0 156.83 19.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.1 t -56.9 -28.87 62.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.845 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 t -140.9 177.35 8.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.427 ' HB3' ' NH1' ' A' ' 132' ' ' ARG . 12.5 t60 -76.64 -59.01 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.5 m -39.37 -54.39 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -44.78 -49.91 10.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 1.112 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -60.61 -57.11 14.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.09 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -38.65 -45.56 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.5 -62.17 1.68 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.07 -27.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.736 HD11 HD22 ' A' ' 136' ' ' LEU . 74.1 mt -76.77 -64.8 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -64.64 -7.9 12.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -99.26 -24.74 14.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.103 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.594 HD13 ' CE1' ' A' ' 154' ' ' PHE . 23.1 mt -132.36 27.12 4.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.2 t60 -93.04 122.43 35.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 36.39 31.06 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.461 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -99.23 -36.98 9.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.358 . . . . 0.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.636 ' NE2' HD22 ' A' ' 207' ' ' LEU . 16.2 pt20 -100.35 165.06 11.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 205' ' ' SER . 18.4 m -134.96 85.82 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.474 ' CE ' ' OE1' ' A' ' 198' ' ' GLN . 14.2 mmt -44.95 139.78 3.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.706 . . . . 0.0 110.901 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -48.15 137.45 23.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.692 2.261 . . . . 0.0 112.326 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 91.21 -48.12 2.92 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.481 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -76.51 131.63 39.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.079 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.7 p -86.4 -7.39 58.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 199' ' ' THR . 4.7 t -99.71 171.45 7.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.4 m -100.08 143.19 30.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.636 HD22 ' NE2' ' A' ' 198' ' ' GLN . 14.8 tp -40.04 151.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.53 103.93 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.43 HG12 HG12 ' A' ' 191' ' ' ILE . 4.4 t -113.23 121.06 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -156.92 152.42 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -51.5 139.22 20.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.05 -42.66 80.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.11 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -156.83 163.63 38.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.3 t -162.9 169.85 19.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.153 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -123.57 79.7 1.72 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -56.92 127.74 33.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -109.54 113.97 27.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.6 t -121.43 155.29 35.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 165.86 74.59 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.57 -45.92 15.45 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.711 2.274 . . . . 0.0 112.337 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.5 m -138.67 160.47 39.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 17.6 t -139.35 117.89 12.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.478 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 96.5 p -78.82 140.03 38.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.869 0.366 . . . . 0.0 110.843 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.8 p -64.89 114.57 4.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.824 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.91 -145.92 8.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.436 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 t -82.56 136.42 34.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 110.856 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.7 p -103.21 -53.37 2.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 170.03 144.52 4.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 m -49.11 -57.42 6.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.866 0.365 . . . . 0.0 110.826 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -148.31 152.3 36.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.4 m -120.82 45.4 2.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.883 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -110.04 115.42 29.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 163.32 -84.84 0.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.43 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -140.72 93.34 0.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -46.12 130.91 10.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.28 118.58 22.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.903 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 181' ' ' PHE . 21.9 ttm105 -124.69 42.5 3.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.518 ' HD3' ' CD1' ' A' ' 178' ' ' PHE . 7.7 ttmt -117.75 139.5 50.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.733 HD21 ' HB1' ' A' ' 187' ' ' ALA . 55.5 mt -112.32 139.34 47.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -109.23 116.01 31.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.13 146.36 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.545 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -140.13 179.86 18.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 mmt 57.3 48.23 15.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.803 0.335 . . . . 0.0 110.879 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 48.9 mt -108.27 162.7 13.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -103.77 172.17 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -88.64 16.05 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -106.92 -18.21 13.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.976 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -87.77 147.92 24.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.951 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.3 p -124.77 -179.19 4.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.554 ' HG3' HG23 ' A' ' 165' ' ' VAL . 39.2 mp0 -63.21 -32.57 74.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -66.43 -48.02 71.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -50.92 -49.53 59.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.802 HG13 ' CE1' ' A' ' 154' ' ' PHE . 83.6 t -68.33 -50.35 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 mt -56.59 -32.24 65.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.421 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 11.7 mmm180 -81.24 -36.12 30.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.901 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.7 tp -85.01 -14.04 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.802 ' CE1' HG13 ' A' ' 150' ' ' VAL . 4.1 m-85 -100.05 -37.25 9.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 3.7 mt-30 -47.19 -48.91 54.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.635 0.731 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.8 Cg_exo -47.97 -17.08 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.428 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.6 m-85 -100.43 -30.28 11.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 173.86 158.69 18.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.512 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.52 135.74 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 111.156 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.689 HD11 ' CB ' ' A' ' 154' ' ' PHE . 55.2 mt -111.75 125.22 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -69.89 -65.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -143.31 141.03 30.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.617 ' SG ' HG22 ' A' ' 179' ' ' VAL . 44.1 t -132.22 108.43 9.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.8 m -109.66 128.13 55.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.154 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.554 HG23 ' HG3' ' A' ' 147' ' ' GLU . 73.4 t -91.91 135.91 25.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.165 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 47.1 mt -76.16 142.95 41.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -154.04 171.67 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -104.12 -171.97 25.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.0 -9.28 17.98 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.673 2.249 . . . . 0.0 112.341 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -90.92 -37.29 13.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 132.06 -19.19 4.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.459 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 12.8 t -67.9 170.66 7.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 14.3 t -106.53 144.38 33.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -83.97 20.34 1.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 58.38 24.17 55.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 17.9 m -147.77 165.08 31.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.842 0.353 . . . . 0.0 110.902 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.62 -179.06 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.518 ' CD1' ' HD3' ' A' ' 135' ' ' LYS . 57.7 m-85 -131.31 124.91 31.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.617 HG22 ' SG ' ' A' ' 163' ' ' CYS . 45.7 t -119.96 123.32 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -108.32 119.24 38.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.496 ' O ' ' CD ' ' A' ' 134' ' ' ARG . 30.5 m-85 -92.98 164.98 13.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.1 m -72.43 -32.37 66.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 t -133.37 160.28 37.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.827 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -64.72 -59.82 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 186' ' ' GLU . 53.0 m -38.68 -64.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.8 OUTLIER -36.6 -53.0 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.733 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.22 -59.8 4.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.101 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 187' ' ' ALA . 1.5 mm-40 -37.3 -47.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 190' ' ' ALA . . . -62.47 -67.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -35.56 -38.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.051 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.632 HD11 HD22 ' A' ' 136' ' ' LEU . 93.1 mt -62.74 -73.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.111 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -55.33 -14.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.428 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.69 -41.08 14.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 19.1 mt -118.43 30.54 7.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -99.51 122.98 43.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 45.75 20.16 0.39 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.46 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 60.7 p -100.04 -35.71 9.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.819 0.342 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -100.1 154.82 18.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 205' ' ' SER . 49.3 m -134.78 86.33 2.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 12.4 mmt -47.11 138.31 7.75 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.582 0.706 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -48.62 153.03 3.7 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.734 2.29 . . . . 0.0 112.331 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.55 -35.67 2.45 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.537 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.93 136.09 34.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.077 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 84.0 p -85.69 -13.93 46.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 199' ' ' THR . 7.7 m -100.0 157.72 16.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.867 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 6.1 p -79.81 -178.75 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 139' ' ' GLY . 15.7 tp -77.31 149.22 35.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.48 ' CG1' ' HE2' ' A' ' 210' ' ' LYS . 73.8 t -118.0 103.93 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.444 HG12 HG12 ' A' ' 191' ' ' ILE . 11.9 t -113.48 123.15 68.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.48 ' HE2' ' CG1' ' A' ' 208' ' ' VAL . 0.9 OUTLIER -159.96 148.48 17.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -47.68 157.36 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 213' ' ' ASP . . . -78.3 138.75 38.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 212' ' ' ALA . 2.5 p-10 -36.94 128.52 0.88 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.839 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 59.1 p -109.76 109.47 20.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -154.46 142.33 20.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -156.41 105.47 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -144.87 136.82 25.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.5 t -134.1 110.2 9.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 50.97 -146.37 9.85 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.22 98.67 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.655 2.237 . . . . 0.0 112.345 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 80.1 p -174.4 126.22 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 30.5 p -103.22 132.55 49.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.453 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.3 m -90.3 121.2 32.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.799 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.4 t -141.8 128.9 20.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.819 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.72 124.42 0.98 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.478 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.3 m -82.29 101.84 10.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.862 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 61.4 p -99.52 42.31 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.85 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 122.68 45.0 0.32 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.442 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.6 t -49.65 136.74 16.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.329 . . . . 0.0 110.856 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 127' ' ' GLU . 1.2 pp20? -83.14 43.15 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.867 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 m -83.9 88.96 7.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -86.82 176.7 7.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.878 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.01 -173.58 29.67 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.497 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -61.65 -142.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.48 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.437 ' O ' ' CG ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -150.72 160.66 43.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.516 ' HB2' ' CD1' ' A' ' 211' ' ' PHE . 5.1 m-20 -162.29 117.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 tpp85 -65.84 -22.93 66.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -100.14 138.65 36.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.845 HD21 ' HB1' ' A' ' 187' ' ' ALA . 38.4 mt -121.46 157.8 29.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.928 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -125.7 119.28 27.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 29.5 t -101.46 148.12 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -141.58 -179.65 18.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.9 mmt 57.95 39.88 26.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.454 ' CD2' HD11 ' A' ' 207' ' ' LEU . 67.3 mt -97.04 158.24 15.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 21.2 t-20 -113.16 170.99 7.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -79.49 44.65 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -133.01 -40.75 0.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.448 ' CD ' ' SD ' ' A' ' 200' ' ' MET . 31.2 mt-30 -81.89 121.84 26.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 57.1 p -106.02 173.79 6.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 165' ' ' VAL . 1.8 mp0 -47.78 -46.51 30.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -53.84 -51.79 62.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -47.75 -68.0 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.847 HG13 ' CE1' ' A' ' 154' ' ' PHE . 96.8 t -47.16 -54.99 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.795 HD21 ' HB2' ' A' ' 163' ' ' CYS . 32.1 mt -52.18 -39.77 60.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -70.2 -38.68 75.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.405 HD21 ' OE1' ' A' ' 198' ' ' GLN . 13.5 tp -85.08 -9.09 58.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.855 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -100.04 -38.94 8.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.1 tm0? -46.99 -47.01 54.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.627 0.727 . . . . 0.0 110.958 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.5 Cg_exo -47.94 -20.34 2.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.695 2.263 . . . . 0.0 112.304 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -100.04 -43.35 6.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.65 156.37 27.53 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.8 t -74.75 96.9 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 111.129 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.855 HD11 ' CB ' ' A' ' 154' ' ' PHE . 41.9 mt -66.3 141.52 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -94.42 -54.39 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -141.52 141.76 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.795 ' HB2' HD21 ' A' ' 151' ' ' LEU . 43.2 t -133.97 143.61 48.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 165' ' ' VAL . 96.8 m -148.96 154.08 38.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.169 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.595 HG13 ' HB2' ' A' ' 177' ' ' ALA . 58.0 t -124.9 142.94 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.121 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 59.1 mt -85.54 139.32 31.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -146.2 158.38 43.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -77.82 -166.89 28.72 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.47 -47.99 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.718 2.279 . . . . 0.0 112.331 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -70.26 -31.39 68.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 118.16 44.4 0.53 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 173' ' ' SER . 73.9 p -113.55 96.98 6.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 110.817 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 172' ' ' SER . 46.8 t -34.62 135.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.889 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -94.9 10.75 34.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 61.56 24.52 64.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.442 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 4.9 p -139.65 138.43 36.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 0.0 110.906 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.595 ' HB2' HG13 ' A' ' 165' ' ' VAL . . . -150.57 168.04 25.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -121.45 144.86 48.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.02 132.37 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.694 ' O ' HG23 ' A' ' 160' ' ' ILE . 23.5 ttmt -112.36 128.25 56.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.513 ' HE1' HD12 ' A' ' 136' ' ' LEU . 37.7 m-85 -100.27 162.51 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.0 p -67.09 -23.14 65.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.8 t -151.71 150.98 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.873 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -51.26 -57.45 8.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 186' ' ' GLU . 63.6 m -38.19 -66.6 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.08 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.3 OUTLIER -37.97 -51.09 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.845 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.29 -57.27 13.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.079 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.461 ' HA ' HD12 ' A' ' 191' ' ' ILE . 0.7 OUTLIER -40.44 -43.41 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 191' ' ' ILE . . . -65.77 -68.48 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.082 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -35.57 -33.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.575 HD11 HD22 ' A' ' 136' ' ' LEU . 83.3 mt -66.62 -70.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -62.04 -15.62 45.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.859 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -90.44 -22.7 21.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.077 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.733 HD22 ' NE2' ' A' ' 198' ' ' GLN . 75.7 mt -132.51 23.38 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.8 t60 -89.04 124.59 34.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.447 ' C ' ' HB3' ' A' ' 206' ' ' SER . . . 36.18 29.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.543 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 195' ' ' HIS . 76.4 p -100.14 -35.27 9.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.328 . . . . 0.0 110.846 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.733 ' NE2' HD22 ' A' ' 194' ' ' LEU . 22.4 mt-30 -100.28 155.05 17.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 205' ' ' SER . 25.7 m -129.18 81.51 2.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.448 ' SD ' ' CD ' ' A' ' 145' ' ' GLN . 14.9 mmt -45.67 141.03 4.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.547 0.689 . . . . 0.0 110.93 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.415 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 74.5 Cg_exo -47.97 153.05 2.83 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.708 2.272 . . . . 0.0 112.312 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 79.24 -41.79 2.29 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.446 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.15 140.06 31.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.346 . . . . 0.0 111.064 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 25.2 t -94.8 -8.82 36.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 199' ' ' THR . 2.8 t -100.06 172.48 7.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.447 ' HB3' ' C ' ' A' ' 196' ' ' GLY . 19.4 m -97.96 145.93 25.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.454 HD11 ' CD2' ' A' ' 141' ' ' LEU . 8.6 tp -42.31 154.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.934 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 73.3 t -125.66 104.08 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.4 t -111.72 122.25 65.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -151.31 146.94 26.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 133' ' ' ASP . 34.2 m-85 -47.39 135.33 10.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -87.1 162.11 17.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.1 t0 64.41 42.4 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 27.2 p -64.93 130.55 43.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -104.1 106.08 16.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' A' ' 217' ' ' GLU . 14.2 tptm -84.94 146.51 27.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.422 ' N ' ' HG3' ' A' ' 216' ' ' LYS . 7.6 mm-40 -100.46 124.99 46.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 87.7 p -98.93 91.66 5.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 69.65 65.4 2.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.98 173.32 14.65 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.739 2.292 . . . . 0.0 112.367 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.0 t -97.86 -49.35 4.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 51.3 p -117.33 156.18 28.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.827 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.514 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 m 55.56 44.39 26.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 0.0 110.859 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.0 t -161.41 140.99 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.09 179.12 27.45 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.459 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.2 m -81.79 83.13 7.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -47.75 119.1 2.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.62 137.63 5.86 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.53 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.2 p -63.48 137.31 58.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.07 91.1 3.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -62.59 97.89 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 61.73 41.23 12.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.87 119.5 6.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.474 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.45 89.32 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.472 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -54.5 6.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 0.0 110.902 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -48.83 159.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -118.97 40.02 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -125.91 152.09 46.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 1.034 HD21 ' HB1' ' A' ' 187' ' ' ALA . 19.8 mt -137.69 145.82 43.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -109.15 110.77 22.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.4 t -97.68 147.57 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.661 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -144.14 -175.81 17.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.519 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.2 mmt 56.45 48.24 17.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.5 mt -109.06 165.1 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.931 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -106.75 174.03 6.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -87.71 16.3 5.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -105.99 -22.92 12.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.475 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 16.3 mt-30 -82.25 149.67 27.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.8 p -130.94 172.69 11.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -50.54 -51.03 51.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -52.16 -52.79 49.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -42.53 -67.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.556 HG13 ' CE1' ' A' ' 154' ' ' PHE . 35.9 t -52.87 -51.28 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.136 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.677 HD21 ' CB ' ' A' ' 163' ' ' CYS . 39.1 mt -54.04 -32.17 53.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -79.61 -37.04 37.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.7 tp -84.35 -14.17 50.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.802 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.4 m-85 -100.22 -35.97 9.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.534 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 3.7 mt-30 -47.18 -49.0 53.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.549 0.69 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.5 Cg_exo -47.98 -17.13 0.71 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.425 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.2 m-85 -100.03 -34.14 10.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.9 169.59 42.55 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.481 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.38 107.75 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 111.126 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.802 HD11 ' CB ' ' A' ' 154' ' ' PHE . 82.7 mt -79.15 126.27 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.4 ' HB2' ' CD ' ' A' ' 180' ' ' LYS . 3.2 m-20 -86.47 -65.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -114.65 126.02 54.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.677 ' CB ' HD21 ' A' ' 151' ' ' LEU . 16.7 t -133.15 127.11 33.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.88 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.3 m -146.38 149.66 34.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.407 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 77.7 t -114.53 137.89 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 176' ' ' CYS . 27.2 mt -71.97 148.69 45.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 15.1 mtt85 -158.76 147.31 18.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.56 174.08 54.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.537 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.28 -56.41 2.94 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.397 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -82.74 42.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 40.81 73.05 0.21 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.459 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 173' ' ' SER . 8.3 t -128.29 94.5 3.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.88 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 172' ' ' SER . 1.1 t -35.28 117.35 0.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -81.39 3.64 23.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.1 24.69 76.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.51 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.411 ' HB2' HD12 ' A' ' 166' ' ' LEU . 1.8 m -146.78 154.78 41.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 110.866 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -156.45 176.07 13.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.058 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -129.02 124.14 34.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.469 HG11 ' HD2' ' A' ' 154' ' ' PHE . 39.1 t -117.83 134.72 60.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 160' ' ' ILE . 30.6 ttmt -114.99 144.28 43.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -118.9 161.13 20.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 17.3 t -59.16 -34.25 71.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.5 t -142.42 171.79 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.416 ' CG ' ' N ' ' A' ' 185' ' ' THR . 44.5 p-80 -64.76 -54.95 23.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.416 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 48.7 m -36.84 -63.92 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 185' ' ' THR . 23.8 mm-40 -37.8 -53.39 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 1.034 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -55.9 -59.13 5.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -40.26 -41.51 1.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -71.4 -63.73 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.68 -34.02 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.112 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 136' ' ' LEU . 72.5 mt -65.89 -71.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -59.15 -13.73 8.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.425 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -88.98 -32.05 17.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.097 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.442 HD13 ' CE1' ' A' ' 154' ' ' PHE . 32.5 mt -125.78 24.98 6.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.9 t60 -86.68 123.04 31.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.56 32.94 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.455 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 195' ' ' HIS . 82.6 p -100.13 -35.14 9.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 110.874 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.21 155.8 17.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 205' ' ' SER . 90.2 m -132.61 77.51 1.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.475 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 11.5 mmt -39.92 139.13 1.0 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.601 0.715 . . . . 0.0 110.845 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.21 150.49 5.17 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.732 2.288 . . . . 0.0 112.358 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.48 -36.22 2.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -89.58 136.92 32.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.322 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 15.7 t -90.77 -10.87 41.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.847 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 199' ' ' THR . 4.9 t -99.51 172.08 7.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.4 m -99.82 154.79 18.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 139' ' ' GLY . 13.5 tp -54.36 138.16 40.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.468 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 54.1 t -108.09 117.09 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.146 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.1 t -123.23 124.8 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.468 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 14.6 ptpt -160.8 144.67 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -47.39 153.28 0.53 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.09 154.21 18.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.095 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 52.93 52.95 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.845 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 47.6 m -100.34 137.6 38.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -137.86 127.33 24.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 10.1 ttpp -129.24 41.77 3.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.67 -49.27 66.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 22.9 t -65.12 -53.11 50.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.828 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.83 161.66 9.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.61 169.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.5 t -87.62 -55.73 3.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.6 t -100.6 114.98 29.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.468 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.6 t -171.63 148.22 2.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.6 m -162.16 118.99 2.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -135.92 58.25 0.67 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.9 p -140.4 164.16 30.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.915 0.388 . . . . 0.0 110.845 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.2 m -138.57 132.06 30.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 141.86 117.26 1.3 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.505 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.0 m -56.34 144.05 32.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.364 . . . . 0.0 110.824 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.66 82.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.8 m -44.93 -45.07 10.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.429 ' HB3' ' NH1' ' A' ' 129' ' ' ARG . 12.2 ttp-105 -105.95 87.08 2.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.87 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.78 -42.01 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.477 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -88.92 133.76 12.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.518 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.21 74.13 0.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.826 0.346 . . . . 0.0 110.87 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -120.08 129.01 54.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -112.8 40.4 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -128.72 127.15 41.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.732 HD22 HD11 ' A' ' 191' ' ' ILE . 65.8 mt -119.11 152.21 36.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -119.78 121.02 38.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.23 144.05 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.118 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -138.08 -172.41 12.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.5 mmt 54.05 51.48 14.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.333 . . . . 0.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.2 mt -111.06 155.42 22.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.462 ' ND2' ' HD2' ' A' ' 201' ' ' PRO . 3.2 p30 -91.58 159.49 15.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -81.95 42.67 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.425 ' HG2' ' CG ' ' A' ' 142' ' ' ASN . 6.2 pt20 -133.22 -35.02 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.413 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 34.0 mt-30 -71.12 150.27 45.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.0 p -119.59 -177.85 3.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.411 ' HG3' HG23 ' A' ' 165' ' ' VAL . 21.9 mt-10 -63.03 -46.88 85.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -54.71 -50.82 67.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -42.72 -47.68 5.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.624 HG13 ' CE1' ' A' ' 154' ' ' PHE . 95.8 t -70.31 -45.78 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.177 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 163' ' ' CYS . 86.0 mt -57.57 -32.44 67.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.403 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 16.1 mmt180 -81.35 -35.39 30.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.2 tp -84.32 -16.09 44.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.717 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -100.18 -35.3 9.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.532 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 6.1 mt-30 -47.2 -49.04 53.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.6 0.714 . . . . 0.0 110.865 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.7 Cg_exo -47.96 -17.02 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.707 2.272 . . . . 0.0 112.303 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -99.9 -36.53 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.62 163.38 35.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.528 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.62 104.84 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.717 HD11 ' CB ' ' A' ' 154' ' ' PHE . 62.2 mt -76.04 128.12 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -76.48 -54.33 6.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -147.07 145.3 29.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.595 ' HB2' HD21 ' A' ' 151' ' ' LEU . 43.1 t -133.74 148.0 51.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.439 ' O ' ' HB1' ' A' ' 177' ' ' ALA . 24.0 m -151.49 151.5 31.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.161 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 177' ' ' ALA . 68.4 t -122.63 146.98 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.755 HD12 ' SG ' ' A' ' 176' ' ' CYS . 79.3 mt -87.19 139.99 30.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.491 ' HD3' ' N ' ' A' ' 173' ' ' SER . 6.7 mmt-85 -133.79 138.85 45.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.85 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -75.33 160.49 52.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.455 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.13 -37.75 18.47 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.259 . . . . 0.0 112.337 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -88.58 40.35 0.96 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 39.77 56.73 2.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.499 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 173' ' ' SER . 4.2 t -136.69 110.38 8.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.491 ' N ' ' HD3' ' A' ' 167' ' ' ARG . 22.6 t -35.46 137.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -97.3 26.88 4.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 49.55 30.57 13.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.48 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.755 ' SG ' HD12 ' A' ' 166' ' ' LEU . 7.1 p -149.79 149.47 30.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 164' ' ' THR . . . -160.03 161.18 33.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -113.71 133.26 55.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 70.4 t -122.81 126.09 73.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 160' ' ' ILE . 15.6 tttp -108.63 123.18 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -97.52 168.34 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.866 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 84.2 p -68.92 -36.72 78.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.8 m -135.25 171.79 13.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.495 ' H ' ' CD2' ' A' ' 184' ' ' HIS . 7.8 p80 -72.17 -44.71 62.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 88.4 m -52.24 -59.46 4.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -41.54 -49.68 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -58.05 -59.17 5.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -38.87 -47.37 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -62.42 -63.19 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.37 -39.37 1.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.732 HD11 HD22 ' A' ' 136' ' ' LEU . 73.8 mt -60.99 -72.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -57.34 -12.95 2.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -87.5 -37.74 16.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.086 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 154' ' ' PHE . 18.5 mt -120.22 23.53 10.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.0 t60 -83.36 123.03 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.7 33.34 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.9 p -100.31 -36.51 9.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.798 0.332 . . . . 0.0 110.859 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.55 HE21 HD22 ' A' ' 194' ' ' LEU . 31.7 mt-30 -100.4 160.66 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 37.9 m -134.16 81.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.413 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 15.9 mmt -41.38 137.47 1.68 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.56 0.695 . . . . 0.0 110.884 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.462 ' HD2' ' ND2' ' A' ' 142' ' ' ASN . 75.5 Cg_exo -48.74 147.06 10.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 0.0 112.317 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.65 -34.44 3.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.482 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -93.33 141.4 28.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.069 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 57.7 m -93.52 -12.81 28.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 66.7 m -99.53 157.17 16.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.9 m -78.36 172.13 14.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 196' ' ' GLY . 13.7 tp -71.97 140.15 48.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.2 t -106.24 106.72 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.7 t -117.99 120.3 64.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -159.54 156.29 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -56.23 131.85 49.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -47.66 -69.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -172.95 146.35 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.5 p -115.35 118.65 33.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.76 108.47 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -86.39 114.28 23.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -113.93 -51.25 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 67.5 p -163.41 175.99 10.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 145.56 73.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.53 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.52 131.76 12.51 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.713 2.276 . . . . 0.0 112.321 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 38.4 t -88.96 -53.91 4.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.905 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 72.1 p -38.98 -43.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.471 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.0 p -90.05 158.09 17.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.922 0.391 . . . . 0.0 110.862 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.1 m -77.73 170.55 16.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.3 72.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 t -122.46 113.95 20.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 82.1 p -137.4 114.79 11.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.827 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 169.91 -60.93 0.18 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.7 p -98.2 95.72 7.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 110.843 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -129.46 111.85 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 129' ' ' ARG . 5.6 p -93.42 136.42 33.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -34.89 -60.68 0.44 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.19 -131.65 2.92 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.504 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.9 61.17 7.48 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.472 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -111.92 83.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.0 110.872 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.76 114.43 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 183' ' ' SER . 16.5 ttm180 -100.6 32.35 3.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -117.96 140.77 49.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.665 ' CD2' HD11 ' A' ' 191' ' ' ILE . 54.8 mt -117.26 157.6 25.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -125.25 122.11 36.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.9 140.88 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -136.23 -176.98 14.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.5 mmt 60.17 38.26 20.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.2 mt -99.02 154.61 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 144' ' ' GLN . 23.1 p30 -98.11 170.29 9.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -80.57 -0.18 36.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.409 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 57.0 mt-30 -102.05 32.68 3.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -134.99 154.18 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.4 p -132.25 167.0 20.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.558 ' CG ' HG23 ' A' ' 165' ' ' VAL . 50.1 mt-10 -54.41 -44.83 72.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -53.74 -45.9 70.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -50.3 -55.2 16.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.786 HG13 ' CE1' ' A' ' 154' ' ' PHE . 71.8 t -60.87 -46.3 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.901 HD21 ' CB ' ' A' ' 163' ' ' CYS . 35.1 mt -57.97 -39.09 77.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.906 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -70.08 -38.87 75.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 15.9 tp -84.05 -10.32 57.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.888 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.17 -36.4 9.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.557 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -46.92 -47.03 53.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.638 0.732 . . . . 0.0 110.938 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.0 Cg_exo -47.99 -18.85 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.695 2.263 . . . . 0.0 112.314 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.406 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 75.8 m-85 -100.32 -38.07 8.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -172.49 162.7 34.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.8 t -76.41 103.4 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 111.102 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.888 HD11 ' CB ' ' A' ' 154' ' ' PHE . 20.7 mt -73.4 142.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.083 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -103.13 -61.62 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -114.18 119.31 36.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.901 ' CB ' HD21 ' A' ' 151' ' ' LEU . 25.5 t -134.14 121.0 20.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -141.37 151.67 43.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.558 HG23 ' CG ' ' A' ' 147' ' ' GLU . 95.0 t -116.16 139.93 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 60.0 mt -79.51 147.06 32.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -151.25 170.46 19.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -100.43 171.6 23.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.97 -50.42 9.82 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.257 . . . . 0.0 112.361 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.14 -38.52 86.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.15 -39.36 1.63 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 63.9 m -41.98 146.61 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.82 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.9 t -79.47 143.43 34.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -85.86 12.83 8.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.78 76.01 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -139.37 153.79 47.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 110.862 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.476 ' HB2' HG13 ' A' ' 165' ' ' VAL . . . -161.94 157.46 23.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -109.2 144.65 37.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.615 HG11 ' HD2' ' A' ' 154' ' ' PHE . 59.0 t -134.86 126.62 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.13 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 160' ' ' ILE . 11.6 tttp -113.8 123.94 51.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -99.79 162.95 12.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.8 t -66.28 -37.34 85.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 134' ' ' ARG . 1.2 t -132.83 158.09 43.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.87 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.5 ' CG ' ' N ' ' A' ' 185' ' ' THR . 26.2 p-80 -59.24 -53.61 56.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.5 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 26.3 m -45.59 -52.73 10.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -47.27 -45.25 23.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.533 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -64.37 -59.27 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.407 ' HA ' HD12 ' A' ' 191' ' ' ILE . 1.8 mm-40 -40.19 -38.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -69.53 -63.84 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.071 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.32 -31.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.665 HD11 ' CD2' ' A' ' 136' ' ' LEU . 74.7 mt -69.44 -71.51 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -56.73 -15.78 5.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.816 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.406 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -87.91 -34.93 17.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.471 ' HB3' ' NE2' ' A' ' 198' ' ' GLN . 26.0 mt -122.39 25.55 8.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.917 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.9 t60 -89.04 122.18 32.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.862 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.49 32.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 195' ' ' HIS . 60.3 p -100.14 -37.08 9.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.844 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.697 ' NE2' HD22 ' A' ' 207' ' ' LEU . 10.4 pt20 -100.37 161.77 13.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 205' ' ' SER . 27.0 m -131.19 84.59 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 16.9 mmt -39.19 139.2 0.81 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.555 0.693 . . . . 0.0 110.856 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.27 137.94 23.66 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.677 2.251 . . . . 0.0 112.331 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.41 -49.0 3.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.43 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -69.93 139.36 52.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.1 m -92.82 -8.63 42.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 199' ' ' THR . 4.6 t -99.94 170.89 8.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 25.0 m -100.14 145.05 28.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.697 HD22 ' NE2' ' A' ' 198' ' ' GLN . 10.9 tp -44.86 143.72 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.5 t -115.67 108.57 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.42 HG12 HG12 ' A' ' 191' ' ' ILE . 15.8 t -115.77 121.61 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -157.27 148.35 21.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -45.87 154.54 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.08 144.14 31.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.057 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 51.01 46.44 26.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.8 m -125.96 92.5 3.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.149 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -77.15 170.42 16.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.85 145.95 47.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -161.76 154.26 19.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 62.8 p -153.46 119.85 5.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 118.35 96.91 1.81 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.91 -28.06 9.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 0.0 112.357 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 66.2 m -118.5 145.27 45.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 30.2 p -101.34 157.31 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.49 179.967 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 t 57.28 42.18 25.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.8 p -51.28 -51.95 49.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.3 -43.45 2.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 t -81.98 108.71 15.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.8 p -47.84 118.65 2.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 172.31 104.84 0.18 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.0 p -57.53 146.94 28.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.853 0.359 . . . . 0.0 110.828 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.6 OUTLIER -45.21 166.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.888 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.5 m -102.6 168.39 9.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.429 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 21.3 mtm105 -150.77 154.04 36.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 132.2 -60.55 0.67 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -149.63 92.68 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.502 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 163.06 9.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -133.93 119.81 19.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.1 mtm-85 -93.98 73.87 4.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.918 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 136' ' ' LEU . 13.3 tppt? -155.64 157.79 37.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.834 ' CD2' HD11 ' A' ' 191' ' ' ILE . 63.6 mt -139.2 135.57 34.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -102.45 117.13 34.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 209' ' ' VAL . 5.9 t -106.53 145.43 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.124 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.552 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -140.03 -164.18 9.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.507 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.9 mmt 48.8 49.77 18.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.668 HD23 ' HG3' ' A' ' 200' ' ' MET . 58.4 mt -110.31 153.31 25.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.645 HD21 ' N ' ' A' ' 201' ' ' PRO . 0.4 OUTLIER -95.12 173.96 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -90.38 42.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -134.4 -35.34 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.448 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 26.7 mt-30 -70.88 145.8 50.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.9 p -121.51 -178.53 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.58 ' HG3' HG23 ' A' ' 165' ' ' VAL . 6.1 mp0 -64.69 -35.07 79.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -64.2 -35.67 81.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.56 -65.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.899 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.85 HG13 ' CE1' ' A' ' 154' ' ' PHE . 92.8 t -53.72 -53.02 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.132 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 163' ' ' CYS . 70.3 mt -52.46 -39.36 61.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -69.62 -39.5 77.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.5 tp -84.7 -9.28 58.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.89 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -99.98 -37.27 9.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.2 tm0? -47.29 -46.76 57.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.597 0.713 . . . . 0.0 110.934 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.3 Cg_exo -47.99 -17.18 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.663 2.242 . . . . 0.0 112.307 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' HE2' HD11 ' A' ' 194' ' ' LEU . 73.6 m-85 -100.27 -32.2 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.95 171.71 43.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.8 t -80.79 105.27 10.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.869 0.366 . . . . 0.0 111.072 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.89 HD11 ' CB ' ' A' ' 154' ' ' PHE . 47.5 mt -75.35 130.06 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.34 -61.31 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.838 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -146.37 145.25 30.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.732 ' CB ' HD21 ' A' ' 151' ' ' LEU . 16.2 t -133.81 118.36 17.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 37.9 m -124.48 140.1 53.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.154 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.58 HG23 ' HG3' ' A' ' 147' ' ' GLU . 97.6 t -108.15 138.09 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.1 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.589 HD12 ' SG ' ' A' ' 176' ' ' CYS . 37.4 mt -77.32 148.22 35.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.482 ' HD3' ' N ' ' A' ' 173' ' ' SER . 4.8 mmt85 -142.15 136.11 29.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -59.32 -164.08 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.468 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.59 -46.6 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.736 2.291 . . . . 0.0 112.34 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.69 41.12 1.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 53.84 60.95 7.62 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.534 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 173' ' ' SER . 72.1 m -131.71 90.77 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.849 0.357 . . . . 0.0 110.851 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.482 ' N ' ' HD3' ' A' ' 167' ' ' ARG . 29.2 t -34.53 128.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.881 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -85.98 24.83 1.22 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.886 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 54.69 30.87 52.65 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.472 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.589 ' SG ' HD12 ' A' ' 166' ' ' LEU . 13.7 p -144.27 160.57 40.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.823 0.344 . . . . 0.0 110.847 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -166.76 171.09 11.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -124.53 130.33 52.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.24 131.24 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -114.38 122.62 47.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.546 ' CE1' HD12 ' A' ' 136' ' ' LEU . 37.5 m-85 -94.95 163.96 13.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.8 p -70.46 -26.42 63.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.0 t -143.25 151.48 40.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.544 ' CG ' ' N ' ' A' ' 185' ' ' THR . 17.2 p80 -55.81 -51.62 66.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.544 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 66.4 m -43.03 -66.37 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.155 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 185' ' ' THR . 0.3 OUTLIER -37.2 -52.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.577 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -55.68 -59.26 5.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.545 ' HA ' HD12 ' A' ' 191' ' ' ILE . 1.8 mm-40 -38.7 -48.17 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.2 -63.28 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -40.09 -30.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.072 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.834 HD11 ' CD2' ' A' ' 136' ' ' LEU . 72.5 mt -69.51 -71.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -64.63 -9.28 18.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -90.29 -25.59 20.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.431 HD11 ' HE2' ' A' ' 157' ' ' PHE . 24.6 mt -133.29 16.11 4.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 191' ' ' ILE . 2.0 t60 -87.89 126.45 35.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.854 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 45.66 20.15 0.37 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.526 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 60.4 p -100.38 -37.35 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 199' ' ' THR . 1.5 tt0 -100.44 156.26 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 205' ' ' SER . 85.9 m -127.61 80.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.668 ' HG3' HD23 ' A' ' 141' ' ' LEU . 20.1 mmt -37.03 137.85 0.56 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.573 0.701 . . . . 0.0 110.859 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.645 ' N ' HD21 ' A' ' 142' ' ' ASN . 72.8 Cg_exo -47.21 154.29 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.7 2.267 . . . . 0.0 112.343 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.7 -45.92 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.498 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -79.14 136.08 37.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.086 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.4 t -87.48 -11.57 48.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 199' ' ' THR . 71.0 m -99.41 163.66 12.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.817 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 58.8 p -80.91 174.52 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 139' ' ' GLY . 20.1 tp -74.61 155.38 37.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.486 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 49.2 t -122.62 104.35 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 138' ' ' VAL . 12.0 t -118.58 121.53 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.148 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.486 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 12.7 ptpt -159.15 146.5 17.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -40.76 142.98 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -53.43 163.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -58.44 101.7 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 20.8 p -91.82 146.94 23.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -165.72 110.99 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -145.76 153.31 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -161.46 154.01 20.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 46.4 t -145.72 132.34 19.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 153.97 -176.86 31.72 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 221' ' ' SER . 62.5 Cg_endo -76.91 42.27 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.665 2.243 . . . . 0.0 112.357 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 220' ' ' PRO . 60.6 p 37.17 40.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.3 t -69.83 -54.61 12.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.843 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 82.5 p -123.52 146.41 48.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.1 p -76.66 158.56 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.9 160.77 28.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.5 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.7 t -159.28 151.72 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 0.0 110.873 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.0 t -85.99 -60.79 1.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.859 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.72 124.86 0.92 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.532 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.1 t -90.84 126.55 36.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.855 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.64 41.65 3.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.6 m -110.3 153.03 25.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -112.02 99.74 8.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.42 138.81 2.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.489 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.47 -172.4 42.8 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.529 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -148.45 161.6 41.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 39.23 39.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -79.5 45.96 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -126.07 120.55 30.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.761 HD11 ' HB1' ' A' ' 187' ' ' ALA . 78.6 mt -106.97 154.67 20.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -121.59 115.26 22.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.36 149.3 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -142.73 -176.59 16.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.5 mmt 59.28 38.68 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.828 0.347 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 36.1 mt -98.98 153.65 18.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -105.27 164.88 11.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -77.61 47.6 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -133.77 -34.1 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.496 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 6.3 mt-30 -82.31 140.04 33.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 59.6 p -119.22 171.56 8.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -47.94 -51.92 21.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -54.93 26.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -43.14 -65.53 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.573 HG13 ' CE1' ' A' ' 154' ' ' PHE . 71.0 t -49.05 -62.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.885 HD21 ' CB ' ' A' ' 163' ' ' CYS . 29.4 mt -46.85 -37.3 8.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -69.9 -39.78 76.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.8 tp -83.83 -9.83 58.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.861 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.26 -36.19 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -46.99 -47.07 54.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.558 0.694 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 66.1 Cg_exo -47.94 -18.38 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.706 2.271 . . . . 0.0 112.329 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -101.4 -45.33 5.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.05 156.72 27.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 83.1 t -74.86 95.34 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 111.12 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.861 HD11 ' CB ' ' A' ' 154' ' ' PHE . 40.3 mt -65.98 143.74 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.48 -59.7 2.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -138.69 137.15 36.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.885 ' CB ' HD21 ' A' ' 151' ' ' LEU . 42.7 t -134.06 143.3 47.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 99.4 m -151.76 140.34 20.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.477 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 79.0 t -105.31 141.35 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 32.4 mt -81.57 142.2 33.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -150.92 170.89 18.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -97.17 -170.18 33.49 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.509 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.28 -20.36 12.69 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.673 2.249 . . . . 0.0 112.356 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.27 -31.72 21.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 132.07 -30.52 3.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 16.3 t -53.66 157.85 2.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 0.0 110.88 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.9 t -101.47 146.47 27.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.84 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -84.51 0.88 48.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 75.37 30.2 58.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.492 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.18 151.37 30.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.857 0.361 . . . . 0.0 110.891 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -152.91 178.14 9.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -128.87 125.78 38.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.74 123.42 70.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.179 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -106.38 122.26 45.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.46 164.8 12.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.856 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.6 t -66.31 -35.76 81.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.1 t -137.65 168.12 20.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -66.15 -60.06 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 85.7 m -39.67 -52.74 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -47.3 -49.96 22.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.761 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -61.22 -55.97 25.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -39.97 -42.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -68.45 -64.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.52 -35.58 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.631 HD11 HD22 ' A' ' 136' ' ' LEU . 61.8 mt -67.15 -70.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -56.21 -13.59 2.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -89.62 -39.72 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.469 ' HB3' ' NE2' ' A' ' 198' ' ' GLN . 23.1 mt -118.23 29.19 7.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.3 t60 -96.32 122.54 39.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 42.36 24.15 0.2 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.531 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 195' ' ' HIS . 51.3 p -100.26 -37.44 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 0.0 110.877 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.469 ' NE2' ' HB3' ' A' ' 194' ' ' LEU . 1.9 pt20 -100.54 151.18 21.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 205' ' ' SER . 59.9 m -123.97 86.08 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.496 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 16.9 mmt -43.7 139.66 2.71 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.539 0.685 . . . . 0.0 110.895 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.67 151.14 5.38 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 82.31 -47.97 3.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.459 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -77.24 148.53 35.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.09 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 45.1 t -94.86 -17.76 21.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 199' ' ' THR . 4.2 m -100.07 164.71 11.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.921 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.0 p -79.13 -174.91 4.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.875 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 139' ' ' GLY . 13.1 tp -83.41 152.29 25.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -118.15 107.75 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.5 t -116.47 121.24 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.139 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -157.85 149.43 21.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -55.0 152.73 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -91.99 -41.49 10.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.099 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -136.26 126.12 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.603 HG22 ' N ' ' A' ' 215' ' ' ASP . 90.6 m -150.34 164.41 35.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.603 ' N ' HG22 ' A' ' 214' ' ' THR . 5.4 t70 -107.76 -60.36 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -109.36 156.5 19.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -82.08 130.27 35.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t 68.19 37.03 2.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.815 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 45.05 -152.15 0.72 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.76 133.49 13.71 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.627 2.218 . . . . 0.0 112.384 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.1 p -45.98 135.23 7.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 70.9 m -78.71 -60.4 2.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.816 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.975 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 t 63.15 42.17 7.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.2 m -124.93 124.92 43.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.54 -120.32 0.97 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.449 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.4 t -39.33 -44.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.851 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.2 t -72.24 155.02 40.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.807 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 152.42 154.96 6.86 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.506 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.3 m -78.26 139.14 38.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.871 0.367 . . . . 0.0 110.863 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.21 37.38 3.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.7 m -69.15 92.96 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.877 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.92 117.4 19.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 131.29 159.24 9.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.33 121.93 0.8 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.526 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.75 79.37 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.842 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' OD2' HG21 ' A' ' 214' ' ' THR . 0.4 OUTLIER -110.48 138.86 46.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -125.48 48.35 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.506 ' HE2' ' CD1' ' A' ' 178' ' ' PHE . 48.2 tttt -137.04 136.23 38.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.913 HD21 ' HB1' ' A' ' 187' ' ' ALA . 28.8 mt -121.31 152.5 38.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -117.72 114.95 24.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.55 146.77 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -145.33 -178.99 21.31 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.482 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 10.4 mmt 55.59 48.23 19.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.529 ' CD2' HD11 ' A' ' 207' ' ' LEU . 42.4 mt -106.37 165.23 11.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -105.41 165.04 11.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.73 41.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -128.75 -35.67 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.35 152.97 36.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 54.7 p -129.23 178.9 6.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.768 ' HG3' HG23 ' A' ' 165' ' ' VAL . 5.2 mt-10 -57.02 -41.44 78.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.59 -55.03 38.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -43.2 -64.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.595 HG13 ' CE1' ' A' ' 154' ' ' PHE . 66.4 t -49.96 -60.76 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.868 HD21 ' CB ' ' A' ' 163' ' ' CYS . 35.8 mt -47.37 -37.61 11.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -69.48 -40.17 77.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.6 tp -83.81 -10.27 58.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.872 ' HB3' HD11 ' A' ' 160' ' ' ILE . 3.1 m-85 -99.64 -35.54 9.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.566 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.0 tt0 -47.04 -46.96 55.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.601 0.715 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.2 Cg_exo -48.02 -17.13 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.621 2.214 . . . . 0.0 112.349 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.455 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 73.8 m-85 -100.63 -37.06 8.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.12 165.2 38.53 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.8 t -80.79 93.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.785 0.326 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.872 HD11 ' HB3' ' A' ' 154' ' ' PHE . 51.5 mt -65.37 129.31 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -77.77 -64.64 1.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -132.35 137.78 47.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.868 ' CB ' HD21 ' A' ' 151' ' ' LEU . 42.8 t -134.07 139.21 45.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.1 m -144.44 153.88 42.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.153 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.768 HG23 ' HG3' ' A' ' 147' ' ' GLU . 81.6 t -113.41 147.69 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.163 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 37.0 mt -87.87 148.31 24.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -150.2 164.2 36.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.05 -153.18 30.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.499 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.09 -47.72 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.67 2.247 . . . . 0.0 112.303 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -86.87 43.73 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 46.57 39.08 10.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.454 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.0 m -102.89 119.46 38.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.837 0.351 . . . . 0.0 110.823 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.1 t -58.83 133.68 56.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.841 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -89.99 11.64 19.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.928 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 67.68 25.69 73.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.65 153.36 41.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 0.0 110.868 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -156.34 159.21 38.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.506 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 49.1 m-85 -108.98 141.12 41.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.76 125.4 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.673 ' O ' HG23 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -108.65 125.63 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -99.71 162.47 12.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.3 t -63.53 -30.7 71.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.0 m -141.39 168.95 18.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -68.23 -52.45 33.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 99.3 m -44.85 -61.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -40.04 -45.76 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.913 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -64.0 -54.44 34.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.541 ' HA ' HD12 ' A' ' 191' ' ' ILE . 1.2 mm-40 -43.36 -36.18 1.81 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.54 -59.72 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -45.61 -30.07 1.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 188' ' ' GLN . 67.9 mt -68.43 -72.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -59.53 -17.3 31.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.455 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -80.51 -36.38 33.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.553 HD13 ' CE1' ' A' ' 154' ' ' PHE . 14.9 mt -123.28 23.05 9.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.2 t60 -87.24 124.34 33.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.87 30.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.525 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.08 -36.6 9.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.809 0.338 . . . . 0.0 110.872 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.783 ' OE1' HD22 ' A' ' 207' ' ' LEU . 1.6 pt20 -100.37 159.55 15.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 30.0 m -134.47 81.04 1.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.175 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.6 mmt -41.55 140.28 1.35 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.584 0.707 . . . . 0.0 110.865 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.08 139.51 20.62 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.737 2.291 . . . . 0.0 112.328 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 90.47 -47.91 3.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.508 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -78.98 126.84 31.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.761 0.315 . . . . 0.0 111.147 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.8 t -83.26 -7.39 59.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.826 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.8 p -100.11 157.7 16.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.838 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -87.13 144.64 26.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.783 HD22 ' OE1' ' A' ' 198' ' ' GLN . 14.3 tp -44.57 144.63 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.943 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 63.6 t -112.74 114.61 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 15.5 t -125.5 119.59 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.128 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -158.43 150.6 21.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -49.72 148.51 2.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -84.85 163.28 19.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.114 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -61.31 86.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 214' ' ' THR . 15.1 t -89.57 44.91 1.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.146 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -141.14 109.11 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -65.57 -52.64 50.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -101.01 171.93 7.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 81.8 p -83.23 146.14 28.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -64.21 -146.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.515 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.96 122.18 7.06 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.668 2.245 . . . . 0.0 112.322 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.9 p -170.92 176.12 4.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 88.7 p -92.54 141.23 28.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.9 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 -179.951 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.8 t -134.98 167.35 21.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.923 0.392 . . . . 0.0 110.833 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.3 t -93.0 -61.58 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.815 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.08 51.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.9 p -93.9 134.5 36.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.358 . . . . 0.0 110.842 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 82.4 p -100.4 87.35 3.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.93 179.77 43.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.438 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.9 p -143.41 114.32 7.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.885 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -89.78 164.83 14.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.1 p -82.13 154.04 25.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -80.55 -54.19 5.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . 99.56 -42.99 1.88 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.519 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . -35.65 139.22 0.26 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.51 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 133' ' ' ASP . 17.9 ttt180 -122.07 -53.35 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.35 . . . . 0.0 110.867 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 132' ' ' ARG . 1.3 t70 -34.69 110.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -84.33 32.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.549 ' CG ' ' HB3' ' A' ' 212' ' ' ALA . 2.9 tppp? -120.91 156.38 32.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.628 ' CD2' HD11 ' A' ' 191' ' ' ILE . 96.6 mt -136.32 144.94 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -112.92 122.48 47.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 t -113.05 144.45 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.21 -169.01 11.45 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.8 mmt 52.34 39.37 27.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.901 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.8 mt -100.26 145.51 28.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -89.64 -177.76 5.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.17 -7.24 59.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -99.99 29.4 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.936 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.418 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 59.8 mt-30 -127.04 105.56 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.946 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.1 p -103.08 166.32 10.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.475 ' HG3' HG23 ' A' ' 165' ' ' VAL . 5.4 mp0 -43.8 -41.85 5.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -59.55 -48.11 82.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -50.52 -54.43 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.685 HG13 ' CE1' ' A' ' 154' ' ' PHE . 73.6 t -66.62 -55.93 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.618 HD23 HD13 ' A' ' 160' ' ' ILE . 73.6 mt -50.9 -33.61 24.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.422 ' O ' ' CD ' ' A' ' 156' ' ' PRO . 15.2 mmm180 -77.65 -37.51 49.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.2 tp -84.31 -12.84 53.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.868 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.6 m-85 -100.46 -37.21 8.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.52 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 4.6 mt-30 -47.07 -49.31 51.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.541 0.686 . . . . 0.0 110.929 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.94 -17.19 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.717 2.278 . . . . 0.0 112.339 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.515 ' CE1' ' HB1' ' A' ' 193' ' ' ALA . 73.3 m-85 -100.87 -39.98 7.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.77 155.67 27.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 69.6 t -71.43 93.9 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.868 HD11 ' CB ' ' A' ' 154' ' ' PHE . 75.1 mt -61.82 143.44 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -92.44 -59.53 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -140.5 144.44 36.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.524 ' CB ' HD21 ' A' ' 151' ' ' LEU . 3.7 t -134.02 133.14 40.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.7 m -137.2 125.75 23.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.175 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.475 HG23 ' HG3' ' A' ' 147' ' ' GLU . 58.8 t -96.95 151.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.496 HD11 ' HE1' ' A' ' 178' ' ' PHE . 38.4 mt -95.67 136.54 35.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.427 ' C ' ' HG3' ' A' ' 174' ' ' LYS . 18.2 mtt85 -125.71 135.42 52.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -59.16 -166.22 0.15 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.465 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.53 -48.76 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.14 -35.45 59.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.872 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 106.86 50.19 0.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 36.7 t -124.57 -75.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.7 m -174.99 153.5 1.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.427 ' HG3' ' C ' ' A' ' 167' ' ' ARG . 10.4 mttp -107.09 -4.46 18.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.84 24.86 70.98 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.32 160.07 42.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.812 0.339 . . . . 0.0 110.898 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -163.45 158.39 20.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.496 ' HE1' HD11 ' A' ' 166' ' ' LEU . 76.8 m-85 -112.27 132.98 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.22 137.96 55.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 160' ' ' ILE . 23.9 ttmt -119.13 135.88 54.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.603 ' HE1' HD12 ' A' ' 136' ' ' LEU . 43.2 m-85 -107.94 167.93 9.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.5 t -71.44 -23.89 61.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.5 m -143.84 176.23 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.837 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.409 ' CD2' ' H ' ' A' ' 184' ' ' HIS . 10.2 p80 -80.33 -42.23 23.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.812 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.4 m -53.56 -58.0 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -42.92 -47.3 5.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.617 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -59.65 -60.31 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -39.71 -41.67 1.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.39 -63.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.16 -32.69 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.127 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.628 HD11 ' CD2' ' A' ' 136' ' ' LEU . 40.5 mt -66.34 -71.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.138 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -59.25 -10.98 3.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.515 ' HB1' ' CE1' ' A' ' 157' ' ' PHE . . . -96.2 -24.44 16.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.526 HD22 HE22 ' A' ' 198' ' ' GLN . 30.2 mt -131.42 24.42 4.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 191' ' ' ILE . 2.4 t60 -90.6 119.8 31.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.69 33.74 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.49 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 195' ' ' HIS . 38.3 p -100.27 -38.07 8.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.826 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.526 HE22 HD22 ' A' ' 194' ' ' LEU . 18.3 mt-30 -100.53 163.2 12.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 205' ' ' SER . 26.3 m -129.93 84.58 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.418 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 21.4 mmt -40.52 137.9 1.29 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.612 0.72 . . . . 0.0 110.866 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.49 143.89 14.86 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.303 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 82.28 -40.15 2.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.507 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.66 138.85 35.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 90.9 p -92.42 -9.48 41.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 199' ' ' THR . 49.4 m -99.03 167.19 10.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.4 m -92.48 154.1 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 196' ' ' GLY . 11.6 tp -51.55 141.28 16.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.6 t -112.1 111.66 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.3 133.3 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -165.7 144.12 6.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -41.69 155.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.549 ' HB3' ' CG ' ' A' ' 135' ' ' LYS . . . -104.93 115.93 31.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.2 t70 70.5 53.99 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.7 m -126.7 127.5 45.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.155 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -161.44 166.59 27.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.897 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -64.16 112.31 2.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -72.05 -54.63 9.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.7 t -39.36 -47.99 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 106.29 -144.85 15.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.452 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.05 111.74 3.4 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.32 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.7 p -95.15 176.58 6.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.849 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 93.4 p -68.45 112.28 5.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.877 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.9 m -135.43 127.68 30.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.6 m -138.05 120.89 16.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.802 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.93 151.26 10.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.527 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.2 t -58.75 155.49 12.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.8 t -171.75 113.15 0.33 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -175.22 -138.93 2.9 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.513 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.1 m -141.41 144.45 34.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.832 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.87 174.48 11.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 m -71.31 122.67 20.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.419 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 19.4 mtm105 -111.29 117.53 33.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -103.73 -138.91 9.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -49.89 151.31 4.42 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.473 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.09 167.62 19.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 110.893 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -150.78 136.95 18.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.437 ' NH1' ' HB2' ' A' ' 134' ' ' ARG . 20.3 mtm105 -105.41 30.01 6.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.843 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -116.0 141.47 48.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.796 HD21 ' HB1' ' A' ' 187' ' ' ALA . 44.7 mt -120.09 153.78 35.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -120.44 120.13 35.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.2 t -107.69 147.62 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -141.04 -170.54 12.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 8.6 mmt 54.91 34.11 21.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.563 ' CD2' HD11 ' A' ' 207' ' ' LEU . 47.0 mt -93.31 153.52 18.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -106.95 165.58 11.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -77.32 46.9 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -133.81 -34.55 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -81.23 145.48 30.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 77.1 p -125.6 169.86 12.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.468 ' HG3' HG23 ' A' ' 165' ' ' VAL . 9.9 mt-10 -49.57 -46.84 49.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.935 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -54.61 -53.28 56.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -45.56 -65.69 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.885 HG13 ' CE1' ' A' ' 154' ' ' PHE . 95.2 t -48.9 -60.29 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.09 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.925 HD21 ' CB ' ' A' ' 163' ' ' CYS . 35.2 mt -47.53 -40.09 17.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -69.69 -39.42 76.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.458 HD21 HD22 ' A' ' 194' ' ' LEU . 13.1 tp -84.8 -9.1 58.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.885 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.2 m-85 -100.34 -37.32 8.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -47.29 -46.87 57.65 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 0.0 110.877 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.9 Cg_exo -48.0 -18.46 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.654 2.236 . . . . 0.0 112.366 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.457 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 75.5 m-85 -100.38 -47.32 4.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -158.57 164.77 33.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.51 104.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.83 HD11 ' HB3' ' A' ' 154' ' ' PHE . 45.1 mt -76.91 131.47 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.43 -64.38 1.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -122.37 132.21 54.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.925 ' CB ' HD21 ' A' ' 151' ' ' LEU . 34.9 t -132.73 136.79 46.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 165' ' ' VAL . 96.4 m -153.7 152.81 31.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.57 HG22 ' CB ' ' A' ' 177' ' ' ALA . 65.6 t -117.12 148.24 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.09 140.52 29.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -145.19 175.38 10.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -96.43 -155.17 30.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.07 -40.1 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.254 . . . . 0.0 112.312 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 171' ' ' GLY . 12.3 p-10 -107.05 70.94 0.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 170' ' ' ASP . . . 34.82 40.56 0.21 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.486 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.0 m -102.44 97.76 7.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 12.6 t -56.93 142.15 42.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -101.11 26.52 6.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 51.86 29.4 26.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 17.0 p -144.28 151.48 39.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.57 ' CB ' HG22 ' A' ' 165' ' ' VAL . . . -160.18 166.12 30.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -117.72 144.94 44.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 26.6 t -137.51 121.54 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.731 ' O ' HG23 ' A' ' 160' ' ' ILE . 23.1 ttmt -103.89 129.86 51.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.412 ' HE1' HD12 ' A' ' 136' ' ' LEU . 36.4 m-85 -103.66 164.73 11.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 88.2 p -63.49 -33.12 74.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.6 m -141.49 179.05 7.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -75.44 -51.85 12.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 31.0 m -48.83 -53.32 19.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.101 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -47.04 -47.98 22.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.796 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -62.37 -57.57 10.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.132 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.574 ' HA ' HD12 ' A' ' 191' ' ' ILE . 2.3 mm-40 -40.71 -40.67 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.905 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -67.36 -61.1 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.61 -31.67 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.095 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.684 HD11 HD22 ' A' ' 136' ' ' LEU . 74.6 mt -67.5 -71.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.175 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -57.17 -13.64 3.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.834 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.457 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.72 -41.15 14.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 154' ' ' PHE . 33.2 mt -113.51 16.26 18.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -83.03 126.21 32.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 37.94 28.43 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.541 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 195' ' ' HIS . 77.2 p -100.4 -39.61 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.351 . . . . 0.0 110.843 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.616 ' OE1' HD22 ' A' ' 207' ' ' LEU . 6.6 pt20 -100.66 160.83 14.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 205' ' ' SER . 96.3 m -135.0 81.14 1.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.468 ' CE ' ' NE2' ' A' ' 198' ' ' GLN . 26.5 mmt -37.72 137.84 0.67 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.582 0.706 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.77 153.66 3.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 2.286 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 78.33 -42.88 2.21 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.509 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.62 138.23 35.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 111.101 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.9 t -87.22 -13.41 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 199' ' ' THR . 6.0 t -100.08 169.61 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 24.6 p -87.86 -174.81 4.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.616 HD22 ' OE1' ' A' ' 198' ' ' GLN . 11.7 tp -86.86 122.67 31.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.53 109.48 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.101 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 36.4 t -118.22 124.81 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.083 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -164.33 150.6 10.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -46.5 163.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -89.14 152.55 21.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.08 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -42.08 123.8 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 13.8 t -126.04 159.93 31.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.084 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -77.25 96.29 4.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -84.11 145.85 28.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -126.49 42.05 3.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 90.7 p -107.98 171.98 7.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -146.35 159.54 27.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.69 171.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.619 2.212 . . . . 0.0 112.341 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 68.0 m -143.14 158.29 43.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.3 t -126.31 158.05 36.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.508 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 66.0 m -44.09 150.92 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.6 t -68.48 118.36 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.846 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 60.35 94.57 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.503 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.2 m -46.57 167.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.867 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.5 m -97.51 165.59 11.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.884 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 42.27 80.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.472 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.8 m -115.63 165.8 12.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.868 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -79.74 10.6 3.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.9 m -102.66 -41.33 6.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.89 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.81 130.88 4.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -133.87 170.17 22.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.446 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.27 -146.7 20.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.508 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.18 155.09 2.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.797 0.332 . . . . 0.0 110.879 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -94.87 -54.3 3.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.42 ' NH1' ' HB2' ' A' ' 134' ' ' ARG . 23.6 mtm105 48.28 36.1 6.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -133.52 109.82 9.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.978 HD21 ' HB1' ' A' ' 187' ' ' ALA . 37.3 mt -96.41 150.52 20.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -116.13 113.27 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.86 143.71 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.679 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -140.02 -171.56 12.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.491 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.4 mmt 51.6 42.4 29.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 49.6 mt -102.19 157.33 16.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -99.17 168.12 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -84.14 37.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -127.62 -44.05 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -62.9 146.79 52.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 53.5 p -122.81 178.31 5.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' A' ' 165' ' ' VAL . 13.0 mt-10 -58.3 -48.19 81.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -54.18 -50.23 67.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -44.98 -68.91 0.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.69 HG13 ' CE1' ' A' ' 154' ' ' PHE . 46.9 t -49.04 -60.31 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.751 HD23 HD13 ' A' ' 160' ' ' ILE . 35.4 mt -46.48 -38.06 8.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -69.21 -40.4 78.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.93 -10.55 57.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.731 ' CE1' HD13 ' A' ' 194' ' ' LEU . 3.1 m-85 -98.83 -35.75 10.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.3 OUTLIER -47.18 -46.94 56.58 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.551 0.691 . . . . 0.0 110.908 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.6 Cg_exo -48.0 -16.95 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.639 2.226 . . . . 0.0 112.359 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.48 ' CE1' ' HB1' ' A' ' 193' ' ' ALA . 72.7 m-85 -99.85 -46.83 5.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.409 ' HA3' ' CG ' ' A' ' 186' ' ' GLU . . . -160.1 174.49 36.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.5 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.4 t -87.6 102.32 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.751 HD13 HD23 ' A' ' 151' ' ' LEU . 23.7 mt -74.07 134.37 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.46 -60.36 2.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -139.9 142.26 36.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.83 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.719 ' HB2' HD21 ' A' ' 151' ' ' LEU . 9.8 t -134.01 144.78 48.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.6 m -153.81 144.08 22.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.485 HG23 ' HG3' ' A' ' 147' ' ' GLU . 58.0 t -112.23 139.52 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 67.4 mt -76.94 139.63 40.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 20.2 mtt85 -143.78 163.18 34.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.98 -169.97 38.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.479 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.97 -46.62 0.15 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.672 2.248 . . . . 0.0 112.372 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -62.97 -40.1 96.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 125.73 43.66 0.28 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.505 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.0 t -126.49 122.08 34.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.809 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.2 t -61.87 142.24 57.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.848 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -89.63 17.9 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 59.46 28.95 65.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 6.2 p -145.93 156.43 43.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -160.47 172.1 17.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -126.61 124.01 38.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 85.7 t -115.9 130.58 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.693 ' O ' HG23 ' A' ' 160' ' ' ILE . 20.7 ttmt -111.9 131.22 55.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 186' ' ' GLU . 40.9 m-85 -105.77 166.8 10.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.7 t -81.53 -3.14 52.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.0 m -162.96 149.76 12.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.858 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -59.84 -46.04 90.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 45.7 m -48.71 -61.14 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.108 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 181' ' ' PHE . 0.5 OUTLIER -42.33 -51.24 4.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.978 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -57.75 -56.84 16.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.098 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -38.62 -51.51 1.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.955 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.39 -61.21 2.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -40.99 -35.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.786 HD11 HD22 ' A' ' 136' ' ' LEU . 63.4 mt -65.69 -69.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -62.25 -14.56 39.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.91 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.48 ' HB1' ' CE1' ' A' ' 157' ' ' PHE . . . -90.84 -25.03 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.731 HD13 ' CE1' ' A' ' 154' ' ' PHE . 76.9 mt -130.06 23.03 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -85.95 123.66 31.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.15 39.46 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.478 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 22.6 p -100.09 -37.73 8.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -100.57 164.82 11.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 205' ' ' SER . 28.6 m -135.01 79.7 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.155 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 199' ' ' THR . 15.0 mmt -38.36 138.42 0.73 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.606 0.717 . . . . 0.0 110.853 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.27 145.18 11.74 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.42 -39.19 2.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.532 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -83.83 129.03 34.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.3 m -84.98 -7.51 59.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 199' ' ' THR . 9.8 t -99.3 170.4 8.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.816 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.1 m -99.94 151.97 20.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 139' ' ' GLY . 16.4 tp -53.19 137.82 33.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.62 119.34 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.01 117.52 49.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.073 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -158.05 153.01 25.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.894 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -52.7 139.97 24.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.09 162.18 22.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.123 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -54.16 113.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 82.4 p -101.35 108.17 19.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -122.5 168.61 11.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -106.18 -48.71 3.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -126.69 165.24 19.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.3 t -101.43 146.11 28.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 94.38 69.85 1.09 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.544 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.68 104.14 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.684 2.256 . . . . 0.0 112.314 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.3 t -69.0 84.04 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 59.7 p -49.46 142.7 7.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -105.63 163.65 12.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.1 p -67.77 157.23 35.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.15 134.45 2.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 m -99.87 148.64 24.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 71.3 m -96.77 163.1 13.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.14 -75.43 1.14 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.513 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.3 t -85.24 135.95 33.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.855 0.359 . . . . 0.0 110.864 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -100.56 145.09 28.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.882 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 t -72.12 145.1 48.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -43.03 143.9 0.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -116.66 175.05 15.54 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.27 151.26 38.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.506 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -128.18 130.03 47.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.898 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.18 119.29 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -84.12 44.34 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -119.56 142.29 48.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.732 ' CD2' HD11 ' A' ' 191' ' ' ILE . 43.8 mt -126.75 156.79 40.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -125.77 115.96 20.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 139' ' ' GLY . 84.5 t -100.8 153.93 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.126 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.434 ' N ' HG12 ' A' ' 138' ' ' VAL . . . -144.42 -172.88 15.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.0 mmt 51.11 50.14 19.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HB2' ' C ' ' A' ' 175' ' ' GLY . 34.1 mt -107.71 154.97 20.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -99.43 171.06 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -86.26 28.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.89 -31.44 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.439 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 6.6 mt-30 -79.62 147.02 32.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.2 p -124.62 -176.61 3.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -62.69 -44.29 96.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -57.03 -45.16 83.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -52.33 -58.94 5.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.792 HG13 ' CE1' ' A' ' 154' ' ' PHE . 83.6 t -57.4 -50.49 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.868 HD21 ' CB ' ' A' ' 163' ' ' CYS . 33.9 mt -55.54 -39.49 70.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -70.05 -38.68 75.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.8 tp -84.22 -10.47 57.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.799 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.15 -35.93 9.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.562 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.01 -46.92 54.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.601 0.715 . . . . 0.0 110.936 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.97 -17.13 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -101.66 -44.59 5.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.36 164.72 35.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.18 103.76 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.352 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.799 HD11 ' CB ' ' A' ' 154' ' ' PHE . 44.0 mt -75.25 137.79 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.97 -61.89 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.78 134.9 47.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.868 ' CB ' HD21 ' A' ' 151' ' ' LEU . 36.7 t -134.08 135.12 43.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 80.4 m -147.76 145.3 28.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.109 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.47 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 77.3 t -112.56 148.02 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 40.6 mt -88.8 135.63 33.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.912 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.43 ' C ' ' HG3' ' A' ' 174' ' ' LYS . 64.7 mtm-85 -116.79 143.68 45.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -64.35 -178.31 5.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.541 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -46.08 -46.99 15.28 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.692 2.261 . . . . 0.0 112.322 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 171' ' ' GLY . 26.5 t70 -84.46 38.27 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.799 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 170' ' ' ASP . . . 34.22 61.43 0.53 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.522 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.51 -74.78 0.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.371 . . . . 0.0 110.862 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.8 t -167.79 143.67 3.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.834 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.43 ' HG3' ' C ' ' A' ' 167' ' ' ARG . 19.5 mttm -111.01 -4.38 15.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.421 ' C ' ' HB2' ' A' ' 141' ' ' LEU . . . 82.83 -3.33 83.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.472 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.3 169.0 16.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.835 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -164.67 173.59 11.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -123.94 132.39 53.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 64.1 t -125.61 131.58 71.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -117.45 113.11 21.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -86.26 166.35 15.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 95.6 p -68.47 -35.17 77.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -134.51 164.92 26.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -65.92 -50.97 62.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.91 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.4 m -48.96 -62.39 1.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.179 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -44.38 -42.05 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -59.39 -60.56 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.787 ' HA ' HD12 ' A' ' 191' ' ' ILE . 7.2 mt-30 -45.76 -50.28 14.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -50.28 -55.57 14.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.1 -35.68 59.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.787 HD12 ' HA ' ' A' ' 188' ' ' GLN . 58.3 mt -64.87 -68.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.146 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -57.88 -12.39 3.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -91.08 -39.02 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.704 HD13 ' CE1' ' A' ' 154' ' ' PHE . 28.6 mt -115.2 25.68 10.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.8 t60 -88.72 122.62 32.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.61 33.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.478 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 195' ' ' HIS . 23.5 p -100.22 -38.33 8.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 110.866 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -100.52 162.47 12.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 47.5 m -132.75 84.1 2.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.439 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 14.6 mmt -39.93 137.92 1.12 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.568 0.699 . . . . 0.0 110.881 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -48.83 144.46 15.01 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.659 2.24 . . . . 0.0 112.332 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.34 -40.93 3.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.515 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -83.36 142.42 31.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 111.108 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 73.9 p -94.2 -12.65 27.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.7 m -98.94 157.94 15.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.7 m -78.27 174.94 10.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 196' ' ' GLY . 9.9 tp -73.97 145.6 44.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.926 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 57.3 t -113.46 111.51 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.6 t -122.27 123.6 69.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.093 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -161.81 149.56 14.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -47.25 142.49 3.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.95 94.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.02 43.77 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 214' ' ' THR . 13.3 t -85.22 42.11 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -42.07 149.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -106.4 42.26 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -44.18 136.36 3.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 36.0 t -72.18 164.33 26.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 168.25 74.43 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 42.66 1.15 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.676 2.251 . . . . 0.0 112.325 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 20.5 t -87.81 81.99 7.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.888 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 57.7 p -135.39 147.07 48.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.5 t -132.09 156.1 46.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.367 . . . . 0.0 110.839 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.1 m -146.85 138.87 24.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.819 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.67 73.49 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.471 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.5 m -124.84 86.04 2.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.837 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.2 m -72.52 144.98 47.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.96 -149.69 17.75 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.7 m -121.13 105.29 10.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.862 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -48.63 -46.23 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 77.6 p -119.8 149.62 41.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.857 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -106.55 -51.36 2.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 167.89 60.79 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.532 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -64.85 -88.23 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.473 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 53.6 37.01 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 110.885 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -103.72 146.68 28.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 78.9 mtm-85 -73.26 -31.53 64.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -96.0 140.63 30.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.698 HD21 ' HB1' ' A' ' 187' ' ' ALA . 18.9 mt -121.7 153.86 37.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -116.0 109.99 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.54 139.29 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -133.83 -173.05 13.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.452 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.9 mmt 57.36 43.32 23.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.403 ' CD2' HD11 ' A' ' 207' ' ' LEU . 43.6 mt -102.23 156.89 17.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -96.23 161.32 14.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -81.98 43.12 0.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -134.38 -37.84 0.85 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.492 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 5.9 mt-30 -67.87 151.36 47.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.0 p -129.6 164.27 24.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.831 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.413 ' HG3' HG23 ' A' ' 165' ' ' VAL . 4.7 mp0 -44.33 -48.52 9.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.24 -54.42 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -42.55 -67.79 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.834 HG13 ' CE1' ' A' ' 154' ' ' PHE . 99.7 t -49.63 -61.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.142 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 155' ' ' GLN . 34.2 mt -44.83 -38.25 4.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.887 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -69.45 -40.52 77.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.93 -9.38 58.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.883 ' HB3' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -100.26 -35.81 9.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.564 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 2.2 tt0 -47.13 -46.97 56.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.92 -16.67 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.325 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.453 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.4 m-85 -99.69 -41.95 7.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.22 168.02 37.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.62 134.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.153 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.883 HD11 ' HB3' ' A' ' 154' ' ' PHE . 75.4 mt -109.04 109.08 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.143 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' LYS . 18.5 m-20 -45.3 -61.28 1.73 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.875 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -157.88 148.43 20.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . . . . . . . . . 20.6 t -133.74 135.61 44.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.8 m -139.44 141.9 37.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.413 HG23 ' HG3' ' A' ' 147' ' ' GLU . 98.3 t -104.69 135.06 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.548 HD11 ' HE2' ' A' ' 178' ' ' PHE . 95.9 mt -75.25 144.55 42.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -150.39 148.76 29.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.34 163.55 35.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.472 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.26 -37.02 18.11 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.702 2.268 . . . . 0.0 112.357 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.25 39.03 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 42.88 53.09 5.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.532 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 173' ' ' SER . 22.5 p -121.59 90.01 3.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.902 0.382 . . . . 0.0 110.881 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 172' ' ' SER . 27.4 t -35.03 133.09 0.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.83 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.5 mttm -87.71 23.32 2.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.875 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 50.48 33.65 25.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 29.7 m -150.03 169.05 22.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 110.856 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -165.69 179.24 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.548 ' HE2' HD11 ' A' ' 166' ' ' LEU . 91.5 m-85 -133.98 118.7 18.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 97.9 t -110.85 118.91 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 161' ' ' ASP . 13.4 ttmm -105.02 117.91 35.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.944 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -93.29 154.14 18.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 m -57.4 -41.04 79.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -134.38 136.01 43.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 187' ' ' ALA . 7.6 p-80 -38.57 -56.32 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.425 ' H ' ' CD2' ' A' ' 184' ' ' HIS . 94.3 m -37.53 -67.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -41.03 -43.62 2.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.698 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -62.0 -53.95 48.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.623 ' HA ' HD12 ' A' ' 191' ' ' ILE . 0.1 OUTLIER -45.21 -46.93 12.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -60.94 -65.74 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -39.4 -38.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.661 HD11 HD22 ' A' ' 136' ' ' LEU . 62.3 mt -61.63 -71.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.146 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -57.09 -13.14 2.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.453 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -90.94 -32.33 16.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.125 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.684 HD13 ' CE1' ' A' ' 154' ' ' PHE . 40.8 mt -122.43 20.64 10.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.6 t60 -86.53 123.96 32.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 41.52 28.36 0.36 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 82.9 p -100.53 -38.67 8.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.862 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.689 ' NE2' HD22 ' A' ' 207' ' ' LEU . 9.7 pt20 -100.58 146.0 27.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 205' ' ' SER . 86.9 m -123.91 80.25 1.79 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.147 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.492 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 14.1 mmt -34.58 138.1 0.34 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.558 0.694 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.63 151.58 7.43 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.733 2.289 . . . . 0.0 112.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.69 -43.9 2.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -78.84 136.33 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 111.097 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 70.1 m -86.49 -13.0 47.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 199' ' ' THR . 23.1 m -100.08 161.24 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 35.3 p -85.27 -178.41 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.689 HD22 ' NE2' ' A' ' 198' ' ' GLN . 11.9 tp -82.71 123.49 29.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.4 t -92.24 106.04 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 14.6 t -113.27 117.43 55.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.16 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -157.46 150.6 23.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -54.68 152.61 6.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -94.24 -40.72 9.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -115.38 119.29 35.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 40.3 p -98.01 111.32 23.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -133.2 139.88 47.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -160.95 170.06 21.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -58.24 116.27 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 57.7 m -66.62 -51.55 55.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.823 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 129.21 93.26 0.71 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.45 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 116.65 4.25 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.3 t -48.3 102.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.2 t -103.62 99.43 9.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.446 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.2 t -171.25 153.52 3.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 110.915 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.1 m -91.89 144.66 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.27 70.32 0.27 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.514 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.9 m -81.66 113.94 20.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 110.838 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.7 p -154.27 149.89 27.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.784 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.3 137.39 5.77 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.4 p -78.39 126.55 30.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.819 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -83.0 -56.27 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.857 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.9 m -62.78 108.89 1.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -107.77 133.84 51.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 158.76 156.11 7.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.14 120.2 2.35 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -103.12 82.64 2.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -112.88 126.68 55.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.837 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -109.23 33.82 4.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.819 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -96.84 137.12 36.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 1.015 HD21 ' HB1' ' A' ' 187' ' ' ALA . 58.1 mt -115.92 153.3 31.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -123.36 114.04 19.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.2 t -101.18 143.75 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -139.77 -173.85 13.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.6 mmt 57.8 37.46 27.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.804 0.335 . . . . 0.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.446 ' CD2' ' OE1' ' A' ' 145' ' ' GLN . 24.3 mt -95.37 155.1 16.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -108.84 173.99 6.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.66 12.51 2.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -99.96 -22.61 15.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.451 ' CD ' ' SD ' ' A' ' 200' ' ' MET . 34.4 mt-30 -97.57 149.36 22.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 p -130.77 178.16 6.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.42 ' HG3' HG23 ' A' ' 165' ' ' VAL . 13.7 mt-10 -56.94 -49.24 76.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -52.23 -59.47 4.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -39.65 -67.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.773 HG13 ' CE1' ' A' ' 154' ' ' PHE . 84.1 t -45.16 -60.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.907 HD21 ' HB2' ' A' ' 163' ' ' CYS . 33.9 mt -47.98 -40.31 22.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -69.57 -39.53 77.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.426 HD21 HE22 ' A' ' 198' ' ' GLN . 13.5 tp -84.19 -10.04 58.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.845 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -99.94 -36.2 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -47.11 -47.01 55.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.592 0.71 . . . . 0.0 110.919 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.2 Cg_exo -48.01 -17.13 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.695 2.263 . . . . 0.0 112.332 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.447 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 74.2 m-85 -101.32 -48.15 4.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -156.3 160.43 30.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.44 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.88 93.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.117 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.845 HD11 ' CB ' ' A' ' 154' ' ' PHE . 63.5 mt -62.87 138.6 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -95.13 -62.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.28 132.92 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.907 ' HB2' HD21 ' A' ' 151' ' ' LEU . 42.7 t -134.02 136.17 43.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 50.7 m -152.69 139.52 18.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 53.5 t -104.06 144.84 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 53.1 mt -84.61 145.05 28.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.921 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -141.31 178.49 7.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -103.82 -153.43 23.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.26 -46.86 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.692 2.261 . . . . 0.0 112.361 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -101.1 63.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 38.08 45.71 1.72 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.4 m -108.55 98.88 8.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.842 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.7 t -46.44 138.84 5.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.863 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -94.68 -0.62 54.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.74 10.79 86.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.35 148.13 50.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.835 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -153.37 166.15 33.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.126 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -120.83 136.06 55.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.928 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 81.2 t -130.51 124.31 56.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -107.9 129.65 55.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.429 ' CE1' HD12 ' A' ' 136' ' ' LEU . 28.4 m-85 -103.59 167.71 9.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.3 t -64.97 -32.31 73.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.3 t -143.19 175.94 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.569 ' CG ' ' N ' ' A' ' 185' ' ' THR . 4.4 p-80 -72.13 -49.63 34.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.569 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 89.4 m -43.79 -61.54 1.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -40.94 -51.31 3.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 1.015 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -56.6 -57.63 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.065 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -39.65 -47.24 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 190' ' ' ALA . . . -61.95 -67.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 189' ' ' ALA . . . -36.53 -42.93 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.126 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.507 HD11 HD22 ' A' ' 136' ' ' LEU . 77.7 mt -57.36 -74.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -57.05 -13.3 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.447 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -86.86 -35.79 18.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 21.5 mt -126.51 26.41 6.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 197' ' ' SER . 1.8 t60 -86.41 121.41 28.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 207' ' ' LEU . . . 33.86 32.99 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.51 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.38 -38.77 8.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.343 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.426 HE22 HD21 ' A' ' 153' ' ' LEU . 33.2 mt-30 -100.62 160.1 14.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 205' ' ' SER . 19.3 m -130.83 87.59 2.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.451 ' SD ' ' CD ' ' A' ' 145' ' ' GLN . 16.8 mmt -39.62 154.86 0.17 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.87 122.73 9.65 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 2.273 . . . . 0.0 112.305 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 111.97 -43.91 1.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -82.94 153.05 25.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 84.5 p -98.63 -12.8 20.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 199' ' ' THR . 64.8 m -100.14 164.96 11.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.852 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 67.5 m -87.49 161.28 17.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.834 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 196' ' ' GLY . 14.9 tp -57.09 141.65 45.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.457 ' CG1' ' HE3' ' A' ' 210' ' ' LYS . 55.8 t -110.28 107.12 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.1 t -118.24 114.52 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.457 ' HE3' ' CG1' ' A' ' 208' ' ' VAL . 17.6 ptpt -148.3 155.4 41.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -55.98 150.46 13.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -75.85 135.81 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -38.02 154.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 74.1 p -135.4 150.36 49.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.55 133.56 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -106.82 138.16 43.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -118.77 -43.31 2.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 24.8 p -62.29 -16.47 54.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 69.45 154.38 0.88 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.468 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.25 141.01 20.13 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.679 2.253 . . . . 0.0 112.361 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 86.4 p -68.09 90.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 50.7 m -76.65 172.77 12.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.533 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.441 -0.263 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 m -71.97 112.58 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.902 0.382 . . . . 0.0 110.865 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.2 t -148.83 141.09 24.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.82 69.01 1.08 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.514 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.1 t -85.02 41.36 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.0 t -128.08 156.28 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -173.18 -77.9 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 88.0 p -112.93 54.74 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.882 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -91.09 49.38 1.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.6 p -99.59 103.73 15.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.857 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -132.5 149.55 52.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.14 50.58 0.99 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.457 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 123.83 -130.52 7.67 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.465 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -149.51 171.07 17.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.848 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -164.78 129.34 2.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.829 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 74.3 mtm-85 -125.13 37.11 4.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -128.29 144.3 51.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 1.019 HD21 ' HB1' ' A' ' 187' ' ' ALA . 21.0 mt -125.06 144.93 50.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -112.64 114.76 27.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -103.85 146.33 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.133 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -142.34 -173.53 14.32 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.417 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.3 mmt 55.81 42.35 29.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.4 mt -103.35 154.87 18.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -98.12 165.82 11.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -82.48 39.93 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -128.53 -38.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -69.49 151.29 46.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.1 p -128.55 176.67 7.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.843 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -55.41 -44.62 76.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.861 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.83 -49.18 74.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.12 -69.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.748 HG13 ' CE1' ' A' ' 154' ' ' PHE . 74.6 t -49.96 -59.75 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.866 HD21 ' CB ' ' A' ' 163' ' ' CYS . 25.4 mt -47.34 -38.34 12.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -69.62 -40.13 76.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.1 tp -84.49 -8.96 58.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.748 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -100.18 -37.24 9.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.2 tm0? -47.2 -46.89 56.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.645 0.736 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 64.3 Cg_exo -47.97 -17.28 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.242 . . . . 0.0 112.361 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.706 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 73.3 m-85 -99.88 -33.4 10.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -175.97 164.02 33.84 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.441 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 94.5 t -76.47 103.41 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 154' ' ' PHE . 85.6 mt -72.37 133.99 30.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -81.51 -62.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -141.89 139.79 32.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.866 ' CB ' HD21 ' A' ' 151' ' ' LEU . 45.0 t -134.04 141.11 47.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 76.6 m -146.7 139.44 25.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 87.3 t -105.6 136.63 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.569 HD12 ' SG ' ' A' ' 176' ' ' CYS . 49.9 mt -72.03 138.13 47.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -151.98 140.99 21.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -68.74 159.62 52.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.62 -35.67 13.09 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.661 2.241 . . . . 0.0 112.319 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -72.85 -38.97 66.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 121.03 40.1 0.57 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.446 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 t -116.75 112.28 20.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.839 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 t -55.91 131.13 46.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -90.63 26.26 2.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.873 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 55.94 38.94 77.01 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.482 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.569 ' SG ' HD12 ' A' ' 166' ' ' LEU . 22.7 p -156.17 149.76 24.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.805 0.336 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -159.47 166.77 30.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.087 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.5 136.05 54.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.482 HG22 ' SG ' ' A' ' 163' ' ' CYS . 10.5 t -127.18 125.25 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.615 ' O ' HG23 ' A' ' 160' ' ' ILE . 30.9 tttm -105.72 130.72 53.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.405 ' CE1' HD12 ' A' ' 136' ' ' LEU . 22.8 m-85 -106.29 158.83 16.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.7 t -53.21 -43.6 67.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.6 m -128.26 173.53 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.492 ' H ' ' CD2' ' A' ' 184' ' ' HIS . 7.7 p80 -71.8 -49.97 33.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 15.5 m -47.67 -63.62 1.01 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -40.25 -39.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 1.019 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -63.22 -65.76 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.424 ' C ' ' CD ' ' A' ' 188' ' ' GLN . 0.0 OUTLIER -43.39 -36.82 2.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -61.95 -61.87 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.44 -34.68 4.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.509 HD11 HD22 ' A' ' 136' ' ' LEU . 45.1 mt -60.04 -71.83 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -55.59 -18.73 8.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.843 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.706 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -79.05 -37.4 39.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.46 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 12.2 mt -126.51 28.26 5.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 191' ' ' ILE . 1.5 t60 -84.81 120.98 27.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 33.04 34.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.452 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 195' ' ' HIS . 59.8 p -100.3 -38.84 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.844 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -100.6 152.23 20.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 200' ' ' MET . 15.7 m -122.31 86.28 2.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 199' ' ' THR . 13.2 mmt -37.11 155.25 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 110.855 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.41 128.11 15.87 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.695 2.263 . . . . 0.0 112.372 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 103.51 -39.46 2.79 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.96 154.71 21.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.067 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.7 t -99.98 -14.96 18.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.1 m -100.12 161.54 13.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 66.9 m -88.64 158.27 18.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 139' ' ' GLY . 14.3 tp -52.45 141.75 19.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 52.4 t -110.08 108.64 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.15 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.492 HG12 HG12 ' A' ' 191' ' ' ILE . 4.7 t -118.6 124.45 73.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -158.85 148.59 19.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.461 ' CZ ' HD12 ' A' ' 191' ' ' ILE . 68.4 m-85 -55.51 150.41 12.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -84.47 154.4 22.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.096 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -42.23 119.84 1.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.1 p -75.98 -34.82 59.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -173.56 176.91 2.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -83.2 -55.22 4.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -129.75 99.37 5.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 61.5 m -46.99 -56.16 6.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -118.86 146.2 18.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.522 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.67 -0.93 11.11 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.639 2.226 . . . . 0.0 112.35 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 75.1 p -52.5 170.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.7 m -86.39 -49.31 7.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.808 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.451 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.0 t -73.59 171.75 12.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.908 0.385 . . . . 0.0 110.838 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -98.59 144.53 27.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.27 49.78 0.76 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.8 m -78.13 94.97 4.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 110.863 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 46.4 t -39.84 152.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -66.48 -178.61 9.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.462 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.9 t 55.68 44.89 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.788 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 128' ' ' SER . 11.9 pt-20 -92.12 -42.7 9.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.451 ' N ' ' HG3' ' A' ' 127' ' ' GLU . 35.7 t -107.0 140.24 40.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 41.53 38.44 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.89 -44.53 37.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 138.6 -162.02 25.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.7 ttm105 -133.19 118.25 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 0.0 110.873 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -149.86 128.31 12.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -95.16 32.71 1.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -125.85 157.5 37.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.788 ' CD2' HD11 ' A' ' 191' ' ' ILE . 88.7 mt -140.1 150.66 44.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -117.2 117.61 30.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.11 147.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.49 ' O ' HD12 ' A' ' 207' ' ' LEU . . . -139.41 -170.5 11.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.52 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.4 mmt 51.68 51.19 17.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.778 0.323 . . . . 0.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.462 HD22 ' OE1' ' A' ' 145' ' ' GLN . 43.5 mt -111.13 155.75 22.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -97.61 165.07 12.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -82.37 40.69 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -129.16 -40.05 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.462 ' OE1' HD22 ' A' ' 141' ' ' LEU . 62.9 mt-30 -69.43 144.65 53.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.3 p -122.91 171.27 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.566 ' HG3' HG23 ' A' ' 165' ' ' VAL . 12.9 mp0 -48.43 -48.71 37.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.45 ' OE1' ' C ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -51.74 -51.41 56.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -46.6 -67.35 0.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.601 HG13 ' CE1' ' A' ' 154' ' ' PHE . 31.7 t -49.27 -62.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.813 HD21 ' CB ' ' A' ' 163' ' ' CYS . 25.0 mt -46.49 -38.35 9.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -69.51 -40.1 77.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.76 -10.2 58.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.825 ' CB ' HD11 ' A' ' 160' ' ' ILE . 3.2 m-85 -99.84 -35.73 9.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -47.1 -47.07 55.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.59 0.71 . . . . 0.0 110.897 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -47.99 -17.27 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.666 2.244 . . . . 0.0 112.365 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.492 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 74.1 m-85 -101.26 -47.16 4.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -159.97 166.14 34.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.503 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 96.5 t -80.6 101.8 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 0.0 111.14 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.825 HD11 ' CB ' ' A' ' 154' ' ' PHE . 38.5 mt -73.07 131.37 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.69 -64.17 1.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -130.77 140.98 50.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.813 ' CB ' HD21 ' A' ' 151' ' ' LEU . 12.3 t -134.13 131.61 38.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.4 m -136.43 138.19 41.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.566 HG23 ' HG3' ' A' ' 147' ' ' GLU . 92.3 t -108.45 135.36 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 176' ' ' CYS . 78.9 mt -67.88 147.11 52.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -158.02 148.02 20.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.66 168.06 41.32 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.468 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.16 -38.23 19.27 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.696 2.264 . . . . 0.0 112.335 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -101.74 41.82 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 48.85 58.1 8.0 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 41.3 t -115.06 88.61 2.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.876 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.9 t -41.97 121.4 1.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -79.79 9.61 5.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 67.68 20.61 72.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.501 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.673 ' HB2' HD12 ' A' ' 166' ' ' LEU . 21.3 m -143.49 164.43 30.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.792 0.33 . . . . 0.0 110.883 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -164.02 170.92 15.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.05 121.9 36.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 94.3 t -114.22 131.51 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.704 ' O ' HG23 ' A' ' 160' ' ' ILE . 24.9 ttpt -110.71 129.57 55.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.891 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -102.47 165.23 11.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.7 p -67.32 -39.14 85.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.0 p -132.52 146.09 51.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.42 ' CG ' ' N ' ' A' ' 185' ' ' THR . 6.8 p80 -50.44 -50.41 52.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.42 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 85.9 m -48.66 -53.34 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -45.75 -50.42 13.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -59.89 -48.51 81.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.126 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.596 ' HA ' HD12 ' A' ' 191' ' ' ILE . 0.9 OUTLIER -46.71 -43.41 17.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.41 -59.2 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.106 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.01 -36.81 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.788 HD11 ' CD2' ' A' ' 136' ' ' LEU . 63.3 mt -61.37 -73.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.1 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -57.41 -12.05 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.492 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -85.09 -40.09 17.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 17.3 mt -120.92 19.41 11.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.4 t60 -80.08 124.97 29.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 34.21 32.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.495 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 195' ' ' HIS . 58.8 p -100.38 -39.31 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.83 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -100.53 160.47 14.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 205' ' ' SER . 19.6 m -135.02 86.62 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 199' ' ' THR . 13.8 mmt -36.1 154.56 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.584 0.706 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.45 129.32 17.71 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.64 2.227 . . . . 0.0 112.359 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 101.66 -38.62 3.08 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.482 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -85.48 146.91 26.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.31 . . . . 0.0 111.081 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.8 t -93.39 -12.38 30.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 199' ' ' THR . 69.3 m -100.16 158.77 15.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.828 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 70.1 m -85.3 169.32 13.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.826 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 139' ' ' GLY . 19.5 tp -65.87 128.12 34.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.944 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.1 113.86 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 17.9 t -123.19 124.08 69.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -162.3 148.61 13.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -48.04 141.22 6.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -63.14 164.88 7.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.03 103.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 40.5 p -89.26 109.21 20.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.96 174.62 5.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -144.01 142.16 30.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -113.5 -52.6 2.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 48.8 m -90.42 165.65 13.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -123.17 95.59 0.53 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.79 156.03 43.94 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.708 2.272 . . . . 0.0 112.368 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.0 t -159.9 134.17 7.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 60.4 p -146.91 134.73 21.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.471 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.7 m -138.99 128.38 24.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 110.828 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.1 p -124.53 160.25 28.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 136.7 -151.04 20.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.468 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 83.5 p -72.28 117.31 13.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.881 0.372 . . . . 0.0 110.857 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.8 t -122.74 124.14 42.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.818 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 41.15 92.24 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.507 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.5 m -71.77 101.34 2.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -78.2 82.51 4.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.2 t 57.16 45.52 20.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -94.69 95.31 8.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.466 ' O ' HG21 ' A' ' 214' ' ' THR . . . -169.16 126.52 1.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.48 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.47 132.08 7.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.506 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.425 ' HB2' ' NH1' ' A' ' 132' ' ' ARG . 18.9 mtm105 -97.31 95.69 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.96 150.76 46.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -107.26 11.07 29.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -100.06 139.11 36.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.964 HD21 ' HB1' ' A' ' 187' ' ' ALA . 36.0 mt -121.81 155.0 36.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' CE1' ' HB3' ' A' ' 176' ' ' CYS . 44.7 t80 -124.42 112.79 17.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.52 152.66 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -146.16 174.93 25.89 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.4 mmt 57.48 46.01 18.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.336 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.507 ' CD2' HD11 ' A' ' 207' ' ' LEU . 60.2 mt -100.07 147.32 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 201' ' ' PRO . 36.4 t30 -90.12 164.82 14.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.46 ' HA ' ' CB ' ' A' ' 173' ' ' SER . 19.1 pttt -66.98 -3.66 7.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.427 HE21 ' ND2' ' A' ' 142' ' ' ASN . 6.2 pt20 -109.31 43.71 1.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.496 ' NE2' ' SD ' ' A' ' 200' ' ' MET . 74.1 mt-30 -135.21 109.24 8.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 p -104.08 170.74 7.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -52.86 -41.93 64.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.5 -47.32 86.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -48.03 -63.99 0.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.839 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.858 HG13 ' CE1' ' A' ' 154' ' ' PHE . 94.9 t -58.49 -60.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.662 HD23 HD13 ' A' ' 160' ' ' ILE . 29.6 mt -44.4 -38.68 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -68.82 -41.11 79.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.461 HD21 HE22 ' A' ' 198' ' ' GLN . 13.5 tp -84.0 -9.78 58.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.858 ' CE1' HG13 ' A' ' 150' ' ' VAL . 3.1 m-85 -99.14 -35.88 9.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.56 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.0 OUTLIER -47.18 -46.91 56.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 0.0 110.914 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 155' ' ' GLN . 65.6 Cg_exo -48.03 -16.75 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.652 2.235 . . . . 0.0 112.315 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.406 ' CZ ' ' HB1' ' A' ' 193' ' ' ALA . 72.4 m-85 -99.87 -42.1 6.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.73 171.16 42.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -80.48 102.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.848 HD11 ' CB ' ' A' ' 154' ' ' PHE . 38.3 mt -72.13 151.34 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -103.13 -57.15 2.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.479 ' CG ' ' HB3' ' A' ' 180' ' ' LYS . 9.7 pt-20 -138.69 137.89 37.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' CYS . . . . . 0.66 ' CB ' HD21 ' A' ' 151' ' ' LEU . 1.7 t -133.72 102.14 5.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.3 m -107.51 119.64 39.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.163 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.467 ' HA ' ' CB ' ' A' ' 177' ' ' ALA . 50.3 t -99.91 131.87 46.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.131 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.3 140.57 52.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -145.48 177.06 9.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.869 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -110.19 -161.43 18.42 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.31 -51.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.649 2.233 . . . . 0.0 112.355 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.79 -37.16 78.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 118.85 36.54 0.88 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 173' ' ' SER . 38.1 p -115.55 117.99 31.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.893 0.378 . . . . 0.0 110.874 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.46 ' CB ' ' HA ' ' A' ' 143' ' ' LYS . 8.2 t -35.05 141.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.84 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -81.25 -18.56 45.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.45 -16.3 44.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.46 ' HB3' ' CE1' ' A' ' 137' ' ' PHE . 1.7 m -125.99 160.14 30.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 110.87 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . . . -158.73 175.98 12.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.146 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -136.04 126.27 26.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.18 130.0 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.479 ' HB3' ' CG ' ' A' ' 162' ' ' GLU . 27.0 tttt -106.25 130.35 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.41 ' HE1' HD12 ' A' ' 136' ' ' LEU . 33.6 m-85 -104.0 160.63 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.4 t -72.43 -19.85 61.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.863 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.2 m -142.15 164.94 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.451 ' CG ' ' N ' ' A' ' 185' ' ' THR . 4.4 p-80 -75.39 -41.75 55.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.806 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.451 ' N ' ' CG ' ' A' ' 184' ' ' HIS . 44.7 m -54.64 -59.76 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -41.12 -47.73 3.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.964 ' HB1' HD21 ' A' ' 136' ' ' LEU . . . -60.79 -62.05 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.093 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 187' ' ' ALA . 1.8 mm-40 -35.44 -44.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.85 -63.89 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.054 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -41.36 -28.86 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.074 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.556 HD11 HD22 ' A' ' 136' ' ' LEU . 36.2 mt -70.71 -72.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.143 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -59.85 -17.14 34.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.406 ' HB1' ' CZ ' ' A' ' 157' ' ' PHE . . . -84.74 -25.8 28.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.129 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.418 HD13 ' CE1' ' A' ' 154' ' ' PHE . 25.5 mt -132.59 24.95 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 197' ' ' SER . 2.3 t60 -89.69 121.45 31.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.842 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 195' ' ' HIS . . . 35.1 30.96 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 195' ' ' HIS . 60.6 p -100.25 -39.48 8.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.778 0.323 . . . . 0.0 110.83 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.829 ' OE1' HD22 ' A' ' 207' ' ' LEU . 4.9 pt20 -100.66 163.98 12.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 205' ' ' SER . 29.3 m -134.82 81.3 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.496 ' SD ' ' NE2' ' A' ' 145' ' ' GLN . 13.9 mmt -37.03 156.01 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.698 . . . . 0.0 110.882 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.473 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 54.1 Cg_endo -68.0 136.48 38.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.395 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 97.12 -35.95 4.17 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -89.36 150.85 22.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.5 t -100.08 -12.48 19.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.867 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.593 ' O ' HG23 ' A' ' 199' ' ' THR . 7.1 t -100.08 170.07 8.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -94.27 148.94 21.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.808 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.829 HD22 ' OE1' ' A' ' 198' ' ' GLN . 10.7 tp -45.68 151.4 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.97 104.29 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 191' ' ' ILE . 6.6 t -115.94 116.41 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -155.35 148.36 24.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -49.08 140.82 8.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 213' ' ' ASP . . . -70.0 177.5 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.064 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 212' ' ' ALA . 4.5 p-10 -36.81 117.34 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 130' ' ' GLY . 32.8 m -117.91 115.15 24.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -125.94 103.5 7.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -127.56 114.41 17.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -89.12 96.86 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 69.3 p -68.69 -60.8 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -120.98 100.15 0.74 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -44.1 120.6 2.56 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.728 2.285 . . . . 0.0 112.337 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.3 t -39.95 121.89 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.835 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 18.7 m -71.56 -49.63 38.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.475 179.999 . . . . . . . . 0 0 . 1 stop_ save_